#begin document (1851382); part 000
1851382	0	1	SirT1	NN	-	-	-	-	-	-	-	(1)
1851382	0	2	modulates	VBZ	-	-	-	-	-	-	-	-
1851382	0	3	the	DT	-	-	-	-	-	-	-	(2
1851382	0	4	estrogen	NN	-	-	-	-	-	-	-	(3
1851382	0	5	–	HYPH	-	-	-	-	-	-	-	-
1851382	0	6	insulin	NN	-	-	-	-	-	-	-	-
1851382	0	7	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	8	like	JJ	-	-	-	-	-	-	-	-
1851382	0	9	growth	NN	-	-	-	-	-	-	-	-
1851382	0	10	factor	NN	-	-	-	-	-	-	-	-
1851382	0	11	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	12	1	CD	-	-	-	-	-	-	-	3)
1851382	0	13	signaling	NN	-	-	-	-	-	-	-	-
1851382	0	14	for	IN	-	-	-	-	-	-	-	-
1851382	0	15	postnatal	JJ	-	-	-	-	-	-	-	(4
1851382	0	16	development	NN	-	-	-	-	-	-	-	-
1851382	0	17	of	IN	-	-	-	-	-	-	-	-
1851382	0	18	mammary	JJ	-	-	-	-	-	-	-	(5
1851382	0	19	gland	NN	-	-	-	-	-	-	-	-
1851382	0	20	in	IN	-	-	-	-	-	-	-	-
1851382	0	21	mice	NNS	-	-	-	-	-	-	-	(6)|5)|4)|2)

1851382	0	1	Abstract	NN	-	-	-	-	-	-	-	-

1851382	0	1	Introduction	NN	-	-	-	-	-	-	-	-

1851382	0	1	Estrogen	NN	-	-	-	-	-	-	-	(3|(7)
1851382	0	2	and	CC	-	-	-	-	-	-	-	-
1851382	0	3	insulin	NN	-	-	-	-	-	-	-	(8
1851382	0	4	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	5	like	JJ	-	-	-	-	-	-	-	-
1851382	0	6	growth	NN	-	-	-	-	-	-	-	-
1851382	0	7	factor	NN	-	-	-	-	-	-	-	-
1851382	0	8	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	9	1	CD	-	-	-	-	-	-	-	8)|3)
1851382	0	10	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	11	IGF	NN	-	-	-	-	-	-	-	-
1851382	0	12	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	13	1	CD	-	-	-	-	-	-	-	-
1851382	0	14	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	15	play	VBP	-	-	-	-	-	-	-	-
1851382	0	16	important	JJ	-	-	-	-	-	-	-	-
1851382	0	17	roles	NNS	-	-	-	-	-	-	-	-
1851382	0	18	in	IN	-	-	-	-	-	-	-	-
1851382	0	19	mammary	JJ	-	-	-	-	-	-	-	(10|(9
1851382	0	20	gland	NN	-	-	-	-	-	-	-	9)
1851382	0	21	development	NN	-	-	-	-	-	-	-	10)
1851382	0	22	and	CC	-	-	-	-	-	-	-	-
1851382	0	23	breast	NN	-	-	-	-	-	-	-	(11
1851382	0	24	cancer	NN	-	-	-	-	-	-	-	11)
1851382	0	25	.	.	-	-	-	-	-	-	-	-

1851382	0	1	SirT1	NN	-	-	-	-	-	-	-	(1)
1851382	0	2	is	VBZ	-	-	-	-	-	-	-	-
1851382	0	3	a	DT	-	-	-	-	-	-	-	-
1851382	0	4	highly	RB	-	-	-	-	-	-	-	-
1851382	0	5	conserved	VBN	-	-	-	-	-	-	-	-
1851382	0	6	protein	NN	-	-	-	-	-	-	-	-
1851382	0	7	deacetylase	NN	-	-	-	-	-	-	-	-
1851382	0	8	that	WDT	-	-	-	-	-	-	-	-
1851382	0	9	can	MD	-	-	-	-	-	-	-	-
1851382	0	10	regulate	VB	-	-	-	-	-	-	-	-
1851382	0	11	the	DT	-	-	-	-	-	-	-	-
1851382	0	12	insulin	NN	-	-	-	-	-	-	-	(12)
1851382	0	13	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	14	IGF	NN	-	-	-	-	-	-	-	(8
1851382	0	15	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	16	1	CD	-	-	-	-	-	-	-	8)
1851382	0	17	signaling	NN	-	-	-	-	-	-	-	-
1851382	0	18	in	IN	-	-	-	-	-	-	-	-
1851382	0	19	lower	JJR	-	-	-	-	-	-	-	(13
1851382	0	20	organisms	NNS	-	-	-	-	-	-	-	13)
1851382	0	21	,	,	-	-	-	-	-	-	-	-
1851382	0	22	as	RB	-	-	-	-	-	-	-	-
1851382	0	23	well	RB	-	-	-	-	-	-	-	-
1851382	0	24	as	IN	-	-	-	-	-	-	-	-
1851382	0	25	a	DT	-	-	-	-	-	-	-	-
1851382	0	26	growing	VBG	-	-	-	-	-	-	-	-
1851382	0	27	number	NN	-	-	-	-	-	-	-	-
1851382	0	28	of	IN	-	-	-	-	-	-	-	-
1851382	0	29	transcription	NN	-	-	-	-	-	-	-	(15|(14)
1851382	0	30	factors	NNS	-	-	-	-	-	-	-	-
1851382	0	31	,	,	-	-	-	-	-	-	-	-
1851382	0	32	including	VBG	-	-	-	-	-	-	-	-
1851382	0	33	NF	NN	-	-	-	-	-	-	-	(16
1851382	0	34	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	35	κB	NN	-	-	-	-	-	-	-	16)
1851382	0	36	,	,	-	-	-	-	-	-	-	-
1851382	0	37	in	IN	-	-	-	-	-	-	-	-
1851382	0	38	mammalian	JJ	-	-	-	-	-	-	-	(17
1851382	0	39	cells	NNS	-	-	-	-	-	-	-	17)|15)
1851382	0	40	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Whether	IN	-	-	-	-	-	-	-	-
1851382	0	2	SirT1	NN	-	-	-	-	-	-	-	(18|(1)
1851382	0	3	regulates	VBZ	-	-	-	-	-	-	-	-
1851382	0	4	the	DT	-	-	-	-	-	-	-	(19
1851382	0	5	IGF	NN	-	-	-	-	-	-	-	(8
1851382	0	6	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	7	1	CD	-	-	-	-	-	-	-	8)
1851382	0	8	signaling	NN	-	-	-	-	-	-	-	19)
1851382	0	9	for	IN	-	-	-	-	-	-	-	-
1851382	0	10	mammary	JJ	-	-	-	-	-	-	-	(10|(20a|(9
1851382	0	11	gland	NN	-	-	-	-	-	-	-	9)|20a)
1851382	0	12	development	NN	-	-	-	-	-	-	-	10)
1851382	0	13	and	CC	-	-	-	-	-	-	-	-
1851382	0	14	function	NN	-	-	-	-	-	-	-	(20a)|18)
1851382	0	15	,	,	-	-	-	-	-	-	-	-
1851382	0	16	however	RB	-	-	-	-	-	-	-	-
1851382	0	17	,	,	-	-	-	-	-	-	-	-
1851382	0	18	is	VBZ	-	-	-	-	-	-	-	-
1851382	0	19	not	RB	-	-	-	-	-	-	-	-
1851382	0	20	clear	JJ	-	-	-	-	-	-	-	-
1851382	0	21	.	.	-	-	-	-	-	-	-	-

1851382	0	1	In	IN	-	-	-	-	-	-	-	-
1851382	0	2	the	DT	-	-	-	-	-	-	-	(21
1851382	0	3	present	JJ	-	-	-	-	-	-	-	-
1851382	0	4	study	NN	-	-	-	-	-	-	-	21)
1851382	0	5	,	,	-	-	-	-	-	-	-	-
1851382	0	6	this	DT	-	-	-	-	-	-	-	(18
1851382	0	7	role	NN	-	-	-	-	-	-	-	-
1851382	0	8	of	IN	-	-	-	-	-	-	-	-
1851382	0	9	SirT1	NN	-	-	-	-	-	-	-	(1)|18)
1851382	0	10	was	VBD	-	-	-	-	-	-	-	-
1851382	0	11	examined	VBN	-	-	-	-	-	-	-	-
1851382	0	12	by	IN	-	-	-	-	-	-	-	-
1851382	0	13	studying	VBG	-	-	-	-	-	-	-	-
1851382	0	14	SirT1	NN	-	-	-	-	-	-	-	(22
1851382	0	15	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	16	deficient	JJ	-	-	-	-	-	-	-	-
1851382	0	17	mice	NNS	-	-	-	-	-	-	-	22)
1851382	0	18	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Methods	NNS	-	-	-	-	-	-	-	(23)

1851382	0	1	SirT1	NN	-	-	-	-	-	-	-	(22|(24|(24a
1851382	0	2	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	3	deficient	JJ	-	-	-	-	-	-	-	24a)|24)
1851382	0	4	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	5	SirT1ko	NN	-	-	-	-	-	-	-	-
1851382	0	6	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	7	ko	NN	-	-	-	-	-	-	-	-
1851382	0	8	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	9	mice	NNS	-	-	-	-	-	-	-	(24a)|22)
1851382	0	10	were	VBD	-	-	-	-	-	-	-	-
1851382	0	11	generated	VBN	-	-	-	-	-	-	-	-
1851382	0	12	by	IN	-	-	-	-	-	-	-	-
1851382	0	13	crossing	VBG	-	-	-	-	-	-	-	-
1851382	0	14	a	DT	-	-	-	-	-	-	-	-
1851382	0	15	new	JJ	-	-	-	-	-	-	-	-
1851382	0	16	strain	NN	-	-	-	-	-	-	-	-
1851382	0	17	of	IN	-	-	-	-	-	-	-	-
1851382	0	18	mice	NNS	-	-	-	-	-	-	-	(25
1851382	0	19	harboring	VBG	-	-	-	-	-	-	-	-
1851382	0	20	a	DT	-	-	-	-	-	-	-	-
1851382	0	21	conditional	JJ	-	-	-	-	-	-	-	-
1851382	0	22	targeted	VBN	-	-	-	-	-	-	-	-
1851382	0	23	mutation	NN	-	-	-	-	-	-	-	-
1851382	0	24	in	IN	-	-	-	-	-	-	-	-
1851382	0	25	the	DT	-	-	-	-	-	-	-	(1
1851382	0	26	SirT1	NN	-	-	-	-	-	-	-	-
1851382	0	27	gene	NN	-	-	-	-	-	-	-	1)
1851382	0	28	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	29	SirT1co	NN	-	-	-	-	-	-	-	(26
1851382	0	30	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	31	co	NN	-	-	-	-	-	-	-	26)
1851382	0	32	)	-RRB-	-	-	-	-	-	-	-	25)
1851382	0	33	with	IN	-	-	-	-	-	-	-	-
1851382	0	34	CMV	NN	-	-	-	-	-	-	-	(27|(28
1851382	0	35	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	36	Cre	NN	-	-	-	-	-	-	-	27)
1851382	0	37	transgenic	JJ	-	-	-	-	-	-	-	-
1851382	0	38	mice	NNS	-	-	-	-	-	-	-	28)
1851382	0	39	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Whole	JJ	-	-	-	-	-	-	-	(29|(30b
1851382	0	2	mount	NN	-	-	-	-	-	-	-	30b)
1851382	0	3	and	CC	-	-	-	-	-	-	-	-
1851382	0	4	histology	NN	-	-	-	-	-	-	-	(31
1851382	0	5	analyses	NNS	-	-	-	-	-	-	-	(30b)|31)|29)
1851382	0	6	,	,	-	-	-	-	-	-	-	-
1851382	0	7	immunofluorescence	NN	-	-	-	-	-	-	-	-
1851382	0	8	staining	NN	-	-	-	-	-	-	-	-
1851382	0	9	,	,	-	-	-	-	-	-	-	-
1851382	0	10	immunohistochemistry	NN	-	-	-	-	-	-	-	-
1851382	0	11	,	,	-	-	-	-	-	-	-	-
1851382	0	12	and	CC	-	-	-	-	-	-	-	-
1851382	0	13	western	NNP	-	-	-	-	-	-	-	-
1851382	0	14	blotting	NN	-	-	-	-	-	-	-	-
1851382	0	15	were	VBD	-	-	-	-	-	-	-	-
1851382	0	16	used	VBN	-	-	-	-	-	-	-	-
1851382	0	17	to	TO	-	-	-	-	-	-	-	-
1851382	0	18	characterize	VB	-	-	-	-	-	-	-	-
1851382	0	19	mammary	JJ	-	-	-	-	-	-	-	(9
1851382	0	20	gland	NN	-	-	-	-	-	-	-	9)
1851382	0	21	development	NN	-	-	-	-	-	-	-	-
1851382	0	22	in	IN	-	-	-	-	-	-	-	-
1851382	0	23	virgin	JJ	-	-	-	-	-	-	-	(32a)
1851382	0	24	and	CC	-	-	-	-	-	-	-	-
1851382	0	25	pregnant	JJ	-	-	-	-	-	-	-	(33
1851382	0	26	mice	NNS	-	-	-	-	-	-	-	(32a)|33)
1851382	0	27	.	.	-	-	-	-	-	-	-	-

1851382	0	1	The	DT	-	-	-	-	-	-	-	(34
1851382	0	2	effect	NN	-	-	-	-	-	-	-	-
1851382	0	3	of	IN	-	-	-	-	-	-	-	-
1851382	0	4	exogenous	JJ	-	-	-	-	-	-	-	(7
1851382	0	5	estrogen	NN	-	-	-	-	-	-	-	7)|34)
1851382	0	6	was	VBD	-	-	-	-	-	-	-	-
1851382	0	7	also	RB	-	-	-	-	-	-	-	-
1851382	0	8	examined	VBN	-	-	-	-	-	-	-	-
1851382	0	9	by	IN	-	-	-	-	-	-	-	-
1851382	0	10	subcutaneous	JJ	-	-	-	-	-	-	-	-
1851382	0	11	implantation	NN	-	-	-	-	-	-	-	-
1851382	0	12	of	IN	-	-	-	-	-	-	-	-
1851382	0	13	a	DT	-	-	-	-	-	-	-	(35
1851382	0	14	slow	RB	-	-	-	-	-	-	-	-
1851382	0	15	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	16	releasing	VBG	-	-	-	-	-	-	-	-
1851382	0	17	pellet	NN	-	-	-	-	-	-	-	-
1851382	0	18	in	IN	-	-	-	-	-	-	-	-
1851382	0	19	the	DT	-	-	-	-	-	-	-	(36
1851382	0	20	subscapular	JJ	-	-	-	-	-	-	-	-
1851382	0	21	region	NN	-	-	-	-	-	-	-	36)|35)
1851382	0	22	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Results	NNS	-	-	-	-	-	-	-	(37)

1851382	0	1	Both	CC	-	-	-	-	-	-	-	(38
1851382	0	2	male	JJ	-	-	-	-	-	-	-	(39a)
1851382	0	3	and	CC	-	-	-	-	-	-	-	-
1851382	0	4	female	JJ	-	-	-	-	-	-	-	(40
1851382	0	5	SirT1ko	NN	-	-	-	-	-	-	-	(39a
1851382	0	6	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	7	ko	NN	-	-	-	-	-	-	-	-
1851382	0	8	mice	NNS	-	-	-	-	-	-	-	40)|39a)|38)
1851382	0	9	can	MD	-	-	-	-	-	-	-	-
1851382	0	10	be	VB	-	-	-	-	-	-	-	-
1851382	0	11	fertile	JJ	-	-	-	-	-	-	-	-
1851382	0	12	despite	IN	-	-	-	-	-	-	-	-
1851382	0	13	the	DT	-	-	-	-	-	-	-	(41
1851382	0	14	growth	NN	-	-	-	-	-	-	-	(42
1851382	0	15	retardation	NN	-	-	-	-	-	-	-	42)
1851382	0	16	phenotype	NN	-	-	-	-	-	-	-	41)
1851382	0	17	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Virgin	JJ	-	-	-	-	-	-	-	(32
1851382	0	2	SirT1ko	NN	-	-	-	-	-	-	-	-
1851382	0	3	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	4	ko	NN	-	-	-	-	-	-	-	-
1851382	0	5	mice	NNS	-	-	-	-	-	-	-	32)
1851382	0	6	displayed	VBD	-	-	-	-	-	-	-	-
1851382	0	7	impeded	VBN	-	-	-	-	-	-	-	(43
1851382	0	8	ductal	JJ	-	-	-	-	-	-	-	-
1851382	0	9	morphogenesis	NN	-	-	-	-	-	-	-	43)
1851382	0	10	,	,	-	-	-	-	-	-	-	-
1851382	0	11	whereas	IN	-	-	-	-	-	-	-	-
1851382	0	12	pregnant	JJ	-	-	-	-	-	-	-	(33
1851382	0	13	SirT1ko	NN	-	-	-	-	-	-	-	-
1851382	0	14	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	15	ko	NN	-	-	-	-	-	-	-	-
1851382	0	16	mice	NNS	-	-	-	-	-	-	-	33)
1851382	0	17	manifested	VBD	-	-	-	-	-	-	-	-
1851382	0	18	lactation	NN	-	-	-	-	-	-	-	(45|(44)
1851382	0	19	failure	NN	-	-	-	-	-	-	-	45)
1851382	0	20	due	IN	-	-	-	-	-	-	-	-
1851382	0	21	to	IN	-	-	-	-	-	-	-	-
1851382	0	22	an	DT	-	-	-	-	-	-	-	-
1851382	0	23	underdeveloped	JJ	-	-	-	-	-	-	-	-
1851382	0	24	lobuloalveolar	JJ	-	-	-	-	-	-	-	-
1851382	0	25	network	NN	-	-	-	-	-	-	-	-
1851382	0	26	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Estrogen	NN	-	-	-	-	-	-	-	(46|(7)
1851382	0	2	implantation	NN	-	-	-	-	-	-	-	46)
1851382	0	3	was	VBD	-	-	-	-	-	-	-	-
1851382	0	4	sufficient	JJ	-	-	-	-	-	-	-	-
1851382	0	5	to	TO	-	-	-	-	-	-	-	-
1851382	0	6	rescue	VB	-	-	-	-	-	-	-	-
1851382	0	7	ductal	JJ	-	-	-	-	-	-	-	(43
1851382	0	8	morphogenesis	NN	-	-	-	-	-	-	-	43)
1851382	0	9	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Exogenous	JJ	-	-	-	-	-	-	-	(7
1851382	0	2	estrogen	NN	-	-	-	-	-	-	-	7)
1851382	0	3	reversed	VBD	-	-	-	-	-	-	-	-
1851382	0	4	the	DT	-	-	-	-	-	-	-	-
1851382	0	5	increased	VBN	-	-	-	-	-	-	-	-
1851382	0	6	basal	JJ	-	-	-	-	-	-	-	-
1851382	0	7	level	NN	-	-	-	-	-	-	-	-
1851382	0	8	of	IN	-	-	-	-	-	-	-	-
1851382	0	9	IGF	NN	-	-	-	-	-	-	-	(47|(48|(8
1851382	0	10	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	11	1	CD	-	-	-	-	-	-	-	8)
1851382	0	12	binding	NN	-	-	-	-	-	-	-	-
1851382	0	13	protein	NN	-	-	-	-	-	-	-	-
1851382	0	14	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	15	1	CD	-	-	-	-	-	-	-	47)
1851382	0	16	expression	NN	-	-	-	-	-	-	-	-
1851382	0	17	in	IN	-	-	-	-	-	-	-	-
1851382	0	18	SirT1ko	NN	-	-	-	-	-	-	-	(24|(49
1851382	0	19	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	20	ko	NN	-	-	-	-	-	-	-	24)
1851382	0	21	mammary	JJ	-	-	-	-	-	-	-	-
1851382	0	22	tissues	NNS	-	-	-	-	-	-	-	49)|48)
1851382	0	23	,	,	-	-	-	-	-	-	-	-
1851382	0	24	but	CC	-	-	-	-	-	-	-	-
1851382	0	25	not	RB	-	-	-	-	-	-	-	-
1851382	0	26	that	DT	-	-	-	-	-	-	-	-
1851382	0	27	of	IN	-	-	-	-	-	-	-	-
1851382	0	28	IκBα	NN	-	-	-	-	-	-	-	(51|(50)
1851382	0	29	expression	NN	-	-	-	-	-	-	-	51)
1851382	0	30	,	,	-	-	-	-	-	-	-	-
1851382	0	31	suggesting	VBG	-	-	-	-	-	-	-	-
1851382	0	32	that	IN	-	-	-	-	-	-	-	-
1851382	0	33	increased	VBN	-	-	-	-	-	-	-	(52
1851382	0	34	levels	NNS	-	-	-	-	-	-	-	-
1851382	0	35	of	IN	-	-	-	-	-	-	-	-
1851382	0	36	estrogen	NN	-	-	-	-	-	-	-	(7)|52)
1851382	0	37	enhanced	VBD	-	-	-	-	-	-	-	-
1851382	0	38	the	DT	-	-	-	-	-	-	-	(53
1851382	0	39	production	NN	-	-	-	-	-	-	-	-
1851382	0	40	of	IN	-	-	-	-	-	-	-	-
1851382	0	41	local	JJ	-	-	-	-	-	-	-	(54
1851382	0	42	IGF	NN	-	-	-	-	-	-	-	-
1851382	0	43	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	44	1	CD	-	-	-	-	-	-	-	54)|53)
1851382	0	45	and	CC	-	-	-	-	-	-	-	-
1851382	0	46	rescued	VBD	-	-	-	-	-	-	-	-
1851382	0	47	ductal	JJ	-	-	-	-	-	-	-	(43
1851382	0	48	morphogenesis	NN	-	-	-	-	-	-	-	43)
1851382	0	49	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Additionally	RB	-	-	-	-	-	-	-	-
1851382	0	2	,	,	-	-	-	-	-	-	-	-
1851382	0	3	TNFα	NN	-	-	-	-	-	-	-	(55)
1851382	0	4	treatment	NN	-	-	-	-	-	-	-	-
1851382	0	5	enhanced	VBD	-	-	-	-	-	-	-	-
1851382	0	6	the	DT	-	-	-	-	-	-	-	-
1851382	0	7	level	NN	-	-	-	-	-	-	-	-
1851382	0	8	of	IN	-	-	-	-	-	-	-	-
1851382	0	9	the	DT	-	-	-	-	-	-	-	(56
1851382	0	10	newly	RB	-	-	-	-	-	-	-	-
1851382	0	11	synthesized	VBN	-	-	-	-	-	-	-	-
1851382	0	12	IκBα	NN	-	-	-	-	-	-	-	-
1851382	0	13	in	IN	-	-	-	-	-	-	-	-
1851382	0	14	SirT1ko	NN	-	-	-	-	-	-	-	(24|(57
1851382	0	15	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	16	ko	NN	-	-	-	-	-	-	-	24)
1851382	0	17	cells	NNS	-	-	-	-	-	-	-	57)|56)
1851382	0	18	.	.	-	-	-	-	-	-	-	-

1851382	0	1	SirT1	NN	-	-	-	-	-	-	-	(58|(1)
1851382	0	2	deficiency	NN	-	-	-	-	-	-	-	58)
1851382	0	3	therefore	RB	-	-	-	-	-	-	-	-
1851382	0	4	affects	VBZ	-	-	-	-	-	-	-	-
1851382	0	5	the	DT	-	-	-	-	-	-	-	-
1851382	0	6	cellular	JJ	-	-	-	-	-	-	-	-
1851382	0	7	response	NN	-	-	-	-	-	-	-	-
1851382	0	8	to	IN	-	-	-	-	-	-	-	-
1851382	0	9	multiple	JJ	-	-	-	-	-	-	-	-
1851382	0	10	extrinsic	JJ	-	-	-	-	-	-	-	-
1851382	0	11	signals	NNS	-	-	-	-	-	-	-	-
1851382	0	12	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Conclusion	NN	-	-	-	-	-	-	-	(59)

1851382	0	1	SirT1	NN	-	-	-	-	-	-	-	(1)
1851382	0	2	modulates	VBZ	-	-	-	-	-	-	-	-
1851382	0	3	the	DT	-	-	-	-	-	-	-	-
1851382	0	4	IGF	NN	-	-	-	-	-	-	-	(8
1851382	0	5	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	6	1	CD	-	-	-	-	-	-	-	8)
1851382	0	7	signaling	NN	-	-	-	-	-	-	-	-
1851382	0	8	critical	JJ	-	-	-	-	-	-	-	-
1851382	0	9	for	IN	-	-	-	-	-	-	-	-
1851382	0	10	both	CC	-	-	-	-	-	-	-	-
1851382	0	11	growth	NN	-	-	-	-	-	-	-	-
1851382	0	12	regulation	NN	-	-	-	-	-	-	-	-
1851382	0	13	and	CC	-	-	-	-	-	-	-	-
1851382	0	14	mammary	JJ	-	-	-	-	-	-	-	(9
1851382	0	15	gland	NN	-	-	-	-	-	-	-	9)
1851382	0	16	development	NN	-	-	-	-	-	-	-	-
1851382	0	17	in	IN	-	-	-	-	-	-	-	-
1851382	0	18	mice	NNS	-	-	-	-	-	-	-	(6)
1851382	0	19	.	.	-	-	-	-	-	-	-	-

1851382	0	1	SirT1	NN	-	-	-	-	-	-	-	(58|(60|(1)
1851382	0	2	deficiency	NN	-	-	-	-	-	-	-	58)
1851382	0	3	deregulates	VBZ	-	-	-	-	-	-	-	-
1851382	0	4	the	DT	-	-	-	-	-	-	-	(48
1851382	0	5	expression	NN	-	-	-	-	-	-	-	-
1851382	0	6	of	IN	-	-	-	-	-	-	-	-
1851382	0	7	IGF	NN	-	-	-	-	-	-	-	(47|(8
1851382	0	8	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	9	1	CD	-	-	-	-	-	-	-	8)
1851382	0	10	binding	VBG	-	-	-	-	-	-	-	-
1851382	0	11	protein	NN	-	-	-	-	-	-	-	-
1851382	0	12	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	13	1	CD	-	-	-	-	-	-	-	48)|47)
1851382	0	14	and	CC	-	-	-	-	-	-	-	-
1851382	0	15	attenuates	VBZ	-	-	-	-	-	-	-	-
1851382	0	16	the	DT	-	-	-	-	-	-	-	-
1851382	0	17	effect	NN	-	-	-	-	-	-	-	-
1851382	0	18	of	IN	-	-	-	-	-	-	-	-
1851382	0	19	IGF	NN	-	-	-	-	-	-	-	(8
1851382	0	20	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	21	1	CD	-	-	-	-	-	-	-	8)
1851382	0	22	signals	NNS	-	-	-	-	-	-	-	-
1851382	0	23	,	,	-	-	-	-	-	-	-	-
1851382	0	24	including	VBG	-	-	-	-	-	-	-	-
1851382	0	25	estrogen	NN	-	-	-	-	-	-	-	(54|(61
1851382	0	26	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	27	stimulated	VBN	-	-	-	-	-	-	-	-
1851382	0	28	local	JJ	-	-	-	-	-	-	-	-
1851382	0	29	IGF	NN	-	-	-	-	-	-	-	-
1851382	0	30	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	31	1	CD	-	-	-	-	-	-	-	54)
1851382	0	32	signaling	NN	-	-	-	-	-	-	-	-
1851382	0	33	for	IN	-	-	-	-	-	-	-	-
1851382	0	34	the	DT	-	-	-	-	-	-	-	-
1851382	0	35	onset	NN	-	-	-	-	-	-	-	-
1851382	0	36	of	IN	-	-	-	-	-	-	-	-
1851382	0	37	ductal	JJ	-	-	-	-	-	-	-	(62
1851382	0	38	morphogenesis	NN	-	-	-	-	-	-	-	62)|61)|60)
1851382	0	39	.	.	-	-	-	-	-	-	-	-

1851382	0	1	These	DT	-	-	-	-	-	-	-	(60
1851382	0	2	findings	NNS	-	-	-	-	-	-	-	60)
1851382	0	3	suggest	VBP	-	-	-	-	-	-	-	-
1851382	0	4	that	IN	-	-	-	-	-	-	-	-
1851382	0	5	the	DT	-	-	-	-	-	-	-	(63
1851382	0	6	enzymatic	JJ	-	-	-	-	-	-	-	-
1851382	0	7	activity	NN	-	-	-	-	-	-	-	-
1851382	0	8	of	IN	-	-	-	-	-	-	-	-
1851382	0	9	SirT1	NN	-	-	-	-	-	-	-	(1)|63)
1851382	0	10	may	MD	-	-	-	-	-	-	-	-
1851382	0	11	influence	VB	-	-	-	-	-	-	-	-
1851382	0	12	both	CC	-	-	-	-	-	-	-	-
1851382	0	13	normal	JJ	-	-	-	-	-	-	-	-
1851382	0	14	growth	NN	-	-	-	-	-	-	-	-
1851382	0	15	and	CC	-	-	-	-	-	-	-	-
1851382	0	16	malignant	JJ	-	-	-	-	-	-	-	-
1851382	0	17	growth	NN	-	-	-	-	-	-	-	-
1851382	0	18	of	IN	-	-	-	-	-	-	-	-
1851382	0	19	mammary	JJ	-	-	-	-	-	-	-	(64
1851382	0	20	epithelial	JJ	-	-	-	-	-	-	-	-
1851382	0	21	cells	NNS	-	-	-	-	-	-	-	64)
1851382	0	22	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Introduction	NN	-	-	-	-	-	-	-	-

1851382	0	1	Mammalian	JJ	-	-	-	-	-	-	-	(65
1851382	0	2	SirT1	NN	-	-	-	-	-	-	-	65)
1851382	0	3	belongs	VBZ	-	-	-	-	-	-	-	-
1851382	0	4	to	IN	-	-	-	-	-	-	-	-
1851382	0	5	a	DT	-	-	-	-	-	-	-	-
1851382	0	6	family	NN	-	-	-	-	-	-	-	-
1851382	0	7	of	IN	-	-	-	-	-	-	-	-
1851382	0	8	nicotinamide	NN	-	-	-	-	-	-	-	-
1851382	0	9	adenine	NN	-	-	-	-	-	-	-	-
1851382	0	10	dinucleotide	NN	-	-	-	-	-	-	-	-
1851382	0	11	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	12	dependent	JJ	-	-	-	-	-	-	-	-
1851382	0	13	histone	NN	-	-	-	-	-	-	-	-
1851382	0	14	deacetylases	NNS	-	-	-	-	-	-	-	-
1851382	0	15	[	-LRB-	-	-	-	-	-	-	-	-
1851382	0	16	1	CD	-	-	-	-	-	-	-	-
1851382	0	17	,	,	-	-	-	-	-	-	-	-
1851382	0	18	2	CD	-	-	-	-	-	-	-	-
1851382	0	19	]	-RRB-	-	-	-	-	-	-	-	-
1851382	0	20	.	.	-	-	-	-	-	-	-	-

1851382	0	1	SirT1	NN	-	-	-	-	-	-	-	(1)
1851382	0	2	is	VBZ	-	-	-	-	-	-	-	-
1851382	0	3	most	RBS	-	-	-	-	-	-	-	-
1851382	0	4	closely	RB	-	-	-	-	-	-	-	-
1851382	0	5	related	JJ	-	-	-	-	-	-	-	-
1851382	0	6	to	IN	-	-	-	-	-	-	-	-
1851382	0	7	yeast	NN	-	-	-	-	-	-	-	(66
1851382	0	8	Sir2	NN	-	-	-	-	-	-	-	66)
1851382	0	9	,	,	-	-	-	-	-	-	-	-
1851382	0	10	the	DT	-	-	-	-	-	-	-	-
1851382	0	11	founding	JJ	-	-	-	-	-	-	-	-
1851382	0	12	member	NN	-	-	-	-	-	-	-	-
1851382	0	13	of	IN	-	-	-	-	-	-	-	-
1851382	0	14	the	DT	-	-	-	-	-	-	-	-
1851382	0	15	evolutionarily	RB	-	-	-	-	-	-	-	-
1851382	0	16	conserved	VBN	-	-	-	-	-	-	-	-
1851382	0	17	Sir2	NN	-	-	-	-	-	-	-	-
1851382	0	18	family	NN	-	-	-	-	-	-	-	-
1851382	0	19	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Yeast	NN	-	-	-	-	-	-	-	(66
1851382	0	2	Sir2	NN	-	-	-	-	-	-	-	66)
1851382	0	3	is	VBZ	-	-	-	-	-	-	-	-
1851382	0	4	required	JJ	-	-	-	-	-	-	-	-
1851382	0	5	for	IN	-	-	-	-	-	-	-	-
1851382	0	6	silencing	VBG	-	-	-	-	-	-	-	-
1851382	0	7	transcription	NN	-	-	-	-	-	-	-	-
1851382	0	8	at	IN	-	-	-	-	-	-	-	-
1851382	0	9	the	DT	-	-	-	-	-	-	-	-
1851382	0	10	telomeric	JJ	-	-	-	-	-	-	-	-
1851382	0	11	region	NN	-	-	-	-	-	-	-	-
1851382	0	12	and	CC	-	-	-	-	-	-	-	-
1851382	0	13	mating	NN	-	-	-	-	-	-	-	-
1851382	0	14	type	NN	-	-	-	-	-	-	-	-
1851382	0	15	loci	NNS	-	-	-	-	-	-	-	-
1851382	0	16	,	,	-	-	-	-	-	-	-	-
1851382	0	17	and	CC	-	-	-	-	-	-	-	-
1851382	0	18	for	IN	-	-	-	-	-	-	-	-
1851382	0	19	suppression	NN	-	-	-	-	-	-	-	-
1851382	0	20	of	IN	-	-	-	-	-	-	-	-
1851382	0	21	ribosomal	JJ	-	-	-	-	-	-	-	-
1851382	0	22	DNA	NN	-	-	-	-	-	-	-	-
1851382	0	23	recombination	NN	-	-	-	-	-	-	-	-
1851382	0	24	[	-LRB-	-	-	-	-	-	-	-	-
1851382	0	25	3	CD	-	-	-	-	-	-	-	-
1851382	0	26	,	,	-	-	-	-	-	-	-	-
1851382	0	27	4	CD	-	-	-	-	-	-	-	-
1851382	0	28	]	-RRB-	-	-	-	-	-	-	-	-
1851382	0	29	.	.	-	-	-	-	-	-	-	-

1851382	0	1	The	DT	-	-	-	-	-	-	-	-
1851382	0	2	expression	NN	-	-	-	-	-	-	-	-
1851382	0	3	of	IN	-	-	-	-	-	-	-	-
1851382	0	4	an	DT	-	-	-	-	-	-	-	-
1851382	0	5	extra	JJ	-	-	-	-	-	-	-	-
1851382	0	6	copy	NN	-	-	-	-	-	-	-	-
1851382	0	7	of	IN	-	-	-	-	-	-	-	-
1851382	0	8	Sir2	NN	-	-	-	-	-	-	-	-
1851382	0	9	in	IN	-	-	-	-	-	-	-	-
1851382	0	10	either	CC	-	-	-	-	-	-	-	-
1851382	0	11	yeast	NN	-	-	-	-	-	-	-	-
1851382	0	12	mother	NN	-	-	-	-	-	-	-	-
1851382	0	13	cells	NNS	-	-	-	-	-	-	-	-
1851382	0	14	or	CC	-	-	-	-	-	-	-	-
1851382	0	15	multicell	JJ	-	-	-	-	-	-	-	-
1851382	0	16	organisms	NNS	-	-	-	-	-	-	-	-
1851382	0	17	such	JJ	-	-	-	-	-	-	-	-
1851382	0	18	as	IN	-	-	-	-	-	-	-	-
1851382	0	19	nematodes	NNS	-	-	-	-	-	-	-	-
1851382	0	20	can	MD	-	-	-	-	-	-	-	-
1851382	0	21	significantly	RB	-	-	-	-	-	-	-	-
1851382	0	22	extend	VB	-	-	-	-	-	-	-	-
1851382	0	23	the	DT	-	-	-	-	-	-	-	(67
1851382	0	24	lifespan	NN	-	-	-	-	-	-	-	67)
1851382	0	25	[	-LRB-	-	-	-	-	-	-	-	-
1851382	0	26	5	CD	-	-	-	-	-	-	-	-
1851382	0	27	,	,	-	-	-	-	-	-	-	-
1851382	0	28	6	CD	-	-	-	-	-	-	-	-
1851382	0	29	]	-RRB-	-	-	-	-	-	-	-	-
1851382	0	30	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Inactivation	NN	-	-	-	-	-	-	-	-
1851382	0	2	of	IN	-	-	-	-	-	-	-	-
1851382	0	3	Sir2	NN	-	-	-	-	-	-	-	(68)
1851382	0	4	enhances	VBZ	-	-	-	-	-	-	-	-
1851382	0	5	stress	NN	-	-	-	-	-	-	-	(69)
1851382	0	6	resistance	NN	-	-	-	-	-	-	-	-
1851382	0	7	and	CC	-	-	-	-	-	-	-	-
1851382	0	8	extends	VBZ	-	-	-	-	-	-	-	-
1851382	0	9	chronological	JJ	-	-	-	-	-	-	-	-
1851382	0	10	lifespan	NN	-	-	-	-	-	-	-	-
1851382	0	11	of	IN	-	-	-	-	-	-	-	-
1851382	0	12	nondividing	JJ	-	-	-	-	-	-	-	-
1851382	0	13	yeast	NN	-	-	-	-	-	-	-	-
1851382	0	14	cells	NNS	-	-	-	-	-	-	-	-
1851382	0	15	,	,	-	-	-	-	-	-	-	-
1851382	0	16	which	WDT	-	-	-	-	-	-	-	-
1851382	0	17	is	VBZ	-	-	-	-	-	-	-	-
1851382	0	18	opposite	JJ	-	-	-	-	-	-	-	-
1851382	0	19	to	IN	-	-	-	-	-	-	-	-
1851382	0	20	the	DT	-	-	-	-	-	-	-	-
1851382	0	21	requirement	NN	-	-	-	-	-	-	-	-
1851382	0	22	for	IN	-	-	-	-	-	-	-	-
1851382	0	23	Sir2	NN	-	-	-	-	-	-	-	(68)
1851382	0	24	function	NN	-	-	-	-	-	-	-	-
1851382	0	25	in	IN	-	-	-	-	-	-	-	-
1851382	0	26	the	DT	-	-	-	-	-	-	-	(70
1851382	0	27	reproductive	JJ	-	-	-	-	-	-	-	-
1851382	0	28	lifespan	NN	-	-	-	-	-	-	-	70)
1851382	0	29	[	-LRB-	-	-	-	-	-	-	-	-
1851382	0	30	7	CD	-	-	-	-	-	-	-	-
1851382	0	31	]	-RRB-	-	-	-	-	-	-	-	-
1851382	0	32	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Whether	IN	-	-	-	-	-	-	-	-
1851382	0	2	SirT1	NN	-	-	-	-	-	-	-	(1)
1851382	0	3	regulates	VBZ	-	-	-	-	-	-	-	-
1851382	0	4	the	DT	-	-	-	-	-	-	-	(70a
1851382	0	5	reproductive	JJ	-	-	-	-	-	-	-	-
1851382	0	6	lifespan	NN	-	-	-	-	-	-	-	70a)
1851382	0	7	and	CC	-	-	-	-	-	-	-	-
1851382	0	8	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	9	or	CC	-	-	-	-	-	-	-	-
1851382	0	10	the	DT	-	-	-	-	-	-	-	(67
1851382	0	11	chronological	JJ	-	-	-	-	-	-	-	-
1851382	0	12	lifespan	NN	-	-	-	-	-	-	-	-
1851382	0	13	in	IN	-	-	-	-	-	-	-	(70a
1851382	0	14	mammals	NNS	-	-	-	-	-	-	-	(71)|70a)|67)
1851382	0	15	remains	VBZ	-	-	-	-	-	-	-	-
1851382	0	16	unknown	JJ	-	-	-	-	-	-	-	-
1851382	0	17	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Sir2	NN	-	-	-	-	-	-	-	(68)
1851382	0	2	is	VBZ	-	-	-	-	-	-	-	-
1851382	0	3	an	DT	-	-	-	-	-	-	-	-
1851382	0	4	integral	JJ	-	-	-	-	-	-	-	-
1851382	0	5	part	NN	-	-	-	-	-	-	-	-
1851382	0	6	of	IN	-	-	-	-	-	-	-	-
1851382	0	7	an	DT	-	-	-	-	-	-	-	(72
1851382	0	8	evolutionarily	RB	-	-	-	-	-	-	-	-
1851382	0	9	conserved	VBN	-	-	-	-	-	-	-	-
1851382	0	10	insulin	NN	-	-	-	-	-	-	-	(8|(12)
1851382	0	11	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	12	insulin	NN	-	-	-	-	-	-	-	-
1851382	0	13	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	14	like	JJ	-	-	-	-	-	-	-	-
1851382	0	15	growth	NN	-	-	-	-	-	-	-	-
1851382	0	16	factor	NN	-	-	-	-	-	-	-	-
1851382	0	17	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	18	1	CD	-	-	-	-	-	-	-	8)
1851382	0	19	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	20	IGF	NN	-	-	-	-	-	-	-	-
1851382	0	21	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	22	1	CD	-	-	-	-	-	-	-	-
1851382	0	23	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	24	signaling	NN	-	-	-	-	-	-	-	-
1851382	0	25	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	26	IIS	NN	-	-	-	-	-	-	-	(73)
1851382	0	27	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	28	system	NN	-	-	-	-	-	-	-	-
1851382	0	29	in	IN	-	-	-	-	-	-	-	-
1851382	0	30	worms	NNS	-	-	-	-	-	-	-	(74)
1851382	0	31	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	32	Caenorhabditis	NNP	-	-	-	-	-	-	-	(75
1851382	0	33	elegans	NNP	-	-	-	-	-	-	-	75)
1851382	0	34	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	35	,	,	-	-	-	-	-	-	-	-
1851382	0	36	fruit	NN	-	-	-	-	-	-	-	-
1851382	0	37	flies	NNS	-	-	-	-	-	-	-	-
1851382	0	38	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	39	Drosophila	NNP	-	-	-	-	-	-	-	-
1851382	0	40	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	41	,	,	-	-	-	-	-	-	-	-
1851382	0	42	mice	NNS	-	-	-	-	-	-	-	(76|(6)
1851382	0	43	,	,	-	-	-	-	-	-	-	-
1851382	0	44	and	CC	-	-	-	-	-	-	-	-
1851382	0	45	humans	NNS	-	-	-	-	-	-	-	(77)|76)|72)
1851382	0	46	[	-LRB-	-	-	-	-	-	-	-	-
1851382	0	47	8	CD	-	-	-	-	-	-	-	-
1851382	0	48	,	,	-	-	-	-	-	-	-	-
1851382	0	49	9	CD	-	-	-	-	-	-	-	-
1851382	0	50	]	-RRB-	-	-	-	-	-	-	-	-
1851382	0	51	.	.	-	-	-	-	-	-	-	-

1851382	0	1	The	DT	-	-	-	-	-	-	-	(72
1851382	0	2	IIS	NN	-	-	-	-	-	-	-	(73)
1851382	0	3	system	NN	-	-	-	-	-	-	-	72)
1851382	0	4	includes	VBZ	-	-	-	-	-	-	-	-
1851382	0	5	membrane	NN	-	-	-	-	-	-	-	(78
1851382	0	6	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	7	bound	VBN	-	-	-	-	-	-	-	-
1851382	0	8	receptors	NNS	-	-	-	-	-	-	-	-
1851382	0	9	,	,	-	-	-	-	-	-	-	-
1851382	0	10	cytoplasmic	JJ	-	-	-	-	-	-	-	-
1851382	0	11	kinases	NNS	-	-	-	-	-	-	-	-
1851382	0	12	,	,	-	-	-	-	-	-	-	-
1851382	0	13	and	CC	-	-	-	-	-	-	-	-
1851382	0	14	nuclear	JJ	-	-	-	-	-	-	-	-
1851382	0	15	transcription	NN	-	-	-	-	-	-	-	-
1851382	0	16	factors	NNS	-	-	-	-	-	-	-	78)
1851382	0	17	.	.	-	-	-	-	-	-	-	-

1851382	0	1	To	TO	-	-	-	-	-	-	-	-
1851382	0	2	maintain	VB	-	-	-	-	-	-	-	-
1851382	0	3	the	DT	-	-	-	-	-	-	-	-
1851382	0	4	proper	JJ	-	-	-	-	-	-	-	-
1851382	0	5	expression	NN	-	-	-	-	-	-	-	-
1851382	0	6	of	IN	-	-	-	-	-	-	-	-
1851382	0	7	the	DT	-	-	-	-	-	-	-	(79
1851382	0	8	effector	NN	-	-	-	-	-	-	-	-
1851382	0	9	genes	NNS	-	-	-	-	-	-	-	-
1851382	0	10	for	IN	-	-	-	-	-	-	-	-
1851382	0	11	the	DT	-	-	-	-	-	-	-	(72
1851382	0	12	IIS	NN	-	-	-	-	-	-	-	(73)
1851382	0	13	system	NN	-	-	-	-	-	-	-	79)|72)
1851382	0	14	,	,	-	-	-	-	-	-	-	-
1851382	0	15	these	DT	-	-	-	-	-	-	-	(78
1851382	0	16	conserved	VBN	-	-	-	-	-	-	-	-
1851382	0	17	components	NNS	-	-	-	-	-	-	-	78)
1851382	0	18	form	VBP	-	-	-	-	-	-	-	-
1851382	0	19	a	DT	-	-	-	-	-	-	-	-
1851382	0	20	sophisticated	JJ	-	-	-	-	-	-	-	-
1851382	0	21	regulatory	JJ	-	-	-	-	-	-	-	-
1851382	0	22	system	NN	-	-	-	-	-	-	-	-
1851382	0	23	,	,	-	-	-	-	-	-	-	-
1851382	0	24	which	WDT	-	-	-	-	-	-	-	-
1851382	0	25	centers	VBZ	-	-	-	-	-	-	-	-
1851382	0	26	on	IN	-	-	-	-	-	-	-	-
1851382	0	27	a	DT	-	-	-	-	-	-	-	-
1851382	0	28	family	NN	-	-	-	-	-	-	-	-
1851382	0	29	of	IN	-	-	-	-	-	-	-	-
1851382	0	30	forkhead	NN	-	-	-	-	-	-	-	-
1851382	0	31	transcription	NN	-	-	-	-	-	-	-	-
1851382	0	32	factors	NNS	-	-	-	-	-	-	-	-
1851382	0	33	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	34	forkhead	NN	-	-	-	-	-	-	-	(80
1851382	0	35	box	NN	-	-	-	-	-	-	-	-
1851382	0	36	'	``	-	-	-	-	-	-	-	-
1851382	0	37	other	JJ	-	-	-	-	-	-	-	-
1851382	0	38	'	''	-	-	-	-	-	-	-	-
1851382	0	39	proteins	NN	-	-	-	-	-	-	-	80)
1851382	0	40	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	41	FoxOs	NNS	-	-	-	-	-	-	-	-
1851382	0	42	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	43	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	44	,	,	-	-	-	-	-	-	-	-
1851382	0	45	and	CC	-	-	-	-	-	-	-	-
1851382	0	46	operates	VBZ	-	-	-	-	-	-	-	-
1851382	0	47	on	IN	-	-	-	-	-	-	-	-
1851382	0	48	two	CD	-	-	-	-	-	-	-	-
1851382	0	49	levels	NNS	-	-	-	-	-	-	-	-
1851382	0	50	.	.	-	-	-	-	-	-	-	-

1851382	0	1	On	IN	-	-	-	-	-	-	-	-
1851382	0	2	one	CD	-	-	-	-	-	-	-	-
1851382	0	3	level	NN	-	-	-	-	-	-	-	-
1851382	0	4	,	,	-	-	-	-	-	-	-	-
1851382	0	5	SirT1	NN	-	-	-	-	-	-	-	-
1851382	0	6	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	7	mediated	VBN	-	-	-	-	-	-	-	-
1851382	0	8	protein	NN	-	-	-	-	-	-	-	-
1851382	0	9	deacetylation	NN	-	-	-	-	-	-	-	-
1851382	0	10	attenuates	VBZ	-	-	-	-	-	-	-	-
1851382	0	11	the	DT	-	-	-	-	-	-	-	(81
1851382	0	12	transcriptional	JJ	-	-	-	-	-	-	-	-
1851382	0	13	activity	NN	-	-	-	-	-	-	-	-
1851382	0	14	of	IN	-	-	-	-	-	-	-	-
1851382	0	15	nuclear	JJ	-	-	-	-	-	-	-	(82
1851382	0	16	FoxO	NN	-	-	-	-	-	-	-	-
1851382	0	17	transcription	NN	-	-	-	-	-	-	-	-
1851382	0	18	factors	NNS	-	-	-	-	-	-	-	82)|81)
1851382	0	19	[	-LRB-	-	-	-	-	-	-	-	-
1851382	0	20	10	CD	-	-	-	-	-	-	-	-
1851382	0	21	-	SYM	-	-	-	-	-	-	-	-
1851382	0	22	12	CD	-	-	-	-	-	-	-	-
1851382	0	23	]	-RRB-	-	-	-	-	-	-	-	-
1851382	0	24	.	.	-	-	-	-	-	-	-	-

1851382	0	1	On	IN	-	-	-	-	-	-	-	-
1851382	0	2	the	DT	-	-	-	-	-	-	-	-
1851382	0	3	second	JJ	-	-	-	-	-	-	-	-
1851382	0	4	level	NN	-	-	-	-	-	-	-	-
1851382	0	5	,	,	-	-	-	-	-	-	-	-
1851382	0	6	the	DT	-	-	-	-	-	-	-	(82
1851382	0	7	FoxO	NNP	-	-	-	-	-	-	-	(80)
1851382	0	8	transcription	NN	-	-	-	-	-	-	-	-
1851382	0	9	factors	NNS	-	-	-	-	-	-	-	82)
1851382	0	10	can	MD	-	-	-	-	-	-	-	-
1851382	0	11	be	VB	-	-	-	-	-	-	-	-
1851382	0	12	sequestered	VBN	-	-	-	-	-	-	-	-
1851382	0	13	within	IN	-	-	-	-	-	-	-	-
1851382	0	14	the	DT	-	-	-	-	-	-	-	-
1851382	0	15	cytoplasm	NN	-	-	-	-	-	-	-	-
1851382	0	16	when	WRB	-	-	-	-	-	-	-	-
1851382	0	17	phosphorylated	VBN	-	-	-	-	-	-	-	-
1851382	0	18	by	IN	-	-	-	-	-	-	-	-
1851382	0	19	activated	VBN	-	-	-	-	-	-	-	(83
1851382	0	20	Akt	NN	-	-	-	-	-	-	-	-
1851382	0	21	kinases	NNS	-	-	-	-	-	-	-	-
1851382	0	22	in	IN	-	-	-	-	-	-	-	-
1851382	0	23	response	NN	-	-	-	-	-	-	-	-
1851382	0	24	to	IN	-	-	-	-	-	-	-	-
1851382	0	25	insulin	NN	-	-	-	-	-	-	-	(84|(12)
1851382	0	26	and	CC	-	-	-	-	-	-	-	-
1851382	0	27	IGF	NN	-	-	-	-	-	-	-	(8|(85
1851382	0	28	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	29	1	CD	-	-	-	-	-	-	-	8)
1851382	0	30	signals	NNS	-	-	-	-	-	-	-	85)|84)|83)
1851382	0	31	[	-LRB-	-	-	-	-	-	-	-	-
1851382	0	32	13	CD	-	-	-	-	-	-	-	-
1851382	0	33	]	-RRB-	-	-	-	-	-	-	-	-
1851382	0	34	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Conceivably	RB	-	-	-	-	-	-	-	-
1851382	0	2	,	,	-	-	-	-	-	-	-	-
1851382	0	3	the	DT	-	-	-	-	-	-	-	(72
1851382	0	4	IIS	NN	-	-	-	-	-	-	-	(73)
1851382	0	5	system	NN	-	-	-	-	-	-	-	72)
1851382	0	6	senses	VBZ	-	-	-	-	-	-	-	-
1851382	0	7	the	DT	-	-	-	-	-	-	-	-
1851382	0	8	levels	NNS	-	-	-	-	-	-	-	-
1851382	0	9	of	IN	-	-	-	-	-	-	-	-
1851382	0	10	insulin	NN	-	-	-	-	-	-	-	(86|(12)
1851382	0	11	and	CC	-	-	-	-	-	-	-	-
1851382	0	12	IGF	NN	-	-	-	-	-	-	-	(8
1851382	0	13	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	14	1	CD	-	-	-	-	-	-	-	86)|8)
1851382	0	15	and	CC	-	-	-	-	-	-	-	-
1851382	0	16	negatively	RB	-	-	-	-	-	-	-	-
1851382	0	17	regulates	VBZ	-	-	-	-	-	-	-	-
1851382	0	18	the	DT	-	-	-	-	-	-	-	-
1851382	0	19	expression	NN	-	-	-	-	-	-	-	-
1851382	0	20	of	IN	-	-	-	-	-	-	-	-
1851382	0	21	the	DT	-	-	-	-	-	-	-	(79
1851382	0	22	effector	NN	-	-	-	-	-	-	-	-
1851382	0	23	genes	NNS	-	-	-	-	-	-	-	79)
1851382	0	24	.	.	-	-	-	-	-	-	-	-

1851382	0	1	The	DT	-	-	-	-	-	-	-	(72
1851382	0	2	IIS	NN	-	-	-	-	-	-	-	(73)
1851382	0	3	system	NN	-	-	-	-	-	-	-	72)
1851382	0	4	is	VBZ	-	-	-	-	-	-	-	-
1851382	0	5	responsible	JJ	-	-	-	-	-	-	-	-
1851382	0	6	for	IN	-	-	-	-	-	-	-	-
1851382	0	7	food	NN	-	-	-	-	-	-	-	-
1851382	0	8	storage	NN	-	-	-	-	-	-	-	-
1851382	0	9	,	,	-	-	-	-	-	-	-	-
1851382	0	10	stress	NN	-	-	-	-	-	-	-	(69)
1851382	0	11	tolerance	NN	-	-	-	-	-	-	-	-
1851382	0	12	,	,	-	-	-	-	-	-	-	-
1851382	0	13	and	CC	-	-	-	-	-	-	-	-
1851382	0	14	longevity	NN	-	-	-	-	-	-	-	-
1851382	0	15	in	IN	-	-	-	-	-	-	-	-
1851382	0	16	lower	JJR	-	-	-	-	-	-	-	-
1851382	0	17	organisms	NNS	-	-	-	-	-	-	-	-
1851382	0	18	,	,	-	-	-	-	-	-	-	-
1851382	0	19	such	JJ	-	-	-	-	-	-	-	-
1851382	0	20	as	IN	-	-	-	-	-	-	-	-
1851382	0	21	C.	NNP	-	-	-	-	-	-	-	(75
1851382	0	22	elegans	NNP	-	-	-	-	-	-	-	75)
1851382	0	23	[	-LRB-	-	-	-	-	-	-	-	-
1851382	0	24	8	CD	-	-	-	-	-	-	-	-
1851382	0	25	,	,	-	-	-	-	-	-	-	-
1851382	0	26	9	CD	-	-	-	-	-	-	-	-
1851382	0	27	,	,	-	-	-	-	-	-	-	-
1851382	0	28	14	CD	-	-	-	-	-	-	-	-
1851382	0	29	]	-RRB-	-	-	-	-	-	-	-	-
1851382	0	30	.	.	-	-	-	-	-	-	-	-

1851382	0	1	In	IN	-	-	-	-	-	-	-	-
1851382	0	2	more	RBR	-	-	-	-	-	-	-	-
1851382	0	3	advanced	JJ	-	-	-	-	-	-	-	-
1851382	0	4	species	NNS	-	-	-	-	-	-	-	-
1851382	0	5	,	,	-	-	-	-	-	-	-	-
1851382	0	6	steroid	NN	-	-	-	-	-	-	-	(87
1851382	0	7	hormones	NNS	-	-	-	-	-	-	-	87)
1851382	0	8	evolved	VBD	-	-	-	-	-	-	-	-
1851382	0	9	to	TO	-	-	-	-	-	-	-	-
1851382	0	10	regulate	VB	-	-	-	-	-	-	-	-
1851382	0	11	the	DT	-	-	-	-	-	-	-	(72
1851382	0	12	IIS	NN	-	-	-	-	-	-	-	(73)
1851382	0	13	system	NN	-	-	-	-	-	-	-	72)
1851382	0	14	[	-LRB-	-	-	-	-	-	-	-	-
1851382	0	15	15	CD	-	-	-	-	-	-	-	-
1851382	0	16	]	-RRB-	-	-	-	-	-	-	-	-
1851382	0	17	.	.	-	-	-	-	-	-	-	-

1851382	0	1	In	IN	-	-	-	-	-	-	-	-
1851382	0	2	mice	NNS	-	-	-	-	-	-	-	(76|(6)
1851382	0	3	and	CC	-	-	-	-	-	-	-	-
1851382	0	4	humans	NNS	-	-	-	-	-	-	-	(77)|76)
1851382	0	5	,	,	-	-	-	-	-	-	-	-
1851382	0	6	the	DT	-	-	-	-	-	-	-	(88
1851382	0	7	IGF	NN	-	-	-	-	-	-	-	(8
1851382	0	8	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	9	1	CD	-	-	-	-	-	-	-	8)
1851382	0	10	signaling	NN	-	-	-	-	-	-	-	-
1851382	0	11	of	IN	-	-	-	-	-	-	-	-
1851382	0	12	the	DT	-	-	-	-	-	-	-	(72
1851382	0	13	IIS	NN	-	-	-	-	-	-	-	(73)
1851382	0	14	system	NN	-	-	-	-	-	-	-	88)|72)
1851382	0	15	mediates	VBZ	-	-	-	-	-	-	-	-
1851382	0	16	local	JJ	-	-	-	-	-	-	-	-
1851382	0	17	effects	NNS	-	-	-	-	-	-	-	-
1851382	0	18	for	IN	-	-	-	-	-	-	-	-
1851382	0	19	growth	NN	-	-	-	-	-	-	-	-
1851382	0	20	and	CC	-	-	-	-	-	-	-	-
1851382	0	21	hormonal	JJ	-	-	-	-	-	-	-	-
1851382	0	22	regulation	NN	-	-	-	-	-	-	-	-
1851382	0	23	for	IN	-	-	-	-	-	-	-	-
1851382	0	24	multiple	JJ	-	-	-	-	-	-	-	-
1851382	0	25	tissues	NNS	-	-	-	-	-	-	-	-
1851382	0	26	,	,	-	-	-	-	-	-	-	-
1851382	0	27	including	VBG	-	-	-	-	-	-	-	-
1851382	0	28	mammary	JJ	-	-	-	-	-	-	-	(5
1851382	0	29	glands	NNS	-	-	-	-	-	-	-	5)
1851382	0	30	[	-LRB-	-	-	-	-	-	-	-	-
1851382	0	31	16	CD	-	-	-	-	-	-	-	-
1851382	0	32	,	,	-	-	-	-	-	-	-	-
1851382	0	33	17	CD	-	-	-	-	-	-	-	-
1851382	0	34	]	-RRB-	-	-	-	-	-	-	-	-
1851382	0	35	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Mammalian	JJ	-	-	-	-	-	-	-	(65
1851382	0	2	SirT1	NN	-	-	-	-	-	-	-	65)
1851382	0	3	has	VBZ	-	-	-	-	-	-	-	-
1851382	0	4	evolved	VBN	-	-	-	-	-	-	-	-
1851382	0	5	to	TO	-	-	-	-	-	-	-	-
1851382	0	6	modify	VB	-	-	-	-	-	-	-	-
1851382	0	7	the	DT	-	-	-	-	-	-	-	-
1851382	0	8	activity	NN	-	-	-	-	-	-	-	-
1851382	0	9	of	IN	-	-	-	-	-	-	-	-
1851382	0	10	a	DT	-	-	-	-	-	-	-	-
1851382	0	11	growing	VBG	-	-	-	-	-	-	-	-
1851382	0	12	number	NN	-	-	-	-	-	-	-	-
1851382	0	13	of	IN	-	-	-	-	-	-	-	-
1851382	0	14	transcription	NN	-	-	-	-	-	-	-	(15a|(14)
1851382	0	15	factors	NNS	-	-	-	-	-	-	-	-
1851382	0	16	,	,	-	-	-	-	-	-	-	-
1851382	0	17	including	VBG	-	-	-	-	-	-	-	15a)
1851382	0	18	p53	NN	-	-	-	-	-	-	-	-
1851382	0	19	,	,	-	-	-	-	-	-	-	-
1851382	0	20	NF	NN	-	-	-	-	-	-	-	(15a|(16
1851382	0	21	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	22	κB	NN	-	-	-	-	-	-	-	16)|15a)
1851382	0	23	,	,	-	-	-	-	-	-	-	-
1851382	0	24	and	CC	-	-	-	-	-	-	-	-
1851382	0	25	PGC	NN	-	-	-	-	-	-	-	-
1851382	0	26	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	27	1α	NN	-	-	-	-	-	-	-	-
1851382	0	28	,	,	-	-	-	-	-	-	-	-
1851382	0	29	suggesting	VBG	-	-	-	-	-	-	-	-
1851382	0	30	that	IN	-	-	-	-	-	-	-	-
1851382	0	31	SirT1	NN	-	-	-	-	-	-	-	(1)
1851382	0	32	functions	VBZ	-	-	-	-	-	-	-	-
1851382	0	33	in	IN	-	-	-	-	-	-	-	-
1851382	0	34	a	DT	-	-	-	-	-	-	-	-
1851382	0	35	wide	JJ	-	-	-	-	-	-	-	-
1851382	0	36	range	NN	-	-	-	-	-	-	-	-
1851382	0	37	of	IN	-	-	-	-	-	-	-	-
1851382	0	38	cellular	JJ	-	-	-	-	-	-	-	-
1851382	0	39	responses	NNS	-	-	-	-	-	-	-	-
1851382	0	40	to	IN	-	-	-	-	-	-	-	-
1851382	0	41	stress	NN	-	-	-	-	-	-	-	(69)
1851382	0	42	,	,	-	-	-	-	-	-	-	-
1851382	0	43	inflammation	NN	-	-	-	-	-	-	-	-
1851382	0	44	,	,	-	-	-	-	-	-	-	-
1851382	0	45	and	CC	-	-	-	-	-	-	-	-
1851382	0	46	nutrients	NNS	-	-	-	-	-	-	-	(89)
1851382	0	47	[	-LRB-	-	-	-	-	-	-	-	-
1851382	0	48	18	CD	-	-	-	-	-	-	-	-
1851382	0	49	-	SYM	-	-	-	-	-	-	-	-
1851382	0	50	21	CD	-	-	-	-	-	-	-	-
1851382	0	51	]	-RRB-	-	-	-	-	-	-	-	-
1851382	0	52	.	.	-	-	-	-	-	-	-	-

1851382	0	1	SirT1	NN	-	-	-	-	-	-	-	(22
1851382	0	2	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	3	deficient	JJ	-	-	-	-	-	-	-	-
1851382	0	4	mice	NNS	-	-	-	-	-	-	-	22)
1851382	0	5	display	VBP	-	-	-	-	-	-	-	-
1851382	0	6	characteristic	JJ	-	-	-	-	-	-	-	(41a|(90|(91|(92
1851382	0	7	phenotypes	NNS	-	-	-	-	-	-	-	-
1851382	0	8	of	IN	-	-	-	-	-	-	-	41a)
1851382	0	9	perinatal	JJ	-	-	-	-	-	-	-	(93|(94
1851382	0	10	death	NN	-	-	-	-	-	-	-	93)|90)
1851382	0	11	and	CC	-	-	-	-	-	-	-	-
1851382	0	12	growth	NN	-	-	-	-	-	-	-	(41a|(42
1851382	0	13	retardation	NN	-	-	-	-	-	-	-	94)|91)|42)|41a)
1851382	0	14	as	RB	-	-	-	-	-	-	-	-
1851382	0	15	well	RB	-	-	-	-	-	-	-	-
1851382	0	16	as	IN	-	-	-	-	-	-	-	-
1851382	0	17	other	JJ	-	-	-	-	-	-	-	-
1851382	0	18	diverse	JJ	-	-	-	-	-	-	-	-
1851382	0	19	phenotypes	NNS	-	-	-	-	-	-	-	-
1851382	0	20	,	,	-	-	-	-	-	-	-	-
1851382	0	21	such	JJ	-	-	-	-	-	-	-	-
1851382	0	22	as	IN	-	-	-	-	-	-	-	-
1851382	0	23	eye	NN	-	-	-	-	-	-	-	-
1851382	0	24	defects	NNS	-	-	-	-	-	-	-	-
1851382	0	25	,	,	-	-	-	-	-	-	-	-
1851382	0	26	with	IN	-	-	-	-	-	-	-	-
1851382	0	27	varying	VBG	-	-	-	-	-	-	-	-
1851382	0	28	severity	NN	-	-	-	-	-	-	-	92)
1851382	0	29	[	-LRB-	-	-	-	-	-	-	-	-
1851382	0	30	22	CD	-	-	-	-	-	-	-	-
1851382	0	31	,	,	-	-	-	-	-	-	-	-
1851382	0	32	23	CD	-	-	-	-	-	-	-	-
1851382	0	33	]	-RRB-	-	-	-	-	-	-	-	-
1851382	0	34	.	.	-	-	-	-	-	-	-	-

1851382	0	1	The	DT	-	-	-	-	-	-	-	-
1851382	0	2	underlying	VBG	-	-	-	-	-	-	-	-
1851382	0	3	causal	JJ	-	-	-	-	-	-	-	-
1851382	0	4	mechanism	NN	-	-	-	-	-	-	-	-
1851382	0	5	for	IN	-	-	-	-	-	-	-	-
1851382	0	6	these	DT	-	-	-	-	-	-	-	(92
1851382	0	7	phenotypes	NNS	-	-	-	-	-	-	-	92)
1851382	0	8	,	,	-	-	-	-	-	-	-	-
1851382	0	9	however	RB	-	-	-	-	-	-	-	-
1851382	0	10	,	,	-	-	-	-	-	-	-	-
1851382	0	11	remains	VBZ	-	-	-	-	-	-	-	-
1851382	0	12	unknown	JJ	-	-	-	-	-	-	-	-
1851382	0	13	.	.	-	-	-	-	-	-	-	-

1851382	0	1	We	PRP	-	-	-	-	-	-	-	(95)
1851382	0	2	recently	RB	-	-	-	-	-	-	-	-
1851382	0	3	generated	VBD	-	-	-	-	-	-	-	-
1851382	0	4	SirT1	NN	-	-	-	-	-	-	-	(22|(24b
1851382	0	5	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	6	deficient	JJ	-	-	-	-	-	-	-	24b)
1851382	0	7	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	8	SirT1ko	NN	-	-	-	-	-	-	-	-
1851382	0	9	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	10	ko	NN	-	-	-	-	-	-	-	-
1851382	0	11	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	12	mice	NNS	-	-	-	-	-	-	-	(24b)|22)
1851382	0	13	and	CC	-	-	-	-	-	-	-	-
1851382	0	14	found	VBD	-	-	-	-	-	-	-	-
1851382	0	15	that	IN	-	-	-	-	-	-	-	-
1851382	0	16	both	CC	-	-	-	-	-	-	-	(38|(96
1851382	0	17	male	JJ	-	-	-	-	-	-	-	(39d)
1851382	0	18	and	CC	-	-	-	-	-	-	-	-
1851382	0	19	female	JJ	-	-	-	-	-	-	-	(40
1851382	0	20	SirT1ko	NN	-	-	-	-	-	-	-	(39d
1851382	0	21	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	22	ko	NN	-	-	-	-	-	-	-	-
1851382	0	23	mice	NNS	-	-	-	-	-	-	-	40)|39d)|38)
1851382	0	24	can	MD	-	-	-	-	-	-	-	-
1851382	0	25	be	VB	-	-	-	-	-	-	-	-
1851382	0	26	fertile	JJ	-	-	-	-	-	-	-	-
1851382	0	27	,	,	-	-	-	-	-	-	-	-
1851382	0	28	which	WDT	-	-	-	-	-	-	-	-
1851382	0	29	is	VBZ	-	-	-	-	-	-	-	-
1851382	0	30	in	IN	-	-	-	-	-	-	-	(97
1851382	0	31	contrast	NN	-	-	-	-	-	-	-	-
1851382	0	32	to	IN	-	-	-	-	-	-	-	-
1851382	0	33	the	DT	-	-	-	-	-	-	-	(98
1851382	0	34	sterile	JJ	-	-	-	-	-	-	-	-
1851382	0	35	phenotypes	NNS	-	-	-	-	-	-	-	-
1851382	0	36	observed	VBN	-	-	-	-	-	-	-	-
1851382	0	37	in	IN	-	-	-	-	-	-	-	-
1851382	0	38	one	CD	-	-	-	-	-	-	-	(99
1851382	0	39	strain	NN	-	-	-	-	-	-	-	-
1851382	0	40	of	IN	-	-	-	-	-	-	-	-
1851382	0	41	SirT1	NN	-	-	-	-	-	-	-	(22
1851382	0	42	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	43	deficient	JJ	-	-	-	-	-	-	-	-
1851382	0	44	mice	NNS	-	-	-	-	-	-	-	99)|98)|97)|96)|22)
1851382	0	45	[	-LRB-	-	-	-	-	-	-	-	-
1851382	0	46	22	CD	-	-	-	-	-	-	-	-
1851382	0	47	]	-RRB-	-	-	-	-	-	-	-	-
1851382	0	48	.	.	-	-	-	-	-	-	-	-

1851382	0	1	This	DT	-	-	-	-	-	-	-	(96)
1851382	0	2	led	VBD	-	-	-	-	-	-	-	-
1851382	0	3	to	IN	-	-	-	-	-	-	-	-
1851382	0	4	our	PRP$	-	-	-	-	-	-	-	(21|(95)
1851382	0	5	study	NN	-	-	-	-	-	-	-	-
1851382	0	6	of	IN	-	-	-	-	-	-	-	-
1851382	0	7	the	DT	-	-	-	-	-	-	-	-
1851382	0	8	link	NN	-	-	-	-	-	-	-	-
1851382	0	9	between	IN	-	-	-	-	-	-	-	-
1851382	0	10	SirT1	NN	-	-	-	-	-	-	-	(1)
1851382	0	11	and	CC	-	-	-	-	-	-	-	-
1851382	0	12	IGF	NN	-	-	-	-	-	-	-	(19|(8
1851382	0	13	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	14	1	CD	-	-	-	-	-	-	-	8)
1851382	0	15	signaling	NN	-	-	-	-	-	-	-	19)
1851382	0	16	using	VBG	-	-	-	-	-	-	-	-
1851382	0	17	the	DT	-	-	-	-	-	-	-	(5
1851382	0	18	mammary	JJ	-	-	-	-	-	-	-	-
1851382	0	19	gland	NN	-	-	-	-	-	-	-	5)
1851382	0	20	as	IN	-	-	-	-	-	-	-	-
1851382	0	21	a	DT	-	-	-	-	-	-	-	-
1851382	0	22	model	NN	-	-	-	-	-	-	-	-
1851382	0	23	organ	NN	-	-	-	-	-	-	-	21)
1851382	0	24	.	.	-	-	-	-	-	-	-	-

1851382	0	1	The	DT	-	-	-	-	-	-	-	(9
1851382	0	2	mammary	JJ	-	-	-	-	-	-	-	-
1851382	0	3	gland	NN	-	-	-	-	-	-	-	9)
1851382	0	4	is	VBZ	-	-	-	-	-	-	-	-
1851382	0	5	a	DT	-	-	-	-	-	-	-	-
1851382	0	6	unique	JJ	-	-	-	-	-	-	-	-
1851382	0	7	organ	NN	-	-	-	-	-	-	-	-
1851382	0	8	because	IN	-	-	-	-	-	-	-	-
1851382	0	9	it	PRP	-	-	-	-	-	-	-	(9)
1851382	0	10	develops	VBZ	-	-	-	-	-	-	-	-
1851382	0	11	after	IN	-	-	-	-	-	-	-	-
1851382	0	12	birth	NN	-	-	-	-	-	-	-	(100)
1851382	0	13	and	CC	-	-	-	-	-	-	-	-
1851382	0	14	undergoes	VBZ	-	-	-	-	-	-	-	-
1851382	0	15	dynamic	JJ	-	-	-	-	-	-	-	-
1851382	0	16	changes	NNS	-	-	-	-	-	-	-	-
1851382	0	17	throughout	IN	-	-	-	-	-	-	-	-
1851382	0	18	the	DT	-	-	-	-	-	-	-	-
1851382	0	19	reproductive	JJ	-	-	-	-	-	-	-	-
1851382	0	20	lifespan	NN	-	-	-	-	-	-	-	-
1851382	0	21	of	IN	-	-	-	-	-	-	-	-
1851382	0	22	a	DT	-	-	-	-	-	-	-	(101
1851382	0	23	female	NN	-	-	-	-	-	-	-	101)
1851382	0	24	.	.	-	-	-	-	-	-	-	-

1851382	0	1	At	IN	-	-	-	-	-	-	-	-
1851382	0	2	the	DT	-	-	-	-	-	-	-	(102
1851382	0	3	onset	NN	-	-	-	-	-	-	-	-
1851382	0	4	of	IN	-	-	-	-	-	-	-	-
1851382	0	5	puberty	NN	-	-	-	-	-	-	-	(103)|102)
1851382	0	6	,	,	-	-	-	-	-	-	-	-
1851382	0	7	ovarian	JJ	-	-	-	-	-	-	-	-
1851382	0	8	estrogen	NN	-	-	-	-	-	-	-	-
1851382	0	9	stimulates	VBZ	-	-	-	-	-	-	-	-
1851382	0	10	ductal	JJ	-	-	-	-	-	-	-	(62
1851382	0	11	morphogenesis	NN	-	-	-	-	-	-	-	62)
1851382	0	12	during	IN	-	-	-	-	-	-	-	-
1851382	0	13	which	WDT	-	-	-	-	-	-	-	-
1851382	0	14	mammary	JJ	-	-	-	-	-	-	-	(104
1851382	0	15	epithelial	JJ	-	-	-	-	-	-	-	-
1851382	0	16	progenitor	NN	-	-	-	-	-	-	-	-
1851382	0	17	cells	NNS	-	-	-	-	-	-	-	104)
1851382	0	18	differentiate	VBP	-	-	-	-	-	-	-	-
1851382	0	19	and	CC	-	-	-	-	-	-	-	-
1851382	0	20	proliferate	VBP	-	-	-	-	-	-	-	-
1851382	0	21	while	IN	-	-	-	-	-	-	-	-
1851382	0	22	interacting	VBG	-	-	-	-	-	-	-	-
1851382	0	23	with	IN	-	-	-	-	-	-	-	-
1851382	0	24	adipocytes	NNS	-	-	-	-	-	-	-	(105a)
1851382	0	25	and	CC	-	-	-	-	-	-	-	-
1851382	0	26	stromal	JJ	-	-	-	-	-	-	-	(106
1851382	0	27	cells	NNS	-	-	-	-	-	-	-	-
1851382	0	28	within	IN	-	-	-	-	-	-	-	(105a
1851382	0	29	mammary	JJ	-	-	-	-	-	-	-	(107|(108
1851382	0	30	fat	NN	-	-	-	-	-	-	-	107)
1851382	0	31	pad	NN	-	-	-	-	-	-	-	108)|106)|105a)
1851382	0	32	[	-LRB-	-	-	-	-	-	-	-	-
1851382	0	33	17	CD	-	-	-	-	-	-	-	-
1851382	0	34	,	,	-	-	-	-	-	-	-	-
1851382	0	35	24	CD	-	-	-	-	-	-	-	-
1851382	0	36	,	,	-	-	-	-	-	-	-	-
1851382	0	37	25	CD	-	-	-	-	-	-	-	-
1851382	0	38	]	-RRB-	-	-	-	-	-	-	-	-
1851382	0	39	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Ovarian	JJ	-	-	-	-	-	-	-	(109
1851382	0	2	estrogen	NN	-	-	-	-	-	-	-	-
1851382	0	3	,	,	-	-	-	-	-	-	-	-
1851382	0	4	in	IN	-	-	-	-	-	-	-	-
1851382	0	5	synergy	NN	-	-	-	-	-	-	-	(110
1851382	0	6	with	IN	-	-	-	-	-	-	-	-
1851382	0	7	pituitary	JJ	-	-	-	-	-	-	-	(111
1851382	0	8	growth	NN	-	-	-	-	-	-	-	(112
1851382	0	9	hormone	NN	-	-	-	-	-	-	-	112)|111)|110)|109)
1851382	0	10	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	11	GH	NN	-	-	-	-	-	-	-	(112)
1851382	0	12	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	13	,	,	-	-	-	-	-	-	-	-
1851382	0	14	stimulates	VBZ	-	-	-	-	-	-	-	-
1851382	0	15	stromal	JJ	-	-	-	-	-	-	-	(106
1851382	0	16	cells	NNS	-	-	-	-	-	-	-	106)
1851382	0	17	to	TO	-	-	-	-	-	-	-	-
1851382	0	18	produce	VB	-	-	-	-	-	-	-	-
1851382	0	19	local	JJ	-	-	-	-	-	-	-	(54
1851382	0	20	IGF	NN	-	-	-	-	-	-	-	-
1851382	0	21	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	22	1	CD	-	-	-	-	-	-	-	54)
1851382	0	23	.	.	-	-	-	-	-	-	-	-

1851382	0	1	The	DT	-	-	-	-	-	-	-	(54
1851382	0	2	local	JJ	-	-	-	-	-	-	-	-
1851382	0	3	IGF	NN	-	-	-	-	-	-	-	-
1851382	0	4	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	5	1	CD	-	-	-	-	-	-	-	54)
1851382	0	6	,	,	-	-	-	-	-	-	-	-
1851382	0	7	but	CC	-	-	-	-	-	-	-	-
1851382	0	8	not	RB	-	-	-	-	-	-	-	-
1851382	0	9	liver	NN	-	-	-	-	-	-	-	-
1851382	0	10	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	11	produced	VBN	-	-	-	-	-	-	-	-
1851382	0	12	systemic	JJ	-	-	-	-	-	-	-	-
1851382	0	13	IGF	NN	-	-	-	-	-	-	-	-
1851382	0	14	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	15	1	CD	-	-	-	-	-	-	-	-
1851382	0	16	,	,	-	-	-	-	-	-	-	-
1851382	0	17	provides	VBZ	-	-	-	-	-	-	-	-
1851382	0	18	a	DT	-	-	-	-	-	-	-	-
1851382	0	19	paracrine	JJ	-	-	-	-	-	-	-	-
1851382	0	20	signal	NN	-	-	-	-	-	-	-	-
1851382	0	21	for	IN	-	-	-	-	-	-	-	-
1851382	0	22	commencing	VBG	-	-	-	-	-	-	-	-
1851382	0	23	ductal	JJ	-	-	-	-	-	-	-	(62
1851382	0	24	morphogenesis	NN	-	-	-	-	-	-	-	62)
1851382	0	25	[	-LRB-	-	-	-	-	-	-	-	-
1851382	0	26	26	CD	-	-	-	-	-	-	-	-
1851382	0	27	]	-RRB-	-	-	-	-	-	-	-	-
1851382	0	28	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Mice	NNS	-	-	-	-	-	-	-	(113|(114b|(115d|(116|(117a|(118a
1851382	0	2	lacking	VBG	-	-	-	-	-	-	-	118a)|117a)|115d)|114b)
1851382	0	3	GH	NN	-	-	-	-	-	-	-	(119|(112)|113)
1851382	0	4	,	,	-	-	-	-	-	-	-	-
1851382	0	5	estrogen	NN	-	-	-	-	-	-	-	(3|(114b)|(7)|119)
1851382	0	6	,	,	-	-	-	-	-	-	-	-
1851382	0	7	IGF	NN	-	-	-	-	-	-	-	(115d|(118a|(8
1851382	0	8	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	9	1	CD	-	-	-	-	-	-	-	8)|3)|118a)|116)|115d)
1851382	0	10	,	,	-	-	-	-	-	-	-	-
1851382	0	11	GH	NN	-	-	-	-	-	-	-	(120|(112)
1851382	0	12	receptor	NN	-	-	-	-	-	-	-	120)
1851382	0	13	,	,	-	-	-	-	-	-	-	-
1851382	0	14	or	CC	-	-	-	-	-	-	-	(118a
1851382	0	15	estrogen	NN	-	-	-	-	-	-	-	(117a|(121|(7)
1851382	0	16	receptor	NN	-	-	-	-	-	-	-	-
1851382	0	17	alpha	NN	-	-	-	-	-	-	-	121)|118a)|117a)
1851382	0	18	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	19	ERα	NN	-	-	-	-	-	-	-	-
1851382	0	20	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	21	fail	VBP	-	-	-	-	-	-	-	-
1851382	0	22	to	TO	-	-	-	-	-	-	-	-
1851382	0	23	undergo	VB	-	-	-	-	-	-	-	-
1851382	0	24	postnatal	JJ	-	-	-	-	-	-	-	-
1851382	0	25	ductal	JJ	-	-	-	-	-	-	-	-
1851382	0	26	morphogenesis	NN	-	-	-	-	-	-	-	-
1851382	0	27	[	-LRB-	-	-	-	-	-	-	-	-
1851382	0	28	17	CD	-	-	-	-	-	-	-	-
1851382	0	29	,	,	-	-	-	-	-	-	-	-
1851382	0	30	24	CD	-	-	-	-	-	-	-	-
1851382	0	31	-	SYM	-	-	-	-	-	-	-	-
1851382	0	32	31	CD	-	-	-	-	-	-	-	-
1851382	0	33	]	-RRB-	-	-	-	-	-	-	-	-
1851382	0	34	,	,	-	-	-	-	-	-	-	-
1851382	0	35	indicating	VBG	-	-	-	-	-	-	-	-
1851382	0	36	that	IN	-	-	-	-	-	-	-	-
1851382	0	37	both	CC	-	-	-	-	-	-	-	-
1851382	0	38	steroid	NN	-	-	-	-	-	-	-	(87
1851382	0	39	hormones	NNS	-	-	-	-	-	-	-	87)
1851382	0	40	and	CC	-	-	-	-	-	-	-	-
1851382	0	41	IGF	NN	-	-	-	-	-	-	-	(8
1851382	0	42	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	43	1	CD	-	-	-	-	-	-	-	8)
1851382	0	44	are	VBP	-	-	-	-	-	-	-	-
1851382	0	45	on	IN	-	-	-	-	-	-	-	-
1851382	0	46	the	DT	-	-	-	-	-	-	-	-
1851382	0	47	common	JJ	-	-	-	-	-	-	-	-
1851382	0	48	pathway	NN	-	-	-	-	-	-	-	-
1851382	0	49	for	IN	-	-	-	-	-	-	-	-
1851382	0	50	a	DT	-	-	-	-	-	-	-	-
1851382	0	51	critical	JJ	-	-	-	-	-	-	-	-
1851382	0	52	developmental	JJ	-	-	-	-	-	-	-	-
1851382	0	53	checkpoint	NN	-	-	-	-	-	-	-	-
1851382	0	54	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Once	IN	-	-	-	-	-	-	-	-
1851382	0	2	the	DT	-	-	-	-	-	-	-	-
1851382	0	3	arborated	VBN	-	-	-	-	-	-	-	-
1851382	0	4	ductal	JJ	-	-	-	-	-	-	-	-
1851382	0	5	network	NN	-	-	-	-	-	-	-	-
1851382	0	6	is	VBZ	-	-	-	-	-	-	-	-
1851382	0	7	established	VBN	-	-	-	-	-	-	-	-
1851382	0	8	,	,	-	-	-	-	-	-	-	-
1851382	0	9	cycles	NNS	-	-	-	-	-	-	-	-
1851382	0	10	of	IN	-	-	-	-	-	-	-	-
1851382	0	11	differentiation	NN	-	-	-	-	-	-	-	-
1851382	0	12	,	,	-	-	-	-	-	-	-	-
1851382	0	13	proliferation	NN	-	-	-	-	-	-	-	-
1851382	0	14	,	,	-	-	-	-	-	-	-	-
1851382	0	15	and	CC	-	-	-	-	-	-	-	-
1851382	0	16	death	NN	-	-	-	-	-	-	-	-
1851382	0	17	of	IN	-	-	-	-	-	-	-	-
1851382	0	18	secretory	JJ	-	-	-	-	-	-	-	-
1851382	0	19	alveolar	JJ	-	-	-	-	-	-	-	-
1851382	0	20	epithelium	NN	-	-	-	-	-	-	-	-
1851382	0	21	repeat	VBP	-	-	-	-	-	-	-	-
1851382	0	22	with	IN	-	-	-	-	-	-	-	-
1851382	0	23	each	DT	-	-	-	-	-	-	-	-
1851382	0	24	pregnancy	NN	-	-	-	-	-	-	-	-
1851382	0	25	[	-LRB-	-	-	-	-	-	-	-	-
1851382	0	26	17	CD	-	-	-	-	-	-	-	-
1851382	0	27	,	,	-	-	-	-	-	-	-	-
1851382	0	28	24	CD	-	-	-	-	-	-	-	-
1851382	0	29	,	,	-	-	-	-	-	-	-	-
1851382	0	30	25	CD	-	-	-	-	-	-	-	-
1851382	0	31	]	-RRB-	-	-	-	-	-	-	-	-
1851382	0	32	.	.	-	-	-	-	-	-	-	-

1851382	0	1	In	IN	-	-	-	-	-	-	-	-
1851382	0	2	the	DT	-	-	-	-	-	-	-	-
1851382	0	3	present	JJ	-	-	-	-	-	-	-	-
1851382	0	4	article	NN	-	-	-	-	-	-	-	-
1851382	0	5	we	PRP	-	-	-	-	-	-	-	(95)
1851382	0	6	report	VBP	-	-	-	-	-	-	-	-
1851382	0	7	the	DT	-	-	-	-	-	-	-	-
1851382	0	8	finding	NN	-	-	-	-	-	-	-	-
1851382	0	9	and	CC	-	-	-	-	-	-	-	-
1851382	0	10	characterization	NN	-	-	-	-	-	-	-	(122
1851382	0	11	of	IN	-	-	-	-	-	-	-	-
1851382	0	12	impeded	VBN	-	-	-	-	-	-	-	(123|(43
1851382	0	13	ductal	JJ	-	-	-	-	-	-	-	-
1851382	0	14	morphogenesis	NN	-	-	-	-	-	-	-	-
1851382	0	15	in	IN	-	-	-	-	-	-	-	-
1851382	0	16	virgin	JJ	-	-	-	-	-	-	-	(32
1851382	0	17	SirT1ko	NN	-	-	-	-	-	-	-	-
1851382	0	18	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	19	ko	NN	-	-	-	-	-	-	-	-
1851382	0	20	mice	NNS	-	-	-	-	-	-	-	43)|32)
1851382	0	21	and	CC	-	-	-	-	-	-	-	-
1851382	0	22	lactation	NN	-	-	-	-	-	-	-	(44)
1851382	0	23	failure	NN	-	-	-	-	-	-	-	-
1851382	0	24	in	IN	-	-	-	-	-	-	-	-
1851382	0	25	SirT1ko	NN	-	-	-	-	-	-	-	(124|(24
1851382	0	26	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	27	ko	NN	-	-	-	-	-	-	-	24)
1851382	0	28	mothers	NNS	-	-	-	-	-	-	-	124)|123)|122)
1851382	0	29	.	.	-	-	-	-	-	-	-	-

1851382	0	1	The	DT	-	-	-	-	-	-	-	(122
1851382	0	2	characterization	NN	-	-	-	-	-	-	-	-
1851382	0	3	of	IN	-	-	-	-	-	-	-	-
1851382	0	4	these	DT	-	-	-	-	-	-	-	(123
1851382	0	5	phenotypes	NNS	-	-	-	-	-	-	-	123)|122)
1851382	0	6	has	VBZ	-	-	-	-	-	-	-	-
1851382	0	7	identified	VBN	-	-	-	-	-	-	-	-
1851382	0	8	a	DT	-	-	-	-	-	-	-	-
1851382	0	9	SirT1	NN	-	-	-	-	-	-	-	-
1851382	0	10	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	11	dependent	JJ	-	-	-	-	-	-	-	-
1851382	0	12	regulatory	JJ	-	-	-	-	-	-	-	-
1851382	0	13	mechanism	NN	-	-	-	-	-	-	-	-
1851382	0	14	by	IN	-	-	-	-	-	-	-	-
1851382	0	15	which	WDT	-	-	-	-	-	-	-	-
1851382	0	16	SirT1	NN	-	-	-	-	-	-	-	(1)
1851382	0	17	modulates	VBZ	-	-	-	-	-	-	-	-
1851382	0	18	the	DT	-	-	-	-	-	-	-	(125
1851382	0	19	effectiveness	NN	-	-	-	-	-	-	-	-
1851382	0	20	of	IN	-	-	-	-	-	-	-	-
1851382	0	21	the	DT	-	-	-	-	-	-	-	(2
1851382	0	22	estrogen	NN	-	-	-	-	-	-	-	(3
1851382	0	23	–	HYPH	-	-	-	-	-	-	-	-
1851382	0	24	IGF	NN	-	-	-	-	-	-	-	-
1851382	0	25	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	26	1	CD	-	-	-	-	-	-	-	3)
1851382	0	27	signaling	NN	-	-	-	-	-	-	-	-
1851382	0	28	for	IN	-	-	-	-	-	-	-	-
1851382	0	29	mammary	JJ	-	-	-	-	-	-	-	(10|(9
1851382	0	30	gland	NN	-	-	-	-	-	-	-	9)
1851382	0	31	development	NN	-	-	-	-	-	-	-	2)|125)|10)
1851382	0	32	.	.	-	-	-	-	-	-	-	-

1851382	0	1	The	DT	-	-	-	-	-	-	-	(2
1851382	0	2	estrogen	NN	-	-	-	-	-	-	-	-
1851382	0	3	–	HYPH	-	-	-	-	-	-	-	-
1851382	0	4	IGF	NN	-	-	-	-	-	-	-	-
1851382	0	5	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	6	1	CD	-	-	-	-	-	-	-	-
1851382	0	7	signaling	NN	-	-	-	-	-	-	-	2)
1851382	0	8	is	VBZ	-	-	-	-	-	-	-	-
1851382	0	9	defined	VBN	-	-	-	-	-	-	-	-
1851382	0	10	as	IN	-	-	-	-	-	-	-	-
1851382	0	11	the	DT	-	-	-	-	-	-	-	-
1851382	0	12	ovarian	JJ	-	-	-	-	-	-	-	(54
1851382	0	13	estrogen	NN	-	-	-	-	-	-	-	-
1851382	0	14	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	15	regulated	VBN	-	-	-	-	-	-	-	-
1851382	0	16	,	,	-	-	-	-	-	-	-	-
1851382	0	17	stromal	JJ	-	-	-	-	-	-	-	-
1851382	0	18	cell	NN	-	-	-	-	-	-	-	-
1851382	0	19	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	20	produced	VBN	-	-	-	-	-	-	-	-
1851382	0	21	local	JJ	-	-	-	-	-	-	-	-
1851382	0	22	IGF	NN	-	-	-	-	-	-	-	-
1851382	0	23	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	24	1	CD	-	-	-	-	-	-	-	54)
1851382	0	25	signal	NN	-	-	-	-	-	-	-	-
1851382	0	26	for	IN	-	-	-	-	-	-	-	-
1851382	0	27	stimulating	VBG	-	-	-	-	-	-	-	-
1851382	0	28	mammary	JJ	-	-	-	-	-	-	-	(64
1851382	0	29	epithelial	JJ	-	-	-	-	-	-	-	-
1851382	0	30	cells	NNS	-	-	-	-	-	-	-	64)
1851382	0	31	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Materials	NNS	-	-	-	-	-	-	-	(127|(126)
1851382	0	2	and	CC	-	-	-	-	-	-	-	-
1851382	0	3	methods	NNS	-	-	-	-	-	-	-	(23)|127)

1851382	0	1	Mice	NNS	-	-	-	-	-	-	-	(6)

1851382	0	1	A	DT	-	-	-	-	-	-	-	-
1851382	0	2	previously	RB	-	-	-	-	-	-	-	-
1851382	0	3	described	VBN	-	-	-	-	-	-	-	-
1851382	0	4	SirT1	NN	-	-	-	-	-	-	-	-
1851382	0	5	targeting	NN	-	-	-	-	-	-	-	-
1851382	0	6	construct	NN	-	-	-	-	-	-	-	-
1851382	0	7	,	,	-	-	-	-	-	-	-	-
1851382	0	8	KOII	NN	-	-	-	-	-	-	-	-
1851382	0	9	[	-LRB-	-	-	-	-	-	-	-	-
1851382	0	10	23	CD	-	-	-	-	-	-	-	-
1851382	0	11	]	-RRB-	-	-	-	-	-	-	-	-
1851382	0	12	,	,	-	-	-	-	-	-	-	-
1851382	0	13	was	VBD	-	-	-	-	-	-	-	-
1851382	0	14	used	VBN	-	-	-	-	-	-	-	-
1851382	0	15	to	TO	-	-	-	-	-	-	-	-
1851382	0	16	generate	VB	-	-	-	-	-	-	-	-
1851382	0	17	mice	NNS	-	-	-	-	-	-	-	-
1851382	0	18	harboring	VBG	-	-	-	-	-	-	-	-
1851382	0	19	a	DT	-	-	-	-	-	-	-	(128
1851382	0	20	conditional	JJ	-	-	-	-	-	-	-	-
1851382	0	21	targeted	VBN	-	-	-	-	-	-	-	-
1851382	0	22	mutation	NN	-	-	-	-	-	-	-	-
1851382	0	23	in	IN	-	-	-	-	-	-	-	-
1851382	0	24	the	DT	-	-	-	-	-	-	-	(1
1851382	0	25	SirT1	NN	-	-	-	-	-	-	-	-
1851382	0	26	gene	NN	-	-	-	-	-	-	-	128)|1)
1851382	0	27	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	28	SirT1co	NN	-	-	-	-	-	-	-	(25|(26
1851382	0	29	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	30	co	NN	-	-	-	-	-	-	-	26)
1851382	0	31	mice	NNS	-	-	-	-	-	-	-	25)
1851382	0	32	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	33	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	34	see	VB	-	-	-	-	-	-	-	-
1851382	0	35	Additional	JJ	-	-	-	-	-	-	-	(129
1851382	0	36	file	NN	-	-	-	-	-	-	-	-
1851382	0	37	1	CD	-	-	-	-	-	-	-	129)
1851382	0	38	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	39	.	.	-	-	-	-	-	-	-	-

1851382	0	1	The	DT	-	-	-	-	-	-	-	-
1851382	0	2	breeding	NN	-	-	-	-	-	-	-	-
1851382	0	3	of	IN	-	-	-	-	-	-	-	-
1851382	0	4	SirT1co	NN	-	-	-	-	-	-	-	(25|(26
1851382	0	5	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	6	co	NN	-	-	-	-	-	-	-	26)
1851382	0	7	mice	NNS	-	-	-	-	-	-	-	25)
1851382	0	8	and	CC	-	-	-	-	-	-	-	-
1851382	0	9	CMV	NN	-	-	-	-	-	-	-	(27|(28
1851382	0	10	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	11	Cre	NN	-	-	-	-	-	-	-	27)
1851382	0	12	transgenic	JJ	-	-	-	-	-	-	-	-
1851382	0	13	mice	NNS	-	-	-	-	-	-	-	28)
1851382	0	14	results	VBZ	-	-	-	-	-	-	-	-
1851382	0	15	in	IN	-	-	-	-	-	-	-	-
1851382	0	16	mice	NNS	-	-	-	-	-	-	-	-
1851382	0	17	harboring	VBG	-	-	-	-	-	-	-	-
1851382	0	18	a	DT	-	-	-	-	-	-	-	(130
1851382	0	19	germline	NN	-	-	-	-	-	-	-	-
1851382	0	20	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	21	transmitted	VBN	-	-	-	-	-	-	-	-
1851382	0	22	deletion	NN	-	-	-	-	-	-	-	-
1851382	0	23	of	IN	-	-	-	-	-	-	-	-
1851382	0	24	exon	NN	-	-	-	-	-	-	-	(131
1851382	0	25	4	CD	-	-	-	-	-	-	-	-
1851382	0	26	of	IN	-	-	-	-	-	-	-	-
1851382	0	27	the	DT	-	-	-	-	-	-	-	(1
1851382	0	28	SirT1	NN	-	-	-	-	-	-	-	-
1851382	0	29	gene	NN	-	-	-	-	-	-	-	131)|130)|1)
1851382	0	30	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	31	SirT1	NN	-	-	-	-	-	-	-	(132|(133
1851382	0	32	+	SYM	-	-	-	-	-	-	-	-
1851382	0	33	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	34	ko	NN	-	-	-	-	-	-	-	132)
1851382	0	35	mice	NNS	-	-	-	-	-	-	-	133)
1851382	0	36	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	37	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Both	CC	-	-	-	-	-	-	-	-
1851382	0	2	SirT1co	NN	-	-	-	-	-	-	-	(25|(26
1851382	0	3	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	4	co	NN	-	-	-	-	-	-	-	26)
1851382	0	5	mice	NNS	-	-	-	-	-	-	-	25)
1851382	0	6	and	CC	-	-	-	-	-	-	-	-
1851382	0	7	SirT1	NN	-	-	-	-	-	-	-	-
1851382	0	8	+	SYM	-	-	-	-	-	-	-	-
1851382	0	9	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	10	co	NN	-	-	-	-	-	-	-	-
1851382	0	11	mice	NNS	-	-	-	-	-	-	-	-
1851382	0	12	were	VBD	-	-	-	-	-	-	-	-
1851382	0	13	used	VBN	-	-	-	-	-	-	-	-
1851382	0	14	to	TO	-	-	-	-	-	-	-	-
1851382	0	15	establish	VB	-	-	-	-	-	-	-	-
1851382	0	16	breeding	JJ	-	-	-	-	-	-	-	(134)
1851382	0	17	colonies	NNS	-	-	-	-	-	-	-	-
1851382	0	18	for	IN	-	-	-	-	-	-	-	-
1851382	0	19	generating	VBG	-	-	-	-	-	-	-	-
1851382	0	20	SirT1co	NN	-	-	-	-	-	-	-	(135|(25b|(26
1851382	0	21	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	22	co	NN	-	-	-	-	-	-	-	26)|25b)
1851382	0	23	and	CC	-	-	-	-	-	-	-	-
1851382	0	24	SirT1ko	NN	-	-	-	-	-	-	-	(22|(24
1851382	0	25	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	26	ko	NN	-	-	-	-	-	-	-	24)
1851382	0	27	mice	NNS	-	-	-	-	-	-	-	(25b)|22)|135)
1851382	0	28	,	,	-	-	-	-	-	-	-	-
1851382	0	29	respectively	RB	-	-	-	-	-	-	-	-
1851382	0	30	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Both	CC	-	-	-	-	-	-	-	(135
1851382	0	2	SirT1co	NN	-	-	-	-	-	-	-	(25|(26
1851382	0	3	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	4	co	NN	-	-	-	-	-	-	-	26)
1851382	0	5	mice	NNS	-	-	-	-	-	-	-	25)
1851382	0	6	and	CC	-	-	-	-	-	-	-	-
1851382	0	7	SirT1ko	NN	-	-	-	-	-	-	-	(22|(24
1851382	0	8	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	9	ko	NN	-	-	-	-	-	-	-	24)
1851382	0	10	mice	NNS	-	-	-	-	-	-	-	22)|135)
1851382	0	11	were	VBD	-	-	-	-	-	-	-	-
1851382	0	12	in	IN	-	-	-	-	-	-	-	-
1851382	0	13	a	DT	-	-	-	-	-	-	-	-
1851382	0	14	mixed	VBN	-	-	-	-	-	-	-	-
1851382	0	15	129SvJ	NN	-	-	-	-	-	-	-	-
1851382	0	16	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	17	C57B6	NN	-	-	-	-	-	-	-	-
1851382	0	18	background	NN	-	-	-	-	-	-	-	-
1851382	0	19	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Mice	NNS	-	-	-	-	-	-	-	(6)
1851382	0	2	were	VBD	-	-	-	-	-	-	-	-
1851382	0	3	housed	VBN	-	-	-	-	-	-	-	-
1851382	0	4	in	IN	-	-	-	-	-	-	-	-
1851382	0	5	a	DT	-	-	-	-	-	-	-	-
1851382	0	6	special	JJ	-	-	-	-	-	-	-	-
1851382	0	7	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	8	pathogen	NN	-	-	-	-	-	-	-	-
1851382	0	9	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	10	free	JJ	-	-	-	-	-	-	-	-
1851382	0	11	facility	NN	-	-	-	-	-	-	-	-
1851382	0	12	and	CC	-	-	-	-	-	-	-	-
1851382	0	13	all	DT	-	-	-	-	-	-	-	-
1851382	0	14	procedures	NNS	-	-	-	-	-	-	-	-
1851382	0	15	were	VBD	-	-	-	-	-	-	-	-
1851382	0	16	approved	VBN	-	-	-	-	-	-	-	-
1851382	0	17	by	IN	-	-	-	-	-	-	-	-
1851382	0	18	the	DT	-	-	-	-	-	-	-	(136
1851382	0	19	University	NNP	-	-	-	-	-	-	-	-
1851382	0	20	of	IN	-	-	-	-	-	-	-	-
1851382	0	21	Washington	NNP	-	-	-	-	-	-	-	136)
1851382	0	22	Animal	NNP	-	-	-	-	-	-	-	-
1851382	0	23	Care	NNP	-	-	-	-	-	-	-	-
1851382	0	24	and	CC	-	-	-	-	-	-	-	-
1851382	0	25	Use	NNP	-	-	-	-	-	-	-	-
1851382	0	26	Committee	NN	-	-	-	-	-	-	-	-
1851382	0	27	.	.	-	-	-	-	-	-	-	-

1851382	0	1	A	DT	-	-	-	-	-	-	-	-
1851382	0	2	PCR	NN	-	-	-	-	-	-	-	-
1851382	0	3	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	4	based	VBN	-	-	-	-	-	-	-	-
1851382	0	5	genotyping	NN	-	-	-	-	-	-	-	-
1851382	0	6	method	NN	-	-	-	-	-	-	-	-
1851382	0	7	was	VBD	-	-	-	-	-	-	-	-
1851382	0	8	established	VBN	-	-	-	-	-	-	-	-
1851382	0	9	to	TO	-	-	-	-	-	-	-	-
1851382	0	10	identify	VB	-	-	-	-	-	-	-	-
1851382	0	11	the	DT	-	-	-	-	-	-	-	-
1851382	0	12	wild	JJ	-	-	-	-	-	-	-	(137
1851382	0	13	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	14	type	NN	-	-	-	-	-	-	-	137)
1851382	0	15	,	,	-	-	-	-	-	-	-	-
1851382	0	16	co	NN	-	-	-	-	-	-	-	-
1851382	0	17	,	,	-	-	-	-	-	-	-	-
1851382	0	18	and	CC	-	-	-	-	-	-	-	-
1851382	0	19	ko	NN	-	-	-	-	-	-	-	-
1851382	0	20	loci	NNS	-	-	-	-	-	-	-	-
1851382	0	21	of	IN	-	-	-	-	-	-	-	-
1851382	0	22	the	DT	-	-	-	-	-	-	-	(1
1851382	0	23	SirT1	NN	-	-	-	-	-	-	-	-
1851382	0	24	gene	NN	-	-	-	-	-	-	-	1)
1851382	0	25	using	VBG	-	-	-	-	-	-	-	-
1851382	0	26	three	CD	-	-	-	-	-	-	-	-
1851382	0	27	primers	NNS	-	-	-	-	-	-	-	-
1851382	0	28	:	:	-	-	-	-	-	-	-	-
1851382	0	29	5	CD	-	-	-	-	-	-	-	-
1851382	0	30	'	SYM	-	-	-	-	-	-	-	-
1851382	0	31	co	NN	-	-	-	-	-	-	-	-
1851382	0	32	primer	NN	-	-	-	-	-	-	-	-
1851382	0	33	,	,	-	-	-	-	-	-	-	-
1851382	0	34	5	CD	-	-	-	-	-	-	-	-
1851382	0	35	'	SYM	-	-	-	-	-	-	-	-
1851382	0	36	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	37	GGTTGACTTAGGTCTTGTCTG	NN	-	-	-	-	-	-	-	-
1851382	0	38	;	:	-	-	-	-	-	-	-	-
1851382	0	39	5	CD	-	-	-	-	-	-	-	-
1851382	0	40	'	SYM	-	-	-	-	-	-	-	-
1851382	0	41	ko	NN	-	-	-	-	-	-	-	-
1851382	0	42	primer	NN	-	-	-	-	-	-	-	-
1851382	0	43	,	,	-	-	-	-	-	-	-	-
1851382	0	44	5	CD	-	-	-	-	-	-	-	-
1851382	0	45	'	SYM	-	-	-	-	-	-	-	-
1851382	0	46	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	47	AGGCGGATTTCTGAGTTCGA	NN	-	-	-	-	-	-	-	-
1851382	0	48	;	:	-	-	-	-	-	-	-	-
1851382	0	49	3	CD	-	-	-	-	-	-	-	-
1851382	0	50	'	SYM	-	-	-	-	-	-	-	-
1851382	0	51	primer	NN	-	-	-	-	-	-	-	-
1851382	0	52	,	,	-	-	-	-	-	-	-	-
1851382	0	53	5	CD	-	-	-	-	-	-	-	-
1851382	0	54	'	SYM	-	-	-	-	-	-	-	-
1851382	0	55	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	56	CGTCCCTTGTAATGTTTCCC	NN	-	-	-	-	-	-	-	-
1851382	0	57	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Murine	JJ	-	-	-	-	-	-	-	(138
1851382	0	2	embryonic	JJ	-	-	-	-	-	-	-	-
1851382	0	3	fibroblasts	NNS	-	-	-	-	-	-	-	138)
1851382	0	4	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	5	MEFs	NNS	-	-	-	-	-	-	-	-
1851382	0	6	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	7	were	VBD	-	-	-	-	-	-	-	-
1851382	0	8	isolated	VBN	-	-	-	-	-	-	-	-
1851382	0	9	from	IN	-	-	-	-	-	-	-	-
1851382	0	10	the	DT	-	-	-	-	-	-	-	-
1851382	0	11	embryos	NNS	-	-	-	-	-	-	-	-
1851382	0	12	between	IN	-	-	-	-	-	-	-	-
1851382	0	13	embryonic	JJ	-	-	-	-	-	-	-	-
1851382	0	14	day	NN	-	-	-	-	-	-	-	-
1851382	0	15	12.5	CD	-	-	-	-	-	-	-	-
1851382	0	16	and	CC	-	-	-	-	-	-	-	-
1851382	0	17	embryonic	JJ	-	-	-	-	-	-	-	-
1851382	0	18	day	NN	-	-	-	-	-	-	-	-
1851382	0	19	14.5	CD	-	-	-	-	-	-	-	-
1851382	0	20	.	.	-	-	-	-	-	-	-	-

1851382	0	1	The	DT	-	-	-	-	-	-	-	-
1851382	0	2	body	NN	-	-	-	-	-	-	-	-
1851382	0	3	weight	NN	-	-	-	-	-	-	-	-
1851382	0	4	was	VBD	-	-	-	-	-	-	-	-
1851382	0	5	measured	VBN	-	-	-	-	-	-	-	-
1851382	0	6	once	RB	-	-	-	-	-	-	-	-
1851382	0	7	a	DT	-	-	-	-	-	-	-	-
1851382	0	8	week	NN	-	-	-	-	-	-	-	-
1851382	0	9	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Serum	NN	-	-	-	-	-	-	-	(139
1851382	0	2	insulin	NN	-	-	-	-	-	-	-	-
1851382	0	3	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	4	like	JJ	-	-	-	-	-	-	-	-
1851382	0	5	growth	NN	-	-	-	-	-	-	-	-
1851382	0	6	factor	NN	-	-	-	-	-	-	-	-
1851382	0	7	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	8	1	CD	-	-	-	-	-	-	-	139)

1851382	0	1	A	DT	-	-	-	-	-	-	-	-
1851382	0	2	commercial	JJ	-	-	-	-	-	-	-	-
1851382	0	3	radioimmunoassay	NN	-	-	-	-	-	-	-	-
1851382	0	4	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	5	ALPCO	NNP	-	-	-	-	-	-	-	-
1851382	0	6	Inc.	NNP	-	-	-	-	-	-	-	-
1851382	0	7	,	,	-	-	-	-	-	-	-	-
1851382	0	8	Windham	NNP	-	-	-	-	-	-	-	-
1851382	0	9	,	,	-	-	-	-	-	-	-	-
1851382	0	10	NH	NNP	-	-	-	-	-	-	-	-
1851382	0	11	,	,	-	-	-	-	-	-	-	-
1851382	0	12	USA	NNP	-	-	-	-	-	-	-	-
1851382	0	13	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	14	was	VBD	-	-	-	-	-	-	-	-
1851382	0	15	used	VBN	-	-	-	-	-	-	-	-
1851382	0	16	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Samples	NNS	-	-	-	-	-	-	-	(140)
1851382	0	2	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	3	300	CD	-	-	-	-	-	-	-	-
1851382	0	4	μl	NN	-	-	-	-	-	-	-	-
1851382	0	5	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	6	were	VBD	-	-	-	-	-	-	-	-
1851382	0	7	prepared	VBN	-	-	-	-	-	-	-	-
1851382	0	8	via	IN	-	-	-	-	-	-	-	-
1851382	0	9	an	DT	-	-	-	-	-	-	-	-
1851382	0	10	alcohol	NN	-	-	-	-	-	-	-	-
1851382	0	11	extraction	NN	-	-	-	-	-	-	-	-
1851382	0	12	followed	VBN	-	-	-	-	-	-	-	-
1851382	0	13	by	IN	-	-	-	-	-	-	-	-
1851382	0	14	a	DT	-	-	-	-	-	-	-	-
1851382	0	15	2	CD	-	-	-	-	-	-	-	-
1851382	0	16	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	17	day	NN	-	-	-	-	-	-	-	-
1851382	0	18	disequilibrium	NN	-	-	-	-	-	-	-	-
1851382	0	19	incubation	NN	-	-	-	-	-	-	-	-
1851382	0	20	at	IN	-	-	-	-	-	-	-	-
1851382	0	21	4	CD	-	-	-	-	-	-	-	-
1851382	0	22	°C	NN	-	-	-	-	-	-	-	-
1851382	0	23	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Samples	NNS	-	-	-	-	-	-	-	(140)
1851382	0	2	were	VBD	-	-	-	-	-	-	-	-
1851382	0	3	measured	VBN	-	-	-	-	-	-	-	-
1851382	0	4	in	IN	-	-	-	-	-	-	-	-
1851382	0	5	duplicate	NN	-	-	-	-	-	-	-	-
1851382	0	6	and	CC	-	-	-	-	-	-	-	-
1851382	0	7	data	NNS	-	-	-	-	-	-	-	-
1851382	0	8	were	VBD	-	-	-	-	-	-	-	-
1851382	0	9	calculated	VBN	-	-	-	-	-	-	-	-
1851382	0	10	as	IN	-	-	-	-	-	-	-	-
1851382	0	11	the	DT	-	-	-	-	-	-	-	(140
1851382	0	12	samples	NNS	-	-	-	-	-	-	-	140)
1851382	0	13	were	VBD	-	-	-	-	-	-	-	-
1851382	0	14	counted	VBN	-	-	-	-	-	-	-	-
1851382	0	15	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Six	CD	-	-	-	-	-	-	-	-
1851382	0	2	standards	NNS	-	-	-	-	-	-	-	-
1851382	0	3	ranging	VBG	-	-	-	-	-	-	-	-
1851382	0	4	from	IN	-	-	-	-	-	-	-	-
1851382	0	5	10	CD	-	-	-	-	-	-	-	-
1851382	0	6	to	IN	-	-	-	-	-	-	-	-
1851382	0	7	500	CD	-	-	-	-	-	-	-	-
1851382	0	8	ng	NN	-	-	-	-	-	-	-	-
1851382	0	9	/	SYM	-	-	-	-	-	-	-	-
1851382	0	10	ml	NN	-	-	-	-	-	-	-	-
1851382	0	11	were	VBD	-	-	-	-	-	-	-	-
1851382	0	12	used	VBN	-	-	-	-	-	-	-	-
1851382	0	13	to	TO	-	-	-	-	-	-	-	-
1851382	0	14	generate	VB	-	-	-	-	-	-	-	-
1851382	0	15	the	DT	-	-	-	-	-	-	-	-
1851382	0	16	standard	JJ	-	-	-	-	-	-	-	-
1851382	0	17	curve	NN	-	-	-	-	-	-	-	-
1851382	0	18	.	.	-	-	-	-	-	-	-	-

1851382	0	1	The	DT	-	-	-	-	-	-	-	-
1851382	0	2	lower	JJ	-	-	-	-	-	-	-	-
1851382	0	3	limit	NN	-	-	-	-	-	-	-	-
1851382	0	4	of	IN	-	-	-	-	-	-	-	-
1851382	0	5	detection	NN	-	-	-	-	-	-	-	-
1851382	0	6	was	VBD	-	-	-	-	-	-	-	-
1851382	0	7	10	CD	-	-	-	-	-	-	-	-
1851382	0	8	ng	NN	-	-	-	-	-	-	-	-
1851382	0	9	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Survival	NN	-	-	-	-	-	-	-	(141)
1851382	0	2	assay	NN	-	-	-	-	-	-	-	-

1851382	0	1	To	TO	-	-	-	-	-	-	-	-
1851382	0	2	determine	VB	-	-	-	-	-	-	-	-
1851382	0	3	the	DT	-	-	-	-	-	-	-	-
1851382	0	4	sensitivity	NN	-	-	-	-	-	-	-	-
1851382	0	5	of	IN	-	-	-	-	-	-	-	-
1851382	0	6	embryonic	JJ	-	-	-	-	-	-	-	(142
1851382	0	7	stem	NN	-	-	-	-	-	-	-	-
1851382	0	8	cells	NNS	-	-	-	-	-	-	-	142)
1851382	0	9	after	IN	-	-	-	-	-	-	-	-
1851382	0	10	ionizing	VBG	-	-	-	-	-	-	-	(143|(144
1851382	0	11	radiation	NN	-	-	-	-	-	-	-	143)
1851382	0	12	or	CC	-	-	-	-	-	-	-	-
1851382	0	13	hydrogen	NN	-	-	-	-	-	-	-	(145|(146
1851382	0	14	peroxide	NN	-	-	-	-	-	-	-	145)
1851382	0	15	treatment	NN	-	-	-	-	-	-	-	146)|144)
1851382	0	16	,	,	-	-	-	-	-	-	-	-
1851382	0	17	300	CD	-	-	-	-	-	-	-	-
1851382	0	18	embryonic	JJ	-	-	-	-	-	-	-	-
1851382	0	19	stem	NN	-	-	-	-	-	-	-	-
1851382	0	20	cells	NNS	-	-	-	-	-	-	-	-
1851382	0	21	were	VBD	-	-	-	-	-	-	-	-
1851382	0	22	seeded	VBN	-	-	-	-	-	-	-	-
1851382	0	23	onto	IN	-	-	-	-	-	-	-	-
1851382	0	24	a	DT	-	-	-	-	-	-	-	(147
1851382	0	25	10	CD	-	-	-	-	-	-	-	-
1851382	0	26	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	27	cm	NN	-	-	-	-	-	-	-	-
1851382	0	28	plate	NN	-	-	-	-	-	-	-	147)
1851382	0	29	for	IN	-	-	-	-	-	-	-	-
1851382	0	30	24	CD	-	-	-	-	-	-	-	-
1851382	0	31	hours	NNS	-	-	-	-	-	-	-	-
1851382	0	32	.	.	-	-	-	-	-	-	-	-

1851382	0	1	The	DT	-	-	-	-	-	-	-	(147
1851382	0	2	plates	NNS	-	-	-	-	-	-	-	147)
1851382	0	3	were	VBD	-	-	-	-	-	-	-	-
1851382	0	4	either	CC	-	-	-	-	-	-	-	-
1851382	0	5	exposed	VBN	-	-	-	-	-	-	-	-
1851382	0	6	to	IN	-	-	-	-	-	-	-	-
1851382	0	7	a	DT	-	-	-	-	-	-	-	-
1851382	0	8	137Cs	NNS	-	-	-	-	-	-	-	-
1851382	0	9	source	NN	-	-	-	-	-	-	-	-
1851382	0	10	at	IN	-	-	-	-	-	-	-	-
1851382	0	11	indicated	VBN	-	-	-	-	-	-	-	-
1851382	0	12	doses	NNS	-	-	-	-	-	-	-	-
1851382	0	13	or	CC	-	-	-	-	-	-	-	-
1851382	0	14	were	VBD	-	-	-	-	-	-	-	-
1851382	0	15	treated	VBN	-	-	-	-	-	-	-	-
1851382	0	16	with	IN	-	-	-	-	-	-	-	-
1851382	0	17	embryonic	JJ	-	-	-	-	-	-	-	(142
1851382	0	18	stem	NN	-	-	-	-	-	-	-	142)
1851382	0	19	media	NNS	-	-	-	-	-	-	-	-
1851382	0	20	containing	VBG	-	-	-	-	-	-	-	-
1851382	0	21	hydrogen	NN	-	-	-	-	-	-	-	-
1851382	0	22	peroxide	NN	-	-	-	-	-	-	-	-
1851382	0	23	at	IN	-	-	-	-	-	-	-	-
1851382	0	24	indicated	VBN	-	-	-	-	-	-	-	-
1851382	0	25	concentrations	NNS	-	-	-	-	-	-	-	-
1851382	0	26	for	IN	-	-	-	-	-	-	-	-
1851382	0	27	30	CD	-	-	-	-	-	-	-	-
1851382	0	28	minutes	NNS	-	-	-	-	-	-	-	-
1851382	0	29	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Seven	CD	-	-	-	-	-	-	-	-
1851382	0	2	days	NNS	-	-	-	-	-	-	-	-
1851382	0	3	after	IN	-	-	-	-	-	-	-	-
1851382	0	4	irradiation	NN	-	-	-	-	-	-	-	(144|(143)
1851382	0	5	or	CC	-	-	-	-	-	-	-	-
1851382	0	6	hydrogen	NN	-	-	-	-	-	-	-	(145|(146
1851382	0	7	peroxide	NN	-	-	-	-	-	-	-	145)
1851382	0	8	treatment	NN	-	-	-	-	-	-	-	146)|144)
1851382	0	9	,	,	-	-	-	-	-	-	-	-
1851382	0	10	the	DT	-	-	-	-	-	-	-	-
1851382	0	11	embryonic	JJ	-	-	-	-	-	-	-	(142
1851382	0	12	stem	NN	-	-	-	-	-	-	-	142)
1851382	0	13	colonies	NNS	-	-	-	-	-	-	-	-
1851382	0	14	stained	VBN	-	-	-	-	-	-	-	-
1851382	0	15	with	IN	-	-	-	-	-	-	-	-
1851382	0	16	crystal	JJ	-	-	-	-	-	-	-	-
1851382	0	17	violet	NN	-	-	-	-	-	-	-	-
1851382	0	18	were	VBD	-	-	-	-	-	-	-	-
1851382	0	19	counted	VBN	-	-	-	-	-	-	-	-
1851382	0	20	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Estrogen	NN	-	-	-	-	-	-	-	(46|(7)
1851382	0	2	implantation	NN	-	-	-	-	-	-	-	46)

1851382	0	1	Estrogen	NN	-	-	-	-	-	-	-	(148|(7)
1851382	0	2	pellets	NNS	-	-	-	-	-	-	-	-
1851382	0	3	in	IN	-	-	-	-	-	-	-	-
1851382	0	4	the	DT	-	-	-	-	-	-	-	-
1851382	0	5	form	NN	-	-	-	-	-	-	-	-
1851382	0	6	of	IN	-	-	-	-	-	-	-	-
1851382	0	7	17β	NN	-	-	-	-	-	-	-	-
1851382	0	8	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	9	estradiol	NN	-	-	-	-	-	-	-	148)
1851382	0	10	,	,	-	-	-	-	-	-	-	-
1851382	0	11	at	IN	-	-	-	-	-	-	-	-
1851382	0	12	0.1	CD	-	-	-	-	-	-	-	-
1851382	0	13	mg	NN	-	-	-	-	-	-	-	-
1851382	0	14	,	,	-	-	-	-	-	-	-	-
1851382	0	15	and	CC	-	-	-	-	-	-	-	-
1851382	0	16	the	DT	-	-	-	-	-	-	-	-
1851382	0	17	21	CD	-	-	-	-	-	-	-	(149
1851382	0	18	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	19	day	NN	-	-	-	-	-	-	-	149)
1851382	0	20	releasing	NN	-	-	-	-	-	-	-	-
1851382	0	21	time	NN	-	-	-	-	-	-	-	-
1851382	0	22	were	VBD	-	-	-	-	-	-	-	-
1851382	0	23	obtained	VBN	-	-	-	-	-	-	-	-
1851382	0	24	from	IN	-	-	-	-	-	-	-	-
1851382	0	25	Innovative	NNP	-	-	-	-	-	-	-	(150
1851382	0	26	Research	NNP	-	-	-	-	-	-	-	150)
1851382	0	27	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	28	Sarasota	NNP	-	-	-	-	-	-	-	-
1851382	0	29	,	,	-	-	-	-	-	-	-	-
1851382	0	30	FL	NNP	-	-	-	-	-	-	-	-
1851382	0	31	,	,	-	-	-	-	-	-	-	-
1851382	0	32	USA	NNP	-	-	-	-	-	-	-	-
1851382	0	33	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	34	.	.	-	-	-	-	-	-	-	-

1851382	0	1	One	CD	-	-	-	-	-	-	-	(35
1851382	0	2	pellet	NN	-	-	-	-	-	-	-	35)
1851382	0	3	was	VBD	-	-	-	-	-	-	-	-
1851382	0	4	subcutaneously	RB	-	-	-	-	-	-	-	-
1851382	0	5	implanted	VBN	-	-	-	-	-	-	-	-
1851382	0	6	in	IN	-	-	-	-	-	-	-	-
1851382	0	7	the	DT	-	-	-	-	-	-	-	(36
1851382	0	8	subscapular	JJ	-	-	-	-	-	-	-	-
1851382	0	9	region	NN	-	-	-	-	-	-	-	-
1851382	0	10	of	IN	-	-	-	-	-	-	-	-
1851382	0	11	individual	JJ	-	-	-	-	-	-	-	-
1851382	0	12	female	JJ	-	-	-	-	-	-	-	-
1851382	0	13	mice	NNS	-	-	-	-	-	-	-	36)
1851382	0	14	using	VBG	-	-	-	-	-	-	-	-
1851382	0	15	a	DT	-	-	-	-	-	-	-	-
1851382	0	16	sterilizedmetal	NN	-	-	-	-	-	-	-	-
1851382	0	17	trochar	NN	-	-	-	-	-	-	-	-
1851382	0	18	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	19	Innovative	NNP	-	-	-	-	-	-	-	(150
1851382	0	20	Research	NNP	-	-	-	-	-	-	-	150)
1851382	0	21	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	22	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Whole	JJ	-	-	-	-	-	-	-	(30
1851382	0	2	mount	NN	-	-	-	-	-	-	-	-
1851382	0	3	analysis	NN	-	-	-	-	-	-	-	30)

1851382	0	1	The	DT	-	-	-	-	-	-	-	-
1851382	0	2	inguinoabdominal	JJ	-	-	-	-	-	-	-	-
1851382	0	3	mammary	JJ	-	-	-	-	-	-	-	-
1851382	0	4	fat	NN	-	-	-	-	-	-	-	-
1851382	0	5	pads	NNS	-	-	-	-	-	-	-	-
1851382	0	6	were	VBD	-	-	-	-	-	-	-	-
1851382	0	7	spread	VBN	-	-	-	-	-	-	-	-
1851382	0	8	on	IN	-	-	-	-	-	-	-	-
1851382	0	9	microscope	NN	-	-	-	-	-	-	-	-
1851382	0	10	slides	NNS	-	-	-	-	-	-	-	-
1851382	0	11	,	,	-	-	-	-	-	-	-	-
1851382	0	12	fixed	VBN	-	-	-	-	-	-	-	-
1851382	0	13	in	IN	-	-	-	-	-	-	-	-
1851382	0	14	Carnoy	NNP	-	-	-	-	-	-	-	-
1851382	0	15	's	POS	-	-	-	-	-	-	-	-
1851382	0	16	fixative	NN	-	-	-	-	-	-	-	-
1851382	0	17	overnight	RB	-	-	-	-	-	-	-	-
1851382	0	18	,	,	-	-	-	-	-	-	-	-
1851382	0	19	hydrated	VBN	-	-	-	-	-	-	-	-
1851382	0	20	and	CC	-	-	-	-	-	-	-	-
1851382	0	21	stained	VBN	-	-	-	-	-	-	-	-
1851382	0	22	with	IN	-	-	-	-	-	-	-	-
1851382	0	23	carmine	NN	-	-	-	-	-	-	-	-
1851382	0	24	alum	NN	-	-	-	-	-	-	-	-
1851382	0	25	stain	NN	-	-	-	-	-	-	-	-
1851382	0	26	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	27	Sigma	NNP	-	-	-	-	-	-	-	(151
1851382	0	28	,	,	-	-	-	-	-	-	-	-
1851382	0	29	St.	NNP	-	-	-	-	-	-	-	-
1851382	0	30	Louis	NNP	-	-	-	-	-	-	-	-
1851382	0	31	,	,	-	-	-	-	-	-	-	-
1851382	0	32	MO	NNP	-	-	-	-	-	-	-	-
1851382	0	33	,	,	-	-	-	-	-	-	-	-
1851382	0	34	USA	NNP	-	-	-	-	-	-	-	151)
1851382	0	35	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	36	overnight	RB	-	-	-	-	-	-	-	-
1851382	0	37	,	,	-	-	-	-	-	-	-	-
1851382	0	38	and	CC	-	-	-	-	-	-	-	-
1851382	0	39	were	VBD	-	-	-	-	-	-	-	-
1851382	0	40	then	RB	-	-	-	-	-	-	-	-
1851382	0	41	dehydrated	VBN	-	-	-	-	-	-	-	-
1851382	0	42	,	,	-	-	-	-	-	-	-	-
1851382	0	43	treated	VBN	-	-	-	-	-	-	-	-
1851382	0	44	with	IN	-	-	-	-	-	-	-	-
1851382	0	45	xylene	NN	-	-	-	-	-	-	-	-
1851382	0	46	to	TO	-	-	-	-	-	-	-	-
1851382	0	47	remove	VB	-	-	-	-	-	-	-	-
1851382	0	48	fat	NN	-	-	-	-	-	-	-	(107)
1851382	0	49	,	,	-	-	-	-	-	-	-	-
1851382	0	50	and	CC	-	-	-	-	-	-	-	-
1851382	0	51	mounted	VBN	-	-	-	-	-	-	-	-
1851382	0	52	with	IN	-	-	-	-	-	-	-	-
1851382	0	53	Secure	NNP	-	-	-	-	-	-	-	-
1851382	0	54	Mount	NNP	-	-	-	-	-	-	-	-
1851382	0	55	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	56	Fisher	NNP	-	-	-	-	-	-	-	(152
1851382	0	57	Scientific	NNP	-	-	-	-	-	-	-	-
1851382	0	58	,	,	-	-	-	-	-	-	-	-
1851382	0	59	Pittsburgh	NNP	-	-	-	-	-	-	-	-
1851382	0	60	,	,	-	-	-	-	-	-	-	-
1851382	0	61	PA	NNP	-	-	-	-	-	-	-	-
1851382	0	62	,	,	-	-	-	-	-	-	-	-
1851382	0	63	USA	NNP	-	-	-	-	-	-	-	152)
1851382	0	64	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	65	and	CC	-	-	-	-	-	-	-	-
1851382	0	66	cover	NN	-	-	-	-	-	-	-	-
1851382	0	67	slips	NNS	-	-	-	-	-	-	-	-
1851382	0	68	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Histological	JJ	-	-	-	-	-	-	-	(31a)
1851382	0	2	,	,	-	-	-	-	-	-	-	-
1851382	0	3	immunohistochemical	JJ	-	-	-	-	-	-	-	-
1851382	0	4	,	,	-	-	-	-	-	-	-	-
1851382	0	5	and	CC	-	-	-	-	-	-	-	-
1851382	0	6	immunofluorescence	NN	-	-	-	-	-	-	-	(153
1851382	0	7	analyses	NNS	-	-	-	-	-	-	-	(31a)|153)

1851382	0	1	The	DT	-	-	-	-	-	-	-	(6
1851382	0	2	mice	NNS	-	-	-	-	-	-	-	6)
1851382	0	3	were	VBD	-	-	-	-	-	-	-	-
1851382	0	4	given	VBN	-	-	-	-	-	-	-	-
1851382	0	5	a	DT	-	-	-	-	-	-	-	-
1851382	0	6	single	JJ	-	-	-	-	-	-	-	-
1851382	0	7	dose	NN	-	-	-	-	-	-	-	-
1851382	0	8	of	IN	-	-	-	-	-	-	-	-
1851382	0	9	bromodeoxyurdine	NN	-	-	-	-	-	-	-	(154)
1851382	0	10	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	11	BrdU	NN	-	-	-	-	-	-	-	-
1851382	0	12	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	13	at	IN	-	-	-	-	-	-	-	-
1851382	0	14	100	CD	-	-	-	-	-	-	-	-
1851382	0	15	g	NN	-	-	-	-	-	-	-	-
1851382	0	16	/	SYM	-	-	-	-	-	-	-	-
1851382	0	17	kg	NN	-	-	-	-	-	-	-	-
1851382	0	18	body	NN	-	-	-	-	-	-	-	-
1851382	0	19	weight	NN	-	-	-	-	-	-	-	-
1851382	0	20	via	IN	-	-	-	-	-	-	-	-
1851382	0	21	intraperitoneal	JJ	-	-	-	-	-	-	-	-
1851382	0	22	injection	NN	-	-	-	-	-	-	-	-
1851382	0	23	2	CD	-	-	-	-	-	-	-	-
1851382	0	24	hours	NNS	-	-	-	-	-	-	-	-
1851382	0	25	before	IN	-	-	-	-	-	-	-	-
1851382	0	26	euthanasia	NN	-	-	-	-	-	-	-	-
1851382	0	27	.	.	-	-	-	-	-	-	-	-

1851382	0	1	The	DT	-	-	-	-	-	-	-	(108
1851382	0	2	mammary	JJ	-	-	-	-	-	-	-	(107
1851382	0	3	fat	NN	-	-	-	-	-	-	-	107)
1851382	0	4	pads	NNS	-	-	-	-	-	-	-	108)
1851382	0	5	,	,	-	-	-	-	-	-	-	-
1851382	0	6	as	RB	-	-	-	-	-	-	-	-
1851382	0	7	well	RB	-	-	-	-	-	-	-	-
1851382	0	8	as	IN	-	-	-	-	-	-	-	-
1851382	0	9	other	JJ	-	-	-	-	-	-	-	-
1851382	0	10	tissues	NNS	-	-	-	-	-	-	-	-
1851382	0	11	,	,	-	-	-	-	-	-	-	-
1851382	0	12	were	VBD	-	-	-	-	-	-	-	-
1851382	0	13	collected	VBN	-	-	-	-	-	-	-	-
1851382	0	14	and	CC	-	-	-	-	-	-	-	-
1851382	0	15	fixed	VBN	-	-	-	-	-	-	-	-
1851382	0	16	in	IN	-	-	-	-	-	-	-	-
1851382	0	17	10	CD	-	-	-	-	-	-	-	-
1851382	0	18	%	NN	-	-	-	-	-	-	-	-
1851382	0	19	formalin	NN	-	-	-	-	-	-	-	-
1851382	0	20	solution	NN	-	-	-	-	-	-	-	-
1851382	0	21	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	22	Fisher	NNP	-	-	-	-	-	-	-	(152
1851382	0	23	Scientific	NNP	-	-	-	-	-	-	-	152)
1851382	0	24	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	25	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Paraffin	NN	-	-	-	-	-	-	-	-
1851382	0	2	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	3	embedded	VBN	-	-	-	-	-	-	-	-
1851382	0	4	sections	NNS	-	-	-	-	-	-	-	-
1851382	0	5	were	VBD	-	-	-	-	-	-	-	-
1851382	0	6	prepared	VBN	-	-	-	-	-	-	-	-
1851382	0	7	at	IN	-	-	-	-	-	-	-	-
1851382	0	8	4	CD	-	-	-	-	-	-	-	-
1851382	0	9	μm	NN	-	-	-	-	-	-	-	-
1851382	0	10	thickness	NN	-	-	-	-	-	-	-	-
1851382	0	11	followed	VBN	-	-	-	-	-	-	-	-
1851382	0	12	by	IN	-	-	-	-	-	-	-	-
1851382	0	13	standard	JJ	-	-	-	-	-	-	-	-
1851382	0	14	H	NN	-	-	-	-	-	-	-	-
1851382	0	15	&	CC	-	-	-	-	-	-	-	-
1851382	0	16	E	NN	-	-	-	-	-	-	-	-
1851382	0	17	staining	NN	-	-	-	-	-	-	-	-
1851382	0	18	for	IN	-	-	-	-	-	-	-	-
1851382	0	19	histological	JJ	-	-	-	-	-	-	-	(31
1851382	0	20	analysis	NN	-	-	-	-	-	-	-	31)
1851382	0	21	and	CC	-	-	-	-	-	-	-	-
1851382	0	22	by	IN	-	-	-	-	-	-	-	-
1851382	0	23	immunohistochemical	JJ	-	-	-	-	-	-	-	-
1851382	0	24	staining	NN	-	-	-	-	-	-	-	-
1851382	0	25	for	IN	-	-	-	-	-	-	-	-
1851382	0	26	BrdU	NN	-	-	-	-	-	-	-	-
1851382	0	27	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	28	labeled	VBN	-	-	-	-	-	-	-	-
1851382	0	29	cells	NNS	-	-	-	-	-	-	-	-
1851382	0	30	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	31	Sigma	NNP	-	-	-	-	-	-	-	(151)
1851382	0	32	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	33	and	CC	-	-	-	-	-	-	-	-
1851382	0	34	apoptotic	JJ	-	-	-	-	-	-	-	(155
1851382	0	35	cells	NNS	-	-	-	-	-	-	-	155)
1851382	0	36	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	37	Promega	NNP	-	-	-	-	-	-	-	-
1851382	0	38	,	,	-	-	-	-	-	-	-	-
1851382	0	39	Madison	NNP	-	-	-	-	-	-	-	-
1851382	0	40	,	,	-	-	-	-	-	-	-	-
1851382	0	41	WI	NNP	-	-	-	-	-	-	-	-
1851382	0	42	,	,	-	-	-	-	-	-	-	-
1851382	0	43	USA	NNP	-	-	-	-	-	-	-	-
1851382	0	44	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	45	.	.	-	-	-	-	-	-	-	-

1851382	0	1	To	TO	-	-	-	-	-	-	-	-
1851382	0	2	detect	VB	-	-	-	-	-	-	-	-
1851382	0	3	the	DT	-	-	-	-	-	-	-	-
1851382	0	4	presence	NN	-	-	-	-	-	-	-	-
1851382	0	5	of	IN	-	-	-	-	-	-	-	-
1851382	0	6	mouse	NN	-	-	-	-	-	-	-	(156|(157
1851382	0	7	milk	NN	-	-	-	-	-	-	-	156)
1851382	0	8	proteins	NN	-	-	-	-	-	-	-	157)
1851382	0	9	,	,	-	-	-	-	-	-	-	-
1851382	0	10	a	DT	-	-	-	-	-	-	-	-
1851382	0	11	rabbit	NN	-	-	-	-	-	-	-	-
1851382	0	12	anti-mouse	JJ	-	-	-	-	-	-	-	-
1851382	0	13	milk	NN	-	-	-	-	-	-	-	-
1851382	0	14	specific	JJ	-	-	-	-	-	-	-	-
1851382	0	15	protein	NN	-	-	-	-	-	-	-	-
1851382	0	16	antibody	NN	-	-	-	-	-	-	-	-
1851382	0	17	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	18	Nordic	NNP	-	-	-	-	-	-	-	-
1851382	0	19	Immunology	NNP	-	-	-	-	-	-	-	-
1851382	0	20	,	,	-	-	-	-	-	-	-	-
1851382	0	21	Tillburg	NNP	-	-	-	-	-	-	-	-
1851382	0	22	,	,	-	-	-	-	-	-	-	-
1851382	0	23	The	DT	-	-	-	-	-	-	-	-
1851382	0	24	Netherlands	NNP	-	-	-	-	-	-	-	-
1851382	0	25	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	26	was	VBD	-	-	-	-	-	-	-	-
1851382	0	27	used	VBN	-	-	-	-	-	-	-	-
1851382	0	28	for	IN	-	-	-	-	-	-	-	-
1851382	0	29	immunofluorescent	JJ	-	-	-	-	-	-	-	-
1851382	0	30	staining	NN	-	-	-	-	-	-	-	-
1851382	0	31	,	,	-	-	-	-	-	-	-	-
1851382	0	32	followed	VBN	-	-	-	-	-	-	-	-
1851382	0	33	by	IN	-	-	-	-	-	-	-	-
1851382	0	34	Texas	NNP	-	-	-	-	-	-	-	-
1851382	0	35	Red	NNP	-	-	-	-	-	-	-	-
1851382	0	36	anti-rabbit	JJ	-	-	-	-	-	-	-	-
1851382	0	37	secondary	JJ	-	-	-	-	-	-	-	-
1851382	0	38	antibody	NN	-	-	-	-	-	-	-	-
1851382	0	39	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	40	Molecular	NNP	-	-	-	-	-	-	-	(158
1851382	0	41	Probes	NNP	-	-	-	-	-	-	-	158)
1851382	0	42	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	43	and	CC	-	-	-	-	-	-	-	-
1851382	0	44	DAPI	NN	-	-	-	-	-	-	-	-
1851382	0	45	staining	NN	-	-	-	-	-	-	-	-
1851382	0	46	for	IN	-	-	-	-	-	-	-	-
1851382	0	47	nuclei	NNS	-	-	-	-	-	-	-	-
1851382	0	48	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	49	Molecular	NNP	-	-	-	-	-	-	-	(158
1851382	0	50	Probe	NNP	-	-	-	-	-	-	-	-
1851382	0	51	,	,	-	-	-	-	-	-	-	-
1851382	0	52	Eugene	NNP	-	-	-	-	-	-	-	-
1851382	0	53	,	,	-	-	-	-	-	-	-	-
1851382	0	54	OR	NNP	-	-	-	-	-	-	-	-
1851382	0	55	,	,	-	-	-	-	-	-	-	-
1851382	0	56	USA	NNP	-	-	-	-	-	-	-	158)
1851382	0	57	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	58	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Microscopic	JJ	-	-	-	-	-	-	-	-
1851382	0	2	analyses	NNS	-	-	-	-	-	-	-	-
1851382	0	3	of	IN	-	-	-	-	-	-	-	-
1851382	0	4	all	DT	-	-	-	-	-	-	-	-
1851382	0	5	histological	JJ	-	-	-	-	-	-	-	-
1851382	0	6	findings	NNS	-	-	-	-	-	-	-	-
1851382	0	7	were	VBD	-	-	-	-	-	-	-	-
1851382	0	8	carried	VBN	-	-	-	-	-	-	-	-
1851382	0	9	out	RP	-	-	-	-	-	-	-	-
1851382	0	10	on	IN	-	-	-	-	-	-	-	-
1851382	0	11	an	DT	-	-	-	-	-	-	-	-
1851382	0	12	AxioVert	NNP	-	-	-	-	-	-	-	-
1851382	0	13	200M	NN	-	-	-	-	-	-	-	-
1851382	0	14	microscope	NN	-	-	-	-	-	-	-	-
1851382	0	15	with	IN	-	-	-	-	-	-	-	-
1851382	0	16	AxioVision	NNP	-	-	-	-	-	-	-	-
1851382	0	17	4.5	CD	-	-	-	-	-	-	-	-
1851382	0	18	software	NN	-	-	-	-	-	-	-	-
1851382	0	19	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	20	Carl	NNP	-	-	-	-	-	-	-	-
1851382	0	21	Zeiss	NNP	-	-	-	-	-	-	-	-
1851382	0	22	,	,	-	-	-	-	-	-	-	-
1851382	0	23	München	NNP	-	-	-	-	-	-	-	-
1851382	0	24	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	25	Hallbergmoos	NNP	-	-	-	-	-	-	-	-
1851382	0	26	,	,	-	-	-	-	-	-	-	-
1851382	0	27	Germany	NNP	-	-	-	-	-	-	-	-
1851382	0	28	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	29	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Protein	NN	-	-	-	-	-	-	-	-
1851382	0	2	analysis	NN	-	-	-	-	-	-	-	-

1851382	0	1	Protein	NN	-	-	-	-	-	-	-	(159
1851382	0	2	extracts	NNS	-	-	-	-	-	-	-	159)
1851382	0	3	were	VBD	-	-	-	-	-	-	-	-
1851382	0	4	prepared	VBN	-	-	-	-	-	-	-	-
1851382	0	5	from	IN	-	-	-	-	-	-	-	-
1851382	0	6	mammary	JJ	-	-	-	-	-	-	-	(160
1851382	0	7	tissues	NNS	-	-	-	-	-	-	-	160)
1851382	0	8	as	RB	-	-	-	-	-	-	-	-
1851382	0	9	well	RB	-	-	-	-	-	-	-	-
1851382	0	10	as	IN	-	-	-	-	-	-	-	-
1851382	0	11	from	IN	-	-	-	-	-	-	-	-
1851382	0	12	MEFs	NNS	-	-	-	-	-	-	-	(138)
1851382	0	13	.	.	-	-	-	-	-	-	-	-

1851382	0	1	The	DT	-	-	-	-	-	-	-	-
1851382	0	2	following	VBG	-	-	-	-	-	-	-	-
1851382	0	3	primary	JJ	-	-	-	-	-	-	-	-
1851382	0	4	antibodies	NNS	-	-	-	-	-	-	-	-
1851382	0	5	were	VBD	-	-	-	-	-	-	-	-
1851382	0	6	used	VBN	-	-	-	-	-	-	-	-
1851382	0	7	:	:	-	-	-	-	-	-	-	-
1851382	0	8	anti-SirT1	JJ	-	-	-	-	-	-	-	-
1851382	0	9	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	10	Upstate	NNP	-	-	-	-	-	-	-	-
1851382	0	11	Biotechology	NNP	-	-	-	-	-	-	-	-
1851382	0	12	,	,	-	-	-	-	-	-	-	-
1851382	0	13	Lake	NNP	-	-	-	-	-	-	-	-
1851382	0	14	Placid	NNP	-	-	-	-	-	-	-	-
1851382	0	15	,	,	-	-	-	-	-	-	-	-
1851382	0	16	NY	NNP	-	-	-	-	-	-	-	-
1851382	0	17	,	,	-	-	-	-	-	-	-	-
1851382	0	18	USA	NNP	-	-	-	-	-	-	-	-
1851382	0	19	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	20	,	,	-	-	-	-	-	-	-	-
1851382	0	21	anti-IGF	JJ	-	-	-	-	-	-	-	(47
1851382	0	22	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	23	1	CD	-	-	-	-	-	-	-	-
1851382	0	24	binding	NN	-	-	-	-	-	-	-	-
1851382	0	25	protein	NN	-	-	-	-	-	-	-	-
1851382	0	26	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	27	1	CD	-	-	-	-	-	-	-	47)
1851382	0	28	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	29	IGFBP	NN	-	-	-	-	-	-	-	-
1851382	0	30	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	31	1	CD	-	-	-	-	-	-	-	-
1851382	0	32	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	33	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	34	R	NNP	-	-	-	-	-	-	-	-
1851382	0	35	&	CC	-	-	-	-	-	-	-	-
1851382	0	36	D	NNP	-	-	-	-	-	-	-	-
1851382	0	37	Systems	NNP	-	-	-	-	-	-	-	-
1851382	0	38	,	,	-	-	-	-	-	-	-	-
1851382	0	39	Minneapolis	NNP	-	-	-	-	-	-	-	-
1851382	0	40	,	,	-	-	-	-	-	-	-	-
1851382	0	41	MN	NNP	-	-	-	-	-	-	-	-
1851382	0	42	,	,	-	-	-	-	-	-	-	-
1851382	0	43	USA	NNP	-	-	-	-	-	-	-	-
1851382	0	44	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	45	,	,	-	-	-	-	-	-	-	-
1851382	0	46	and	CC	-	-	-	-	-	-	-	-
1851382	0	47	anti-actin	JJ	-	-	-	-	-	-	-	-
1851382	0	48	and	CC	-	-	-	-	-	-	-	-
1851382	0	49	anti-IκBα	JJ	-	-	-	-	-	-	-	-
1851382	0	50	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	51	Santa	NNP	-	-	-	-	-	-	-	(161
1851382	0	52	Cruz	NNP	-	-	-	-	-	-	-	-
1851382	0	53	Biotechnology	NNP	-	-	-	-	-	-	-	-
1851382	0	54	,	,	-	-	-	-	-	-	-	-
1851382	0	55	Santa	NNP	-	-	-	-	-	-	-	-
1851382	0	56	Cruz	NNP	-	-	-	-	-	-	-	-
1851382	0	57	,	,	-	-	-	-	-	-	-	-
1851382	0	58	CA	NNP	-	-	-	-	-	-	-	-
1851382	0	59	,	,	-	-	-	-	-	-	-	-
1851382	0	60	USA	NNP	-	-	-	-	-	-	-	161)
1851382	0	61	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	62	.	.	-	-	-	-	-	-	-	-

1851382	0	1	The	DT	-	-	-	-	-	-	-	-
1851382	0	2	corresponding	VBG	-	-	-	-	-	-	-	-
1851382	0	3	secondary	JJ	-	-	-	-	-	-	-	-
1851382	0	4	antibodies	NNS	-	-	-	-	-	-	-	-
1851382	0	5	were	VBD	-	-	-	-	-	-	-	-
1851382	0	6	horseradish	NN	-	-	-	-	-	-	-	-
1851382	0	7	peroxidase	NN	-	-	-	-	-	-	-	-
1851382	0	8	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	9	conjugated	VBN	-	-	-	-	-	-	-	-
1851382	0	10	anti-rabbit	JJ	-	-	-	-	-	-	-	-
1851382	0	11	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	12	Pierce	NNP	-	-	-	-	-	-	-	-
1851382	0	13	,	,	-	-	-	-	-	-	-	-
1851382	0	14	Rockford	NNP	-	-	-	-	-	-	-	-
1851382	0	15	,	,	-	-	-	-	-	-	-	-
1851382	0	16	IL	NNP	-	-	-	-	-	-	-	-
1851382	0	17	,	,	-	-	-	-	-	-	-	-
1851382	0	18	USA	NNP	-	-	-	-	-	-	-	-
1851382	0	19	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	20	,	,	-	-	-	-	-	-	-	-
1851382	0	21	anti-rat	JJ	-	-	-	-	-	-	-	-
1851382	0	22	,	,	-	-	-	-	-	-	-	-
1851382	0	23	and	CC	-	-	-	-	-	-	-	-
1851382	0	24	anti-goat	JJ	-	-	-	-	-	-	-	-
1851382	0	25	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	26	Santa	NNP	-	-	-	-	-	-	-	(161
1851382	0	27	Cruz	NNP	-	-	-	-	-	-	-	-
1851382	0	28	Biotechnology	NNP	-	-	-	-	-	-	-	161)
1851382	0	29	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	30	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Results	NNS	-	-	-	-	-	-	-	(37)

1851382	0	1	Growth	NN	-	-	-	-	-	-	-	(42
1851382	0	2	retardation	NN	-	-	-	-	-	-	-	-
1851382	0	3	in	IN	-	-	-	-	-	-	-	-
1851382	0	4	SirT1ko	NN	-	-	-	-	-	-	-	(22|(24
1851382	0	5	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	6	ko	NN	-	-	-	-	-	-	-	24)
1851382	0	7	mice	NNS	-	-	-	-	-	-	-	42)|22)

1851382	0	1	The	DT	-	-	-	-	-	-	-	-
1851382	0	2	conditional	JJ	-	-	-	-	-	-	-	(128
1851382	0	3	targeted	VBN	-	-	-	-	-	-	-	-
1851382	0	4	SirT1	NN	-	-	-	-	-	-	-	-
1851382	0	5	mutant	NN	-	-	-	-	-	-	-	128)
1851382	0	6	mice	NNS	-	-	-	-	-	-	-	-
1851382	0	7	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	8	SirT1co	NN	-	-	-	-	-	-	-	(25|(26
1851382	0	9	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	10	co	NN	-	-	-	-	-	-	-	26)
1851382	0	11	mice	NNS	-	-	-	-	-	-	-	25)
1851382	0	12	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	13	carry	VBP	-	-	-	-	-	-	-	-
1851382	0	14	an	DT	-	-	-	-	-	-	-	(162
1851382	0	15	insertion	NN	-	-	-	-	-	-	-	-
1851382	0	16	mutation	NN	-	-	-	-	-	-	-	-
1851382	0	17	of	IN	-	-	-	-	-	-	-	-
1851382	0	18	the	DT	-	-	-	-	-	-	-	-
1851382	0	19	neomycin	NN	-	-	-	-	-	-	-	-
1851382	0	20	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	21	resistant	JJ	-	-	-	-	-	-	-	-
1851382	0	22	gene	NN	-	-	-	-	-	-	-	-
1851382	0	23	and	CC	-	-	-	-	-	-	-	-
1851382	0	24	lox	NN	-	-	-	-	-	-	-	-
1851382	0	25	sequences	NNS	-	-	-	-	-	-	-	-
1851382	0	26	in	IN	-	-	-	-	-	-	-	-
1851382	0	27	the	DT	-	-	-	-	-	-	-	(1
1851382	0	28	SirT1	NN	-	-	-	-	-	-	-	-
1851382	0	29	gene	NN	-	-	-	-	-	-	-	1)
1851382	0	30	flanking	VBG	-	-	-	-	-	-	-	-
1851382	0	31	exon	NN	-	-	-	-	-	-	-	(131
1851382	0	32	4	CD	-	-	-	-	-	-	-	131)
1851382	0	33	that	WDT	-	-	-	-	-	-	-	-
1851382	0	34	encodes	VBZ	-	-	-	-	-	-	-	-
1851382	0	35	a	DT	-	-	-	-	-	-	-	-
1851382	0	36	conserved	VBN	-	-	-	-	-	-	-	-
1851382	0	37	Sir2	NN	-	-	-	-	-	-	-	-
1851382	0	38	motif	NN	-	-	-	-	-	-	-	162)
1851382	0	39	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	40	Figure	NN	-	-	-	-	-	-	-	(163
1851382	0	41	1a	NN	-	-	-	-	-	-	-	163)
1851382	0	42	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	43	.	.	-	-	-	-	-	-	-	-

1851382	0	1	The	DT	-	-	-	-	-	-	-	(162
1851382	0	2	mutation	NN	-	-	-	-	-	-	-	162)
1851382	0	3	does	VBZ	-	-	-	-	-	-	-	-
1851382	0	4	not	RB	-	-	-	-	-	-	-	-
1851382	0	5	affect	VB	-	-	-	-	-	-	-	-
1851382	0	6	the	DT	-	-	-	-	-	-	-	-
1851382	0	7	expression	NN	-	-	-	-	-	-	-	-
1851382	0	8	of	IN	-	-	-	-	-	-	-	-
1851382	0	9	SirT1	NN	-	-	-	-	-	-	-	(1)
1851382	0	10	in	IN	-	-	-	-	-	-	-	-
1851382	0	11	SirT1co	NN	-	-	-	-	-	-	-	(25|(26
1851382	0	12	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	13	co	NN	-	-	-	-	-	-	-	26)
1851382	0	14	mice	NNS	-	-	-	-	-	-	-	25)
1851382	0	15	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	16	Figure	NN	-	-	-	-	-	-	-	(164
1851382	0	17	1b	NN	-	-	-	-	-	-	-	164)
1851382	0	18	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	19	.	.	-	-	-	-	-	-	-	-

1851382	0	1	As	IN	-	-	-	-	-	-	-	-
1851382	0	2	expected	VBN	-	-	-	-	-	-	-	-
1851382	0	3	,	,	-	-	-	-	-	-	-	-
1851382	0	4	SirT1co	NN	-	-	-	-	-	-	-	(25|(26
1851382	0	5	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	6	co	NN	-	-	-	-	-	-	-	26)
1851382	0	7	mice	NNS	-	-	-	-	-	-	-	25)
1851382	0	8	are	VBP	-	-	-	-	-	-	-	-
1851382	0	9	phenotypically	RB	-	-	-	-	-	-	-	-
1851382	0	10	indistinguishable	JJ	-	-	-	-	-	-	-	-
1851382	0	11	from	IN	-	-	-	-	-	-	-	-
1851382	0	12	wild	JJ	-	-	-	-	-	-	-	(137|(165
1851382	0	13	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	14	type	NN	-	-	-	-	-	-	-	137)
1851382	0	15	mice	NNS	-	-	-	-	-	-	-	165)
1851382	0	16	.	.	-	-	-	-	-	-	-	-

1851382	0	1	To	TO	-	-	-	-	-	-	-	-
1851382	0	2	convert	VB	-	-	-	-	-	-	-	-
1851382	0	3	the	DT	-	-	-	-	-	-	-	-
1851382	0	4	SirT1	NN	-	-	-	-	-	-	-	(1)
1851382	0	5	co	NN	-	-	-	-	-	-	-	-
1851382	0	6	allele	NN	-	-	-	-	-	-	-	-
1851382	0	7	into	IN	-	-	-	-	-	-	-	-
1851382	0	8	the	DT	-	-	-	-	-	-	-	(166
1851382	0	9	SirT1	NN	-	-	-	-	-	-	-	(1)
1851382	0	10	ko	NN	-	-	-	-	-	-	-	-
1851382	0	11	allele	NN	-	-	-	-	-	-	-	166)
1851382	0	12	,	,	-	-	-	-	-	-	-	-
1851382	0	13	SirT1co	NN	-	-	-	-	-	-	-	(25|(26
1851382	0	14	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	15	co	NN	-	-	-	-	-	-	-	26)
1851382	0	16	mice	NNS	-	-	-	-	-	-	-	25)
1851382	0	17	were	VBD	-	-	-	-	-	-	-	-
1851382	0	18	crossed	VBN	-	-	-	-	-	-	-	-
1851382	0	19	with	IN	-	-	-	-	-	-	-	-
1851382	0	20	CMV	NN	-	-	-	-	-	-	-	(27|(28
1851382	0	21	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	22	Cre	NN	-	-	-	-	-	-	-	27)
1851382	0	23	transgenic	JJ	-	-	-	-	-	-	-	-
1851382	0	24	mice	NNS	-	-	-	-	-	-	-	28)
1851382	0	25	to	TO	-	-	-	-	-	-	-	-
1851382	0	26	generate	VB	-	-	-	-	-	-	-	-
1851382	0	27	SirT1	NN	-	-	-	-	-	-	-	(1)
1851382	0	28	heterozygotes	NNS	-	-	-	-	-	-	-	-
1851382	0	29	carrying	VBG	-	-	-	-	-	-	-	-
1851382	0	30	the	DT	-	-	-	-	-	-	-	(132a
1851382	0	31	SirT1	NN	-	-	-	-	-	-	-	-
1851382	0	32	+	SYM	-	-	-	-	-	-	-	-
1851382	0	33	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	34	ko	NN	-	-	-	-	-	-	-	132a)
1851382	0	35	,	,	-	-	-	-	-	-	-	-
1851382	0	36	CMV	NN	-	-	-	-	-	-	-	-
1851382	0	37	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	38	Cre	NN	-	-	-	-	-	-	-	-
1851382	0	39	+	SYM	-	-	-	-	-	-	-	-
1851382	0	40	genotype	NN	-	-	-	-	-	-	-	(132a)
1851382	0	41	.	.	-	-	-	-	-	-	-	-

1851382	0	1	The	DT	-	-	-	-	-	-	-	-
1851382	0	2	expression	NN	-	-	-	-	-	-	-	-
1851382	0	3	of	IN	-	-	-	-	-	-	-	-
1851382	0	4	the	DT	-	-	-	-	-	-	-	(27
1851382	0	5	CMV	NN	-	-	-	-	-	-	-	-
1851382	0	6	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	7	Cre	NN	-	-	-	-	-	-	-	-
1851382	0	8	transgene	NN	-	-	-	-	-	-	-	27)
1851382	0	9	catalyzes	VBZ	-	-	-	-	-	-	-	-
1851382	0	10	the	DT	-	-	-	-	-	-	-	-
1851382	0	11	deletion	NN	-	-	-	-	-	-	-	-
1851382	0	12	of	IN	-	-	-	-	-	-	-	-
1851382	0	13	exon	NN	-	-	-	-	-	-	-	(131
1851382	0	14	4	CD	-	-	-	-	-	-	-	131)
1851382	0	15	in	IN	-	-	-	-	-	-	-	-
1851382	0	16	most	JJS	-	-	-	-	-	-	-	-
1851382	0	17	lineages	NNS	-	-	-	-	-	-	-	-
1851382	0	18	of	IN	-	-	-	-	-	-	-	-
1851382	0	19	cells	NNS	-	-	-	-	-	-	-	(167)
1851382	0	20	,	,	-	-	-	-	-	-	-	-
1851382	0	21	including	VBG	-	-	-	-	-	-	-	-
1851382	0	22	germ	NN	-	-	-	-	-	-	-	-
1851382	0	23	cells	NNS	-	-	-	-	-	-	-	-
1851382	0	24	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	25	Figure	NN	-	-	-	-	-	-	-	(163
1851382	0	26	1a	NN	-	-	-	-	-	-	-	163)
1851382	0	27	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	28	.	.	-	-	-	-	-	-	-	-

1851382	0	1	This	DT	-	-	-	-	-	-	-	(166
1851382	0	2	SirT1	NN	-	-	-	-	-	-	-	(1)
1851382	0	3	ko	NN	-	-	-	-	-	-	-	-
1851382	0	4	allele	NN	-	-	-	-	-	-	-	166)
1851382	0	5	should	MD	-	-	-	-	-	-	-	-
1851382	0	6	be	VB	-	-	-	-	-	-	-	-
1851382	0	7	identical	JJ	-	-	-	-	-	-	-	-
1851382	0	8	to	IN	-	-	-	-	-	-	-	-
1851382	0	9	the	DT	-	-	-	-	-	-	-	-
1851382	0	10	previously	RB	-	-	-	-	-	-	-	-
1851382	0	11	described	VBN	-	-	-	-	-	-	-	-
1851382	0	12	Δex4	NN	-	-	-	-	-	-	-	-
1851382	0	13	mutation	NN	-	-	-	-	-	-	-	-
1851382	0	14	[	-LRB-	-	-	-	-	-	-	-	-
1851382	0	15	23	CD	-	-	-	-	-	-	-	-
1851382	0	16	]	-RRB-	-	-	-	-	-	-	-	-
1851382	0	17	.	.	-	-	-	-	-	-	-	-

1851382	0	1	SirT1	NN	-	-	-	-	-	-	-	(132|(133b
1851382	0	2	+	SYM	-	-	-	-	-	-	-	-
1851382	0	3	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	4	ko	NN	-	-	-	-	-	-	-	133b)|132)
1851382	0	5	,	,	-	-	-	-	-	-	-	-
1851382	0	6	Cre	NN	-	-	-	-	-	-	-	-
1851382	0	7	+	SYM	-	-	-	-	-	-	-	-
1851382	0	8	mice	NNS	-	-	-	-	-	-	-	(133b)
1851382	0	9	were	VBD	-	-	-	-	-	-	-	-
1851382	0	10	backcrossed	VBN	-	-	-	-	-	-	-	-
1851382	0	11	with	IN	-	-	-	-	-	-	-	-
1851382	0	12	wild	JJ	-	-	-	-	-	-	-	(137|(165
1851382	0	13	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	14	type	NN	-	-	-	-	-	-	-	137)
1851382	0	15	mice	NNS	-	-	-	-	-	-	-	165)
1851382	0	16	to	TO	-	-	-	-	-	-	-	-
1851382	0	17	generate	VB	-	-	-	-	-	-	-	-
1851382	0	18	the	DT	-	-	-	-	-	-	-	(133
1851382	0	19	mice	NNS	-	-	-	-	-	-	-	-
1851382	0	20	harboring	VBG	-	-	-	-	-	-	-	-
1851382	0	21	a	DT	-	-	-	-	-	-	-	-
1851382	0	22	germline	NN	-	-	-	-	-	-	-	-
1851382	0	23	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	24	transmitted	VBN	-	-	-	-	-	-	-	-
1851382	0	25	deletion	NN	-	-	-	-	-	-	-	-
1851382	0	26	mutation	NN	-	-	-	-	-	-	-	133)
1851382	0	27	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	28	that	RB	-	-	-	-	-	-	-	-
1851382	0	29	is	RB	-	-	-	-	-	-	-	-
1851382	0	30	,	,	-	-	-	-	-	-	-	-
1851382	0	31	SirT1	NN	-	-	-	-	-	-	-	(132|(133
1851382	0	32	+	SYM	-	-	-	-	-	-	-	-
1851382	0	33	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	34	ko	NN	-	-	-	-	-	-	-	132)
1851382	0	35	mice	NNS	-	-	-	-	-	-	-	133)
1851382	0	36	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	37	.	.	-	-	-	-	-	-	-	-

1851382	0	1	The	DT	-	-	-	-	-	-	-	-
1851382	0	2	breeding	NN	-	-	-	-	-	-	-	-
1851382	0	3	of	IN	-	-	-	-	-	-	-	-
1851382	0	4	SirT1	NN	-	-	-	-	-	-	-	(132|(168|(169
1851382	0	5	+	SYM	-	-	-	-	-	-	-	-
1851382	0	6	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	7	ko	NN	-	-	-	-	-	-	-	132)
1851382	0	8	male	JJ	-	-	-	-	-	-	-	-
1851382	0	9	mice	NNS	-	-	-	-	-	-	-	168)
1851382	0	10	and	CC	-	-	-	-	-	-	-	-
1851382	0	11	SirT1	NN	-	-	-	-	-	-	-	(132|(170
1851382	0	12	+	SYM	-	-	-	-	-	-	-	-
1851382	0	13	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	14	ko	NN	-	-	-	-	-	-	-	132)
1851382	0	15	female	JJ	-	-	-	-	-	-	-	-
1851382	0	16	mice	NNS	-	-	-	-	-	-	-	170)|169)
1851382	0	17	resulted	VBD	-	-	-	-	-	-	-	-
1851382	0	18	in	IN	-	-	-	-	-	-	-	-
1851382	0	19	SirT1ko	NN	-	-	-	-	-	-	-	(22|(24
1851382	0	20	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	21	ko	NN	-	-	-	-	-	-	-	24)
1851382	0	22	mice	NNS	-	-	-	-	-	-	-	22)
1851382	0	23	.	.	-	-	-	-	-	-	-	-

1851382	0	1	The	DT	-	-	-	-	-	-	-	(57a
1851382	0	2	cells	NNS	-	-	-	-	-	-	-	-
1851382	0	3	derived	VBN	-	-	-	-	-	-	-	-
1851382	0	4	from	IN	-	-	-	-	-	-	-	57a)
1851382	0	5	either	CC	-	-	-	-	-	-	-	-
1851382	0	6	SirT1	NN	-	-	-	-	-	-	-	(132|(133
1851382	0	7	+	SYM	-	-	-	-	-	-	-	-
1851382	0	8	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	9	ko	NN	-	-	-	-	-	-	-	132)
1851382	0	10	mice	NNS	-	-	-	-	-	-	-	133)
1851382	0	11	or	CC	-	-	-	-	-	-	-	-
1851382	0	12	SirT1ko	NN	-	-	-	-	-	-	-	(22|(24|(57a
1851382	0	13	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	14	ko	NN	-	-	-	-	-	-	-	24)
1851382	0	15	mice	NNS	-	-	-	-	-	-	-	57a)|22)
1851382	0	16	expressed	VBD	-	-	-	-	-	-	-	-
1851382	0	17	a	DT	-	-	-	-	-	-	-	(171
1851382	0	18	SirT1	NN	-	-	-	-	-	-	-	(1)
1851382	0	19	mutant	NN	-	-	-	-	-	-	-	-
1851382	0	20	protein	NN	-	-	-	-	-	-	-	-
1851382	0	21	due	IN	-	-	-	-	-	-	-	-
1851382	0	22	to	IN	-	-	-	-	-	-	-	-
1851382	0	23	the	DT	-	-	-	-	-	-	-	(130
1851382	0	24	inframe	NN	-	-	-	-	-	-	-	-
1851382	0	25	deletion	NN	-	-	-	-	-	-	-	-
1851382	0	26	of	IN	-	-	-	-	-	-	-	-
1851382	0	27	exon	NN	-	-	-	-	-	-	-	(131
1851382	0	28	4	CD	-	-	-	-	-	-	-	171)|131)|130)
1851382	0	29	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	30	Figure	NN	-	-	-	-	-	-	-	(164
1851382	0	31	1b	NN	-	-	-	-	-	-	-	164)
1851382	0	32	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	33	.	.	-	-	-	-	-	-	-	-

1851382	0	1	This	DT	-	-	-	-	-	-	-	(171
1851382	0	2	SirT1	NN	-	-	-	-	-	-	-	(1)
1851382	0	3	mutant	NN	-	-	-	-	-	-	-	-
1851382	0	4	protein	NN	-	-	-	-	-	-	-	171)
1851382	0	5	may	MD	-	-	-	-	-	-	-	-
1851382	0	6	not	RB	-	-	-	-	-	-	-	-
1851382	0	7	be	VB	-	-	-	-	-	-	-	-
1851382	0	8	functional	JJ	-	-	-	-	-	-	-	-
1851382	0	9	,	,	-	-	-	-	-	-	-	-
1851382	0	10	however	RB	-	-	-	-	-	-	-	-
1851382	0	11	,	,	-	-	-	-	-	-	-	-
1851382	0	12	since	IN	-	-	-	-	-	-	-	-
1851382	0	13	SirT1	NN	-	-	-	-	-	-	-	(132|(133
1851382	0	14	+	SYM	-	-	-	-	-	-	-	-
1851382	0	15	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	16	ko	NN	-	-	-	-	-	-	-	132)
1851382	0	17	mice	NNS	-	-	-	-	-	-	-	133)
1851382	0	18	are	VBP	-	-	-	-	-	-	-	-
1851382	0	19	phenotypically	RB	-	-	-	-	-	-	-	-
1851382	0	20	indistinguishable	JJ	-	-	-	-	-	-	-	-
1851382	0	21	from	IN	-	-	-	-	-	-	-	-
1851382	0	22	wild	JJ	-	-	-	-	-	-	-	(137|(165
1851382	0	23	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	24	type	NN	-	-	-	-	-	-	-	137)
1851382	0	25	mice	NNS	-	-	-	-	-	-	-	165)
1851382	0	26	and	CC	-	-	-	-	-	-	-	-
1851382	0	27	SirT1Δex4	NN	-	-	-	-	-	-	-	-
1851382	0	28	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	29	Δex4	NN	-	-	-	-	-	-	-	-
1851382	0	30	mice	NNS	-	-	-	-	-	-	-	-
1851382	0	31	were	VBD	-	-	-	-	-	-	-	-
1851382	0	32	phenotypically	RB	-	-	-	-	-	-	-	-
1851382	0	33	identical	JJ	-	-	-	-	-	-	-	-
1851382	0	34	to	IN	-	-	-	-	-	-	-	-
1851382	0	35	SirT1	NN	-	-	-	-	-	-	-	(1)
1851382	0	36	null	JJ	-	-	-	-	-	-	-	-
1851382	0	37	mice	NNS	-	-	-	-	-	-	-	-
1851382	0	38	[	-LRB-	-	-	-	-	-	-	-	-
1851382	0	39	23	CD	-	-	-	-	-	-	-	-
1851382	0	40	]	-RRB-	-	-	-	-	-	-	-	-
1851382	0	41	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Similar	JJ	-	-	-	-	-	-	-	-
1851382	0	2	to	IN	-	-	-	-	-	-	-	-
1851382	0	3	other	JJ	-	-	-	-	-	-	-	(172
1851382	0	4	strains	NNS	-	-	-	-	-	-	-	-
1851382	0	5	of	IN	-	-	-	-	-	-	-	-
1851382	0	6	SirT1	NN	-	-	-	-	-	-	-	(22
1851382	0	7	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	8	deficient	JJ	-	-	-	-	-	-	-	-
1851382	0	9	mice	NNS	-	-	-	-	-	-	-	22)|172)
1851382	0	10	,	,	-	-	-	-	-	-	-	-
1851382	0	11	nearly	RB	-	-	-	-	-	-	-	-
1851382	0	12	two	CD	-	-	-	-	-	-	-	-
1851382	0	13	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	14	thirds	NNS	-	-	-	-	-	-	-	-
1851382	0	15	of	IN	-	-	-	-	-	-	-	-
1851382	0	16	SirT1ko	NN	-	-	-	-	-	-	-	(24
1851382	0	17	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	18	ko	NN	-	-	-	-	-	-	-	24)
1851382	0	19	newborns	NNS	-	-	-	-	-	-	-	-
1851382	0	20	die	VBP	-	-	-	-	-	-	-	-
1851382	0	21	shortly	RB	-	-	-	-	-	-	-	-
1851382	0	22	after	IN	-	-	-	-	-	-	-	-
1851382	0	23	birth	NN	-	-	-	-	-	-	-	(100)
1851382	0	24	and	CC	-	-	-	-	-	-	-	-
1851382	0	25	the	DT	-	-	-	-	-	-	-	-
1851382	0	26	majority	NN	-	-	-	-	-	-	-	-
1851382	0	27	of	IN	-	-	-	-	-	-	-	-
1851382	0	28	surviving	VBG	-	-	-	-	-	-	-	(173
1851382	0	29	SirT1ko	NN	-	-	-	-	-	-	-	-
1851382	0	30	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	31	ko	NN	-	-	-	-	-	-	-	-
1851382	0	32	mice	NNS	-	-	-	-	-	-	-	173)
1851382	0	33	manifest	VBP	-	-	-	-	-	-	-	-
1851382	0	34	growth	NN	-	-	-	-	-	-	-	(42
1851382	0	35	retardation	NN	-	-	-	-	-	-	-	42)
1851382	0	36	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	37	Table	NN	-	-	-	-	-	-	-	(174|(175
1851382	0	38	1	CD	-	-	-	-	-	-	-	174)
1851382	0	39	and	CC	-	-	-	-	-	-	-	-
1851382	0	40	Figure	NN	-	-	-	-	-	-	-	(176
1851382	0	41	1c	NN	-	-	-	-	-	-	-	176)|175)
1851382	0	42	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	43	[	-LRB-	-	-	-	-	-	-	-	-
1851382	0	44	22	CD	-	-	-	-	-	-	-	-
1851382	0	45	,	,	-	-	-	-	-	-	-	-
1851382	0	46	23	CD	-	-	-	-	-	-	-	-
1851382	0	47	]	-RRB-	-	-	-	-	-	-	-	-
1851382	0	48	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Growth	NN	-	-	-	-	-	-	-	(42
1851382	0	2	retardation	NN	-	-	-	-	-	-	-	42)
1851382	0	3	may	MD	-	-	-	-	-	-	-	-
1851382	0	4	result	VB	-	-	-	-	-	-	-	-
1851382	0	5	from	IN	-	-	-	-	-	-	-	-
1851382	0	6	a	DT	-	-	-	-	-	-	-	-
1851382	0	7	systemic	JJ	-	-	-	-	-	-	-	-
1851382	0	8	defect	NN	-	-	-	-	-	-	-	-
1851382	0	9	in	IN	-	-	-	-	-	-	-	-
1851382	0	10	hormonal	JJ	-	-	-	-	-	-	-	-
1851382	0	11	regulation	NN	-	-	-	-	-	-	-	-
1851382	0	12	,	,	-	-	-	-	-	-	-	-
1851382	0	13	DNA	NN	-	-	-	-	-	-	-	(177
1851382	0	14	double	JJ	-	-	-	-	-	-	-	-
1851382	0	15	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	16	strand	NN	-	-	-	-	-	-	-	-
1851382	0	17	break	NN	-	-	-	-	-	-	-	-
1851382	0	18	repair	NN	-	-	-	-	-	-	-	177)
1851382	0	19	,	,	-	-	-	-	-	-	-	-
1851382	0	20	or	CC	-	-	-	-	-	-	-	-
1851382	0	21	other	JJ	-	-	-	-	-	-	-	-
1851382	0	22	causal	JJ	-	-	-	-	-	-	-	-
1851382	0	23	mechanisms	NNS	-	-	-	-	-	-	-	-
1851382	0	24	.	.	-	-	-	-	-	-	-	-

1851382	0	1	We	PRP	-	-	-	-	-	-	-	(95)
1851382	0	2	found	VBD	-	-	-	-	-	-	-	-
1851382	0	3	that	IN	-	-	-	-	-	-	-	-
1851382	0	4	SirT1ko	NN	-	-	-	-	-	-	-	(22|(24
1851382	0	5	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	6	ko	NN	-	-	-	-	-	-	-	24)
1851382	0	7	mice	NNS	-	-	-	-	-	-	-	22)
1851382	0	8	have	VBP	-	-	-	-	-	-	-	-
1851382	0	9	reduced	VBN	-	-	-	-	-	-	-	-
1851382	0	10	levels	NNS	-	-	-	-	-	-	-	-
1851382	0	11	of	IN	-	-	-	-	-	-	-	-
1851382	0	12	serum	NN	-	-	-	-	-	-	-	(139
1851382	0	13	IGF	NN	-	-	-	-	-	-	-	-
1851382	0	14	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	15	1	CD	-	-	-	-	-	-	-	139)
1851382	0	16	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	17	Figure	NN	-	-	-	-	-	-	-	-
1851382	0	18	1d	NN	-	-	-	-	-	-	-	-
1851382	0	19	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	20	.	.	-	-	-	-	-	-	-	-

1851382	0	1	IGF	NN	-	-	-	-	-	-	-	(8
1851382	0	2	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	3	1	CD	-	-	-	-	-	-	-	8)
1851382	0	4	often	RB	-	-	-	-	-	-	-	-
1851382	0	5	acts	VBZ	-	-	-	-	-	-	-	-
1851382	0	6	as	IN	-	-	-	-	-	-	-	-
1851382	0	7	a	DT	-	-	-	-	-	-	-	-
1851382	0	8	local	JJ	-	-	-	-	-	-	-	-
1851382	0	9	effector	NN	-	-	-	-	-	-	-	-
1851382	0	10	for	IN	-	-	-	-	-	-	-	-
1851382	0	11	pituitary	JJ	-	-	-	-	-	-	-	(111
1851382	0	12	GH	NN	-	-	-	-	-	-	-	111)
1851382	0	13	.	.	-	-	-	-	-	-	-	-

1851382	0	1	The	DT	-	-	-	-	-	-	-	-
1851382	0	2	serum	NN	-	-	-	-	-	-	-	-
1851382	0	3	level	NN	-	-	-	-	-	-	-	-
1851382	0	4	of	IN	-	-	-	-	-	-	-	-
1851382	0	5	GH	NN	-	-	-	-	-	-	-	-
1851382	0	6	in	IN	-	-	-	-	-	-	-	-
1851382	0	7	SirT1ko	NN	-	-	-	-	-	-	-	(22|(24
1851382	0	8	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	9	ko	NN	-	-	-	-	-	-	-	24)
1851382	0	10	mice	NNS	-	-	-	-	-	-	-	22)
1851382	0	11	,	,	-	-	-	-	-	-	-	-
1851382	0	12	however	RB	-	-	-	-	-	-	-	-
1851382	0	13	,	,	-	-	-	-	-	-	-	-
1851382	0	14	appeared	VBD	-	-	-	-	-	-	-	-
1851382	0	15	to	TO	-	-	-	-	-	-	-	-
1851382	0	16	be	VB	-	-	-	-	-	-	-	-
1851382	0	17	within	IN	-	-	-	-	-	-	-	-
1851382	0	18	the	DT	-	-	-	-	-	-	-	-
1851382	0	19	normal	JJ	-	-	-	-	-	-	-	-
1851382	0	20	range	NN	-	-	-	-	-	-	-	-
1851382	0	21	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	22	data	NNS	-	-	-	-	-	-	-	-
1851382	0	23	not	RB	-	-	-	-	-	-	-	-
1851382	0	24	shown	VBN	-	-	-	-	-	-	-	-
1851382	0	25	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	26	.	.	-	-	-	-	-	-	-	-

1851382	0	1	On	IN	-	-	-	-	-	-	-	-
1851382	0	2	the	DT	-	-	-	-	-	-	-	-
1851382	0	3	other	JJ	-	-	-	-	-	-	-	-
1851382	0	4	hand	NN	-	-	-	-	-	-	-	-
1851382	0	5	,	,	-	-	-	-	-	-	-	-
1851382	0	6	yeast	NN	-	-	-	-	-	-	-	(66
1851382	0	7	Sir2	NN	-	-	-	-	-	-	-	66)
1851382	0	8	and	CC	-	-	-	-	-	-	-	-
1851382	0	9	its	PRP$	-	-	-	-	-	-	-	(66)
1851382	0	10	associated	VBN	-	-	-	-	-	-	-	-
1851382	0	11	Sir	NN	-	-	-	-	-	-	-	-
1851382	0	12	complex	NN	-	-	-	-	-	-	-	-
1851382	0	13	,	,	-	-	-	-	-	-	-	-
1851382	0	14	as	RB	-	-	-	-	-	-	-	-
1851382	0	15	well	RB	-	-	-	-	-	-	-	-
1851382	0	16	as	IN	-	-	-	-	-	-	-	-
1851382	0	17	mouse	NN	-	-	-	-	-	-	-	(6)
1851382	0	18	SirT6	NN	-	-	-	-	-	-	-	-
1851382	0	19	,	,	-	-	-	-	-	-	-	-
1851382	0	20	have	VBP	-	-	-	-	-	-	-	-
1851382	0	21	also	RB	-	-	-	-	-	-	-	-
1851382	0	22	been	VBN	-	-	-	-	-	-	-	-
1851382	0	23	implicated	VBN	-	-	-	-	-	-	-	-
1851382	0	24	in	IN	-	-	-	-	-	-	-	-
1851382	0	25	DNA	NN	-	-	-	-	-	-	-	(177
1851382	0	26	double	JJ	-	-	-	-	-	-	-	-
1851382	0	27	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	28	strand	NN	-	-	-	-	-	-	-	-
1851382	0	29	break	NN	-	-	-	-	-	-	-	-
1851382	0	30	repair	NN	-	-	-	-	-	-	-	177)
1851382	0	31	and	CC	-	-	-	-	-	-	-	-
1851382	0	32	the	DT	-	-	-	-	-	-	-	-
1851382	0	33	maintenance	NN	-	-	-	-	-	-	-	-
1851382	0	34	of	IN	-	-	-	-	-	-	-	-
1851382	0	35	chromosome	NN	-	-	-	-	-	-	-	-
1851382	0	36	stability	NN	-	-	-	-	-	-	-	-
1851382	0	37	[	-LRB-	-	-	-	-	-	-	-	-
1851382	0	38	32	CD	-	-	-	-	-	-	-	-
1851382	0	39	-	SYM	-	-	-	-	-	-	-	-
1851382	0	40	34	CD	-	-	-	-	-	-	-	-
1851382	0	41	]	-RRB-	-	-	-	-	-	-	-	-
1851382	0	42	.	.	-	-	-	-	-	-	-	-

1851382	0	1	We	PRP	-	-	-	-	-	-	-	(95)
1851382	0	2	found	VBD	-	-	-	-	-	-	-	-
1851382	0	3	that	IN	-	-	-	-	-	-	-	-
1851382	0	4	SirT1ko	NN	-	-	-	-	-	-	-	(24
1851382	0	5	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	6	ko	NN	-	-	-	-	-	-	-	24)
1851382	0	7	embryonic	JJ	-	-	-	-	-	-	-	-
1851382	0	8	stem	NN	-	-	-	-	-	-	-	-
1851382	0	9	cells	NNS	-	-	-	-	-	-	-	-
1851382	0	10	do	VBP	-	-	-	-	-	-	-	-
1851382	0	11	not	RB	-	-	-	-	-	-	-	-
1851382	0	12	have	VB	-	-	-	-	-	-	-	-
1851382	0	13	increased	VBN	-	-	-	-	-	-	-	-
1851382	0	14	sensitivity	NN	-	-	-	-	-	-	-	-
1851382	0	15	to	IN	-	-	-	-	-	-	-	-
1851382	0	16	either	CC	-	-	-	-	-	-	-	(144
1851382	0	17	ionizing	VBG	-	-	-	-	-	-	-	(143
1851382	0	18	radiation	NN	-	-	-	-	-	-	-	143)
1851382	0	19	or	CC	-	-	-	-	-	-	-	-
1851382	0	20	hydrogen	NN	-	-	-	-	-	-	-	(145|(146
1851382	0	21	peroxide	NN	-	-	-	-	-	-	-	145)
1851382	0	22	treatment	NN	-	-	-	-	-	-	-	146)|144)
1851382	0	23	when	WRB	-	-	-	-	-	-	-	-
1851382	0	24	compared	VBN	-	-	-	-	-	-	-	-
1851382	0	25	with	IN	-	-	-	-	-	-	-	-
1851382	0	26	wild	JJ	-	-	-	-	-	-	-	(137
1851382	0	27	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	28	type	NN	-	-	-	-	-	-	-	137)
1851382	0	29	cells	NNS	-	-	-	-	-	-	-	-
1851382	0	30	,	,	-	-	-	-	-	-	-	-
1851382	0	31	or	CC	-	-	-	-	-	-	-	-
1851382	0	32	with	IN	-	-	-	-	-	-	-	-
1851382	0	33	positive	JJ	-	-	-	-	-	-	-	-
1851382	0	34	control	NN	-	-	-	-	-	-	-	-
1851382	0	35	cells	NNS	-	-	-	-	-	-	-	-
1851382	0	36	such	JJ	-	-	-	-	-	-	-	-
1851382	0	37	as	IN	-	-	-	-	-	-	-	-
1851382	0	38	Ku70	NN	-	-	-	-	-	-	-	-
1851382	0	39	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	40	deficient	JJ	-	-	-	-	-	-	-	-
1851382	0	41	or	CC	-	-	-	-	-	-	-	-
1851382	0	42	Atm	NN	-	-	-	-	-	-	-	(178
1851382	0	43	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	44	deficient	JJ	-	-	-	-	-	-	-	-
1851382	0	45	cells	NNS	-	-	-	-	-	-	-	178)
1851382	0	46	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	47	Figure	NN	-	-	-	-	-	-	-	-
1851382	0	48	1e	NN	-	-	-	-	-	-	-	-
1851382	0	49	,	,	-	-	-	-	-	-	-	-
1851382	0	50	f	NN	-	-	-	-	-	-	-	-
1851382	0	51	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	52	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Both	CC	-	-	-	-	-	-	-	-
1851382	0	2	Ku70	NN	-	-	-	-	-	-	-	-
1851382	0	3	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	4	deficient	JJ	-	-	-	-	-	-	-	-
1851382	0	5	mice	NNS	-	-	-	-	-	-	-	-
1851382	0	6	and	CC	-	-	-	-	-	-	-	-
1851382	0	7	Atm	NN	-	-	-	-	-	-	-	-
1851382	0	8	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	9	deficient	JJ	-	-	-	-	-	-	-	-
1851382	0	10	mice	NNS	-	-	-	-	-	-	-	-
1851382	0	11	display	VBP	-	-	-	-	-	-	-	-
1851382	0	12	growth	NN	-	-	-	-	-	-	-	(41|(42
1851382	0	13	retardation	NN	-	-	-	-	-	-	-	42)
1851382	0	14	phenotypes	NNS	-	-	-	-	-	-	-	41)
1851382	0	15	[	-LRB-	-	-	-	-	-	-	-	-
1851382	0	16	35	CD	-	-	-	-	-	-	-	-
1851382	0	17	,	,	-	-	-	-	-	-	-	-
1851382	0	18	36	CD	-	-	-	-	-	-	-	-
1851382	0	19	]	-RRB-	-	-	-	-	-	-	-	-
1851382	0	20	.	.	-	-	-	-	-	-	-	-

1851382	0	1	The	DT	-	-	-	-	-	-	-	(41
1851382	0	2	growth	NN	-	-	-	-	-	-	-	(42
1851382	0	3	retardation	NN	-	-	-	-	-	-	-	42)
1851382	0	4	phenotype	NN	-	-	-	-	-	-	-	-
1851382	0	5	in	IN	-	-	-	-	-	-	-	-
1851382	0	6	SirT1ko	NN	-	-	-	-	-	-	-	(22|(24
1851382	0	7	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	8	ko	NN	-	-	-	-	-	-	-	24)
1851382	0	9	mice	NNS	-	-	-	-	-	-	-	41)|22)
1851382	0	10	is	VBZ	-	-	-	-	-	-	-	-
1851382	0	11	therefore	RB	-	-	-	-	-	-	-	-
1851382	0	12	probably	RB	-	-	-	-	-	-	-	-
1851382	0	13	not	RB	-	-	-	-	-	-	-	-
1851382	0	14	due	IN	-	-	-	-	-	-	-	-
1851382	0	15	to	IN	-	-	-	-	-	-	-	-
1851382	0	16	a	DT	-	-	-	-	-	-	-	-
1851382	0	17	defect	NN	-	-	-	-	-	-	-	-
1851382	0	18	in	IN	-	-	-	-	-	-	-	-
1851382	0	19	DNA	NN	-	-	-	-	-	-	-	(177
1851382	0	20	damage	NN	-	-	-	-	-	-	-	-
1851382	0	21	repair	NN	-	-	-	-	-	-	-	177)
1851382	0	22	,	,	-	-	-	-	-	-	-	-
1851382	0	23	but	CC	-	-	-	-	-	-	-	-
1851382	0	24	rather	RB	-	-	-	-	-	-	-	-
1851382	0	25	results	VBZ	-	-	-	-	-	-	-	-
1851382	0	26	from	IN	-	-	-	-	-	-	-	-
1851382	0	27	a	DT	-	-	-	-	-	-	-	-
1851382	0	28	deficit	NN	-	-	-	-	-	-	-	-
1851382	0	29	in	IN	-	-	-	-	-	-	-	-
1851382	0	30	IGF	NN	-	-	-	-	-	-	-	(19|(8
1851382	0	31	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	32	1	CD	-	-	-	-	-	-	-	8)
1851382	0	33	signaling	NN	-	-	-	-	-	-	-	19)
1851382	0	34	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Lactation	NN	-	-	-	-	-	-	-	(45|(44)
1851382	0	2	failure	NN	-	-	-	-	-	-	-	45)

1851382	0	1	Both	CC	-	-	-	-	-	-	-	(38
1851382	0	2	male	JJ	-	-	-	-	-	-	-	(39c)
1851382	0	3	and	CC	-	-	-	-	-	-	-	-
1851382	0	4	female	JJ	-	-	-	-	-	-	-	(40
1851382	0	5	SirT1ko	NN	-	-	-	-	-	-	-	(39c
1851382	0	6	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	7	ko	NN	-	-	-	-	-	-	-	-
1851382	0	8	mice	NNS	-	-	-	-	-	-	-	40)|39c)|38)
1851382	0	9	can	MD	-	-	-	-	-	-	-	-
1851382	0	10	be	VB	-	-	-	-	-	-	-	-
1851382	0	11	fertile	JJ	-	-	-	-	-	-	-	-
1851382	0	12	,	,	-	-	-	-	-	-	-	-
1851382	0	13	which	WDT	-	-	-	-	-	-	-	-
1851382	0	14	is	VBZ	-	-	-	-	-	-	-	-
1851382	0	15	in	IN	-	-	-	-	-	-	-	(97
1851382	0	16	contrast	NN	-	-	-	-	-	-	-	-
1851382	0	17	with	IN	-	-	-	-	-	-	-	-
1851382	0	18	the	DT	-	-	-	-	-	-	-	(98
1851382	0	19	reported	VBN	-	-	-	-	-	-	-	-
1851382	0	20	sterile	JJ	-	-	-	-	-	-	-	-
1851382	0	21	phenotype	NN	-	-	-	-	-	-	-	-
1851382	0	22	in	IN	-	-	-	-	-	-	-	-
1851382	0	23	one	CD	-	-	-	-	-	-	-	(99
1851382	0	24	strain	NN	-	-	-	-	-	-	-	-
1851382	0	25	of	IN	-	-	-	-	-	-	-	-
1851382	0	26	SirT1	NN	-	-	-	-	-	-	-	(22
1851382	0	27	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	28	deficient	JJ	-	-	-	-	-	-	-	-
1851382	0	29	mice	NNS	-	-	-	-	-	-	-	99)|98)|97)|22)
1851382	0	30	[	-LRB-	-	-	-	-	-	-	-	-
1851382	0	31	22	CD	-	-	-	-	-	-	-	-
1851382	0	32	]	-RRB-	-	-	-	-	-	-	-	-
1851382	0	33	.	.	-	-	-	-	-	-	-	-

1851382	0	1	When	WRB	-	-	-	-	-	-	-	-
1851382	0	2	male	JJ	-	-	-	-	-	-	-	(39
1851382	0	3	SirT1ko	NN	-	-	-	-	-	-	-	-
1851382	0	4	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	5	ko	NN	-	-	-	-	-	-	-	-
1851382	0	6	mice	NNS	-	-	-	-	-	-	-	39)
1851382	0	7	impregnated	VBD	-	-	-	-	-	-	-	-
1851382	0	8	female	JJ	-	-	-	-	-	-	-	(170
1851382	0	9	SirT1	NN	-	-	-	-	-	-	-	-
1851382	0	10	+	SYM	-	-	-	-	-	-	-	-
1851382	0	11	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	12	ko	NN	-	-	-	-	-	-	-	-
1851382	0	13	mice	NNS	-	-	-	-	-	-	-	170)
1851382	0	14	,	,	-	-	-	-	-	-	-	-
1851382	0	15	the	DT	-	-	-	-	-	-	-	-
1851382	0	16	number	NN	-	-	-	-	-	-	-	-
1851382	0	17	of	IN	-	-	-	-	-	-	-	-
1851382	0	18	surviving	VBG	-	-	-	-	-	-	-	(173
1851382	0	19	SirT1ko	NN	-	-	-	-	-	-	-	-
1851382	0	20	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	21	ko	NN	-	-	-	-	-	-	-	-
1851382	0	22	offspring	NN	-	-	-	-	-	-	-	173)
1851382	0	23	was	VBD	-	-	-	-	-	-	-	-
1851382	0	24	reduced	VBN	-	-	-	-	-	-	-	-
1851382	0	25	due	IN	-	-	-	-	-	-	-	-
1851382	0	26	to	IN	-	-	-	-	-	-	-	-
1851382	0	27	the	DT	-	-	-	-	-	-	-	(179
1851382	0	28	partial	JJ	-	-	-	-	-	-	-	-
1851382	0	29	perinatal	JJ	-	-	-	-	-	-	-	-
1851382	0	30	lethal	JJ	-	-	-	-	-	-	-	-
1851382	0	31	phenotype	NN	-	-	-	-	-	-	-	179)
1851382	0	32	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	33	Table	NN	-	-	-	-	-	-	-	(174
1851382	0	34	1	CD	-	-	-	-	-	-	-	174)
1851382	0	35	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	36	.	.	-	-	-	-	-	-	-	-

1851382	0	1	In	IN	-	-	-	-	-	-	-	-
1851382	0	2	a	DT	-	-	-	-	-	-	-	-
1851382	0	3	reciprocal	JJ	-	-	-	-	-	-	-	-
1851382	0	4	approach	NN	-	-	-	-	-	-	-	-
1851382	0	5	,	,	-	-	-	-	-	-	-	-
1851382	0	6	male	JJ	-	-	-	-	-	-	-	(168
1851382	0	7	SirT1	NN	-	-	-	-	-	-	-	-
1851382	0	8	+	SYM	-	-	-	-	-	-	-	-
1851382	0	9	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	10	ko	NN	-	-	-	-	-	-	-	-
1851382	0	11	mice	NNS	-	-	-	-	-	-	-	168)
1851382	0	12	can	MD	-	-	-	-	-	-	-	-
1851382	0	13	also	RB	-	-	-	-	-	-	-	-
1851382	0	14	impregnate	VB	-	-	-	-	-	-	-	-
1851382	0	15	female	JJ	-	-	-	-	-	-	-	(40
1851382	0	16	SirT1ko	NN	-	-	-	-	-	-	-	-
1851382	0	17	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	18	ko	NN	-	-	-	-	-	-	-	-
1851382	0	19	mice	NNS	-	-	-	-	-	-	-	40)
1851382	0	20	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	21	Table	NN	-	-	-	-	-	-	-	(174
1851382	0	22	1	CD	-	-	-	-	-	-	-	174)
1851382	0	23	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	24	.	.	-	-	-	-	-	-	-	-

1851382	0	1	After	IN	-	-	-	-	-	-	-	-
1851382	0	2	parturition	NN	-	-	-	-	-	-	-	(100)
1851382	0	3	,	,	-	-	-	-	-	-	-	-
1851382	0	4	SirT1ko	NN	-	-	-	-	-	-	-	(124|(24
1851382	0	5	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	6	ko	NN	-	-	-	-	-	-	-	24)
1851382	0	7	mothers	NNS	-	-	-	-	-	-	-	124)
1851382	0	8	exhibited	VBD	-	-	-	-	-	-	-	-
1851382	0	9	normal	JJ	-	-	-	-	-	-	-	-
1851382	0	10	nursing	NN	-	-	-	-	-	-	-	-
1851382	0	11	behavior	NN	-	-	-	-	-	-	-	-
1851382	0	12	.	.	-	-	-	-	-	-	-	-

1851382	0	1	The	DT	-	-	-	-	-	-	-	(180
1851382	0	2	pups	NNS	-	-	-	-	-	-	-	180)
1851382	0	3	did	VBD	-	-	-	-	-	-	-	-
1851382	0	4	not	RB	-	-	-	-	-	-	-	-
1851382	0	5	survive	VB	-	-	-	-	-	-	-	-
1851382	0	6	for	IN	-	-	-	-	-	-	-	-
1851382	0	7	more	JJR	-	-	-	-	-	-	-	-
1851382	0	8	than	IN	-	-	-	-	-	-	-	-
1851382	0	9	3	CD	-	-	-	-	-	-	-	-
1851382	0	10	days	NNS	-	-	-	-	-	-	-	-
1851382	0	11	after	IN	-	-	-	-	-	-	-	-
1851382	0	12	birth	NN	-	-	-	-	-	-	-	(100)
1851382	0	13	,	,	-	-	-	-	-	-	-	-
1851382	0	14	however	RB	-	-	-	-	-	-	-	-
1851382	0	15	,	,	-	-	-	-	-	-	-	-
1851382	0	16	unless	IN	-	-	-	-	-	-	-	-
1851382	0	17	they	PRP	-	-	-	-	-	-	-	(180)
1851382	0	18	were	VBD	-	-	-	-	-	-	-	-
1851382	0	19	immediately	RB	-	-	-	-	-	-	-	-
1851382	0	20	removed	VBN	-	-	-	-	-	-	-	-
1851382	0	21	and	CC	-	-	-	-	-	-	-	-
1851382	0	22	put	VBN	-	-	-	-	-	-	-	-
1851382	0	23	under	IN	-	-	-	-	-	-	-	-
1851382	0	24	the	DT	-	-	-	-	-	-	-	-
1851382	0	25	care	NN	-	-	-	-	-	-	-	-
1851382	0	26	of	IN	-	-	-	-	-	-	-	-
1851382	0	27	a	DT	-	-	-	-	-	-	-	-
1851382	0	28	foster	NN	-	-	-	-	-	-	-	-
1851382	0	29	mother	NN	-	-	-	-	-	-	-	-
1851382	0	30	.	.	-	-	-	-	-	-	-	-

1851382	0	1	All	DT	-	-	-	-	-	-	-	(181
1851382	0	2	pups	NNS	-	-	-	-	-	-	-	181)
1851382	0	3	died	VBD	-	-	-	-	-	-	-	-
1851382	0	4	of	IN	-	-	-	-	-	-	-	-
1851382	0	5	dehydration	NN	-	-	-	-	-	-	-	-
1851382	0	6	or	CC	-	-	-	-	-	-	-	-
1851382	0	7	starvation	NN	-	-	-	-	-	-	-	-
1851382	0	8	as	IN	-	-	-	-	-	-	-	-
1851382	0	9	a	DT	-	-	-	-	-	-	-	-
1851382	0	10	result	NN	-	-	-	-	-	-	-	-
1851382	0	11	of	IN	-	-	-	-	-	-	-	-
1851382	0	12	lack	NN	-	-	-	-	-	-	-	-
1851382	0	13	of	IN	-	-	-	-	-	-	-	-
1851382	0	14	milk	NN	-	-	-	-	-	-	-	(156)
1851382	0	15	in	IN	-	-	-	-	-	-	-	-
1851382	0	16	their	PRP$	-	-	-	-	-	-	-	(181)
1851382	0	17	stomachs	NNS	-	-	-	-	-	-	-	-
1851382	0	18	.	.	-	-	-	-	-	-	-	-

1851382	0	1	To	TO	-	-	-	-	-	-	-	-
1851382	0	2	determine	VB	-	-	-	-	-	-	-	-
1851382	0	3	whether	IN	-	-	-	-	-	-	-	-
1851382	0	4	the	DT	-	-	-	-	-	-	-	(124
1851382	0	5	SirT1ko	NN	-	-	-	-	-	-	-	(24
1851382	0	6	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	7	ko	NN	-	-	-	-	-	-	-	24)
1851382	0	8	mothers	NNS	-	-	-	-	-	-	-	124)
1851382	0	9	encountered	VBD	-	-	-	-	-	-	-	-
1851382	0	10	a	DT	-	-	-	-	-	-	-	(182
1851382	0	11	lactation	NN	-	-	-	-	-	-	-	(44)
1851382	0	12	defect	NN	-	-	-	-	-	-	-	182)
1851382	0	13	,	,	-	-	-	-	-	-	-	-
1851382	0	14	whole	JJ	-	-	-	-	-	-	-	(29|(30a
1851382	0	15	mount	NN	-	-	-	-	-	-	-	30a)
1851382	0	16	and	CC	-	-	-	-	-	-	-	-
1851382	0	17	histological	JJ	-	-	-	-	-	-	-	(31
1851382	0	18	analyses	NNS	-	-	-	-	-	-	-	(30a)|31)|29)
1851382	0	19	were	VBD	-	-	-	-	-	-	-	-
1851382	0	20	used	VBN	-	-	-	-	-	-	-	-
1851382	0	21	to	TO	-	-	-	-	-	-	-	-
1851382	0	22	characterize	VB	-	-	-	-	-	-	-	-
1851382	0	23	the	DT	-	-	-	-	-	-	-	-
1851382	0	24	morphological	JJ	-	-	-	-	-	-	-	-
1851382	0	25	changes	NNS	-	-	-	-	-	-	-	-
1851382	0	26	in	IN	-	-	-	-	-	-	-	-
1851382	0	27	the	DT	-	-	-	-	-	-	-	(5
1851382	0	28	mammary	JJ	-	-	-	-	-	-	-	-
1851382	0	29	glands	NNS	-	-	-	-	-	-	-	5)
1851382	0	30	.	.	-	-	-	-	-	-	-	-

1851382	0	1	We	PRP	-	-	-	-	-	-	-	(95)
1851382	0	2	found	VBD	-	-	-	-	-	-	-	-
1851382	0	3	that	IN	-	-	-	-	-	-	-	-
1851382	0	4	virgin	JJ	-	-	-	-	-	-	-	(32
1851382	0	5	SirT1ko	NN	-	-	-	-	-	-	-	-
1851382	0	6	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	7	ko	NN	-	-	-	-	-	-	-	-
1851382	0	8	mice	NNS	-	-	-	-	-	-	-	32)
1851382	0	9	displayed	VBD	-	-	-	-	-	-	-	-
1851382	0	10	impeded	VBN	-	-	-	-	-	-	-	-
1851382	0	11	ductal	JJ	-	-	-	-	-	-	-	-
1851382	0	12	morphogenesis	NN	-	-	-	-	-	-	-	-
1851382	0	13	up	IN	-	-	-	-	-	-	-	-
1851382	0	14	to	IN	-	-	-	-	-	-	-	-
1851382	0	15	9	CD	-	-	-	-	-	-	-	-
1851382	0	16	months	NNS	-	-	-	-	-	-	-	-
1851382	0	17	of	IN	-	-	-	-	-	-	-	-
1851382	0	18	age	NN	-	-	-	-	-	-	-	-
1851382	0	19	,	,	-	-	-	-	-	-	-	-
1851382	0	20	while	IN	-	-	-	-	-	-	-	-
1851382	0	21	age	NN	-	-	-	-	-	-	-	-
1851382	0	22	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	23	matched	VBN	-	-	-	-	-	-	-	-
1851382	0	24	virgin	JJ	-	-	-	-	-	-	-	-
1851382	0	25	wild	JJ	-	-	-	-	-	-	-	-
1851382	0	26	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	27	type	NN	-	-	-	-	-	-	-	-
1851382	0	28	mice	NNS	-	-	-	-	-	-	-	-
1851382	0	29	displayed	VBD	-	-	-	-	-	-	-	-
1851382	0	30	extensive	JJ	-	-	-	-	-	-	-	-
1851382	0	31	ductal	JJ	-	-	-	-	-	-	-	-
1851382	0	32	elongation	NN	-	-	-	-	-	-	-	-
1851382	0	33	and	CC	-	-	-	-	-	-	-	-
1851382	0	34	branching	NN	-	-	-	-	-	-	-	-
1851382	0	35	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	36	Figure	NN	-	-	-	-	-	-	-	(183
1851382	0	37	2a	NN	-	-	-	-	-	-	-	183)
1851382	0	38	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	39	.	.	-	-	-	-	-	-	-	-

1851382	0	1	The	DT	-	-	-	-	-	-	-	-
1851382	0	2	absence	NN	-	-	-	-	-	-	-	-
1851382	0	3	of	IN	-	-	-	-	-	-	-	-
1851382	0	4	ductal	JJ	-	-	-	-	-	-	-	(62
1851382	0	5	morphogenesis	NN	-	-	-	-	-	-	-	62)
1851382	0	6	persisted	VBD	-	-	-	-	-	-	-	-
1851382	0	7	in	IN	-	-	-	-	-	-	-	-
1851382	0	8	pregnant	JJ	-	-	-	-	-	-	-	(33
1851382	0	9	SirT1ko	NN	-	-	-	-	-	-	-	-
1851382	0	10	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	11	ko	NN	-	-	-	-	-	-	-	-
1851382	0	12	mice	NNS	-	-	-	-	-	-	-	33)
1851382	0	13	up	IN	-	-	-	-	-	-	-	-
1851382	0	14	to	IN	-	-	-	-	-	-	-	-
1851382	0	15	day	NN	-	-	-	-	-	-	-	(184
1851382	0	16	13	CD	-	-	-	-	-	-	-	-
1851382	0	17	of	IN	-	-	-	-	-	-	-	-
1851382	0	18	pregnancy	NN	-	-	-	-	-	-	-	(185)|184)
1851382	0	19	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	20	Figure	NN	-	-	-	-	-	-	-	(186
1851382	0	21	2b	NN	-	-	-	-	-	-	-	186)
1851382	0	22	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	23	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Despite	IN	-	-	-	-	-	-	-	-
1851382	0	2	the	DT	-	-	-	-	-	-	-	-
1851382	0	3	fact	NN	-	-	-	-	-	-	-	-
1851382	0	4	that	IN	-	-	-	-	-	-	-	-
1851382	0	5	pregnancy	NN	-	-	-	-	-	-	-	(185)
1851382	0	6	can	MD	-	-	-	-	-	-	-	-
1851382	0	7	induce	VB	-	-	-	-	-	-	-	-
1851382	0	8	ductal	JJ	-	-	-	-	-	-	-	-
1851382	0	9	morphogenesis	NN	-	-	-	-	-	-	-	-
1851382	0	10	at	IN	-	-	-	-	-	-	-	-
1851382	0	11	the	DT	-	-	-	-	-	-	-	-
1851382	0	12	late	JJ	-	-	-	-	-	-	-	-
1851382	0	13	stage	NN	-	-	-	-	-	-	-	-
1851382	0	14	of	IN	-	-	-	-	-	-	-	-
1851382	0	15	pregnancy	NN	-	-	-	-	-	-	-	(185)
1851382	0	16	,	,	-	-	-	-	-	-	-	-
1851382	0	17	underdeveloped	VBN	-	-	-	-	-	-	-	-
1851382	0	18	mammary	JJ	-	-	-	-	-	-	-	-
1851382	0	19	glands	NNS	-	-	-	-	-	-	-	-
1851382	0	20	in	IN	-	-	-	-	-	-	-	-
1851382	0	21	SirT1ko	NN	-	-	-	-	-	-	-	(24|(40
1851382	0	22	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	23	ko	NN	-	-	-	-	-	-	-	24)
1851382	0	24	female	JJ	-	-	-	-	-	-	-	-
1851382	0	25	mice	NNS	-	-	-	-	-	-	-	40)
1851382	0	26	cause	VBP	-	-	-	-	-	-	-	-
1851382	0	27	a	DT	-	-	-	-	-	-	-	(187
1851382	0	28	severe	JJ	-	-	-	-	-	-	-	-
1851382	0	29	deficit	NN	-	-	-	-	-	-	-	-
1851382	0	30	in	IN	-	-	-	-	-	-	-	-
1851382	0	31	milk	NN	-	-	-	-	-	-	-	(188|(156)
1851382	0	32	production	NN	-	-	-	-	-	-	-	188)
1851382	0	33	,	,	-	-	-	-	-	-	-	-
1851382	0	34	as	IN	-	-	-	-	-	-	-	-
1851382	0	35	shown	VBN	-	-	-	-	-	-	-	-
1851382	0	36	by	IN	-	-	-	-	-	-	-	-
1851382	0	37	histological	JJ	-	-	-	-	-	-	-	(31
1851382	0	38	analysis	NN	-	-	-	-	-	-	-	31)
1851382	0	39	as	RB	-	-	-	-	-	-	-	-
1851382	0	40	well	RB	-	-	-	-	-	-	-	-
1851382	0	41	as	IN	-	-	-	-	-	-	-	-
1851382	0	42	the	DT	-	-	-	-	-	-	-	(153
1851382	0	43	immunofluorescence	NN	-	-	-	-	-	-	-	-
1851382	0	44	analysis	NN	-	-	-	-	-	-	-	-
1851382	0	45	using	VBG	-	-	-	-	-	-	-	-
1851382	0	46	an	DT	-	-	-	-	-	-	-	-
1851382	0	47	anti-milk	JJ	-	-	-	-	-	-	-	-
1851382	0	48	antibody	NN	-	-	-	-	-	-	-	187)|153)
1851382	0	49	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	50	Figure	NN	-	-	-	-	-	-	-	(186|(189a
1851382	0	51	2b	NN	-	-	-	-	-	-	-	189a)|186)
1851382	0	52	,	,	-	-	-	-	-	-	-	-
1851382	0	53	c	NN	-	-	-	-	-	-	-	(189a)
1851382	0	54	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	55	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Pregnancy	NN	-	-	-	-	-	-	-	(190
1851382	0	2	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	3	induced	VBN	-	-	-	-	-	-	-	-
1851382	0	4	mammary	JJ	-	-	-	-	-	-	-	-
1851382	0	5	gland	NN	-	-	-	-	-	-	-	-
1851382	0	6	development	NN	-	-	-	-	-	-	-	190)

1851382	0	1	To	TO	-	-	-	-	-	-	-	-
1851382	0	2	characterize	VB	-	-	-	-	-	-	-	-
1851382	0	3	the	DT	-	-	-	-	-	-	-	(182
1851382	0	4	developmental	JJ	-	-	-	-	-	-	-	-
1851382	0	5	defect	NN	-	-	-	-	-	-	-	-
1851382	0	6	leading	VBG	-	-	-	-	-	-	-	-
1851382	0	7	to	IN	-	-	-	-	-	-	-	-
1851382	0	8	lactation	NN	-	-	-	-	-	-	-	(45|(44)
1851382	0	9	failure	NN	-	-	-	-	-	-	-	45)|182)
1851382	0	10	,	,	-	-	-	-	-	-	-	-
1851382	0	11	we	PRP	-	-	-	-	-	-	-	(95)
1851382	0	12	analyzed	VBD	-	-	-	-	-	-	-	-
1851382	0	13	the	DT	-	-	-	-	-	-	-	(191
1851382	0	14	mammary	JJ	-	-	-	-	-	-	-	-
1851382	0	15	glands	NNS	-	-	-	-	-	-	-	-
1851382	0	16	of	IN	-	-	-	-	-	-	-	-
1851382	0	17	SirT1ko	NN	-	-	-	-	-	-	-	(192|(24
1851382	0	18	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	19	ko	NN	-	-	-	-	-	-	-	24)
1851382	0	20	female	JJ	-	-	-	-	-	-	-	-
1851382	0	21	mice	NNS	-	-	-	-	-	-	-	-
1851382	0	22	on	IN	-	-	-	-	-	-	-	-
1851382	0	23	lactation	NN	-	-	-	-	-	-	-	(193|(44)
1851382	0	24	day	NN	-	-	-	-	-	-	-	-
1851382	0	25	1	CD	-	-	-	-	-	-	-	193)|192)|191)
1851382	0	26	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Terminal	JJ	-	-	-	-	-	-	-	(194
1851382	0	2	end	NN	-	-	-	-	-	-	-	-
1851382	0	3	buds	NNS	-	-	-	-	-	-	-	194)
1851382	0	4	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	5	TEBs	NNS	-	-	-	-	-	-	-	-
1851382	0	6	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	7	are	VBP	-	-	-	-	-	-	-	-
1851382	0	8	club	NN	-	-	-	-	-	-	-	-
1851382	0	9	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	10	shaped	VBN	-	-	-	-	-	-	-	-
1851382	0	11	transitional	JJ	-	-	-	-	-	-	-	-
1851382	0	12	structures	NNS	-	-	-	-	-	-	-	-
1851382	0	13	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	14	see	VB	-	-	-	-	-	-	-	-
1851382	0	15	Figure	NN	-	-	-	-	-	-	-	(195
1851382	0	16	3a	NN	-	-	-	-	-	-	-	195)
1851382	0	17	,	,	-	-	-	-	-	-	-	-
1851382	0	18	upper	JJ	-	-	-	-	-	-	-	-
1851382	0	19	panel	NN	-	-	-	-	-	-	-	-
1851382	0	20	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	21	.	.	-	-	-	-	-	-	-	-

1851382	0	1	In	IN	-	-	-	-	-	-	-	-
1851382	0	2	wild	JJ	-	-	-	-	-	-	-	(137|(196
1851382	0	3	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	4	type	NN	-	-	-	-	-	-	-	137)
1851382	0	5	female	JJ	-	-	-	-	-	-	-	-
1851382	0	6	mice	NNS	-	-	-	-	-	-	-	196)
1851382	0	7	,	,	-	-	-	-	-	-	-	-
1851382	0	8	TEBs	NNS	-	-	-	-	-	-	-	(194)
1851382	0	9	form	VBP	-	-	-	-	-	-	-	-
1851382	0	10	and	CC	-	-	-	-	-	-	-	-
1851382	0	11	precede	VBP	-	-	-	-	-	-	-	-
1851382	0	12	ductal	JJ	-	-	-	-	-	-	-	-
1851382	0	13	elongation	NN	-	-	-	-	-	-	-	-
1851382	0	14	and	CC	-	-	-	-	-	-	-	-
1851382	0	15	branching	NN	-	-	-	-	-	-	-	-
1851382	0	16	at	IN	-	-	-	-	-	-	-	-
1851382	0	17	the	DT	-	-	-	-	-	-	-	(102
1851382	0	18	onset	NN	-	-	-	-	-	-	-	-
1851382	0	19	of	IN	-	-	-	-	-	-	-	-
1851382	0	20	puberty	NN	-	-	-	-	-	-	-	(103)|102)
1851382	0	21	[	-LRB-	-	-	-	-	-	-	-	-
1851382	0	22	17	CD	-	-	-	-	-	-	-	-
1851382	0	23	,	,	-	-	-	-	-	-	-	-
1851382	0	24	24	CD	-	-	-	-	-	-	-	-
1851382	0	25	,	,	-	-	-	-	-	-	-	-
1851382	0	26	25	CD	-	-	-	-	-	-	-	-
1851382	0	27	]	-RRB-	-	-	-	-	-	-	-	-
1851382	0	28	.	.	-	-	-	-	-	-	-	-

1851382	0	1	When	WRB	-	-	-	-	-	-	-	-
1851382	0	2	TEBs	NNS	-	-	-	-	-	-	-	(194
1851382	0	3	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	4	ducts	NNS	-	-	-	-	-	-	-	194)
1851382	0	5	reach	VBP	-	-	-	-	-	-	-	-
1851382	0	6	the	DT	-	-	-	-	-	-	-	(197
1851382	0	7	edge	NN	-	-	-	-	-	-	-	-
1851382	0	8	of	IN	-	-	-	-	-	-	-	-
1851382	0	9	mammary	JJ	-	-	-	-	-	-	-	(107|(108
1851382	0	10	fat	NN	-	-	-	-	-	-	-	107)
1851382	0	11	pads	NNS	-	-	-	-	-	-	-	197)|108)
1851382	0	12	,	,	-	-	-	-	-	-	-	-
1851382	0	13	TEBs	NNS	-	-	-	-	-	-	-	(194)
1851382	0	14	regress	VBP	-	-	-	-	-	-	-	-
1851382	0	15	as	IN	-	-	-	-	-	-	-	-
1851382	0	16	shown	VBN	-	-	-	-	-	-	-	-
1851382	0	17	in	IN	-	-	-	-	-	-	-	-
1851382	0	18	the	DT	-	-	-	-	-	-	-	(32
1851382	0	19	virgin	JJ	-	-	-	-	-	-	-	-
1851382	0	20	mice	NNS	-	-	-	-	-	-	-	-
1851382	0	21	in	IN	-	-	-	-	-	-	-	-
1851382	0	22	Figure	NN	-	-	-	-	-	-	-	(195
1851382	0	23	3a	NN	-	-	-	-	-	-	-	32)|195)
1851382	0	24	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	25	upper	JJ	-	-	-	-	-	-	-	-
1851382	0	26	panel	NN	-	-	-	-	-	-	-	-
1851382	0	27	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	28	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Interestingly	RB	-	-	-	-	-	-	-	-
1851382	0	2	,	,	-	-	-	-	-	-	-	-
1851382	0	3	the	DT	-	-	-	-	-	-	-	-
1851382	0	4	transitional	JJ	-	-	-	-	-	-	-	-
1851382	0	5	TEBs	NNS	-	-	-	-	-	-	-	-
1851382	0	6	can	MD	-	-	-	-	-	-	-	-
1851382	0	7	be	VB	-	-	-	-	-	-	-	-
1851382	0	8	readily	RB	-	-	-	-	-	-	-	-
1851382	0	9	identified	VBN	-	-	-	-	-	-	-	-
1851382	0	10	in	IN	-	-	-	-	-	-	-	-
1851382	0	11	SirT1ko	NN	-	-	-	-	-	-	-	(192|(24
1851382	0	12	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	13	ko	NN	-	-	-	-	-	-	-	24)
1851382	0	14	female	JJ	-	-	-	-	-	-	-	-
1851382	0	15	mice	NNS	-	-	-	-	-	-	-	-
1851382	0	16	on	IN	-	-	-	-	-	-	-	-
1851382	0	17	lactation	NN	-	-	-	-	-	-	-	(193|(44)
1851382	0	18	day	NN	-	-	-	-	-	-	-	-
1851382	0	19	1	CD	-	-	-	-	-	-	-	193)|192)
1851382	0	20	,	,	-	-	-	-	-	-	-	-
1851382	0	21	manifesting	VBG	-	-	-	-	-	-	-	-
1851382	0	22	as	IN	-	-	-	-	-	-	-	-
1851382	0	23	either	CC	-	-	-	-	-	-	-	-
1851382	0	24	newly	RB	-	-	-	-	-	-	-	-
1851382	0	25	formed	VBN	-	-	-	-	-	-	-	-
1851382	0	26	TEBs	NNS	-	-	-	-	-	-	-	-
1851382	0	27	or	CC	-	-	-	-	-	-	-	-
1851382	0	28	as	IN	-	-	-	-	-	-	-	-
1851382	0	29	TEBs	NNS	-	-	-	-	-	-	-	-
1851382	0	30	attached	VBN	-	-	-	-	-	-	-	-
1851382	0	31	to	IN	-	-	-	-	-	-	-	-
1851382	0	32	developing	VBG	-	-	-	-	-	-	-	-
1851382	0	33	ductal	JJ	-	-	-	-	-	-	-	-
1851382	0	34	and	CC	-	-	-	-	-	-	-	-
1851382	0	35	alveolar	JJ	-	-	-	-	-	-	-	-
1851382	0	36	structures	NNS	-	-	-	-	-	-	-	-
1851382	0	37	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	38	Figure	NN	-	-	-	-	-	-	-	(195
1851382	0	39	3a	NN	-	-	-	-	-	-	-	195)
1851382	0	40	,	,	-	-	-	-	-	-	-	-
1851382	0	41	lower	JJR	-	-	-	-	-	-	-	-
1851382	0	42	panel	NN	-	-	-	-	-	-	-	-
1851382	0	43	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	44	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Moreover	RB	-	-	-	-	-	-	-	-
1851382	0	2	,	,	-	-	-	-	-	-	-	-
1851382	0	3	SirT1ko	NN	-	-	-	-	-	-	-	(198|(22|(24
1851382	0	4	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	5	ko	NN	-	-	-	-	-	-	-	24)
1851382	0	6	mice	NNS	-	-	-	-	-	-	-	22)
1851382	0	7	displayed	VBD	-	-	-	-	-	-	-	-
1851382	0	8	varying	VBG	-	-	-	-	-	-	-	-
1851382	0	9	degrees	NNS	-	-	-	-	-	-	-	-
1851382	0	10	of	IN	-	-	-	-	-	-	-	-
1851382	0	11	ductal	JJ	-	-	-	-	-	-	-	-
1851382	0	12	development	NN	-	-	-	-	-	-	-	-
1851382	0	13	,	,	-	-	-	-	-	-	-	-
1851382	0	14	ranging	VBG	-	-	-	-	-	-	-	-
1851382	0	15	from	IN	-	-	-	-	-	-	-	-
1851382	0	16	a	DT	-	-	-	-	-	-	-	-
1851382	0	17	lack	NN	-	-	-	-	-	-	-	-
1851382	0	18	of	IN	-	-	-	-	-	-	-	-
1851382	0	19	any	DT	-	-	-	-	-	-	-	-
1851382	0	20	ductal	JJ	-	-	-	-	-	-	-	-
1851382	0	21	structure	NN	-	-	-	-	-	-	-	-
1851382	0	22	to	IN	-	-	-	-	-	-	-	-
1851382	0	23	a	DT	-	-	-	-	-	-	-	(199
1851382	0	24	fully	RB	-	-	-	-	-	-	-	-
1851382	0	25	developed	VBN	-	-	-	-	-	-	-	-
1851382	0	26	ductal	JJ	-	-	-	-	-	-	-	-
1851382	0	27	network	NN	-	-	-	-	-	-	-	199)
1851382	0	28	,	,	-	-	-	-	-	-	-	-
1851382	0	29	the	DT	-	-	-	-	-	-	-	(199
1851382	0	30	latter	JJ	-	-	-	-	-	-	-	-
1851382	0	31	of	IN	-	-	-	-	-	-	-	-
1851382	0	32	which	WDT	-	-	-	-	-	-	-	199)
1851382	0	33	is	VBZ	-	-	-	-	-	-	-	-
1851382	0	34	comparable	JJ	-	-	-	-	-	-	-	-
1851382	0	35	with	IN	-	-	-	-	-	-	-	-
1851382	0	36	the	DT	-	-	-	-	-	-	-	-
1851382	0	37	morphology	NN	-	-	-	-	-	-	-	-
1851382	0	38	and	CC	-	-	-	-	-	-	-	-
1851382	0	39	cellularity	NN	-	-	-	-	-	-	-	-
1851382	0	40	of	IN	-	-	-	-	-	-	-	-
1851382	0	41	wild	JJ	-	-	-	-	-	-	-	(137|(200
1851382	0	42	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	43	type	NN	-	-	-	-	-	-	-	137)
1851382	0	44	mammary	JJ	-	-	-	-	-	-	-	-
1851382	0	45	tissues	NNS	-	-	-	-	-	-	-	-
1851382	0	46	on	IN	-	-	-	-	-	-	-	-
1851382	0	47	day	NN	-	-	-	-	-	-	-	(184
1851382	0	48	13	CD	-	-	-	-	-	-	-	-
1851382	0	49	of	IN	-	-	-	-	-	-	-	-
1851382	0	50	pregnancy	NN	-	-	-	-	-	-	-	(185)|200)|198)|184)
1851382	0	51	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	52	Figure	NN	-	-	-	-	-	-	-	(195
1851382	0	53	3a	NN	-	-	-	-	-	-	-	195)
1851382	0	54	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	55	.	.	-	-	-	-	-	-	-	-

1851382	0	1	These	DT	-	-	-	-	-	-	-	(198
1851382	0	2	observations	NNS	-	-	-	-	-	-	-	198)
1851382	0	3	indicated	VBD	-	-	-	-	-	-	-	-
1851382	0	4	that	IN	-	-	-	-	-	-	-	-
1851382	0	5	pregnancy	NN	-	-	-	-	-	-	-	(185)
1851382	0	6	could	MD	-	-	-	-	-	-	-	-
1851382	0	7	rescue	VB	-	-	-	-	-	-	-	-
1851382	0	8	impeded	VBN	-	-	-	-	-	-	-	(43
1851382	0	9	ductal	JJ	-	-	-	-	-	-	-	-
1851382	0	10	morphogenesis	NN	-	-	-	-	-	-	-	-
1851382	0	11	in	IN	-	-	-	-	-	-	-	-
1851382	0	12	virgin	JJ	-	-	-	-	-	-	-	(32
1851382	0	13	SirT1ko	NN	-	-	-	-	-	-	-	-
1851382	0	14	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	15	ko	NN	-	-	-	-	-	-	-	-
1851382	0	16	mice	NNS	-	-	-	-	-	-	-	43)|32)
1851382	0	17	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Normal	JJ	-	-	-	-	-	-	-	-
1851382	0	2	alveolar	JJ	-	-	-	-	-	-	-	-
1851382	0	3	morphogenesis	NN	-	-	-	-	-	-	-	-
1851382	0	4	takes	VBZ	-	-	-	-	-	-	-	-
1851382	0	5	place	NN	-	-	-	-	-	-	-	-
1851382	0	6	under	IN	-	-	-	-	-	-	-	-
1851382	0	7	the	DT	-	-	-	-	-	-	-	(201
1851382	0	8	control	NN	-	-	-	-	-	-	-	-
1851382	0	9	of	IN	-	-	-	-	-	-	-	-
1851382	0	10	additional	JJ	-	-	-	-	-	-	-	-
1851382	0	11	hormones	NNS	-	-	-	-	-	-	-	-
1851382	0	12	and	CC	-	-	-	-	-	-	-	-
1851382	0	13	growth	NN	-	-	-	-	-	-	-	-
1851382	0	14	factors	NNS	-	-	-	-	-	-	-	-
1851382	0	15	during	IN	-	-	-	-	-	-	-	-
1851382	0	16	pregnancy	NN	-	-	-	-	-	-	-	(185)
1851382	0	17	and	CC	-	-	-	-	-	-	-	-
1851382	0	18	lactation	NN	-	-	-	-	-	-	-	(44)|201)
1851382	0	19	[	-LRB-	-	-	-	-	-	-	-	-
1851382	0	20	17	CD	-	-	-	-	-	-	-	-
1851382	0	21	,	,	-	-	-	-	-	-	-	-
1851382	0	22	24	CD	-	-	-	-	-	-	-	-
1851382	0	23	,	,	-	-	-	-	-	-	-	-
1851382	0	24	25	CD	-	-	-	-	-	-	-	-
1851382	0	25	]	-RRB-	-	-	-	-	-	-	-	-
1851382	0	26	.	.	-	-	-	-	-	-	-	-

1851382	0	1	These	DT	-	-	-	-	-	-	-	(201
1851382	0	2	coordinated	VBN	-	-	-	-	-	-	-	-
1851382	0	3	efforts	NNS	-	-	-	-	-	-	-	201)
1851382	0	4	are	VBP	-	-	-	-	-	-	-	-
1851382	0	5	necessary	JJ	-	-	-	-	-	-	-	-
1851382	0	6	to	TO	-	-	-	-	-	-	-	-
1851382	0	7	support	VB	-	-	-	-	-	-	-	-
1851382	0	8	a	DT	-	-	-	-	-	-	-	-
1851382	0	9	densely	RB	-	-	-	-	-	-	-	-
1851382	0	10	saturated	VBN	-	-	-	-	-	-	-	-
1851382	0	11	lobuloalveolar	JJ	-	-	-	-	-	-	-	-
1851382	0	12	system	NN	-	-	-	-	-	-	-	-
1851382	0	13	for	IN	-	-	-	-	-	-	-	-
1851382	0	14	secreting	VBG	-	-	-	-	-	-	-	-
1851382	0	15	milk	NN	-	-	-	-	-	-	-	(156)
1851382	0	16	after	IN	-	-	-	-	-	-	-	-
1851382	0	17	parturition	NN	-	-	-	-	-	-	-	(100)
1851382	0	18	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	19	see	VB	-	-	-	-	-	-	-	-
1851382	0	20	wild	JJ	-	-	-	-	-	-	-	(137|(202
1851382	0	21	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	22	type	NN	-	-	-	-	-	-	-	137)
1851382	0	23	mice	NNS	-	-	-	-	-	-	-	-
1851382	0	24	on	IN	-	-	-	-	-	-	-	-
1851382	0	25	lactation	NN	-	-	-	-	-	-	-	(193|(44)
1851382	0	26	day	NN	-	-	-	-	-	-	-	-
1851382	0	27	1	CD	-	-	-	-	-	-	-	193)
1851382	0	28	in	IN	-	-	-	-	-	-	-	-
1851382	0	29	Figures	NNS	-	-	-	-	-	-	-	(186|(195a)
1851382	0	30	2b	NN	-	-	-	-	-	-	-	186)
1851382	0	31	and	CC	-	-	-	-	-	-	-	-
1851382	0	32	3a	NN	-	-	-	-	-	-	-	(195a)|202)
1851382	0	33	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	34	.	.	-	-	-	-	-	-	-	-

1851382	0	1	In	IN	-	-	-	-	-	-	-	-
1851382	0	2	some	DT	-	-	-	-	-	-	-	-
1851382	0	3	SirT1ko	NN	-	-	-	-	-	-	-	-
1851382	0	4	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	5	ko	NN	-	-	-	-	-	-	-	-
1851382	0	6	mice	NNS	-	-	-	-	-	-	-	-
1851382	0	7	,	,	-	-	-	-	-	-	-	-
1851382	0	8	the	DT	-	-	-	-	-	-	-	(203
1851382	0	9	alveolar	JJ	-	-	-	-	-	-	-	-
1851382	0	10	morphogenesis	NN	-	-	-	-	-	-	-	203)
1851382	0	11	was	VBD	-	-	-	-	-	-	-	-
1851382	0	12	initiated	VBN	-	-	-	-	-	-	-	-
1851382	0	13	,	,	-	-	-	-	-	-	-	-
1851382	0	14	as	IN	-	-	-	-	-	-	-	-
1851382	0	15	indicated	VBN	-	-	-	-	-	-	-	-
1851382	0	16	by	IN	-	-	-	-	-	-	-	-
1851382	0	17	the	DT	-	-	-	-	-	-	-	-
1851382	0	18	presence	NN	-	-	-	-	-	-	-	-
1851382	0	19	of	IN	-	-	-	-	-	-	-	-
1851382	0	20	a	DT	-	-	-	-	-	-	-	-
1851382	0	21	few	JJ	-	-	-	-	-	-	-	-
1851382	0	22	secretory	JJ	-	-	-	-	-	-	-	-
1851382	0	23	alveolar	JJ	-	-	-	-	-	-	-	-
1851382	0	24	epithelial	JJ	-	-	-	-	-	-	-	-
1851382	0	25	cells	NNS	-	-	-	-	-	-	-	-
1851382	0	26	within	IN	-	-	-	-	-	-	-	-
1851382	0	27	scattered	VBN	-	-	-	-	-	-	-	-
1851382	0	28	alveolar	JJ	-	-	-	-	-	-	-	-
1851382	0	29	structures	NNS	-	-	-	-	-	-	-	-
1851382	0	30	sprouted	VBN	-	-	-	-	-	-	-	-
1851382	0	31	from	IN	-	-	-	-	-	-	-	-
1851382	0	32	a	DT	-	-	-	-	-	-	-	-
1851382	0	33	well	RB	-	-	-	-	-	-	-	-
1851382	0	34	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	35	established	VBN	-	-	-	-	-	-	-	-
1851382	0	36	ductal	JJ	-	-	-	-	-	-	-	-
1851382	0	37	branching	NN	-	-	-	-	-	-	-	-
1851382	0	38	network	NN	-	-	-	-	-	-	-	-
1851382	0	39	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	40	Figures	NNS	-	-	-	-	-	-	-	(189|(195b)
1851382	0	41	2c	NN	-	-	-	-	-	-	-	189)
1851382	0	42	and	CC	-	-	-	-	-	-	-	-
1851382	0	43	3a	NN	-	-	-	-	-	-	-	(195b)
1851382	0	44	,	,	-	-	-	-	-	-	-	-
1851382	0	45	lower	JJ	-	-	-	-	-	-	-	-
1851382	0	46	panel	NN	-	-	-	-	-	-	-	-
1851382	0	47	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	48	.	.	-	-	-	-	-	-	-	-

1851382	0	1	The	DT	-	-	-	-	-	-	-	-
1851382	0	2	extent	NN	-	-	-	-	-	-	-	-
1851382	0	3	of	IN	-	-	-	-	-	-	-	-
1851382	0	4	alveolar	JJ	-	-	-	-	-	-	-	(203
1851382	0	5	morphogenesis	NN	-	-	-	-	-	-	-	-
1851382	0	6	in	IN	-	-	-	-	-	-	-	-
1851382	0	7	SirT1ko	NN	-	-	-	-	-	-	-	(22|(24
1851382	0	8	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	9	ko	NN	-	-	-	-	-	-	-	24)
1851382	0	10	mice	NNS	-	-	-	-	-	-	-	22)|203)
1851382	0	11	was	VBD	-	-	-	-	-	-	-	-
1851382	0	12	inadequate	JJ	-	-	-	-	-	-	-	-
1851382	0	13	,	,	-	-	-	-	-	-	-	-
1851382	0	14	however	RB	-	-	-	-	-	-	-	-
1851382	0	15	,	,	-	-	-	-	-	-	-	-
1851382	0	16	as	IN	-	-	-	-	-	-	-	-
1851382	0	17	shown	VBN	-	-	-	-	-	-	-	-
1851382	0	18	by	IN	-	-	-	-	-	-	-	-
1851382	0	19	the	DT	-	-	-	-	-	-	-	(187
1851382	0	20	severe	JJ	-	-	-	-	-	-	-	-
1851382	0	21	deficit	NN	-	-	-	-	-	-	-	-
1851382	0	22	in	IN	-	-	-	-	-	-	-	-
1851382	0	23	milk	NN	-	-	-	-	-	-	-	(188|(156)
1851382	0	24	production	NN	-	-	-	-	-	-	-	188)|187)
1851382	0	25	when	WRB	-	-	-	-	-	-	-	-
1851382	0	26	compared	VBN	-	-	-	-	-	-	-	-
1851382	0	27	with	IN	-	-	-	-	-	-	-	-
1851382	0	28	that	DT	-	-	-	-	-	-	-	-
1851382	0	29	in	IN	-	-	-	-	-	-	-	-
1851382	0	30	wild	JJ	-	-	-	-	-	-	-	(137|(165
1851382	0	31	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	32	type	NN	-	-	-	-	-	-	-	137)
1851382	0	33	mice	NNS	-	-	-	-	-	-	-	165)
1851382	0	34	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	35	Figure	NN	-	-	-	-	-	-	-	(189
1851382	0	36	2c	NN	-	-	-	-	-	-	-	189)
1851382	0	37	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	38	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Exogenous	JJ	-	-	-	-	-	-	-	-
1851382	0	2	estrogen	NN	-	-	-	-	-	-	-	-
1851382	0	3	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	4	induced	VBN	-	-	-	-	-	-	-	-
1851382	0	5	ductal	JJ	-	-	-	-	-	-	-	-
1851382	0	6	morphogenesis	NN	-	-	-	-	-	-	-	-

1851382	0	1	To	TO	-	-	-	-	-	-	-	-
1851382	0	2	test	VB	-	-	-	-	-	-	-	-
1851382	0	3	whether	IN	-	-	-	-	-	-	-	-
1851382	0	4	the	DT	-	-	-	-	-	-	-	-
1851382	0	5	increased	VBN	-	-	-	-	-	-	-	-
1851382	0	6	levels	NNS	-	-	-	-	-	-	-	-
1851382	0	7	of	IN	-	-	-	-	-	-	-	-
1851382	0	8	estrogen	NN	-	-	-	-	-	-	-	-
1851382	0	9	in	IN	-	-	-	-	-	-	-	-
1851382	0	10	pregnant	JJ	-	-	-	-	-	-	-	(33
1851382	0	11	mice	NNS	-	-	-	-	-	-	-	33)
1851382	0	12	were	VBD	-	-	-	-	-	-	-	-
1851382	0	13	sufficient	JJ	-	-	-	-	-	-	-	-
1851382	0	14	to	TO	-	-	-	-	-	-	-	-
1851382	0	15	induce	VB	-	-	-	-	-	-	-	-
1851382	0	16	ductal	JJ	-	-	-	-	-	-	-	(62
1851382	0	17	morphogenesis	NN	-	-	-	-	-	-	-	-
1851382	0	18	in	IN	-	-	-	-	-	-	-	-
1851382	0	19	SirT1ko	NN	-	-	-	-	-	-	-	(22|(24
1851382	0	20	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	21	ko	NN	-	-	-	-	-	-	-	24)
1851382	0	22	mice	NNS	-	-	-	-	-	-	-	62)|22)
1851382	0	23	,	,	-	-	-	-	-	-	-	-
1851382	0	24	a	DT	-	-	-	-	-	-	-	-
1851382	0	25	single	JJ	-	-	-	-	-	-	-	-
1851382	0	26	estrogen	NN	-	-	-	-	-	-	-	-
1851382	0	27	pellet	NN	-	-	-	-	-	-	-	-
1851382	0	28	was	VBD	-	-	-	-	-	-	-	-
1851382	0	29	implanted	VBN	-	-	-	-	-	-	-	-
1851382	0	30	in	IN	-	-	-	-	-	-	-	-
1851382	0	31	the	DT	-	-	-	-	-	-	-	(36
1851382	0	32	subscapular	JJ	-	-	-	-	-	-	-	-
1851382	0	33	region	NN	-	-	-	-	-	-	-	-
1851382	0	34	of	IN	-	-	-	-	-	-	-	-
1851382	0	35	each	DT	-	-	-	-	-	-	-	-
1851382	0	36	virgin	JJ	-	-	-	-	-	-	-	-
1851382	0	37	SirT1ko	NN	-	-	-	-	-	-	-	-
1851382	0	38	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	39	ko	NN	-	-	-	-	-	-	-	-
1851382	0	40	mouse	NN	-	-	-	-	-	-	-	36)
1851382	0	41	and	CC	-	-	-	-	-	-	-	-
1851382	0	42	the	DT	-	-	-	-	-	-	-	(204
1851382	0	43	mammary	JJ	-	-	-	-	-	-	-	-
1851382	0	44	tissues	NNS	-	-	-	-	-	-	-	204)
1851382	0	45	were	VBD	-	-	-	-	-	-	-	-
1851382	0	46	analyzed	VBN	-	-	-	-	-	-	-	-
1851382	0	47	14	CD	-	-	-	-	-	-	-	(205|(206a)
1851382	0	48	and	CC	-	-	-	-	-	-	-	-
1851382	0	49	21	CD	-	-	-	-	-	-	-	(149
1851382	0	50	days	NNS	-	-	-	-	-	-	-	(206a
1851382	0	51	after	IN	-	-	-	-	-	-	-	-
1851382	0	52	the	DT	-	-	-	-	-	-	-	(46
1851382	0	53	implantation	NN	-	-	-	-	-	-	-	46)|206a)|205)|149)
1851382	0	54	.	.	-	-	-	-	-	-	-	-

1851382	0	1	By	IN	-	-	-	-	-	-	-	-
1851382	0	2	day	NN	-	-	-	-	-	-	-	(206
1851382	0	3	14	CD	-	-	-	-	-	-	-	206)
1851382	0	4	,	,	-	-	-	-	-	-	-	-
1851382	0	5	wild	JJ	-	-	-	-	-	-	-	(137|(207
1851382	0	6	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	7	type	NN	-	-	-	-	-	-	-	137)
1851382	0	8	mice	NNS	-	-	-	-	-	-	-	207)
1851382	0	9	displayed	VBD	-	-	-	-	-	-	-	-
1851382	0	10	ductal	JJ	-	-	-	-	-	-	-	(208
1851382	0	11	side	NN	-	-	-	-	-	-	-	-
1851382	0	12	branching	NN	-	-	-	-	-	-	-	-
1851382	0	13	reminiscent	JJ	-	-	-	-	-	-	-	-
1851382	0	14	of	IN	-	-	-	-	-	-	-	-
1851382	0	15	the	DT	-	-	-	-	-	-	-	-
1851382	0	16	morphological	JJ	-	-	-	-	-	-	-	-
1851382	0	17	changes	NNS	-	-	-	-	-	-	-	-
1851382	0	18	during	IN	-	-	-	-	-	-	-	-
1851382	0	19	early	JJ	-	-	-	-	-	-	-	(209
1851382	0	20	pregnancy	NN	-	-	-	-	-	-	-	209)|208)
1851382	0	21	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	22	Figure	NN	-	-	-	-	-	-	-	(210
1851382	0	23	4a	NN	-	-	-	-	-	-	-	210)
1851382	0	24	,	,	-	-	-	-	-	-	-	-
1851382	0	25	left	JJ	-	-	-	-	-	-	-	-
1851382	0	26	panel	NN	-	-	-	-	-	-	-	-
1851382	0	27	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	28	.	.	-	-	-	-	-	-	-	-

1851382	0	1	In	IN	-	-	-	-	-	-	-	-
1851382	0	2	contrast	NN	-	-	-	-	-	-	-	-
1851382	0	3	,	,	-	-	-	-	-	-	-	-
1851382	0	4	SirT1ko	NN	-	-	-	-	-	-	-	(211|(24
1851382	0	5	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	6	ko	NN	-	-	-	-	-	-	-	24)
1851382	0	7	mice	NNS	-	-	-	-	-	-	-	211)
1851382	0	8	showed	VBD	-	-	-	-	-	-	-	-
1851382	0	9	TEBs	NNS	-	-	-	-	-	-	-	(194)
1851382	0	10	and	CC	-	-	-	-	-	-	-	-
1851382	0	11	ductal	JJ	-	-	-	-	-	-	-	(212
1851382	0	12	elongation	NN	-	-	-	-	-	-	-	212)
1851382	0	13	,	,	-	-	-	-	-	-	-	-
1851382	0	14	which	WDT	-	-	-	-	-	-	-	-
1851382	0	15	are	VBP	-	-	-	-	-	-	-	-
1851382	0	16	the	DT	-	-	-	-	-	-	-	-
1851382	0	17	characteristic	JJ	-	-	-	-	-	-	-	-
1851382	0	18	features	NNS	-	-	-	-	-	-	-	-
1851382	0	19	of	IN	-	-	-	-	-	-	-	-
1851382	0	20	ductal	JJ	-	-	-	-	-	-	-	-
1851382	0	21	morphogenesis	NN	-	-	-	-	-	-	-	-
1851382	0	22	in	IN	-	-	-	-	-	-	-	-
1851382	0	23	pubertal	JJ	-	-	-	-	-	-	-	-
1851382	0	24	wild	JJ	-	-	-	-	-	-	-	-
1851382	0	25	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	26	type	NN	-	-	-	-	-	-	-	-
1851382	0	27	mice	NNS	-	-	-	-	-	-	-	-
1851382	0	28	.	.	-	-	-	-	-	-	-	-

1851382	0	1	By	IN	-	-	-	-	-	-	-	-
1851382	0	2	day	NN	-	-	-	-	-	-	-	(149
1851382	0	3	21	CD	-	-	-	-	-	-	-	149)
1851382	0	4	,	,	-	-	-	-	-	-	-	-
1851382	0	5	ductal	JJ	-	-	-	-	-	-	-	(212|(213
1851382	0	6	elongation	NN	-	-	-	-	-	-	-	212)
1851382	0	7	and	CC	-	-	-	-	-	-	-	-
1851382	0	8	side	NN	-	-	-	-	-	-	-	(208
1851382	0	9	branching	NN	-	-	-	-	-	-	-	213)|208)
1851382	0	10	were	VBD	-	-	-	-	-	-	-	-
1851382	0	11	restored	VBN	-	-	-	-	-	-	-	-
1851382	0	12	in	IN	-	-	-	-	-	-	-	-
1851382	0	13	SirT1ko	NN	-	-	-	-	-	-	-	(211|(24
1851382	0	14	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	15	ko	NN	-	-	-	-	-	-	-	24)
1851382	0	16	mice	NNS	-	-	-	-	-	-	-	211)
1851382	0	17	and	CC	-	-	-	-	-	-	-	-
1851382	0	18	the	DT	-	-	-	-	-	-	-	-
1851382	0	19	extent	NN	-	-	-	-	-	-	-	-
1851382	0	20	of	IN	-	-	-	-	-	-	-	-
1851382	0	21	ductal	JJ	-	-	-	-	-	-	-	(62
1851382	0	22	morphogenesis	NN	-	-	-	-	-	-	-	62)
1851382	0	23	was	VBD	-	-	-	-	-	-	-	-
1851382	0	24	indistinguishable	JJ	-	-	-	-	-	-	-	-
1851382	0	25	between	IN	-	-	-	-	-	-	-	-
1851382	0	26	wild	JJ	-	-	-	-	-	-	-	(137|(207b
1851382	0	27	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	28	type	NN	-	-	-	-	-	-	-	207b)|137)
1851382	0	29	and	CC	-	-	-	-	-	-	-	-
1851382	0	30	SirT1ko	NN	-	-	-	-	-	-	-	(24
1851382	0	31	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	32	ko	NN	-	-	-	-	-	-	-	24)
1851382	0	33	female	JJ	-	-	-	-	-	-	-	-
1851382	0	34	mice	NNS	-	-	-	-	-	-	-	(207b)
1851382	0	35	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	36	Figure	NN	-	-	-	-	-	-	-	(210
1851382	0	37	4a	NN	-	-	-	-	-	-	-	210)
1851382	0	38	,	,	-	-	-	-	-	-	-	-
1851382	0	39	right	JJ	-	-	-	-	-	-	-	-
1851382	0	40	panel	NN	-	-	-	-	-	-	-	-
1851382	0	41	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	42	.	.	-	-	-	-	-	-	-	-

1851382	0	1	These	DT	-	-	-	-	-	-	-	-
1851382	0	2	observations	NNS	-	-	-	-	-	-	-	-
1851382	0	3	clearly	RB	-	-	-	-	-	-	-	-
1851382	0	4	indicated	VBD	-	-	-	-	-	-	-	-
1851382	0	5	that	IN	-	-	-	-	-	-	-	-
1851382	0	6	exogenous	JJ	-	-	-	-	-	-	-	(7
1851382	0	7	estrogen	NN	-	-	-	-	-	-	-	7)
1851382	0	8	alone	RB	-	-	-	-	-	-	-	-
1851382	0	9	is	VBZ	-	-	-	-	-	-	-	-
1851382	0	10	sufficient	JJ	-	-	-	-	-	-	-	-
1851382	0	11	to	TO	-	-	-	-	-	-	-	-
1851382	0	12	rescue	VB	-	-	-	-	-	-	-	-
1851382	0	13	ductal	JJ	-	-	-	-	-	-	-	(43
1851382	0	14	morphogenesis	NN	-	-	-	-	-	-	-	-
1851382	0	15	in	IN	-	-	-	-	-	-	-	-
1851382	0	16	virgin	JJ	-	-	-	-	-	-	-	(32
1851382	0	17	SirT1ko	NN	-	-	-	-	-	-	-	-
1851382	0	18	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	19	ko	NN	-	-	-	-	-	-	-	-
1851382	0	20	mice	NNS	-	-	-	-	-	-	-	43)|32)
1851382	0	21	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Furthermore	RB	-	-	-	-	-	-	-	-
1851382	0	2	,	,	-	-	-	-	-	-	-	-
1851382	0	3	the	DT	-	-	-	-	-	-	-	-
1851382	0	4	presence	NN	-	-	-	-	-	-	-	-
1851382	0	5	of	IN	-	-	-	-	-	-	-	-
1851382	0	6	transitional	JJ	-	-	-	-	-	-	-	-
1851382	0	7	TEBs	NNS	-	-	-	-	-	-	-	-
1851382	0	8	on	IN	-	-	-	-	-	-	-	-
1851382	0	9	day	NN	-	-	-	-	-	-	-	(206
1851382	0	10	14	CD	-	-	-	-	-	-	-	206)
1851382	0	11	and	CC	-	-	-	-	-	-	-	-
1851382	0	12	of	IN	-	-	-	-	-	-	-	-
1851382	0	13	ductal	JJ	-	-	-	-	-	-	-	-
1851382	0	14	side	NN	-	-	-	-	-	-	-	-
1851382	0	15	branching	NN	-	-	-	-	-	-	-	-
1851382	0	16	on	IN	-	-	-	-	-	-	-	-
1851382	0	17	day	NN	-	-	-	-	-	-	-	(149
1851382	0	18	21	CD	-	-	-	-	-	-	-	149)
1851382	0	19	suggested	VBD	-	-	-	-	-	-	-	-
1851382	0	20	that	IN	-	-	-	-	-	-	-	-
1851382	0	21	the	DT	-	-	-	-	-	-	-	-
1851382	0	22	characteristic	JJ	-	-	-	-	-	-	-	-
1851382	0	23	features	NNS	-	-	-	-	-	-	-	-
1851382	0	24	of	IN	-	-	-	-	-	-	-	-
1851382	0	25	mammary	JJ	-	-	-	-	-	-	-	(9
1851382	0	26	gland	NN	-	-	-	-	-	-	-	9)
1851382	0	27	development	NN	-	-	-	-	-	-	-	-
1851382	0	28	at	IN	-	-	-	-	-	-	-	-
1851382	0	29	puberty	NN	-	-	-	-	-	-	-	(103)
1851382	0	30	and	CC	-	-	-	-	-	-	-	-
1851382	0	31	during	IN	-	-	-	-	-	-	-	-
1851382	0	32	early	JJ	-	-	-	-	-	-	-	(209
1851382	0	33	pregnancy	NN	-	-	-	-	-	-	-	209)
1851382	0	34	could	MD	-	-	-	-	-	-	-	-
1851382	0	35	be	VB	-	-	-	-	-	-	-	-
1851382	0	36	coupled	VBN	-	-	-	-	-	-	-	-
1851382	0	37	in	IN	-	-	-	-	-	-	-	-
1851382	0	38	response	NN	-	-	-	-	-	-	-	-
1851382	0	39	to	IN	-	-	-	-	-	-	-	-
1851382	0	40	increasing	VBG	-	-	-	-	-	-	-	-
1851382	0	41	levels	NNS	-	-	-	-	-	-	-	-
1851382	0	42	of	IN	-	-	-	-	-	-	-	-
1851382	0	43	estrogen	NN	-	-	-	-	-	-	-	(7)
1851382	0	44	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Increased	VBN	-	-	-	-	-	-	-	(52
1851382	0	2	levels	NNS	-	-	-	-	-	-	-	-
1851382	0	3	of	IN	-	-	-	-	-	-	-	-
1851382	0	4	estrogen	NN	-	-	-	-	-	-	-	(7)|52)
1851382	0	5	,	,	-	-	-	-	-	-	-	-
1851382	0	6	either	CC	-	-	-	-	-	-	-	-
1851382	0	7	during	IN	-	-	-	-	-	-	-	-
1851382	0	8	pregnancy	NN	-	-	-	-	-	-	-	(185)
1851382	0	9	or	CC	-	-	-	-	-	-	-	-
1851382	0	10	through	IN	-	-	-	-	-	-	-	-
1851382	0	11	implantation	NN	-	-	-	-	-	-	-	(46)
1851382	0	12	,	,	-	-	-	-	-	-	-	-
1851382	0	13	were	VBD	-	-	-	-	-	-	-	-
1851382	0	14	therefore	RB	-	-	-	-	-	-	-	-
1851382	0	15	sufficient	JJ	-	-	-	-	-	-	-	-
1851382	0	16	to	TO	-	-	-	-	-	-	-	-
1851382	0	17	stimulate	VB	-	-	-	-	-	-	-	-
1851382	0	18	the	DT	-	-	-	-	-	-	-	(214
1851382	0	19	differentiation	NN	-	-	-	-	-	-	-	-
1851382	0	20	of	IN	-	-	-	-	-	-	-	-
1851382	0	21	epithelial	JJ	-	-	-	-	-	-	-	(104
1851382	0	22	progenitor	NN	-	-	-	-	-	-	-	-
1851382	0	23	cells	NNS	-	-	-	-	-	-	-	214)|104)
1851382	0	24	and	CC	-	-	-	-	-	-	-	-
1851382	0	25	ductal	JJ	-	-	-	-	-	-	-	(43
1851382	0	26	morphogenesis	NN	-	-	-	-	-	-	-	-
1851382	0	27	in	IN	-	-	-	-	-	-	-	-
1851382	0	28	virgin	JJ	-	-	-	-	-	-	-	(32
1851382	0	29	SirT1ko	NN	-	-	-	-	-	-	-	-
1851382	0	30	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	31	ko	NN	-	-	-	-	-	-	-	-
1851382	0	32	mice	NNS	-	-	-	-	-	-	-	43)|32)
1851382	0	33	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Concurrent	JJ	-	-	-	-	-	-	-	(214a|(215|(216
1851382	0	2	mammary	JJ	-	-	-	-	-	-	-	-
1851382	0	3	epithelial	JJ	-	-	-	-	-	-	-	-
1851382	0	4	cell	NN	-	-	-	-	-	-	-	214a)
1851382	0	5	proliferation	NN	-	-	-	-	-	-	-	215)
1851382	0	6	and	CC	-	-	-	-	-	-	-	-
1851382	0	7	differentiation	NN	-	-	-	-	-	-	-	(214a)|216)

1851382	0	1	The	DT	-	-	-	-	-	-	-	-
1851382	0	2	finding	NN	-	-	-	-	-	-	-	-
1851382	0	3	of	IN	-	-	-	-	-	-	-	-
1851382	0	4	pregnancy	NN	-	-	-	-	-	-	-	(190
1851382	0	5	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	6	induced	VBN	-	-	-	-	-	-	-	-
1851382	0	7	mammary	JJ	-	-	-	-	-	-	-	-
1851382	0	8	gland	NN	-	-	-	-	-	-	-	-
1851382	0	9	development	NN	-	-	-	-	-	-	-	190)
1851382	0	10	prompted	VBD	-	-	-	-	-	-	-	-
1851382	0	11	us	PRP	-	-	-	-	-	-	-	(95)
1851382	0	12	to	TO	-	-	-	-	-	-	-	-
1851382	0	13	investigate	VB	-	-	-	-	-	-	-	-
1851382	0	14	how	WRB	-	-	-	-	-	-	-	-
1851382	0	15	mammary	JJ	-	-	-	-	-	-	-	-
1851382	0	16	epithelial	JJ	-	-	-	-	-	-	-	-
1851382	0	17	progenitor	NN	-	-	-	-	-	-	-	-
1851382	0	18	cells	NNS	-	-	-	-	-	-	-	-
1851382	0	19	in	IN	-	-	-	-	-	-	-	-
1851382	0	20	pregnant	JJ	-	-	-	-	-	-	-	(33
1851382	0	21	SirT1ko	NN	-	-	-	-	-	-	-	-
1851382	0	22	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	23	ko	NN	-	-	-	-	-	-	-	-
1851382	0	24	mice	NNS	-	-	-	-	-	-	-	33)
1851382	0	25	can	MD	-	-	-	-	-	-	-	-
1851382	0	26	differentiate	VB	-	-	-	-	-	-	-	-
1851382	0	27	so	RB	-	-	-	-	-	-	-	-
1851382	0	28	rapidly	RB	-	-	-	-	-	-	-	-
1851382	0	29	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Both	CC	-	-	-	-	-	-	-	-
1851382	0	2	BrdU	NN	-	-	-	-	-	-	-	(154)
1851382	0	3	labeling	NN	-	-	-	-	-	-	-	-
1851382	0	4	and	CC	-	-	-	-	-	-	-	-
1851382	0	5	the	DT	-	-	-	-	-	-	-	(217
1851382	0	6	TUNEL	NN	-	-	-	-	-	-	-	-
1851382	0	7	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	8	Terminal	JJ	-	-	-	-	-	-	-	-
1851382	0	9	deoxynucleotidyl	NN	-	-	-	-	-	-	-	-
1851382	0	10	transferase	NN	-	-	-	-	-	-	-	-
1851382	0	11	mediated	VBN	-	-	-	-	-	-	-	-
1851382	0	12	dUTP	NN	-	-	-	-	-	-	-	-
1851382	0	13	Nick	NN	-	-	-	-	-	-	-	-
1851382	0	14	End	NN	-	-	-	-	-	-	-	-
1851382	0	15	Labeling	NN	-	-	-	-	-	-	-	-
1851382	0	16	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	17	assay	NN	-	-	-	-	-	-	-	217)
1851382	0	18	were	VBD	-	-	-	-	-	-	-	-
1851382	0	19	used	VBN	-	-	-	-	-	-	-	-
1851382	0	20	to	TO	-	-	-	-	-	-	-	-
1851382	0	21	measure	VB	-	-	-	-	-	-	-	-
1851382	0	22	the	DT	-	-	-	-	-	-	-	(215a
1851382	0	23	cell	NN	-	-	-	-	-	-	-	(167)
1851382	0	24	proliferation	NN	-	-	-	-	-	-	-	215a)
1851382	0	25	and	CC	-	-	-	-	-	-	-	-
1851382	0	26	apoptosis	NN	-	-	-	-	-	-	-	(218
1851382	0	27	in	IN	-	-	-	-	-	-	-	(215a
1851382	0	28	the	DT	-	-	-	-	-	-	-	(160
1851382	0	29	mammary	JJ	-	-	-	-	-	-	-	-
1851382	0	30	tissues	NNS	-	-	-	-	-	-	-	218)|215a)|160)
1851382	0	31	,	,	-	-	-	-	-	-	-	-
1851382	0	32	respectively	RB	-	-	-	-	-	-	-	-
1851382	0	33	.	.	-	-	-	-	-	-	-	-

1851382	0	1	We	PRP	-	-	-	-	-	-	-	(219|(95)
1851382	0	2	found	VBD	-	-	-	-	-	-	-	-
1851382	0	3	in	IN	-	-	-	-	-	-	-	-
1851382	0	4	SirT1ko	NN	-	-	-	-	-	-	-	(24|(49
1851382	0	5	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	6	ko	NN	-	-	-	-	-	-	-	24)
1851382	0	7	mammary	JJ	-	-	-	-	-	-	-	-
1851382	0	8	tissues	NNS	-	-	-	-	-	-	-	49)
1851382	0	9	that	IN	-	-	-	-	-	-	-	-
1851382	0	10	about	IN	-	-	-	-	-	-	-	-
1851382	0	11	one	CD	-	-	-	-	-	-	-	-
1851382	0	12	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	13	third	NN	-	-	-	-	-	-	-	-
1851382	0	14	of	IN	-	-	-	-	-	-	-	-
1851382	0	15	the	DT	-	-	-	-	-	-	-	-
1851382	0	16	cells	NNS	-	-	-	-	-	-	-	-
1851382	0	17	in	IN	-	-	-	-	-	-	-	-
1851382	0	18	TEBs	NNS	-	-	-	-	-	-	-	(194)
1851382	0	19	were	VBD	-	-	-	-	-	-	-	-
1851382	0	20	BrdU	NN	-	-	-	-	-	-	-	-
1851382	0	21	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	22	positive	JJ	-	-	-	-	-	-	-	-
1851382	0	23	as	IN	-	-	-	-	-	-	-	-
1851382	0	24	compared	VBN	-	-	-	-	-	-	-	-
1851382	0	25	with	IN	-	-	-	-	-	-	-	-
1851382	0	26	the	DT	-	-	-	-	-	-	-	-
1851382	0	27	number	NN	-	-	-	-	-	-	-	-
1851382	0	28	of	IN	-	-	-	-	-	-	-	-
1851382	0	29	BrdU	NN	-	-	-	-	-	-	-	(220
1851382	0	30	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	31	positive	JJ	-	-	-	-	-	-	-	-
1851382	0	32	cells	NNS	-	-	-	-	-	-	-	-
1851382	0	33	in	IN	-	-	-	-	-	-	-	-
1851382	0	34	the	DT	-	-	-	-	-	-	-	(221a
1851382	0	35	newly	RB	-	-	-	-	-	-	-	-
1851382	0	36	differentiated	VBN	-	-	-	-	-	-	-	-
1851382	0	37	ductal	JJ	-	-	-	-	-	-	-	221a)
1851382	0	38	or	CC	-	-	-	-	-	-	-	-
1851382	0	39	alveolar	JJ	-	-	-	-	-	-	-	-
1851382	0	40	epithelial	JJ	-	-	-	-	-	-	-	(221a
1851382	0	41	cells	NNS	-	-	-	-	-	-	-	221a)|220)|219)
1851382	0	42	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	43	Figure	NN	-	-	-	-	-	-	-	(222
1851382	0	44	5a	NN	-	-	-	-	-	-	-	222)
1851382	0	45	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	46	upper	JJ	-	-	-	-	-	-	-	-
1851382	0	47	panel	NN	-	-	-	-	-	-	-	-
1851382	0	48	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	49	,	,	-	-	-	-	-	-	-	-
1851382	0	50	5b	NN	-	-	-	-	-	-	-	-
1851382	0	51	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	52	.	.	-	-	-	-	-	-	-	-

1851382	0	1	This	DT	-	-	-	-	-	-	-	(219
1851382	0	2	BrdU	NN	-	-	-	-	-	-	-	-
1851382	0	3	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	4	positive	JJ	-	-	-	-	-	-	-	-
1851382	0	5	finding	NN	-	-	-	-	-	-	-	219)
1851382	0	6	differs	VBZ	-	-	-	-	-	-	-	-
1851382	0	7	from	IN	-	-	-	-	-	-	-	-
1851382	0	8	that	DT	-	-	-	-	-	-	-	-
1851382	0	9	in	IN	-	-	-	-	-	-	-	-
1851382	0	10	wild	JJ	-	-	-	-	-	-	-	(137|(223
1851382	0	11	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	12	type	NN	-	-	-	-	-	-	-	137)
1851382	0	13	mammary	JJ	-	-	-	-	-	-	-	-
1851382	0	14	tissues	NNS	-	-	-	-	-	-	-	223)
1851382	0	15	,	,	-	-	-	-	-	-	-	-
1851382	0	16	in	IN	-	-	-	-	-	-	-	-
1851382	0	17	which	WDT	-	-	-	-	-	-	-	-
1851382	0	18	less	JJR	-	-	-	-	-	-	-	-
1851382	0	19	than	IN	-	-	-	-	-	-	-	-
1851382	0	20	3	CD	-	-	-	-	-	-	-	-
1851382	0	21	%	NN	-	-	-	-	-	-	-	-
1851382	0	22	of	IN	-	-	-	-	-	-	-	-
1851382	0	23	ductal	JJ	-	-	-	-	-	-	-	(224
1851382	0	24	epithelial	JJ	-	-	-	-	-	-	-	-
1851382	0	25	cells	NNS	-	-	-	-	-	-	-	224)
1851382	0	26	and	CC	-	-	-	-	-	-	-	-
1851382	0	27	about	IN	-	-	-	-	-	-	-	-
1851382	0	28	25	CD	-	-	-	-	-	-	-	-
1851382	0	29	%	NN	-	-	-	-	-	-	-	-
1851382	0	30	of	IN	-	-	-	-	-	-	-	-
1851382	0	31	alveolar	JJ	-	-	-	-	-	-	-	-
1851382	0	32	epithelial	JJ	-	-	-	-	-	-	-	-
1851382	0	33	cells	NNS	-	-	-	-	-	-	-	-
1851382	0	34	were	VBD	-	-	-	-	-	-	-	-
1851382	0	35	BrdU	NN	-	-	-	-	-	-	-	-
1851382	0	36	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	37	positive	JJ	-	-	-	-	-	-	-	-
1851382	0	38	.	.	-	-	-	-	-	-	-	-

1851382	0	1	The	DT	-	-	-	-	-	-	-	(221
1851382	0	2	newly	RB	-	-	-	-	-	-	-	-
1851382	0	3	generated	VBN	-	-	-	-	-	-	-	-
1851382	0	4	ductal	JJ	-	-	-	-	-	-	-	-
1851382	0	5	epithelial	JJ	-	-	-	-	-	-	-	-
1851382	0	6	cells	NNS	-	-	-	-	-	-	-	-
1851382	0	7	in	IN	-	-	-	-	-	-	-	-
1851382	0	8	SirT1ko	NN	-	-	-	-	-	-	-	(22|(24
1851382	0	9	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	10	ko	NN	-	-	-	-	-	-	-	24)
1851382	0	11	mice	NNS	-	-	-	-	-	-	-	221)|22)
1851382	0	12	formed	VBD	-	-	-	-	-	-	-	-
1851382	0	13	elongated	VBN	-	-	-	-	-	-	-	(212|(213
1851382	0	14	ducts	NNS	-	-	-	-	-	-	-	212)
1851382	0	15	and	CC	-	-	-	-	-	-	-	-
1851382	0	16	side	NN	-	-	-	-	-	-	-	(208
1851382	0	17	branches	NNS	-	-	-	-	-	-	-	213)|208)
1851382	0	18	,	,	-	-	-	-	-	-	-	-
1851382	0	19	while	IN	-	-	-	-	-	-	-	-
1851382	0	20	pushing	VBG	-	-	-	-	-	-	-	-
1851382	0	21	TEBs	NNS	-	-	-	-	-	-	-	(194)
1851382	0	22	towards	IN	-	-	-	-	-	-	-	-
1851382	0	23	the	DT	-	-	-	-	-	-	-	(197
1851382	0	24	edge	NN	-	-	-	-	-	-	-	-
1851382	0	25	of	IN	-	-	-	-	-	-	-	-
1851382	0	26	mammary	JJ	-	-	-	-	-	-	-	(107|(108
1851382	0	27	fat	NN	-	-	-	-	-	-	-	107)
1851382	0	28	pad	NN	-	-	-	-	-	-	-	197)|108)
1851382	0	29	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	30	Figure	NN	-	-	-	-	-	-	-	(195
1851382	0	31	3a	NN	-	-	-	-	-	-	-	195)
1851382	0	32	,	,	-	-	-	-	-	-	-	-
1851382	0	33	lower	JJR	-	-	-	-	-	-	-	-
1851382	0	34	panel	NN	-	-	-	-	-	-	-	-
1851382	0	35	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	36	.	.	-	-	-	-	-	-	-	-

1851382	0	1	The	DT	-	-	-	-	-	-	-	(221
1851382	0	2	newly	RB	-	-	-	-	-	-	-	-
1851382	0	3	generated	VBN	-	-	-	-	-	-	-	-
1851382	0	4	ductal	JJ	-	-	-	-	-	-	-	-
1851382	0	5	epithelial	JJ	-	-	-	-	-	-	-	-
1851382	0	6	cells	NNS	-	-	-	-	-	-	-	221)
1851382	0	7	can	MD	-	-	-	-	-	-	-	-
1851382	0	8	consequently	RB	-	-	-	-	-	-	-	-
1851382	0	9	further	RB	-	-	-	-	-	-	-	-
1851382	0	10	differentiate	VB	-	-	-	-	-	-	-	-
1851382	0	11	into	IN	-	-	-	-	-	-	-	-
1851382	0	12	a	DT	-	-	-	-	-	-	-	-
1851382	0	13	few	JJ	-	-	-	-	-	-	-	-
1851382	0	14	observed	VBN	-	-	-	-	-	-	-	-
1851382	0	15	alveolar	JJ	-	-	-	-	-	-	-	-
1851382	0	16	cells	NNS	-	-	-	-	-	-	-	-
1851382	0	17	in	IN	-	-	-	-	-	-	-	-
1851382	0	18	which	WDT	-	-	-	-	-	-	-	-
1851382	0	19	milk	NN	-	-	-	-	-	-	-	(157|(156)
1851382	0	20	proteins	NN	-	-	-	-	-	-	-	157)
1851382	0	21	were	VBD	-	-	-	-	-	-	-	-
1851382	0	22	detected	VBN	-	-	-	-	-	-	-	-
1851382	0	23	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	24	Figure	NN	-	-	-	-	-	-	-	(189
1851382	0	25	2c	NN	-	-	-	-	-	-	-	189)
1851382	0	26	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	27	.	.	-	-	-	-	-	-	-	-

1851382	0	1	These	DT	-	-	-	-	-	-	-	-
1851382	0	2	observations	NNS	-	-	-	-	-	-	-	-
1851382	0	3	suggested	VBD	-	-	-	-	-	-	-	-
1851382	0	4	that	IN	-	-	-	-	-	-	-	-
1851382	0	5	the	DT	-	-	-	-	-	-	-	(215b|(216
1851382	0	6	proliferation	NN	-	-	-	-	-	-	-	215b)
1851382	0	7	and	CC	-	-	-	-	-	-	-	-
1851382	0	8	differentiation	NN	-	-	-	-	-	-	-	(214
1851382	0	9	of	IN	-	-	-	-	-	-	-	(215b
1851382	0	10	epithelial	JJ	-	-	-	-	-	-	-	(104
1851382	0	11	progenitor	NN	-	-	-	-	-	-	-	-
1851382	0	12	cells	NNS	-	-	-	-	-	-	-	216)|215b)|214)|104)
1851382	0	13	,	,	-	-	-	-	-	-	-	-
1851382	0	14	which	WDT	-	-	-	-	-	-	-	-
1851382	0	15	is	VBZ	-	-	-	-	-	-	-	-
1851382	0	16	programmed	VBN	-	-	-	-	-	-	-	-
1851382	0	17	to	TO	-	-	-	-	-	-	-	-
1851382	0	18	take	VB	-	-	-	-	-	-	-	-
1851382	0	19	place	NN	-	-	-	-	-	-	-	-
1851382	0	20	at	IN	-	-	-	-	-	-	-	-
1851382	0	21	different	JJ	-	-	-	-	-	-	-	-
1851382	0	22	times	NNS	-	-	-	-	-	-	-	-
1851382	0	23	of	IN	-	-	-	-	-	-	-	-
1851382	0	24	a	DT	-	-	-	-	-	-	-	-
1851382	0	25	female	NN	-	-	-	-	-	-	-	(101
1851382	0	26	's	POS	-	-	-	-	-	-	-	101)
1851382	0	27	reproductive	JJ	-	-	-	-	-	-	-	-
1851382	0	28	life	NN	-	-	-	-	-	-	-	-
1851382	0	29	,	,	-	-	-	-	-	-	-	-
1851382	0	30	could	MD	-	-	-	-	-	-	-	-
1851382	0	31	be	VB	-	-	-	-	-	-	-	-
1851382	0	32	concurrent	JJ	-	-	-	-	-	-	-	-
1851382	0	33	at	IN	-	-	-	-	-	-	-	-
1851382	0	34	a	DT	-	-	-	-	-	-	-	-
1851382	0	35	late	JJ	-	-	-	-	-	-	-	-
1851382	0	36	stage	NN	-	-	-	-	-	-	-	-
1851382	0	37	of	IN	-	-	-	-	-	-	-	-
1851382	0	38	pregnancy	NN	-	-	-	-	-	-	-	(185)
1851382	0	39	in	IN	-	-	-	-	-	-	-	-
1851382	0	40	SirT1ko	NN	-	-	-	-	-	-	-	(22|(24
1851382	0	41	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	42	ko	NN	-	-	-	-	-	-	-	24)
1851382	0	43	mice	NNS	-	-	-	-	-	-	-	22)
1851382	0	44	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Apoptosis	NN	-	-	-	-	-	-	-	(218)
1851382	0	2	is	VBZ	-	-	-	-	-	-	-	-
1851382	0	3	a	DT	-	-	-	-	-	-	-	-
1851382	0	4	part	NN	-	-	-	-	-	-	-	-
1851382	0	5	of	IN	-	-	-	-	-	-	-	-
1851382	0	6	the	DT	-	-	-	-	-	-	-	-
1851382	0	7	self	NN	-	-	-	-	-	-	-	-
1851382	0	8	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	9	renewal	NN	-	-	-	-	-	-	-	-
1851382	0	10	and	CC	-	-	-	-	-	-	-	-
1851382	0	11	remodeling	NN	-	-	-	-	-	-	-	-
1851382	0	12	processes	NNS	-	-	-	-	-	-	-	-
1851382	0	13	in	IN	-	-	-	-	-	-	-	-
1851382	0	14	normal	JJ	-	-	-	-	-	-	-	-
1851382	0	15	mammary	JJ	-	-	-	-	-	-	-	-
1851382	0	16	tissues	NNS	-	-	-	-	-	-	-	-
1851382	0	17	[	-LRB-	-	-	-	-	-	-	-	-
1851382	0	18	17	CD	-	-	-	-	-	-	-	-
1851382	0	19	,	,	-	-	-	-	-	-	-	-
1851382	0	20	24	CD	-	-	-	-	-	-	-	-
1851382	0	21	,	,	-	-	-	-	-	-	-	-
1851382	0	22	25	CD	-	-	-	-	-	-	-	-
1851382	0	23	]	-RRB-	-	-	-	-	-	-	-	-
1851382	0	24	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Apoptotic	JJ	-	-	-	-	-	-	-	(155
1851382	0	2	epithelial	JJ	-	-	-	-	-	-	-	-
1851382	0	3	cells	NNS	-	-	-	-	-	-	-	155)
1851382	0	4	can	MD	-	-	-	-	-	-	-	-
1851382	0	5	be	VB	-	-	-	-	-	-	-	-
1851382	0	6	readily	RB	-	-	-	-	-	-	-	-
1851382	0	7	identified	VBN	-	-	-	-	-	-	-	-
1851382	0	8	in	IN	-	-	-	-	-	-	-	-
1851382	0	9	both	CC	-	-	-	-	-	-	-	-
1851382	0	10	ductal	JJ	-	-	-	-	-	-	-	-
1851382	0	11	and	CC	-	-	-	-	-	-	-	-
1851382	0	12	alveolar	JJ	-	-	-	-	-	-	-	-
1851382	0	13	epithelium	NN	-	-	-	-	-	-	-	-
1851382	0	14	of	IN	-	-	-	-	-	-	-	-
1851382	0	15	SirT1ko	NN	-	-	-	-	-	-	-	(192|(22|(24
1851382	0	16	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	17	ko	NN	-	-	-	-	-	-	-	24)
1851382	0	18	mice	NNS	-	-	-	-	-	-	-	22)
1851382	0	19	on	IN	-	-	-	-	-	-	-	-
1851382	0	20	lactation	NN	-	-	-	-	-	-	-	(193|(44)
1851382	0	21	day	NN	-	-	-	-	-	-	-	-
1851382	0	22	1	CD	-	-	-	-	-	-	-	193)|192)
1851382	0	23	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	24	Figure	NN	-	-	-	-	-	-	-	(222
1851382	0	25	5a	NN	-	-	-	-	-	-	-	222)
1851382	0	26	,	,	-	-	-	-	-	-	-	-
1851382	0	27	lower	JJ	-	-	-	-	-	-	-	-
1851382	0	28	panel	NN	-	-	-	-	-	-	-	-
1851382	0	29	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	30	.	.	-	-	-	-	-	-	-	-

1851382	0	1	The	DT	-	-	-	-	-	-	-	-
1851382	0	2	levels	NNS	-	-	-	-	-	-	-	-
1851382	0	3	of	IN	-	-	-	-	-	-	-	-
1851382	0	4	apoptotic	JJ	-	-	-	-	-	-	-	(155
1851382	0	5	cells	NNS	-	-	-	-	-	-	-	155)
1851382	0	6	were	VBD	-	-	-	-	-	-	-	-
1851382	0	7	significantly	RB	-	-	-	-	-	-	-	-
1851382	0	8	higher	JJR	-	-	-	-	-	-	-	-
1851382	0	9	than	IN	-	-	-	-	-	-	-	-
1851382	0	10	those	DT	-	-	-	-	-	-	-	-
1851382	0	11	in	IN	-	-	-	-	-	-	-	-
1851382	0	12	wild	JJ	-	-	-	-	-	-	-	(137|(202
1851382	0	13	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	14	type	NN	-	-	-	-	-	-	-	137)
1851382	0	15	mice	NNS	-	-	-	-	-	-	-	-
1851382	0	16	on	IN	-	-	-	-	-	-	-	-
1851382	0	17	lactation	NN	-	-	-	-	-	-	-	(193|(44)
1851382	0	18	day	NN	-	-	-	-	-	-	-	-
1851382	0	19	1	CD	-	-	-	-	-	-	-	202)|193)
1851382	0	20	,	,	-	-	-	-	-	-	-	-
1851382	0	21	but	CC	-	-	-	-	-	-	-	-
1851382	0	22	seemed	VBD	-	-	-	-	-	-	-	-
1851382	0	23	to	TO	-	-	-	-	-	-	-	-
1851382	0	24	be	VB	-	-	-	-	-	-	-	-
1851382	0	25	closer	JJR	-	-	-	-	-	-	-	-
1851382	0	26	to	IN	-	-	-	-	-	-	-	-
1851382	0	27	that	DT	-	-	-	-	-	-	-	-
1851382	0	28	in	IN	-	-	-	-	-	-	-	-
1851382	0	29	wild	JJ	-	-	-	-	-	-	-	(137|(225
1851382	0	30	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	31	type	NN	-	-	-	-	-	-	-	137)
1851382	0	32	mice	NNS	-	-	-	-	-	-	-	-
1851382	0	33	in	IN	-	-	-	-	-	-	-	-
1851382	0	34	mid-pregnancy	NN	-	-	-	-	-	-	-	(184)|225)
1851382	0	35	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	36	e.g.	FW	-	-	-	-	-	-	-	-
1851382	0	37	day	NN	-	-	-	-	-	-	-	(184
1851382	0	38	13	CD	-	-	-	-	-	-	-	-
1851382	0	39	of	IN	-	-	-	-	-	-	-	-
1851382	0	40	pregnancy	NN	-	-	-	-	-	-	-	(185)|184)
1851382	0	41	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	42	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	43	Figure	NN	-	-	-	-	-	-	-	-
1851382	0	44	5c	NN	-	-	-	-	-	-	-	-
1851382	0	45	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	46	.	.	-	-	-	-	-	-	-	-

1851382	0	1	The	DT	-	-	-	-	-	-	-	-
1851382	0	2	rush	NN	-	-	-	-	-	-	-	-
1851382	0	3	of	IN	-	-	-	-	-	-	-	-
1851382	0	4	proliferation	NN	-	-	-	-	-	-	-	(216|(215)
1851382	0	5	and	CC	-	-	-	-	-	-	-	-
1851382	0	6	differentiation	NN	-	-	-	-	-	-	-	-
1851382	0	7	during	IN	-	-	-	-	-	-	-	-
1851382	0	8	pregnancy	NN	-	-	-	-	-	-	-	-
1851382	0	9	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	10	rescued	VBN	-	-	-	-	-	-	-	-
1851382	0	11	ductal	JJ	-	-	-	-	-	-	-	-
1851382	0	12	development	NN	-	-	-	-	-	-	-	-
1851382	0	13	in	IN	-	-	-	-	-	-	-	-
1851382	0	14	SirT1ko	NN	-	-	-	-	-	-	-	(22|(24
1851382	0	15	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	16	ko	NN	-	-	-	-	-	-	-	24)
1851382	0	17	mice	NNS	-	-	-	-	-	-	-	22)|216)
1851382	0	18	manifested	VBD	-	-	-	-	-	-	-	-
1851382	0	19	multiple	JJ	-	-	-	-	-	-	-	-
1851382	0	20	features	NNS	-	-	-	-	-	-	-	-
1851382	0	21	on	IN	-	-	-	-	-	-	-	-
1851382	0	22	lactation	NN	-	-	-	-	-	-	-	(193|(44)
1851382	0	23	day	NN	-	-	-	-	-	-	-	-
1851382	0	24	1	CD	-	-	-	-	-	-	-	193)
1851382	0	25	that	WDT	-	-	-	-	-	-	-	-
1851382	0	26	could	MD	-	-	-	-	-	-	-	-
1851382	0	27	reassemble	VB	-	-	-	-	-	-	-	-
1851382	0	28	some	DT	-	-	-	-	-	-	-	-
1851382	0	29	characteristic	JJ	-	-	-	-	-	-	-	-
1851382	0	30	features	NNS	-	-	-	-	-	-	-	-
1851382	0	31	of	IN	-	-	-	-	-	-	-	-
1851382	0	32	wild	JJ	-	-	-	-	-	-	-	(137|(225
1851382	0	33	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	34	type	NN	-	-	-	-	-	-	-	137)
1851382	0	35	mice	NNS	-	-	-	-	-	-	-	-
1851382	0	36	in	IN	-	-	-	-	-	-	-	-
1851382	0	37	mid-pregnancy	NN	-	-	-	-	-	-	-	(184)|225)
1851382	0	38	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Successive	JJ	-	-	-	-	-	-	-	-
1851382	0	2	pregnancies	NNS	-	-	-	-	-	-	-	-
1851382	0	3	,	,	-	-	-	-	-	-	-	-
1851382	0	4	however	RB	-	-	-	-	-	-	-	-
1851382	0	5	,	,	-	-	-	-	-	-	-	-
1851382	0	6	failed	VBD	-	-	-	-	-	-	-	-
1851382	0	7	to	TO	-	-	-	-	-	-	-	-
1851382	0	8	improve	VB	-	-	-	-	-	-	-	-
1851382	0	9	the	DT	-	-	-	-	-	-	-	-
1851382	0	10	survival	NN	-	-	-	-	-	-	-	-
1851382	0	11	rate	NN	-	-	-	-	-	-	-	-
1851382	0	12	of	IN	-	-	-	-	-	-	-	-
1851382	0	13	either	CC	-	-	-	-	-	-	-	-
1851382	0	14	SirT1	NN	-	-	-	-	-	-	-	(132|(226
1851382	0	15	+	SYM	-	-	-	-	-	-	-	-
1851382	0	16	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	17	ko	NN	-	-	-	-	-	-	-	132)
1851382	0	18	pups	NNS	-	-	-	-	-	-	-	226)
1851382	0	19	or	CC	-	-	-	-	-	-	-	-
1851382	0	20	SirT1ko	NN	-	-	-	-	-	-	-	(180|(24
1851382	0	21	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	22	ko	NN	-	-	-	-	-	-	-	24)
1851382	0	23	pups	NNS	-	-	-	-	-	-	-	180)
1851382	0	24	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	25	three	CD	-	-	-	-	-	-	-	-
1851382	0	26	or	CC	-	-	-	-	-	-	-	-
1851382	0	27	four	CD	-	-	-	-	-	-	-	-
1851382	0	28	pregnancies	NNS	-	-	-	-	-	-	-	-
1851382	0	29	in	IN	-	-	-	-	-	-	-	-
1851382	0	30	3	CD	-	-	-	-	-	-	-	-
1851382	0	31	months	NNS	-	-	-	-	-	-	-	-
1851382	0	32	for	IN	-	-	-	-	-	-	-	-
1851382	0	33	each	DT	-	-	-	-	-	-	-	-
1851382	0	34	of	IN	-	-	-	-	-	-	-	-
1851382	0	35	three	CD	-	-	-	-	-	-	-	-
1851382	0	36	SirT1ko	NN	-	-	-	-	-	-	-	-
1851382	0	37	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	38	ko	NN	-	-	-	-	-	-	-	-
1851382	0	39	females	NNS	-	-	-	-	-	-	-	-
1851382	0	40	tested	VBN	-	-	-	-	-	-	-	-
1851382	0	41	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	42	,	,	-	-	-	-	-	-	-	-
1851382	0	43	indicating	VBG	-	-	-	-	-	-	-	-
1851382	0	44	that	IN	-	-	-	-	-	-	-	-
1851382	0	45	the	DT	-	-	-	-	-	-	-	(182
1851382	0	46	lactation	NN	-	-	-	-	-	-	-	(44)
1851382	0	47	defect	NN	-	-	-	-	-	-	-	182)
1851382	0	48	persisted	VBD	-	-	-	-	-	-	-	-
1851382	0	49	.	.	-	-	-	-	-	-	-	-

1851382	0	1	A	DT	-	-	-	-	-	-	-	(227
1851382	0	2	SirT1	NN	-	-	-	-	-	-	-	(1)
1851382	0	3	deficiency	NN	-	-	-	-	-	-	-	227)
1851382	0	4	therefore	RB	-	-	-	-	-	-	-	-
1851382	0	5	affected	VBD	-	-	-	-	-	-	-	-
1851382	0	6	ductal	JJ	-	-	-	-	-	-	-	(43
1851382	0	7	morphogenesis	NN	-	-	-	-	-	-	-	-
1851382	0	8	in	IN	-	-	-	-	-	-	-	-
1851382	0	9	virgin	JJ	-	-	-	-	-	-	-	(32
1851382	0	10	mice	NNS	-	-	-	-	-	-	-	43)|32)
1851382	0	11	,	,	-	-	-	-	-	-	-	-
1851382	0	12	and	CC	-	-	-	-	-	-	-	-
1851382	0	13	lobuloalveolar	JJ	-	-	-	-	-	-	-	-
1851382	0	14	proliferation	NN	-	-	-	-	-	-	-	-
1851382	0	15	in	IN	-	-	-	-	-	-	-	-
1851382	0	16	parous	JJ	-	-	-	-	-	-	-	-
1851382	0	17	mice	NNS	-	-	-	-	-	-	-	-
1851382	0	18	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Deregulated	VBN	-	-	-	-	-	-	-	(228
1851382	0	2	negative	JJ	-	-	-	-	-	-	-	-
1851382	0	3	feedback	NN	-	-	-	-	-	-	-	-
1851382	0	4	signals	NNS	-	-	-	-	-	-	-	228)

1851382	0	1	The	DT	-	-	-	-	-	-	-	-
1851382	0	2	characterization	NN	-	-	-	-	-	-	-	-
1851382	0	3	of	IN	-	-	-	-	-	-	-	-
1851382	0	4	lactation	NN	-	-	-	-	-	-	-	(45|(44)
1851382	0	5	failure	NN	-	-	-	-	-	-	-	45)
1851382	0	6	has	VBZ	-	-	-	-	-	-	-	-
1851382	0	7	revealed	VBN	-	-	-	-	-	-	-	-
1851382	0	8	two	CD	-	-	-	-	-	-	-	-
1851382	0	9	developmental	JJ	-	-	-	-	-	-	-	-
1851382	0	10	defects	NNS	-	-	-	-	-	-	-	-
1851382	0	11	in	IN	-	-	-	-	-	-	-	-
1851382	0	12	SirT1ko	NN	-	-	-	-	-	-	-	(24|(40
1851382	0	13	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	14	ko	NN	-	-	-	-	-	-	-	24)
1851382	0	15	female	JJ	-	-	-	-	-	-	-	-
1851382	0	16	mice	NNS	-	-	-	-	-	-	-	40)
1851382	0	17	.	.	-	-	-	-	-	-	-	-

1851382	0	1	The	DT	-	-	-	-	-	-	-	(43
1851382	0	2	impeded	VBN	-	-	-	-	-	-	-	-
1851382	0	3	ductal	JJ	-	-	-	-	-	-	-	-
1851382	0	4	morphogenesis	NN	-	-	-	-	-	-	-	-
1851382	0	5	in	IN	-	-	-	-	-	-	-	-
1851382	0	6	virgin	JJ	-	-	-	-	-	-	-	(32
1851382	0	7	SirT1ko	NN	-	-	-	-	-	-	-	-
1851382	0	8	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	9	ko	NN	-	-	-	-	-	-	-	-
1851382	0	10	mice	NNS	-	-	-	-	-	-	-	43)|32)
1851382	0	11	bore	VBD	-	-	-	-	-	-	-	-
1851382	0	12	some	DT	-	-	-	-	-	-	-	-
1851382	0	13	resemblance	NN	-	-	-	-	-	-	-	-
1851382	0	14	to	IN	-	-	-	-	-	-	-	-
1851382	0	15	the	DT	-	-	-	-	-	-	-	-
1851382	0	16	defective	JJ	-	-	-	-	-	-	-	-
1851382	0	17	ductal	JJ	-	-	-	-	-	-	-	-
1851382	0	18	morphogenesis	NN	-	-	-	-	-	-	-	-
1851382	0	19	seen	VBN	-	-	-	-	-	-	-	-
1851382	0	20	in	IN	-	-	-	-	-	-	-	-
1851382	0	21	mice	NNS	-	-	-	-	-	-	-	(113|(114a|(115b|(116
1851382	0	22	lacking	VBG	-	-	-	-	-	-	-	115b)|114a)
1851382	0	23	GH	NN	-	-	-	-	-	-	-	(119|(112)|113)
1851382	0	24	,	,	-	-	-	-	-	-	-	-
1851382	0	25	estrogen	NN	-	-	-	-	-	-	-	(114a)|(7)|119)
1851382	0	26	,	,	-	-	-	-	-	-	-	-
1851382	0	27	or	CC	-	-	-	-	-	-	-	-
1851382	0	28	IGF	NN	-	-	-	-	-	-	-	(115b|(8
1851382	0	29	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	30	1	CD	-	-	-	-	-	-	-	8)|116)|115b)
1851382	0	31	,	,	-	-	-	-	-	-	-	-
1851382	0	32	as	RB	-	-	-	-	-	-	-	-
1851382	0	33	well	RB	-	-	-	-	-	-	-	-
1851382	0	34	as	IN	-	-	-	-	-	-	-	-
1851382	0	35	in	IN	-	-	-	-	-	-	-	-
1851382	0	36	mice	NNS	-	-	-	-	-	-	-	(229
1851382	0	37	harboring	VBG	-	-	-	-	-	-	-	-
1851382	0	38	mutations	NNS	-	-	-	-	-	-	-	(230
1851382	0	39	in	IN	-	-	-	-	-	-	-	-
1851382	0	40	the	DT	-	-	-	-	-	-	-	-
1851382	0	41	corresponding	JJ	-	-	-	-	-	-	-	-
1851382	0	42	receptors	NNS	-	-	-	-	-	-	-	-
1851382	0	43	,	,	-	-	-	-	-	-	-	-
1851382	0	44	such	JJ	-	-	-	-	-	-	-	-
1851382	0	45	as	IN	-	-	-	-	-	-	-	-
1851382	0	46	the	DT	-	-	-	-	-	-	-	(120
1851382	0	47	GH	NN	-	-	-	-	-	-	-	(112)
1851382	0	48	receptor	NN	-	-	-	-	-	-	-	230)|229)|120)
1851382	0	49	and	CC	-	-	-	-	-	-	-	-
1851382	0	50	ERα	NN	-	-	-	-	-	-	-	(121)
1851382	0	51	[	-LRB-	-	-	-	-	-	-	-	-
1851382	0	52	17	CD	-	-	-	-	-	-	-	-
1851382	0	53	,	,	-	-	-	-	-	-	-	-
1851382	0	54	24	CD	-	-	-	-	-	-	-	-
1851382	0	55	-	SYM	-	-	-	-	-	-	-	-
1851382	0	56	31	CD	-	-	-	-	-	-	-	-
1851382	0	57	]	-RRB-	-	-	-	-	-	-	-	-
1851382	0	58	.	.	-	-	-	-	-	-	-	-

1851382	0	1	These	DT	-	-	-	-	-	-	-	-
1851382	0	2	previous	JJ	-	-	-	-	-	-	-	-
1851382	0	3	studies	NNS	-	-	-	-	-	-	-	-
1851382	0	4	have	VBP	-	-	-	-	-	-	-	-
1851382	0	5	established	VBN	-	-	-	-	-	-	-	-
1851382	0	6	the	DT	-	-	-	-	-	-	-	-
1851382	0	7	notion	NN	-	-	-	-	-	-	-	-
1851382	0	8	that	IN	-	-	-	-	-	-	-	-
1851382	0	9	GH	NN	-	-	-	-	-	-	-	(119|(112)
1851382	0	10	and	CC	-	-	-	-	-	-	-	-
1851382	0	11	estrogen	NN	-	-	-	-	-	-	-	(7)|119)
1851382	0	12	synergistically	RB	-	-	-	-	-	-	-	-
1851382	0	13	stimulate	VBP	-	-	-	-	-	-	-	-
1851382	0	14	ductal	JJ	-	-	-	-	-	-	-	(62
1851382	0	15	morphogenesis	NN	-	-	-	-	-	-	-	62)
1851382	0	16	,	,	-	-	-	-	-	-	-	-
1851382	0	17	which	WDT	-	-	-	-	-	-	-	-
1851382	0	18	is	VBZ	-	-	-	-	-	-	-	-
1851382	0	19	mediated	VBN	-	-	-	-	-	-	-	-
1851382	0	20	by	IN	-	-	-	-	-	-	-	-
1851382	0	21	stromal	JJ	-	-	-	-	-	-	-	(54
1851382	0	22	cell	NN	-	-	-	-	-	-	-	-
1851382	0	23	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	24	produced	VBN	-	-	-	-	-	-	-	-
1851382	0	25	local	JJ	-	-	-	-	-	-	-	-
1851382	0	26	IGF	NN	-	-	-	-	-	-	-	-
1851382	0	27	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	28	1	CD	-	-	-	-	-	-	-	-
1851382	0	29	in	IN	-	-	-	-	-	-	-	-
1851382	0	30	mammary	JJ	-	-	-	-	-	-	-	(160
1851382	0	31	tissues	NNS	-	-	-	-	-	-	-	54)|160)
1851382	0	32	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Impeded	VBN	-	-	-	-	-	-	-	(43
1851382	0	2	ductal	JJ	-	-	-	-	-	-	-	-
1851382	0	3	morphogenesis	NN	-	-	-	-	-	-	-	-
1851382	0	4	in	IN	-	-	-	-	-	-	-	-
1851382	0	5	virgin	JJ	-	-	-	-	-	-	-	(32
1851382	0	6	SirT1ko	NN	-	-	-	-	-	-	-	-
1851382	0	7	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	8	ko	NN	-	-	-	-	-	-	-	-
1851382	0	9	mice	NNS	-	-	-	-	-	-	-	43)|32)
1851382	0	10	is	VBZ	-	-	-	-	-	-	-	-
1851382	0	11	therefore	RB	-	-	-	-	-	-	-	-
1851382	0	12	probably	RB	-	-	-	-	-	-	-	-
1851382	0	13	due	IN	-	-	-	-	-	-	-	-
1851382	0	14	to	IN	-	-	-	-	-	-	-	-
1851382	0	15	a	DT	-	-	-	-	-	-	-	-
1851382	0	16	deficit	NN	-	-	-	-	-	-	-	-
1851382	0	17	in	IN	-	-	-	-	-	-	-	-
1851382	0	18	IGF	NN	-	-	-	-	-	-	-	(19|(8
1851382	0	19	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	20	1	CD	-	-	-	-	-	-	-	8)
1851382	0	21	signaling	NN	-	-	-	-	-	-	-	19)
1851382	0	22	.	.	-	-	-	-	-	-	-	-

1851382	0	1	In	IN	-	-	-	-	-	-	-	-
1851382	0	2	addition	NN	-	-	-	-	-	-	-	-
1851382	0	3	to	IN	-	-	-	-	-	-	-	-
1851382	0	4	this	DT	-	-	-	-	-	-	-	-
1851382	0	5	early	JJ	-	-	-	-	-	-	-	-
1851382	0	6	defect	NN	-	-	-	-	-	-	-	-
1851382	0	7	,	,	-	-	-	-	-	-	-	-
1851382	0	8	pregnancy	NN	-	-	-	-	-	-	-	(190
1851382	0	9	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	10	induced	VBN	-	-	-	-	-	-	-	-
1851382	0	11	mammary	JJ	-	-	-	-	-	-	-	-
1851382	0	12	gland	NN	-	-	-	-	-	-	-	-
1851382	0	13	development	NN	-	-	-	-	-	-	-	-
1851382	0	14	in	IN	-	-	-	-	-	-	-	-
1851382	0	15	SirT1ko	NN	-	-	-	-	-	-	-	(22|(24
1851382	0	16	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	17	ko	NN	-	-	-	-	-	-	-	24)
1851382	0	18	mice	NNS	-	-	-	-	-	-	-	22)|190)
1851382	0	19	appeared	VBD	-	-	-	-	-	-	-	-
1851382	0	20	to	TO	-	-	-	-	-	-	-	-
1851382	0	21	be	VB	-	-	-	-	-	-	-	-
1851382	0	22	arrested	VBN	-	-	-	-	-	-	-	-
1851382	0	23	at	IN	-	-	-	-	-	-	-	-
1851382	0	24	the	DT	-	-	-	-	-	-	-	-
1851382	0	25	beginning	NN	-	-	-	-	-	-	-	-
1851382	0	26	of	IN	-	-	-	-	-	-	-	-
1851382	0	27	lobuloalveolar	JJ	-	-	-	-	-	-	-	-
1851382	0	28	development	NN	-	-	-	-	-	-	-	-
1851382	0	29	,	,	-	-	-	-	-	-	-	-
1851382	0	30	which	WDT	-	-	-	-	-	-	-	-
1851382	0	31	is	VBZ	-	-	-	-	-	-	-	-
1851382	0	32	reminiscent	JJ	-	-	-	-	-	-	-	-
1851382	0	33	of	IN	-	-	-	-	-	-	-	-
1851382	0	34	the	DT	-	-	-	-	-	-	-	-
1851382	0	35	phenotype	NN	-	-	-	-	-	-	-	-
1851382	0	36	in	IN	-	-	-	-	-	-	-	-
1851382	0	37	mice	NNS	-	-	-	-	-	-	-	-
1851382	0	38	lacking	VBG	-	-	-	-	-	-	-	-
1851382	0	39	IκB	NN	-	-	-	-	-	-	-	(231|(232
1851382	0	40	kinase	NN	-	-	-	-	-	-	-	-
1851382	0	41	alpha	NN	-	-	-	-	-	-	-	231)
1851382	0	42	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	43	IKKα	NN	-	-	-	-	-	-	-	-
1851382	0	44	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	45	activity	NN	-	-	-	-	-	-	-	232)
1851382	0	46	for	IN	-	-	-	-	-	-	-	-
1851382	0	47	NF	NN	-	-	-	-	-	-	-	(16|(233
1851382	0	48	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	49	κB	NN	-	-	-	-	-	-	-	16)
1851382	0	50	activation	NN	-	-	-	-	-	-	-	233)
1851382	0	51	[	-LRB-	-	-	-	-	-	-	-	-
1851382	0	52	37	CD	-	-	-	-	-	-	-	-
1851382	0	53	]	-RRB-	-	-	-	-	-	-	-	-
1851382	0	54	.	.	-	-	-	-	-	-	-	-

1851382	0	1	IKKα	NN	-	-	-	-	-	-	-	(234
1851382	0	2	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	3	deficient	JJ	-	-	-	-	-	-	-	-
1851382	0	4	mice	NNS	-	-	-	-	-	-	-	234)
1851382	0	5	exhibit	VBP	-	-	-	-	-	-	-	-
1851382	0	6	normal	JJ	-	-	-	-	-	-	-	-
1851382	0	7	ductal	JJ	-	-	-	-	-	-	-	-
1851382	0	8	morphogenesis	NN	-	-	-	-	-	-	-	-
1851382	0	9	at	IN	-	-	-	-	-	-	-	-
1851382	0	10	the	DT	-	-	-	-	-	-	-	(102
1851382	0	11	onset	NN	-	-	-	-	-	-	-	-
1851382	0	12	of	IN	-	-	-	-	-	-	-	-
1851382	0	13	puberty	NN	-	-	-	-	-	-	-	(103)|102)
1851382	0	14	and	CC	-	-	-	-	-	-	-	-
1851382	0	15	exhibit	VBP	-	-	-	-	-	-	-	-
1851382	0	16	normal	JJ	-	-	-	-	-	-	-	-
1851382	0	17	ductal	JJ	-	-	-	-	-	-	-	-
1851382	0	18	side	NN	-	-	-	-	-	-	-	-
1851382	0	19	branching	NN	-	-	-	-	-	-	-	-
1851382	0	20	during	IN	-	-	-	-	-	-	-	-
1851382	0	21	early	JJ	-	-	-	-	-	-	-	(209
1851382	0	22	pregnancy	NN	-	-	-	-	-	-	-	209)
1851382	0	23	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Owing	VBG	-	-	-	-	-	-	-	-
1851382	0	2	to	IN	-	-	-	-	-	-	-	-
1851382	0	3	the	DT	-	-	-	-	-	-	-	-
1851382	0	4	absence	NN	-	-	-	-	-	-	-	-
1851382	0	5	of	IN	-	-	-	-	-	-	-	-
1851382	0	6	NF	NN	-	-	-	-	-	-	-	(16
1851382	0	7	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	8	κB	NN	-	-	-	-	-	-	-	16)
1851382	0	9	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	10	dependent	JJ	-	-	-	-	-	-	-	-
1851382	0	11	cyclin	NN	-	-	-	-	-	-	-	-
1851382	0	12	D1	NN	-	-	-	-	-	-	-	-
1851382	0	13	expression	NN	-	-	-	-	-	-	-	-
1851382	0	14	,	,	-	-	-	-	-	-	-	-
1851382	0	15	however	RB	-	-	-	-	-	-	-	-
1851382	0	16	,	,	-	-	-	-	-	-	-	-
1851382	0	17	IKKα	NN	-	-	-	-	-	-	-	(234
1851382	0	18	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	19	deficient	JJ	-	-	-	-	-	-	-	-
1851382	0	20	mice	NNS	-	-	-	-	-	-	-	234)
1851382	0	21	display	VBP	-	-	-	-	-	-	-	-
1851382	0	22	defective	JJ	-	-	-	-	-	-	-	-
1851382	0	23	alveolar	JJ	-	-	-	-	-	-	-	-
1851382	0	24	epithelial	JJ	-	-	-	-	-	-	-	-
1851382	0	25	cell	NN	-	-	-	-	-	-	-	-
1851382	0	26	proliferation	NN	-	-	-	-	-	-	-	-
1851382	0	27	and	CC	-	-	-	-	-	-	-	-
1851382	0	28	fail	VBP	-	-	-	-	-	-	-	-
1851382	0	29	to	TO	-	-	-	-	-	-	-	-
1851382	0	30	lactate	VB	-	-	-	-	-	-	-	-
1851382	0	31	[	-LRB-	-	-	-	-	-	-	-	-
1851382	0	32	37	CD	-	-	-	-	-	-	-	-
1851382	0	33	]	-RRB-	-	-	-	-	-	-	-	-
1851382	0	34	.	.	-	-	-	-	-	-	-	-

1851382	0	1	While	IN	-	-	-	-	-	-	-	-
1851382	0	2	SirT1	NN	-	-	-	-	-	-	-	(1)
1851382	0	3	negatively	RB	-	-	-	-	-	-	-	-
1851382	0	4	regulates	VBZ	-	-	-	-	-	-	-	-
1851382	0	5	the	DT	-	-	-	-	-	-	-	(235b|(236|(81b
1851382	0	6	transcription	NN	-	-	-	-	-	-	-	(14)
1851382	0	7	activity	NN	-	-	-	-	-	-	-	-
1851382	0	8	of	IN	-	-	-	-	-	-	-	235b)
1851382	0	9	FoxOs	NNS	-	-	-	-	-	-	-	(237|81b)
1851382	0	10	and	CC	-	-	-	-	-	-	-	-
1851382	0	11	NF	NN	-	-	-	-	-	-	-	(235b
1851382	0	12	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	13	κB	NN	-	-	-	-	-	-	-	-
1851382	0	14	in	IN	-	-	-	-	-	-	-	(81b
1851382	0	15	mammalian	JJ	-	-	-	-	-	-	-	(17
1851382	0	16	cells	NNS	-	-	-	-	-	-	-	81b)|237)|236)|235b)|17)
1851382	0	17	[	-LRB-	-	-	-	-	-	-	-	-
1851382	0	18	10	CD	-	-	-	-	-	-	-	-
1851382	0	19	,	,	-	-	-	-	-	-	-	-
1851382	0	20	11	CD	-	-	-	-	-	-	-	-
1851382	0	21	,	,	-	-	-	-	-	-	-	-
1851382	0	22	20	CD	-	-	-	-	-	-	-	-
1851382	0	23	]	-RRB-	-	-	-	-	-	-	-	-
1851382	0	24	,	,	-	-	-	-	-	-	-	-
1851382	0	25	SirT1ko	NN	-	-	-	-	-	-	-	(22|(24
1851382	0	26	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	27	ko	NN	-	-	-	-	-	-	-	24)
1851382	0	28	mice	NNS	-	-	-	-	-	-	-	22)
1851382	0	29	displayed	VBD	-	-	-	-	-	-	-	-
1851382	0	30	the	DT	-	-	-	-	-	-	-	-
1851382	0	31	loss	NN	-	-	-	-	-	-	-	-
1851382	0	32	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	33	of	IN	-	-	-	-	-	-	-	-
1851382	0	34	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	35	function	NN	-	-	-	-	-	-	-	-
1851382	0	36	phenotypes	NNS	-	-	-	-	-	-	-	-
1851382	0	37	.	.	-	-	-	-	-	-	-	-

1851382	0	1	We	PRP	-	-	-	-	-	-	-	(95)
1851382	0	2	hypothesized	VBD	-	-	-	-	-	-	-	-
1851382	0	3	that	IN	-	-	-	-	-	-	-	-
1851382	0	4	SirT1	NN	-	-	-	-	-	-	-	(227|(1)
1851382	0	5	deficiency	NN	-	-	-	-	-	-	-	227)
1851382	0	6	deregulates	VBZ	-	-	-	-	-	-	-	-
1851382	0	7	the	DT	-	-	-	-	-	-	-	-
1851382	0	8	expression	NN	-	-	-	-	-	-	-	-
1851382	0	9	of	IN	-	-	-	-	-	-	-	-
1851382	0	10	negative	JJ	-	-	-	-	-	-	-	(228
1851382	0	11	feedback	NN	-	-	-	-	-	-	-	-
1851382	0	12	signals	NNS	-	-	-	-	-	-	-	228)
1851382	0	13	and	CC	-	-	-	-	-	-	-	-
1851382	0	14	thereby	RB	-	-	-	-	-	-	-	-
1851382	0	15	desensitizes	VBZ	-	-	-	-	-	-	-	-
1851382	0	16	the	DT	-	-	-	-	-	-	-	(17
1851382	0	17	cells	NNS	-	-	-	-	-	-	-	17)
1851382	0	18	to	IN	-	-	-	-	-	-	-	-
1851382	0	19	various	JJ	-	-	-	-	-	-	-	-
1851382	0	20	types	NNS	-	-	-	-	-	-	-	-
1851382	0	21	of	IN	-	-	-	-	-	-	-	-
1851382	0	22	stimulation	NN	-	-	-	-	-	-	-	(238)
1851382	0	23	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Indeed	RB	-	-	-	-	-	-	-	-
1851382	0	2	,	,	-	-	-	-	-	-	-	-
1851382	0	3	among	IN	-	-	-	-	-	-	-	-
1851382	0	4	the	DT	-	-	-	-	-	-	-	-
1851382	0	5	many	JJ	-	-	-	-	-	-	-	-
1851382	0	6	FoxOs	NNS	-	-	-	-	-	-	-	-
1851382	0	7	and	CC	-	-	-	-	-	-	-	-
1851382	0	8	NF	NN	-	-	-	-	-	-	-	-
1851382	0	9	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	10	κB	NN	-	-	-	-	-	-	-	-
1851382	0	11	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	12	regulated	VBN	-	-	-	-	-	-	-	-
1851382	0	13	genes	NNS	-	-	-	-	-	-	-	-
1851382	0	14	,	,	-	-	-	-	-	-	-	-
1851382	0	15	IGFBP	NN	-	-	-	-	-	-	-	(239|(47
1851382	0	16	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	17	1	CD	-	-	-	-	-	-	-	47)
1851382	0	18	and	CC	-	-	-	-	-	-	-	-
1851382	0	19	IκBα	NN	-	-	-	-	-	-	-	(50)|239)
1851382	0	20	encode	VBP	-	-	-	-	-	-	-	-
1851382	0	21	negative	JJ	-	-	-	-	-	-	-	-
1851382	0	22	feedback	NN	-	-	-	-	-	-	-	-
1851382	0	23	signals	NNS	-	-	-	-	-	-	-	-
1851382	0	24	for	IN	-	-	-	-	-	-	-	-
1851382	0	25	IGF	NN	-	-	-	-	-	-	-	(19|(8
1851382	0	26	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	27	1	CD	-	-	-	-	-	-	-	8)
1851382	0	28	signaling	NN	-	-	-	-	-	-	-	19)
1851382	0	29	and	CC	-	-	-	-	-	-	-	-
1851382	0	30	NF	NN	-	-	-	-	-	-	-	(16|(233
1851382	0	31	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	32	κB	NN	-	-	-	-	-	-	-	16)
1851382	0	33	activation	NN	-	-	-	-	-	-	-	233)
1851382	0	34	,	,	-	-	-	-	-	-	-	-
1851382	0	35	respectively	RB	-	-	-	-	-	-	-	-
1851382	0	36	.	.	-	-	-	-	-	-	-	-

1851382	0	1	We	PRP	-	-	-	-	-	-	-	(95)
1851382	0	2	found	VBD	-	-	-	-	-	-	-	-
1851382	0	3	that	IN	-	-	-	-	-	-	-	-
1851382	0	4	the	DT	-	-	-	-	-	-	-	-
1851382	0	5	basal	JJ	-	-	-	-	-	-	-	-
1851382	0	6	levels	NNS	-	-	-	-	-	-	-	-
1851382	0	7	of	IN	-	-	-	-	-	-	-	-
1851382	0	8	both	CC	-	-	-	-	-	-	-	(239
1851382	0	9	IGFBP	NN	-	-	-	-	-	-	-	(47
1851382	0	10	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	11	1	CD	-	-	-	-	-	-	-	47)
1851382	0	12	and	CC	-	-	-	-	-	-	-	-
1851382	0	13	IκBα	NN	-	-	-	-	-	-	-	(50)|239)
1851382	0	14	were	VBD	-	-	-	-	-	-	-	-
1851382	0	15	increased	VBN	-	-	-	-	-	-	-	-
1851382	0	16	in	IN	-	-	-	-	-	-	-	-
1851382	0	17	adipose	JJ	-	-	-	-	-	-	-	-
1851382	0	18	tissues	NNS	-	-	-	-	-	-	-	-
1851382	0	19	from	IN	-	-	-	-	-	-	-	-
1851382	0	20	virgin	JJ	-	-	-	-	-	-	-	(32
1851382	0	21	SirT1ko	NN	-	-	-	-	-	-	-	-
1851382	0	22	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	23	ko	NN	-	-	-	-	-	-	-	-
1851382	0	24	mice	NNS	-	-	-	-	-	-	-	32)
1851382	0	25	and	CC	-	-	-	-	-	-	-	-
1851382	0	26	in	IN	-	-	-	-	-	-	-	-
1851382	0	27	ductal	JJ	-	-	-	-	-	-	-	-
1851382	0	28	epithelial	JJ	-	-	-	-	-	-	-	-
1851382	0	29	cells	NNS	-	-	-	-	-	-	-	-
1851382	0	30	from	IN	-	-	-	-	-	-	-	-
1851382	0	31	SirT1ko	NN	-	-	-	-	-	-	-	(192|(22|(24
1851382	0	32	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	33	ko	NN	-	-	-	-	-	-	-	24)
1851382	0	34	mice	NNS	-	-	-	-	-	-	-	22)
1851382	0	35	on	IN	-	-	-	-	-	-	-	-
1851382	0	36	lactation	NN	-	-	-	-	-	-	-	(193|(44)
1851382	0	37	day	NN	-	-	-	-	-	-	-	-
1851382	0	38	1	CD	-	-	-	-	-	-	-	193)|192)
1851382	0	39	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	40	Figure	NN	-	-	-	-	-	-	-	(240
1851382	0	41	3b	NN	-	-	-	-	-	-	-	240)
1851382	0	42	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	43	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Meanwhile	RB	-	-	-	-	-	-	-	-
1851382	0	2	,	,	-	-	-	-	-	-	-	-
1851382	0	3	the	DT	-	-	-	-	-	-	-	-
1851382	0	4	expression	NN	-	-	-	-	-	-	-	-
1851382	0	5	pattern	NN	-	-	-	-	-	-	-	-
1851382	0	6	of	IN	-	-	-	-	-	-	-	-
1851382	0	7	IGFBP	NN	-	-	-	-	-	-	-	(241|(242a
1851382	0	8	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	9	1	CD	-	-	-	-	-	-	-	242a)
1851382	0	10	and	CC	-	-	-	-	-	-	-	-
1851382	0	11	IκBα	NN	-	-	-	-	-	-	-	(243
1851382	0	12	in	IN	-	-	-	-	-	-	-	(242a
1851382	0	13	wild	JJ	-	-	-	-	-	-	-	(137|(223
1851382	0	14	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	15	type	NN	-	-	-	-	-	-	-	137)
1851382	0	16	mammary	JJ	-	-	-	-	-	-	-	-
1851382	0	17	tissues	NNS	-	-	-	-	-	-	-	223)
1851382	0	18	,	,	-	-	-	-	-	-	-	-
1851382	0	19	shown	VBN	-	-	-	-	-	-	-	-
1851382	0	20	in	IN	-	-	-	-	-	-	-	-
1851382	0	21	Figure	NN	-	-	-	-	-	-	-	(240
1851382	0	22	3b	NN	-	-	-	-	-	-	-	243)|242a)|241)|240)
1851382	0	23	,	,	-	-	-	-	-	-	-	-
1851382	0	24	was	VBD	-	-	-	-	-	-	-	-
1851382	0	25	in	IN	-	-	-	-	-	-	-	-
1851382	0	26	agreement	NN	-	-	-	-	-	-	-	-
1851382	0	27	with	IN	-	-	-	-	-	-	-	-
1851382	0	28	the	DT	-	-	-	-	-	-	-	-
1851382	0	29	findings	NNS	-	-	-	-	-	-	-	-
1851382	0	30	of	IN	-	-	-	-	-	-	-	-
1851382	0	31	others	NNS	-	-	-	-	-	-	-	-
1851382	0	32	[	-LRB-	-	-	-	-	-	-	-	-
1851382	0	33	16	CD	-	-	-	-	-	-	-	-
1851382	0	34	,	,	-	-	-	-	-	-	-	-
1851382	0	35	38	CD	-	-	-	-	-	-	-	-
1851382	0	36	,	,	-	-	-	-	-	-	-	-
1851382	0	37	39	CD	-	-	-	-	-	-	-	-
1851382	0	38	]	-RRB-	-	-	-	-	-	-	-	-
1851382	0	39	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Namely	RB	-	-	-	-	-	-	-	-
1851382	0	2	,	,	-	-	-	-	-	-	-	-
1851382	0	3	the	DT	-	-	-	-	-	-	-	(48
1851382	0	4	expression	NN	-	-	-	-	-	-	-	-
1851382	0	5	of	IN	-	-	-	-	-	-	-	-
1851382	0	6	IGFBP	NN	-	-	-	-	-	-	-	(47
1851382	0	7	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	8	1	CD	-	-	-	-	-	-	-	48)|47)
1851382	0	9	was	VBD	-	-	-	-	-	-	-	-
1851382	0	10	downregulated	VBN	-	-	-	-	-	-	-	-
1851382	0	11	during	IN	-	-	-	-	-	-	-	-
1851382	0	12	pregnancy	NN	-	-	-	-	-	-	-	(185)
1851382	0	13	,	,	-	-	-	-	-	-	-	-
1851382	0	14	whereas	IN	-	-	-	-	-	-	-	-
1851382	0	15	NF	NN	-	-	-	-	-	-	-	(16|(235
1851382	0	16	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	17	κB	NN	-	-	-	-	-	-	-	16)
1851382	0	18	activity	NN	-	-	-	-	-	-	-	235)
1851382	0	19	was	VBD	-	-	-	-	-	-	-	-
1851382	0	20	increased	VBN	-	-	-	-	-	-	-	-
1851382	0	21	at	IN	-	-	-	-	-	-	-	-
1851382	0	22	a	DT	-	-	-	-	-	-	-	-
1851382	0	23	late	JJ	-	-	-	-	-	-	-	-
1851382	0	24	stage	NN	-	-	-	-	-	-	-	-
1851382	0	25	of	IN	-	-	-	-	-	-	-	-
1851382	0	26	pregnancy	NN	-	-	-	-	-	-	-	(185)
1851382	0	27	.	.	-	-	-	-	-	-	-	-

1851382	0	1	The	DT	-	-	-	-	-	-	-	-
1851382	0	2	loss	NN	-	-	-	-	-	-	-	-
1851382	0	3	of	IN	-	-	-	-	-	-	-	-
1851382	0	4	SirT1	NN	-	-	-	-	-	-	-	(1)
1851382	0	5	therefore	RB	-	-	-	-	-	-	-	-
1851382	0	6	increased	VBD	-	-	-	-	-	-	-	-
1851382	0	7	the	DT	-	-	-	-	-	-	-	-
1851382	0	8	basal	JJ	-	-	-	-	-	-	-	-
1851382	0	9	level	NN	-	-	-	-	-	-	-	-
1851382	0	10	of	IN	-	-	-	-	-	-	-	-
1851382	0	11	both	CC	-	-	-	-	-	-	-	-
1851382	0	12	IGFBP	NN	-	-	-	-	-	-	-	-
1851382	0	13	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	14	1	CD	-	-	-	-	-	-	-	-
1851382	0	15	and	CC	-	-	-	-	-	-	-	-
1851382	0	16	IκBα	NN	-	-	-	-	-	-	-	-
1851382	0	17	in	IN	-	-	-	-	-	-	-	-
1851382	0	18	multilineages	NNS	-	-	-	-	-	-	-	-
1851382	0	19	of	IN	-	-	-	-	-	-	-	-
1851382	0	20	cells	NNS	-	-	-	-	-	-	-	(167)
1851382	0	21	,	,	-	-	-	-	-	-	-	-
1851382	0	22	and	CC	-	-	-	-	-	-	-	-
1851382	0	23	potentially	RB	-	-	-	-	-	-	-	-
1851382	0	24	increased	VBD	-	-	-	-	-	-	-	-
1851382	0	25	thresholds	NNS	-	-	-	-	-	-	-	-
1851382	0	26	for	IN	-	-	-	-	-	-	-	-
1851382	0	27	activating	VBG	-	-	-	-	-	-	-	-
1851382	0	28	SirT1	NN	-	-	-	-	-	-	-	(244
1851382	0	29	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	30	modulated	VBN	-	-	-	-	-	-	-	-
1851382	0	31	signaling	NN	-	-	-	-	-	-	-	244)
1851382	0	32	pathways	NNS	-	-	-	-	-	-	-	-
1851382	0	33	.	.	-	-	-	-	-	-	-	-

1851382	0	1	SirT1	NN	-	-	-	-	-	-	-	(227|(1)
1851382	0	2	deficiency	NN	-	-	-	-	-	-	-	227)
1851382	0	3	did	VBD	-	-	-	-	-	-	-	-
1851382	0	4	not	RB	-	-	-	-	-	-	-	-
1851382	0	5	affect	VB	-	-	-	-	-	-	-	-
1851382	0	6	the	DT	-	-	-	-	-	-	-	-
1851382	0	7	ability	NN	-	-	-	-	-	-	-	-
1851382	0	8	of	IN	-	-	-	-	-	-	-	-
1851382	0	9	mammary	JJ	-	-	-	-	-	-	-	(104
1851382	0	10	epithelial	JJ	-	-	-	-	-	-	-	-
1851382	0	11	progenitor	NN	-	-	-	-	-	-	-	-
1851382	0	12	cells	NNS	-	-	-	-	-	-	-	104)
1851382	0	13	to	TO	-	-	-	-	-	-	-	-
1851382	0	14	differentiate	VB	-	-	-	-	-	-	-	-
1851382	0	15	into	IN	-	-	-	-	-	-	-	-
1851382	0	16	functional	JJ	-	-	-	-	-	-	-	-
1851382	0	17	alveolar	JJ	-	-	-	-	-	-	-	-
1851382	0	18	epithelial	JJ	-	-	-	-	-	-	-	-
1851382	0	19	cells	NNS	-	-	-	-	-	-	-	-
1851382	0	20	despite	IN	-	-	-	-	-	-	-	-
1851382	0	21	the	DT	-	-	-	-	-	-	-	(45
1851382	0	22	lactation	NN	-	-	-	-	-	-	-	(44)
1851382	0	23	failure	NN	-	-	-	-	-	-	-	45)
1851382	0	24	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	25	Figure	NN	-	-	-	-	-	-	-	(189
1851382	0	26	2c	NN	-	-	-	-	-	-	-	189)
1851382	0	27	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	28	.	.	-	-	-	-	-	-	-	-

1851382	0	1	SirT1	NN	-	-	-	-	-	-	-	(227|(1)
1851382	0	2	deficiency	NN	-	-	-	-	-	-	-	227)
1851382	0	3	may	MD	-	-	-	-	-	-	-	-
1851382	0	4	therefore	RB	-	-	-	-	-	-	-	-
1851382	0	5	alter	VB	-	-	-	-	-	-	-	-
1851382	0	6	the	DT	-	-	-	-	-	-	-	-
1851382	0	7	homeostasis	NN	-	-	-	-	-	-	-	-
1851382	0	8	of	IN	-	-	-	-	-	-	-	-
1851382	0	9	the	DT	-	-	-	-	-	-	-	(244
1851382	0	10	signals	NNS	-	-	-	-	-	-	-	244)
1851382	0	11	for	IN	-	-	-	-	-	-	-	-
1851382	0	12	ductal	JJ	-	-	-	-	-	-	-	(62
1851382	0	13	morphogenesis	NN	-	-	-	-	-	-	-	62)
1851382	0	14	and	CC	-	-	-	-	-	-	-	-
1851382	0	15	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	16	or	CC	-	-	-	-	-	-	-	-
1851382	0	17	the	DT	-	-	-	-	-	-	-	-
1851382	0	18	cellular	JJ	-	-	-	-	-	-	-	-
1851382	0	19	response	NN	-	-	-	-	-	-	-	-
1851382	0	20	to	IN	-	-	-	-	-	-	-	-
1851382	0	21	the	DT	-	-	-	-	-	-	-	(244
1851382	0	22	signals	NNS	-	-	-	-	-	-	-	244)
1851382	0	23	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Increased	VBN	-	-	-	-	-	-	-	-
1851382	0	2	expression	NN	-	-	-	-	-	-	-	-
1851382	0	3	of	IN	-	-	-	-	-	-	-	-
1851382	0	4	both	CC	-	-	-	-	-	-	-	-
1851382	0	5	IGFBP	NN	-	-	-	-	-	-	-	(245a
1851382	0	6	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	7	1	CD	-	-	-	-	-	-	-	245a)
1851382	0	8	and	CC	-	-	-	-	-	-	-	-
1851382	0	9	IκBα	NN	-	-	-	-	-	-	-	-
1851382	0	10	in	IN	-	-	-	-	-	-	-	(245a
1851382	0	11	adipose	JJ	-	-	-	-	-	-	-	(246
1851382	0	12	tissues	NNS	-	-	-	-	-	-	-	246)|245a)
1851382	0	13	and	CC	-	-	-	-	-	-	-	-
1851382	0	14	mammary	JJ	-	-	-	-	-	-	-	(64
1851382	0	15	epithelial	JJ	-	-	-	-	-	-	-	-
1851382	0	16	cells	NNS	-	-	-	-	-	-	-	64)
1851382	0	17	could	MD	-	-	-	-	-	-	-	-
1851382	0	18	simply	RB	-	-	-	-	-	-	-	-
1851382	0	19	reflect	VB	-	-	-	-	-	-	-	-
1851382	0	20	a	DT	-	-	-	-	-	-	-	-
1851382	0	21	global	JJ	-	-	-	-	-	-	-	-
1851382	0	22	deregulation	NN	-	-	-	-	-	-	-	-
1851382	0	23	of	IN	-	-	-	-	-	-	-	-
1851382	0	24	gene	NN	-	-	-	-	-	-	-	(247
1851382	0	25	expression	NN	-	-	-	-	-	-	-	-
1851382	0	26	in	IN	-	-	-	-	-	-	-	-
1851382	0	27	SirT1ko	NN	-	-	-	-	-	-	-	(24|(57
1851382	0	28	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	29	ko	NN	-	-	-	-	-	-	-	24)
1851382	0	30	cells	NNS	-	-	-	-	-	-	-	57)|247)
1851382	0	31	in	IN	-	-	-	-	-	-	-	-
1851382	0	32	which	WDT	-	-	-	-	-	-	-	-
1851382	0	33	the	DT	-	-	-	-	-	-	-	(235a|(236|(81a
1851382	0	34	activity	NN	-	-	-	-	-	-	-	-
1851382	0	35	of	IN	-	-	-	-	-	-	-	81a)|235a)
1851382	0	36	both	CC	-	-	-	-	-	-	-	(237
1851382	0	37	FoxOs	NNS	-	-	-	-	-	-	-	(80)|(81a)
1851382	0	38	and	CC	-	-	-	-	-	-	-	-
1851382	0	39	NF	NN	-	-	-	-	-	-	-	(16|(235a
1851382	0	40	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	41	κB	NN	-	-	-	-	-	-	-	237)|236)|235a)|16)
1851382	0	42	is	VBZ	-	-	-	-	-	-	-	-
1851382	0	43	increased	VBN	-	-	-	-	-	-	-	-
1851382	0	44	.	.	-	-	-	-	-	-	-	-

1851382	0	1	IGFBP	NN	-	-	-	-	-	-	-	(47
1851382	0	2	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	3	1	CD	-	-	-	-	-	-	-	47)
1851382	0	4	is	VBZ	-	-	-	-	-	-	-	-
1851382	0	5	a	DT	-	-	-	-	-	-	-	-
1851382	0	6	potent	JJ	-	-	-	-	-	-	-	-
1851382	0	7	inhibitor	NN	-	-	-	-	-	-	-	-
1851382	0	8	of	IN	-	-	-	-	-	-	-	-
1851382	0	9	IGF	NN	-	-	-	-	-	-	-	(8
1851382	0	10	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	11	1	CD	-	-	-	-	-	-	-	8)
1851382	0	12	in	FW	-	-	-	-	-	-	-	-
1851382	0	13	vivo	FW	-	-	-	-	-	-	-	-
1851382	0	14	[	-LRB-	-	-	-	-	-	-	-	-
1851382	0	15	40	CD	-	-	-	-	-	-	-	-
1851382	0	16	]	-RRB-	-	-	-	-	-	-	-	-
1851382	0	17	,	,	-	-	-	-	-	-	-	-
1851382	0	18	suggesting	VBG	-	-	-	-	-	-	-	-
1851382	0	19	that	IN	-	-	-	-	-	-	-	-
1851382	0	20	the	DT	-	-	-	-	-	-	-	-
1851382	0	21	elevated	VBN	-	-	-	-	-	-	-	-
1851382	0	22	basal	JJ	-	-	-	-	-	-	-	-
1851382	0	23	level	NN	-	-	-	-	-	-	-	-
1851382	0	24	of	IN	-	-	-	-	-	-	-	-
1851382	0	25	IGFBP	NN	-	-	-	-	-	-	-	(245
1851382	0	26	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	27	1	CD	-	-	-	-	-	-	-	-
1851382	0	28	in	IN	-	-	-	-	-	-	-	-
1851382	0	29	adipose	JJ	-	-	-	-	-	-	-	(246
1851382	0	30	tissues	NNS	-	-	-	-	-	-	-	-
1851382	0	31	in	IN	-	-	-	-	-	-	-	-
1851382	0	32	SirT1ko	NN	-	-	-	-	-	-	-	(22|(24
1851382	0	33	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	34	ko	NN	-	-	-	-	-	-	-	24)
1851382	0	35	mice	NNS	-	-	-	-	-	-	-	246)|245)|22)
1851382	0	36	could	MD	-	-	-	-	-	-	-	-
1851382	0	37	reduce	VB	-	-	-	-	-	-	-	-
1851382	0	38	the	DT	-	-	-	-	-	-	-	-
1851382	0	39	effect	NN	-	-	-	-	-	-	-	-
1851382	0	40	of	IN	-	-	-	-	-	-	-	-
1851382	0	41	IGF	NN	-	-	-	-	-	-	-	(8
1851382	0	42	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	43	1	CD	-	-	-	-	-	-	-	8)
1851382	0	44	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Moreover	RB	-	-	-	-	-	-	-	-
1851382	0	2	,	,	-	-	-	-	-	-	-	-
1851382	0	3	deregulated	VBN	-	-	-	-	-	-	-	(248|(249
1851382	0	4	IGFBP	NN	-	-	-	-	-	-	-	-
1851382	0	5	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	6	1	CD	-	-	-	-	-	-	-	-
1851382	0	7	expression	NN	-	-	-	-	-	-	-	248)
1851382	0	8	,	,	-	-	-	-	-	-	-	-
1851382	0	9	but	CC	-	-	-	-	-	-	-	-
1851382	0	10	not	RB	-	-	-	-	-	-	-	-
1851382	0	11	deregulated	VBN	-	-	-	-	-	-	-	(250
1851382	0	12	IκBα	NN	-	-	-	-	-	-	-	-
1851382	0	13	expression	NN	-	-	-	-	-	-	-	250)
1851382	0	14	,	,	-	-	-	-	-	-	-	-
1851382	0	15	was	VBD	-	-	-	-	-	-	-	-
1851382	0	16	reversed	VBN	-	-	-	-	-	-	-	-
1851382	0	17	in	IN	-	-	-	-	-	-	-	-
1851382	0	18	response	NN	-	-	-	-	-	-	-	-
1851382	0	19	to	IN	-	-	-	-	-	-	-	-
1851382	0	20	increased	VBN	-	-	-	-	-	-	-	-
1851382	0	21	levels	NNS	-	-	-	-	-	-	-	-
1851382	0	22	of	IN	-	-	-	-	-	-	-	-
1851382	0	23	estrogen	NN	-	-	-	-	-	-	-	-
1851382	0	24	in	IN	-	-	-	-	-	-	-	-
1851382	0	25	the	DT	-	-	-	-	-	-	-	(108
1851382	0	26	mammary	JJ	-	-	-	-	-	-	-	(107
1851382	0	27	fat	NN	-	-	-	-	-	-	-	107)
1851382	0	28	pads	NNS	-	-	-	-	-	-	-	108)
1851382	0	29	after	IN	-	-	-	-	-	-	-	-
1851382	0	30	implantation	NN	-	-	-	-	-	-	-	(46)|249)
1851382	0	31	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	32	Figure	NN	-	-	-	-	-	-	-	(251
1851382	0	33	4b	NN	-	-	-	-	-	-	-	251)
1851382	0	34	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	35	.	.	-	-	-	-	-	-	-	-

1851382	0	1	The	DT	-	-	-	-	-	-	-	(249
1851382	0	2	finding	NN	-	-	-	-	-	-	-	249)
1851382	0	3	is	VBZ	-	-	-	-	-	-	-	-
1851382	0	4	relevant	JJ	-	-	-	-	-	-	-	-
1851382	0	5	to	IN	-	-	-	-	-	-	-	-
1851382	0	6	the	DT	-	-	-	-	-	-	-	-
1851382	0	7	fact	NN	-	-	-	-	-	-	-	-
1851382	0	8	that	IN	-	-	-	-	-	-	-	-
1851382	0	9	the	DT	-	-	-	-	-	-	-	(48
1851382	0	10	expression	NN	-	-	-	-	-	-	-	-
1851382	0	11	of	IN	-	-	-	-	-	-	-	-
1851382	0	12	IGFBP	NN	-	-	-	-	-	-	-	(47
1851382	0	13	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	14	1	CD	-	-	-	-	-	-	-	48)|47)
1851382	0	15	is	VBZ	-	-	-	-	-	-	-	-
1851382	0	16	downregulated	VBN	-	-	-	-	-	-	-	-
1851382	0	17	as	IN	-	-	-	-	-	-	-	-
1851382	0	18	the	DT	-	-	-	-	-	-	-	(252
1851382	0	19	level	NN	-	-	-	-	-	-	-	-
1851382	0	20	of	IN	-	-	-	-	-	-	-	-
1851382	0	21	estrogen	NN	-	-	-	-	-	-	-	(7)|252)
1851382	0	22	increases	VBZ	-	-	-	-	-	-	-	-
1851382	0	23	in	IN	-	-	-	-	-	-	-	-
1851382	0	24	pregnant	JJ	-	-	-	-	-	-	-	-
1851382	0	25	wild	JJ	-	-	-	-	-	-	-	-
1851382	0	26	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	27	type	NN	-	-	-	-	-	-	-	-
1851382	0	28	mice	NNS	-	-	-	-	-	-	-	-
1851382	0	29	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	30	Figure	NN	-	-	-	-	-	-	-	(240
1851382	0	31	3b	NN	-	-	-	-	-	-	-	240)
1851382	0	32	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	33	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Increased	VBN	-	-	-	-	-	-	-	(52
1851382	0	2	levels	NNS	-	-	-	-	-	-	-	-
1851382	0	3	of	IN	-	-	-	-	-	-	-	-
1851382	0	4	estrogen	NN	-	-	-	-	-	-	-	(7)|52)
1851382	0	5	therefore	RB	-	-	-	-	-	-	-	-
1851382	0	6	stimulate	VBP	-	-	-	-	-	-	-	-
1851382	0	7	the	DT	-	-	-	-	-	-	-	(53
1851382	0	8	production	NN	-	-	-	-	-	-	-	-
1851382	0	9	of	IN	-	-	-	-	-	-	-	-
1851382	0	10	stromal	JJ	-	-	-	-	-	-	-	(54
1851382	0	11	cell	NN	-	-	-	-	-	-	-	-
1851382	0	12	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	13	derived	VBN	-	-	-	-	-	-	-	-
1851382	0	14	local	JJ	-	-	-	-	-	-	-	-
1851382	0	15	IGF	NN	-	-	-	-	-	-	-	-
1851382	0	16	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	17	1	CD	-	-	-	-	-	-	-	54)|53)
1851382	0	18	,	,	-	-	-	-	-	-	-	-
1851382	0	19	which	WDT	-	-	-	-	-	-	-	-
1851382	0	20	overcomes	VBZ	-	-	-	-	-	-	-	-
1851382	0	21	the	DT	-	-	-	-	-	-	-	-
1851382	0	22	IGFBP	NN	-	-	-	-	-	-	-	(47
1851382	0	23	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	24	1	CD	-	-	-	-	-	-	-	47)
1851382	0	25	barrier	NN	-	-	-	-	-	-	-	-
1851382	0	26	in	IN	-	-	-	-	-	-	-	-
1851382	0	27	SirT1ko	NN	-	-	-	-	-	-	-	(22|(24
1851382	0	28	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	29	ko	NN	-	-	-	-	-	-	-	24)
1851382	0	30	mice	NNS	-	-	-	-	-	-	-	22)
1851382	0	31	and	CC	-	-	-	-	-	-	-	-
1851382	0	32	,	,	-	-	-	-	-	-	-	-
1851382	0	33	ultimately	RB	-	-	-	-	-	-	-	-
1851382	0	34	,	,	-	-	-	-	-	-	-	-
1851382	0	35	reverses	VBZ	-	-	-	-	-	-	-	-
1851382	0	36	the	DT	-	-	-	-	-	-	-	(253
1851382	0	37	increased	VBN	-	-	-	-	-	-	-	-
1851382	0	38	levels	NNS	-	-	-	-	-	-	-	-
1851382	0	39	of	IN	-	-	-	-	-	-	-	-
1851382	0	40	IGFBP	NN	-	-	-	-	-	-	-	(47
1851382	0	41	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	42	1	CD	-	-	-	-	-	-	-	-
1851382	0	43	in	IN	-	-	-	-	-	-	-	-
1851382	0	44	mammary	JJ	-	-	-	-	-	-	-	(160
1851382	0	45	tissues	NNS	-	-	-	-	-	-	-	47)|253)|160)
1851382	0	46	.	.	-	-	-	-	-	-	-	-

1851382	0	1	It	PRP	-	-	-	-	-	-	-	-
1851382	0	2	was	VBD	-	-	-	-	-	-	-	-
1851382	0	3	noted	VBN	-	-	-	-	-	-	-	-
1851382	0	4	that	IN	-	-	-	-	-	-	-	-
1851382	0	5	increased	VBN	-	-	-	-	-	-	-	(52
1851382	0	6	levels	NNS	-	-	-	-	-	-	-	-
1851382	0	7	of	IN	-	-	-	-	-	-	-	-
1851382	0	8	estrogen	NN	-	-	-	-	-	-	-	(7)|52)
1851382	0	9	and	CC	-	-	-	-	-	-	-	-
1851382	0	10	local	JJ	-	-	-	-	-	-	-	(54
1851382	0	11	IGF	NN	-	-	-	-	-	-	-	-
1851382	0	12	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	13	1	CD	-	-	-	-	-	-	-	54)
1851382	0	14	did	VBD	-	-	-	-	-	-	-	-
1851382	0	15	not	RB	-	-	-	-	-	-	-	-
1851382	0	16	interfere	VB	-	-	-	-	-	-	-	-
1851382	0	17	with	IN	-	-	-	-	-	-	-	-
1851382	0	18	the	DT	-	-	-	-	-	-	-	(51
1851382	0	19	expression	NN	-	-	-	-	-	-	-	-
1851382	0	20	of	IN	-	-	-	-	-	-	-	-
1851382	0	21	IκBα	NN	-	-	-	-	-	-	-	(50)|51)
1851382	0	22	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	23	Figure	NN	-	-	-	-	-	-	-	(251
1851382	0	24	4b	NN	-	-	-	-	-	-	-	251)
1851382	0	25	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	26	.	.	-	-	-	-	-	-	-	-

1851382	0	1	To	TO	-	-	-	-	-	-	-	-
1851382	0	2	determine	VB	-	-	-	-	-	-	-	-
1851382	0	3	whether	IN	-	-	-	-	-	-	-	-
1851382	0	4	deregulated	VBN	-	-	-	-	-	-	-	(250
1851382	0	5	IκBα	NN	-	-	-	-	-	-	-	-
1851382	0	6	expression	NN	-	-	-	-	-	-	-	-
1851382	0	7	in	IN	-	-	-	-	-	-	-	-
1851382	0	8	SirT1ko	NN	-	-	-	-	-	-	-	(24|(57
1851382	0	9	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	10	ko	NN	-	-	-	-	-	-	-	24)
1851382	0	11	cells	NNS	-	-	-	-	-	-	-	57)|250)
1851382	0	12	can	MD	-	-	-	-	-	-	-	-
1851382	0	13	be	VB	-	-	-	-	-	-	-	-
1851382	0	14	reversed	VBN	-	-	-	-	-	-	-	-
1851382	0	15	,	,	-	-	-	-	-	-	-	-
1851382	0	16	we	PRP	-	-	-	-	-	-	-	(95)
1851382	0	17	treated	VBD	-	-	-	-	-	-	-	-
1851382	0	18	MEFs	NNS	-	-	-	-	-	-	-	(138)
1851382	0	19	with	IN	-	-	-	-	-	-	-	-
1851382	0	20	TNFα	NN	-	-	-	-	-	-	-	(55)
1851382	0	21	and	CC	-	-	-	-	-	-	-	-
1851382	0	22	measured	VBD	-	-	-	-	-	-	-	-
1851382	0	23	the	DT	-	-	-	-	-	-	-	-
1851382	0	24	kinetics	NNS	-	-	-	-	-	-	-	-
1851382	0	25	of	IN	-	-	-	-	-	-	-	-
1851382	0	26	IκBα	NN	-	-	-	-	-	-	-	(51|(50)
1851382	0	27	expression	NN	-	-	-	-	-	-	-	51)
1851382	0	28	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Three	CD	-	-	-	-	-	-	-	(254
1851382	0	2	independent	JJ	-	-	-	-	-	-	-	-
1851382	0	3	lines	NNS	-	-	-	-	-	-	-	-
1851382	0	4	of	IN	-	-	-	-	-	-	-	-
1851382	0	5	SirT1ko	NN	-	-	-	-	-	-	-	(24|(255
1851382	0	6	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	7	ko	NN	-	-	-	-	-	-	-	24)
1851382	0	8	MEFs	NNS	-	-	-	-	-	-	-	255)|254)
1851382	0	9	were	VBD	-	-	-	-	-	-	-	-
1851382	0	10	used	VBN	-	-	-	-	-	-	-	-
1851382	0	11	,	,	-	-	-	-	-	-	-	-
1851382	0	12	which	WDT	-	-	-	-	-	-	-	-
1851382	0	13	displayed	VBD	-	-	-	-	-	-	-	-
1851382	0	14	varying	VBG	-	-	-	-	-	-	-	-
1851382	0	15	basal	JJ	-	-	-	-	-	-	-	-
1851382	0	16	levels	NNS	-	-	-	-	-	-	-	-
1851382	0	17	of	IN	-	-	-	-	-	-	-	-
1851382	0	18	increased	VBN	-	-	-	-	-	-	-	-
1851382	0	19	IκBα	NN	-	-	-	-	-	-	-	-
1851382	0	20	expression	NN	-	-	-	-	-	-	-	-
1851382	0	21	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Following	VBG	-	-	-	-	-	-	-	-
1851382	0	2	IκBα	NN	-	-	-	-	-	-	-	(50)
1851382	0	3	degradation	NN	-	-	-	-	-	-	-	-
1851382	0	4	induced	VBN	-	-	-	-	-	-	-	-
1851382	0	5	by	IN	-	-	-	-	-	-	-	-
1851382	0	6	TNFα	NN	-	-	-	-	-	-	-	(55)
1851382	0	7	,	,	-	-	-	-	-	-	-	-
1851382	0	8	the	DT	-	-	-	-	-	-	-	(256|(257
1851382	0	9	levels	NNS	-	-	-	-	-	-	-	-
1851382	0	10	of	IN	-	-	-	-	-	-	-	-
1851382	0	11	newly	RB	-	-	-	-	-	-	-	(258
1851382	0	12	synthesized	VBN	-	-	-	-	-	-	-	-
1851382	0	13	IκBα	NN	-	-	-	-	-	-	-	-
1851382	0	14	in	IN	-	-	-	-	-	-	-	-
1851382	0	15	all	DT	-	-	-	-	-	-	-	(254
1851382	0	16	three	CD	-	-	-	-	-	-	-	-
1851382	0	17	SirT1ko	NN	-	-	-	-	-	-	-	-
1851382	0	18	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	19	ko	NN	-	-	-	-	-	-	-	-
1851382	0	20	MEFs	NNS	-	-	-	-	-	-	-	258)|256)|254)
1851382	0	21	were	VBD	-	-	-	-	-	-	-	-
1851382	0	22	always	RB	-	-	-	-	-	-	-	-
1851382	0	23	higher	JJR	-	-	-	-	-	-	-	-
1851382	0	24	than	IN	-	-	-	-	-	-	-	-
1851382	0	25	that	DT	-	-	-	-	-	-	-	-
1851382	0	26	of	IN	-	-	-	-	-	-	-	-
1851382	0	27	wild	JJ	-	-	-	-	-	-	-	(137|(259
1851382	0	28	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	29	type	NN	-	-	-	-	-	-	-	137)
1851382	0	30	MEFs	NNS	-	-	-	-	-	-	-	259)|257)
1851382	0	31	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	32	Figure	NN	-	-	-	-	-	-	-	(260
1851382	0	33	6	CD	-	-	-	-	-	-	-	260)
1851382	0	34	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	35	.	.	-	-	-	-	-	-	-	-

1851382	0	1	This	DT	-	-	-	-	-	-	-	(257
1851382	0	2	in	FW	-	-	-	-	-	-	-	-
1851382	0	3	vitro	FW	-	-	-	-	-	-	-	-
1851382	0	4	finding	NN	-	-	-	-	-	-	-	257)
1851382	0	5	implies	VBZ	-	-	-	-	-	-	-	-
1851382	0	6	that	IN	-	-	-	-	-	-	-	-
1851382	0	7	SirT1	NN	-	-	-	-	-	-	-	(227|(1)
1851382	0	8	deficiency	NN	-	-	-	-	-	-	-	227)
1851382	0	9	affects	VBZ	-	-	-	-	-	-	-	-
1851382	0	10	NF	NN	-	-	-	-	-	-	-	(16|(261
1851382	0	11	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	12	κB	NN	-	-	-	-	-	-	-	16)
1851382	0	13	signaling	NN	-	-	-	-	-	-	-	261)
1851382	0	14	when	WRB	-	-	-	-	-	-	-	-
1851382	0	15	the	DT	-	-	-	-	-	-	-	(232
1851382	0	16	IκB	NN	-	-	-	-	-	-	-	(262
1851382	0	17	kinase	NN	-	-	-	-	-	-	-	262)
1851382	0	18	activation	NN	-	-	-	-	-	-	-	232)
1851382	0	19	is	VBZ	-	-	-	-	-	-	-	-
1851382	0	20	normal	JJ	-	-	-	-	-	-	-	-
1851382	0	21	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Our	PRP$	-	-	-	-	-	-	-	(95)
1851382	0	2	current	JJ	-	-	-	-	-	-	-	-
1851382	0	3	system	NN	-	-	-	-	-	-	-	-
1851382	0	4	might	MD	-	-	-	-	-	-	-	-
1851382	0	5	not	RB	-	-	-	-	-	-	-	-
1851382	0	6	be	VB	-	-	-	-	-	-	-	-
1851382	0	7	suitable	JJ	-	-	-	-	-	-	-	-
1851382	0	8	for	IN	-	-	-	-	-	-	-	-
1851382	0	9	studying	VBG	-	-	-	-	-	-	-	-
1851382	0	10	the	DT	-	-	-	-	-	-	-	-
1851382	0	11	effects	NNS	-	-	-	-	-	-	-	-
1851382	0	12	of	IN	-	-	-	-	-	-	-	-
1851382	0	13	SirT1	NN	-	-	-	-	-	-	-	(227|(1)
1851382	0	14	deficiency	NN	-	-	-	-	-	-	-	227)
1851382	0	15	on	IN	-	-	-	-	-	-	-	-
1851382	0	16	NF	NN	-	-	-	-	-	-	-	(16|(233
1851382	0	17	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	18	κB	NN	-	-	-	-	-	-	-	16)
1851382	0	19	activation	NN	-	-	-	-	-	-	-	-
1851382	0	20	in	FW	-	-	-	-	-	-	-	-
1851382	0	21	vivo	FW	-	-	-	-	-	-	-	233)
1851382	0	22	.	.	-	-	-	-	-	-	-	-

1851382	0	1	NF	NN	-	-	-	-	-	-	-	(16|(261
1851382	0	2	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	3	κB	NN	-	-	-	-	-	-	-	16)
1851382	0	4	signaling	NN	-	-	-	-	-	-	-	261)
1851382	0	5	exhibits	VBZ	-	-	-	-	-	-	-	-
1851382	0	6	distinct	JJ	-	-	-	-	-	-	-	-
1851382	0	7	biological	JJ	-	-	-	-	-	-	-	-
1851382	0	8	responses	NNS	-	-	-	-	-	-	-	-
1851382	0	9	because	IN	-	-	-	-	-	-	-	-
1851382	0	10	the	DT	-	-	-	-	-	-	-	(51
1851382	0	11	expression	NN	-	-	-	-	-	-	-	-
1851382	0	12	of	IN	-	-	-	-	-	-	-	-
1851382	0	13	IκBα	NN	-	-	-	-	-	-	-	(50)|51)
1851382	0	14	depends	VBZ	-	-	-	-	-	-	-	-
1851382	0	15	on	IN	-	-	-	-	-	-	-	-
1851382	0	16	NF	NN	-	-	-	-	-	-	-	(16|(233
1851382	0	17	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	18	κB	NN	-	-	-	-	-	-	-	16)
1851382	0	19	activation	NN	-	-	-	-	-	-	-	233)
1851382	0	20	while	IN	-	-	-	-	-	-	-	-
1851382	0	21	the	DT	-	-	-	-	-	-	-	-
1851382	0	22	other	JJ	-	-	-	-	-	-	-	-
1851382	0	23	isoforms	NNS	-	-	-	-	-	-	-	-
1851382	0	24	of	IN	-	-	-	-	-	-	-	-
1851382	0	25	IκB	NN	-	-	-	-	-	-	-	(262)
1851382	0	26	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	27	β	NN	-	-	-	-	-	-	-	-
1851382	0	28	and	CC	-	-	-	-	-	-	-	-
1851382	0	29	ε	NN	-	-	-	-	-	-	-	-
1851382	0	30	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	31	are	VBP	-	-	-	-	-	-	-	-
1851382	0	32	independent	JJ	-	-	-	-	-	-	-	-
1851382	0	33	of	IN	-	-	-	-	-	-	-	-
1851382	0	34	NF	NN	-	-	-	-	-	-	-	(16
1851382	0	35	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	36	κB	NN	-	-	-	-	-	-	-	16)
1851382	0	37	feedback	NN	-	-	-	-	-	-	-	-
1851382	0	38	[	-LRB-	-	-	-	-	-	-	-	-
1851382	0	39	41	CD	-	-	-	-	-	-	-	-
1851382	0	40	]	-RRB-	-	-	-	-	-	-	-	-
1851382	0	41	.	.	-	-	-	-	-	-	-	-

1851382	0	1	For	IN	-	-	-	-	-	-	-	-
1851382	0	2	example	NN	-	-	-	-	-	-	-	-
1851382	0	3	,	,	-	-	-	-	-	-	-	-
1851382	0	4	TNFα	NN	-	-	-	-	-	-	-	(263|(55)
1851382	0	5	stimulation	NN	-	-	-	-	-	-	-	263)
1851382	0	6	induces	VBZ	-	-	-	-	-	-	-	-
1851382	0	7	dampened	VBN	-	-	-	-	-	-	-	-
1851382	0	8	oscillatory	JJ	-	-	-	-	-	-	-	-
1851382	0	9	behavior	NN	-	-	-	-	-	-	-	-
1851382	0	10	after	IN	-	-	-	-	-	-	-	-
1851382	0	11	the	DT	-	-	-	-	-	-	-	(264
1851382	0	12	first	JJ	-	-	-	-	-	-	-	-
1851382	0	13	hour	NN	-	-	-	-	-	-	-	264)
1851382	0	14	,	,	-	-	-	-	-	-	-	-
1851382	0	15	whereas	IN	-	-	-	-	-	-	-	-
1851382	0	16	lipopolysacharide	NN	-	-	-	-	-	-	-	-
1851382	0	17	treatment	NN	-	-	-	-	-	-	-	-
1851382	0	18	leads	VBZ	-	-	-	-	-	-	-	-
1851382	0	19	to	IN	-	-	-	-	-	-	-	-
1851382	0	20	stable	JJ	-	-	-	-	-	-	-	-
1851382	0	21	NF	NN	-	-	-	-	-	-	-	-
1851382	0	22	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	23	κB	NN	-	-	-	-	-	-	-	-
1851382	0	24	activation	NN	-	-	-	-	-	-	-	-
1851382	0	25	[	-LRB-	-	-	-	-	-	-	-	-
1851382	0	26	42	CD	-	-	-	-	-	-	-	-
1851382	0	27	,	,	-	-	-	-	-	-	-	-
1851382	0	28	43	CD	-	-	-	-	-	-	-	-
1851382	0	29	]	-RRB-	-	-	-	-	-	-	-	-
1851382	0	30	.	.	-	-	-	-	-	-	-	-

1851382	0	1	The	DT	-	-	-	-	-	-	-	(261
1851382	0	2	NF	NN	-	-	-	-	-	-	-	(16
1851382	0	3	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	4	κB	NN	-	-	-	-	-	-	-	16)
1851382	0	5	signaling	NN	-	-	-	-	-	-	-	-
1851382	0	6	in	IN	-	-	-	-	-	-	-	-
1851382	0	7	the	DT	-	-	-	-	-	-	-	(265
1851382	0	8	developing	VBG	-	-	-	-	-	-	-	-
1851382	0	9	mammary	JJ	-	-	-	-	-	-	-	-
1851382	0	10	gland	NN	-	-	-	-	-	-	-	265)|261)
1851382	0	11	is	VBZ	-	-	-	-	-	-	-	-
1851382	0	12	under	IN	-	-	-	-	-	-	-	-
1851382	0	13	the	DT	-	-	-	-	-	-	-	-
1851382	0	14	temporal	JJ	-	-	-	-	-	-	-	-
1851382	0	15	control	NN	-	-	-	-	-	-	-	-
1851382	0	16	of	IN	-	-	-	-	-	-	-	-
1851382	0	17	RANK	NN	-	-	-	-	-	-	-	(267|(268|(266)
1851382	0	18	signaling	NN	-	-	-	-	-	-	-	267)
1851382	0	19	and	CC	-	-	-	-	-	-	-	-
1851382	0	20	IKKα	NN	-	-	-	-	-	-	-	(232|(231)
1851382	0	21	activation	NN	-	-	-	-	-	-	-	268)|232)
1851382	0	22	[	-LRB-	-	-	-	-	-	-	-	-
1851382	0	23	37	CD	-	-	-	-	-	-	-	-
1851382	0	24	]	-RRB-	-	-	-	-	-	-	-	-
1851382	0	25	.	.	-	-	-	-	-	-	-	-

1851382	0	1	The	DT	-	-	-	-	-	-	-	-
1851382	0	2	finding	NN	-	-	-	-	-	-	-	-
1851382	0	3	of	IN	-	-	-	-	-	-	-	-
1851382	0	4	increased	VBN	-	-	-	-	-	-	-	-
1851382	0	5	levels	NNS	-	-	-	-	-	-	-	-
1851382	0	6	of	IN	-	-	-	-	-	-	-	-
1851382	0	7	newly	RB	-	-	-	-	-	-	-	(56
1851382	0	8	synthesized	VBN	-	-	-	-	-	-	-	-
1851382	0	9	IκBα	NN	-	-	-	-	-	-	-	56)
1851382	0	10	within	IN	-	-	-	-	-	-	-	-
1851382	0	11	the	DT	-	-	-	-	-	-	-	(264
1851382	0	12	first	JJ	-	-	-	-	-	-	-	-
1851382	0	13	hour	NN	-	-	-	-	-	-	-	264)
1851382	0	14	indicated	VBD	-	-	-	-	-	-	-	-
1851382	0	15	that	IN	-	-	-	-	-	-	-	-
1851382	0	16	SirT1	NN	-	-	-	-	-	-	-	(227|(1)
1851382	0	17	deficiency	NN	-	-	-	-	-	-	-	227)
1851382	0	18	could	MD	-	-	-	-	-	-	-	-
1851382	0	19	disrupt	VB	-	-	-	-	-	-	-	-
1851382	0	20	the	DT	-	-	-	-	-	-	-	-
1851382	0	21	temporal	JJ	-	-	-	-	-	-	-	-
1851382	0	22	control	NN	-	-	-	-	-	-	-	-
1851382	0	23	of	IN	-	-	-	-	-	-	-	-
1851382	0	24	NF	NN	-	-	-	-	-	-	-	(16|(261
1851382	0	25	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	26	κB	NN	-	-	-	-	-	-	-	16)
1851382	0	27	signaling	NN	-	-	-	-	-	-	-	261)
1851382	0	28	to	IN	-	-	-	-	-	-	-	-
1851382	0	29	all	DT	-	-	-	-	-	-	-	-
1851382	0	30	types	NNS	-	-	-	-	-	-	-	-
1851382	0	31	of	IN	-	-	-	-	-	-	-	-
1851382	0	32	stimulation	NN	-	-	-	-	-	-	-	(238)
1851382	0	33	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	34	Figure	NN	-	-	-	-	-	-	-	(260
1851382	0	35	6	CD	-	-	-	-	-	-	-	260)
1851382	0	36	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	37	.	.	-	-	-	-	-	-	-	-

1851382	0	1	It	PRP	-	-	-	-	-	-	-	-
1851382	0	2	remains	VBZ	-	-	-	-	-	-	-	-
1851382	0	3	unknown	JJ	-	-	-	-	-	-	-	-
1851382	0	4	,	,	-	-	-	-	-	-	-	-
1851382	0	5	however	RB	-	-	-	-	-	-	-	-
1851382	0	6	,	,	-	-	-	-	-	-	-	-
1851382	0	7	whether	IN	-	-	-	-	-	-	-	-
1851382	0	8	the	DT	-	-	-	-	-	-	-	-
1851382	0	9	reduced	VBN	-	-	-	-	-	-	-	-
1851382	0	10	IGF	NN	-	-	-	-	-	-	-	-
1851382	0	11	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	12	1	CD	-	-	-	-	-	-	-	-
1851382	0	13	signaling	NN	-	-	-	-	-	-	-	-
1851382	0	14	would	MD	-	-	-	-	-	-	-	-
1851382	0	15	affect	VB	-	-	-	-	-	-	-	-
1851382	0	16	the	DT	-	-	-	-	-	-	-	-
1851382	0	17	efficacy	NN	-	-	-	-	-	-	-	-
1851382	0	18	of	IN	-	-	-	-	-	-	-	-
1851382	0	19	RANK	NN	-	-	-	-	-	-	-	(267|(268|(266)
1851382	0	20	signaling	NN	-	-	-	-	-	-	-	267)
1851382	0	21	and	CC	-	-	-	-	-	-	-	-
1851382	0	22	IKKα	NN	-	-	-	-	-	-	-	(232|(231)
1851382	0	23	activation	NN	-	-	-	-	-	-	-	-
1851382	0	24	in	IN	-	-	-	-	-	-	-	-
1851382	0	25	developing	VBG	-	-	-	-	-	-	-	(265
1851382	0	26	mammary	JJ	-	-	-	-	-	-	-	-
1851382	0	27	glands	NNS	-	-	-	-	-	-	-	268)|265)|232)
1851382	0	28	.	.	-	-	-	-	-	-	-	-

1851382	0	1	The	DT	-	-	-	-	-	-	-	-
1851382	0	2	fact	NN	-	-	-	-	-	-	-	-
1851382	0	3	that	IN	-	-	-	-	-	-	-	-
1851382	0	4	individual	JJ	-	-	-	-	-	-	-	(269
1851382	0	5	SirT1ko	NN	-	-	-	-	-	-	-	-
1851382	0	6	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	7	ko	NN	-	-	-	-	-	-	-	-
1851382	0	8	mice	NNS	-	-	-	-	-	-	-	269)
1851382	0	9	manifested	VBD	-	-	-	-	-	-	-	-
1851382	0	10	varying	VBG	-	-	-	-	-	-	-	-
1851382	0	11	degrees	NNS	-	-	-	-	-	-	-	-
1851382	0	12	of	IN	-	-	-	-	-	-	-	-
1851382	0	13	ductal	JJ	-	-	-	-	-	-	-	(62
1851382	0	14	morphogenesis	NN	-	-	-	-	-	-	-	62)
1851382	0	15	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	16	Figure	NN	-	-	-	-	-	-	-	(195
1851382	0	17	3a	NN	-	-	-	-	-	-	-	195)
1851382	0	18	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	19	makes	VBZ	-	-	-	-	-	-	-	-
1851382	0	20	it	PRP	-	-	-	-	-	-	-	-
1851382	0	21	difficult	JJ	-	-	-	-	-	-	-	-
1851382	0	22	to	TO	-	-	-	-	-	-	-	-
1851382	0	23	dissect	VB	-	-	-	-	-	-	-	-
1851382	0	24	the	DT	-	-	-	-	-	-	-	(270
1851382	0	25	potential	JJ	-	-	-	-	-	-	-	-
1851382	0	26	compound	NN	-	-	-	-	-	-	-	-
1851382	0	27	effect	NN	-	-	-	-	-	-	-	-
1851382	0	28	of	IN	-	-	-	-	-	-	-	-
1851382	0	29	SirT1	NN	-	-	-	-	-	-	-	(227|(1)
1851382	0	30	deficiency	NN	-	-	-	-	-	-	-	227)
1851382	0	31	on	IN	-	-	-	-	-	-	-	-
1851382	0	32	both	CC	-	-	-	-	-	-	-	-
1851382	0	33	upstream	JJ	-	-	-	-	-	-	-	-
1851382	0	34	IKKα	NN	-	-	-	-	-	-	-	-
1851382	0	35	activation	NN	-	-	-	-	-	-	-	-
1851382	0	36	and	CC	-	-	-	-	-	-	-	-
1851382	0	37	downstream	JJ	-	-	-	-	-	-	-	-
1851382	0	38	NF	NN	-	-	-	-	-	-	-	-
1851382	0	39	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	40	κB	NN	-	-	-	-	-	-	-	-
1851382	0	41	signaling	NN	-	-	-	-	-	-	-	270)
1851382	0	42	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Other	JJ	-	-	-	-	-	-	-	-
1851382	0	2	experimental	JJ	-	-	-	-	-	-	-	-
1851382	0	3	systems	NNS	-	-	-	-	-	-	-	-
1851382	0	4	,	,	-	-	-	-	-	-	-	-
1851382	0	5	such	JJ	-	-	-	-	-	-	-	-
1851382	0	6	as	IN	-	-	-	-	-	-	-	-
1851382	0	7	mammary	JJ	-	-	-	-	-	-	-	-
1851382	0	8	epithelial	JJ	-	-	-	-	-	-	-	-
1851382	0	9	cell	NN	-	-	-	-	-	-	-	-
1851382	0	10	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	11	specific	JJ	-	-	-	-	-	-	-	-
1851382	0	12	SirT1ko	NN	-	-	-	-	-	-	-	-
1851382	0	13	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	14	ko	NN	-	-	-	-	-	-	-	-
1851382	0	15	female	JJ	-	-	-	-	-	-	-	-
1851382	0	16	mice	NNS	-	-	-	-	-	-	-	-
1851382	0	17	,	,	-	-	-	-	-	-	-	-
1851382	0	18	may	MD	-	-	-	-	-	-	-	-
1851382	0	19	be	VB	-	-	-	-	-	-	-	-
1851382	0	20	used	VBN	-	-	-	-	-	-	-	-
1851382	0	21	to	TO	-	-	-	-	-	-	-	-
1851382	0	22	address	VB	-	-	-	-	-	-	-	-
1851382	0	23	this	DT	-	-	-	-	-	-	-	(270
1851382	0	24	issue	NN	-	-	-	-	-	-	-	270)
1851382	0	25	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Discussion	NN	-	-	-	-	-	-	-	-

1851382	0	1	Our	PRP$	-	-	-	-	-	-	-	(21|(95)
1851382	0	2	study	NN	-	-	-	-	-	-	-	-
1851382	0	3	of	IN	-	-	-	-	-	-	-	-
1851382	0	4	SirT1ko	NN	-	-	-	-	-	-	-	(22|(24
1851382	0	5	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	6	ko	NN	-	-	-	-	-	-	-	24)
1851382	0	7	mice	NNS	-	-	-	-	-	-	-	22)|21)
1851382	0	8	has	VBZ	-	-	-	-	-	-	-	-
1851382	0	9	unveiled	VBN	-	-	-	-	-	-	-	-
1851382	0	10	a	DT	-	-	-	-	-	-	-	-
1851382	0	11	regulatory	JJ	-	-	-	-	-	-	-	-
1851382	0	12	mechanism	NN	-	-	-	-	-	-	-	-
1851382	0	13	by	IN	-	-	-	-	-	-	-	-
1851382	0	14	which	WDT	-	-	-	-	-	-	-	-
1851382	0	15	SirT1	NN	-	-	-	-	-	-	-	(1)
1851382	0	16	modulates	VBZ	-	-	-	-	-	-	-	-
1851382	0	17	the	DT	-	-	-	-	-	-	-	-
1851382	0	18	efficacy	NN	-	-	-	-	-	-	-	-
1851382	0	19	of	IN	-	-	-	-	-	-	-	-
1851382	0	20	estrogen	NN	-	-	-	-	-	-	-	(54|(61
1851382	0	21	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	22	stimulated	VBN	-	-	-	-	-	-	-	-
1851382	0	23	local	JJ	-	-	-	-	-	-	-	-
1851382	0	24	IGF	NN	-	-	-	-	-	-	-	-
1851382	0	25	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	26	1	CD	-	-	-	-	-	-	-	54)
1851382	0	27	signaling	NN	-	-	-	-	-	-	-	-
1851382	0	28	for	IN	-	-	-	-	-	-	-	-
1851382	0	29	ductal	JJ	-	-	-	-	-	-	-	(62
1851382	0	30	morphogenesis	NN	-	-	-	-	-	-	-	62)|61)
1851382	0	31	.	.	-	-	-	-	-	-	-	-

1851382	0	1	SirT1	NN	-	-	-	-	-	-	-	(227|(1)
1851382	0	2	deficiency	NN	-	-	-	-	-	-	-	227)
1851382	0	3	alters	VBZ	-	-	-	-	-	-	-	-
1851382	0	4	the	DT	-	-	-	-	-	-	-	-
1851382	0	5	homeostasis	NN	-	-	-	-	-	-	-	-
1851382	0	6	of	IN	-	-	-	-	-	-	-	-
1851382	0	7	gene	NN	-	-	-	-	-	-	-	(247
1851382	0	8	expression	NN	-	-	-	-	-	-	-	247)
1851382	0	9	and	CC	-	-	-	-	-	-	-	-
1851382	0	10	attenuates	VBZ	-	-	-	-	-	-	-	-
1851382	0	11	the	DT	-	-	-	-	-	-	-	(125
1851382	0	12	efficacy	NN	-	-	-	-	-	-	-	-
1851382	0	13	of	IN	-	-	-	-	-	-	-	-
1851382	0	14	IGF	NN	-	-	-	-	-	-	-	(19|(8
1851382	0	15	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	16	1	CD	-	-	-	-	-	-	-	8)
1851382	0	17	signaling	NN	-	-	-	-	-	-	-	19)|125)
1851382	0	18	.	.	-	-	-	-	-	-	-	-

1851382	0	1	As	IN	-	-	-	-	-	-	-	-
1851382	0	2	a	DT	-	-	-	-	-	-	-	-
1851382	0	3	result	NN	-	-	-	-	-	-	-	-
1851382	0	4	,	,	-	-	-	-	-	-	-	-
1851382	0	5	SirT1ko	NN	-	-	-	-	-	-	-	(22|(24
1851382	0	6	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	7	ko	NN	-	-	-	-	-	-	-	24)
1851382	0	8	mice	NNS	-	-	-	-	-	-	-	22)
1851382	0	9	manifest	VBP	-	-	-	-	-	-	-	-
1851382	0	10	partial	JJ	-	-	-	-	-	-	-	(179a
1851382	0	11	perinatal	JJ	-	-	-	-	-	-	-	-
1851382	0	12	lethality	NN	-	-	-	-	-	-	-	179a)
1851382	0	13	and	CC	-	-	-	-	-	-	-	-
1851382	0	14	lactation	NN	-	-	-	-	-	-	-	(45
1851382	0	15	failure	NN	-	-	-	-	-	-	-	45)
1851382	0	16	phenotypes	NNS	-	-	-	-	-	-	-	(179a)
1851382	0	17	,	,	-	-	-	-	-	-	-	-
1851382	0	18	implicating	VBG	-	-	-	-	-	-	-	-
1851382	0	19	the	DT	-	-	-	-	-	-	-	-
1851382	0	20	role	NN	-	-	-	-	-	-	-	-
1851382	0	21	of	IN	-	-	-	-	-	-	-	-
1851382	0	22	evolutionarily	RB	-	-	-	-	-	-	-	-
1851382	0	23	conserved	VBN	-	-	-	-	-	-	-	-
1851382	0	24	SirT1	NN	-	-	-	-	-	-	-	-
1851382	0	25	in	IN	-	-	-	-	-	-	-	-
1851382	0	26	both	CC	-	-	-	-	-	-	-	-
1851382	0	27	postnatal	JJ	-	-	-	-	-	-	-	-
1851382	0	28	survival	NN	-	-	-	-	-	-	-	-
1851382	0	29	and	CC	-	-	-	-	-	-	-	-
1851382	0	30	offspring	NN	-	-	-	-	-	-	-	(173
1851382	0	31	survival	NN	-	-	-	-	-	-	-	-
1851382	0	32	of	IN	-	-	-	-	-	-	-	-
1851382	0	33	mammals	NNS	-	-	-	-	-	-	-	(22)|173)
1851382	0	34	.	.	-	-	-	-	-	-	-	-

1851382	0	1	SirT1	NN	-	-	-	-	-	-	-	(1)
1851382	0	2	balances	VBZ	-	-	-	-	-	-	-	-
1851382	0	3	the	DT	-	-	-	-	-	-	-	(271a|(272|(273a
1851382	0	4	homeostasis	NN	-	-	-	-	-	-	-	-
1851382	0	5	of	IN	-	-	-	-	-	-	-	271a)
1851382	0	6	IGF	NN	-	-	-	-	-	-	-	(274|(8
1851382	0	7	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	8	1	CD	-	-	-	-	-	-	-	8)|273a)
1851382	0	9	and	CC	-	-	-	-	-	-	-	-
1851382	0	10	IGFBP	NN	-	-	-	-	-	-	-	(271a|(47
1851382	0	11	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	12	1	CD	-	-	-	-	-	-	-	47)|274)
1851382	0	13	in	FW	-	-	-	-	-	-	-	(273a
1851382	0	14	vivo	FW	-	-	-	-	-	-	-	273a)|272)|271a)

1851382	0	1	SirT1	NN	-	-	-	-	-	-	-	(1)
1851382	0	2	is	VBZ	-	-	-	-	-	-	-	-
1851382	0	3	an	DT	-	-	-	-	-	-	-	-
1851382	0	4	integral	JJ	-	-	-	-	-	-	-	-
1851382	0	5	part	NN	-	-	-	-	-	-	-	-
1851382	0	6	of	IN	-	-	-	-	-	-	-	-
1851382	0	7	the	DT	-	-	-	-	-	-	-	(72
1851382	0	8	IIS	NN	-	-	-	-	-	-	-	(73)
1851382	0	9	system	NN	-	-	-	-	-	-	-	-
1851382	0	10	that	WDT	-	-	-	-	-	-	-	-
1851382	0	11	checks	VBZ	-	-	-	-	-	-	-	-
1851382	0	12	and	CC	-	-	-	-	-	-	-	-
1851382	0	13	balances	VBZ	-	-	-	-	-	-	-	-
1851382	0	14	the	DT	-	-	-	-	-	-	-	(125a
1851382	0	15	efficacy	NN	-	-	-	-	-	-	-	-
1851382	0	16	of	IN	-	-	-	-	-	-	-	125a)
1851382	0	17	insulin	NN	-	-	-	-	-	-	-	(84|(12)
1851382	0	18	and	CC	-	-	-	-	-	-	-	-
1851382	0	19	IGF	NN	-	-	-	-	-	-	-	(125a|(8|(85
1851382	0	20	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	21	1	CD	-	-	-	-	-	-	-	8)
1851382	0	22	signals	NNS	-	-	-	-	-	-	-	85)|84)|72)|125a)
1851382	0	23	.	.	-	-	-	-	-	-	-	-

1851382	0	1	The	DT	-	-	-	-	-	-	-	(88
1851382	0	2	IGF	NN	-	-	-	-	-	-	-	(8
1851382	0	3	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	4	1	CD	-	-	-	-	-	-	-	8)
1851382	0	5	signaling	NN	-	-	-	-	-	-	-	-
1851382	0	6	of	IN	-	-	-	-	-	-	-	-
1851382	0	7	the	DT	-	-	-	-	-	-	-	(72
1851382	0	8	IIS	NN	-	-	-	-	-	-	-	(73)
1851382	0	9	system	NN	-	-	-	-	-	-	-	88)|72)
1851382	0	10	is	VBZ	-	-	-	-	-	-	-	-
1851382	0	11	required	VBN	-	-	-	-	-	-	-	-
1851382	0	12	for	IN	-	-	-	-	-	-	-	-
1851382	0	13	survival	NN	-	-	-	-	-	-	-	-
1851382	0	14	after	IN	-	-	-	-	-	-	-	-
1851382	0	15	birth	NN	-	-	-	-	-	-	-	(100)
1851382	0	16	.	.	-	-	-	-	-	-	-	-

1851382	0	1	As	IN	-	-	-	-	-	-	-	-
1851382	0	2	illustrated	VBN	-	-	-	-	-	-	-	-
1851382	0	3	in	IN	-	-	-	-	-	-	-	-
1851382	0	4	Figure	NN	-	-	-	-	-	-	-	(275
1851382	0	5	7a	NN	-	-	-	-	-	-	-	275)
1851382	0	6	,	,	-	-	-	-	-	-	-	-
1851382	0	7	the	DT	-	-	-	-	-	-	-	-
1851382	0	8	function	NN	-	-	-	-	-	-	-	-
1851382	0	9	of	IN	-	-	-	-	-	-	-	-
1851382	0	10	SirT1	NN	-	-	-	-	-	-	-	(1)
1851382	0	11	parallels	VBZ	-	-	-	-	-	-	-	-
1851382	0	12	the	DT	-	-	-	-	-	-	-	(276
1851382	0	13	linear	JJ	-	-	-	-	-	-	-	-
1851382	0	14	IGF	NN	-	-	-	-	-	-	-	-
1851382	0	15	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	16	1	CD	-	-	-	-	-	-	-	-
1851382	0	17	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	18	IGF	NN	-	-	-	-	-	-	-	-
1851382	0	19	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	20	1	CD	-	-	-	-	-	-	-	-
1851382	0	21	receptor	NN	-	-	-	-	-	-	-	-
1851382	0	22	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	23	phosphoinositide	NN	-	-	-	-	-	-	-	(277
1851382	0	24	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	25	3	CD	-	-	-	-	-	-	-	-
1851382	0	26	'	SYM	-	-	-	-	-	-	-	-
1851382	0	27	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	28	OH	NN	-	-	-	-	-	-	-	-
1851382	0	29	kinase	NN	-	-	-	-	-	-	-	-
1851382	0	30	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	31	Akt	NN	-	-	-	-	-	-	-	-
1851382	0	32	signaling	NN	-	-	-	-	-	-	-	-
1851382	0	33	pathway	NN	-	-	-	-	-	-	-	277)|276)
1851382	0	34	,	,	-	-	-	-	-	-	-	-
1851382	0	35	both	DT	-	-	-	-	-	-	-	(276
1851382	0	36	of	IN	-	-	-	-	-	-	-	-
1851382	0	37	which	WDT	-	-	-	-	-	-	-	276)
1851382	0	38	can	MD	-	-	-	-	-	-	-	-
1851382	0	39	negatively	RB	-	-	-	-	-	-	-	-
1851382	0	40	regulate	VB	-	-	-	-	-	-	-	-
1851382	0	41	the	DT	-	-	-	-	-	-	-	(81
1851382	0	42	transcription	NN	-	-	-	-	-	-	-	(14)
1851382	0	43	activity	NN	-	-	-	-	-	-	-	-
1851382	0	44	of	IN	-	-	-	-	-	-	-	-
1851382	0	45	FoxOs	NNS	-	-	-	-	-	-	-	(80)|81)
1851382	0	46	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Mice	NNS	-	-	-	-	-	-	-	(229a
1851382	0	2	harboring	VBG	-	-	-	-	-	-	-	-
1851382	0	3	targeted	VBN	-	-	-	-	-	-	-	(230a
1851382	0	4	mutations	NNS	-	-	-	-	-	-	-	-
1851382	0	5	in	IN	-	-	-	-	-	-	-	230a)|229a)
1851382	0	6	either	CC	-	-	-	-	-	-	-	-
1851382	0	7	IGF	NN	-	-	-	-	-	-	-	(8
1851382	0	8	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	9	1	CD	-	-	-	-	-	-	-	8)
1851382	0	10	or	CC	-	-	-	-	-	-	-	-
1851382	0	11	the	DT	-	-	-	-	-	-	-	(229a|(230a
1851382	0	12	IGF	NN	-	-	-	-	-	-	-	(278|(8
1851382	0	13	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	14	1	CD	-	-	-	-	-	-	-	8)
1851382	0	15	receptor	NN	-	-	-	-	-	-	-	278)
1851382	0	16	gene	NN	-	-	-	-	-	-	-	230a)|229a)
1851382	0	17	exhibit	VBP	-	-	-	-	-	-	-	-
1851382	0	18	perinatal	JJ	-	-	-	-	-	-	-	(93|(94
1851382	0	19	lethality	NN	-	-	-	-	-	-	-	93)
1851382	0	20	and	CC	-	-	-	-	-	-	-	-
1851382	0	21	growth	NN	-	-	-	-	-	-	-	(42
1851382	0	22	retardation	NN	-	-	-	-	-	-	-	94)|42)
1851382	0	23	[	-LRB-	-	-	-	-	-	-	-	-
1851382	0	24	44	CD	-	-	-	-	-	-	-	-
1851382	0	25	,	,	-	-	-	-	-	-	-	-
1851382	0	26	45	CD	-	-	-	-	-	-	-	-
1851382	0	27	]	-RRB-	-	-	-	-	-	-	-	-
1851382	0	28	.	.	-	-	-	-	-	-	-	-

1851382	0	1	In	IN	-	-	-	-	-	-	-	-
1851382	0	2	the	DT	-	-	-	-	-	-	-	-
1851382	0	3	IGF	NN	-	-	-	-	-	-	-	(8
1851382	0	4	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	5	1	CD	-	-	-	-	-	-	-	8)
1851382	0	6	receptor	NN	-	-	-	-	-	-	-	-
1851382	0	7	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	8	expressing	VBG	-	-	-	-	-	-	-	-
1851382	0	9	cells	NNS	-	-	-	-	-	-	-	-
1851382	0	10	,	,	-	-	-	-	-	-	-	-
1851382	0	11	the	DT	-	-	-	-	-	-	-	-
1851382	0	12	binding	NN	-	-	-	-	-	-	-	-
1851382	0	13	of	IN	-	-	-	-	-	-	-	-
1851382	0	14	insulin	NN	-	-	-	-	-	-	-	(86|(12)
1851382	0	15	and	CC	-	-	-	-	-	-	-	-
1851382	0	16	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	17	or	CC	-	-	-	-	-	-	-	-
1851382	0	18	IGF	NN	-	-	-	-	-	-	-	(8
1851382	0	19	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	20	1	CD	-	-	-	-	-	-	-	86)|8)
1851382	0	21	activates	VBZ	-	-	-	-	-	-	-	-
1851382	0	22	the	DT	-	-	-	-	-	-	-	-
1851382	0	23	phosphoinositide	NN	-	-	-	-	-	-	-	-
1851382	0	24	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	25	3	CD	-	-	-	-	-	-	-	-
1851382	0	26	'	SYM	-	-	-	-	-	-	-	-
1851382	0	27	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	28	OH	NN	-	-	-	-	-	-	-	-
1851382	0	29	kinase	NN	-	-	-	-	-	-	-	-
1851382	0	30	and	CC	-	-	-	-	-	-	-	-
1851382	0	31	Akt	NN	-	-	-	-	-	-	-	(83
1851382	0	32	kinase	NN	-	-	-	-	-	-	-	83)
1851382	0	33	cascade	NN	-	-	-	-	-	-	-	-
1851382	0	34	for	IN	-	-	-	-	-	-	-	-
1851382	0	35	survival	NN	-	-	-	-	-	-	-	(141)
1851382	0	36	[	-LRB-	-	-	-	-	-	-	-	-
1851382	0	37	8	CD	-	-	-	-	-	-	-	-
1851382	0	38	,	,	-	-	-	-	-	-	-	-
1851382	0	39	9	CD	-	-	-	-	-	-	-	-
1851382	0	40	,	,	-	-	-	-	-	-	-	-
1851382	0	41	13	CD	-	-	-	-	-	-	-	-
1851382	0	42	]	-RRB-	-	-	-	-	-	-	-	-
1851382	0	43	.	.	-	-	-	-	-	-	-	-

1851382	0	1	The	DT	-	-	-	-	-	-	-	(277
1851382	0	2	phosphoinositide	NN	-	-	-	-	-	-	-	-
1851382	0	3	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	4	3	CD	-	-	-	-	-	-	-	-
1851382	0	5	'	SYM	-	-	-	-	-	-	-	-
1851382	0	6	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	7	OH	NN	-	-	-	-	-	-	-	-
1851382	0	8	kinase	NN	-	-	-	-	-	-	-	-
1851382	0	9	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	10	Akt	NN	-	-	-	-	-	-	-	-
1851382	0	11	signaling	NN	-	-	-	-	-	-	-	-
1851382	0	12	pathway	NN	-	-	-	-	-	-	-	277)
1851382	0	13	is	VBZ	-	-	-	-	-	-	-	-
1851382	0	14	also	RB	-	-	-	-	-	-	-	-
1851382	0	15	highly	RB	-	-	-	-	-	-	-	-
1851382	0	16	conserved	JJ	-	-	-	-	-	-	-	-
1851382	0	17	from	IN	-	-	-	-	-	-	-	-
1851382	0	18	worms	NNS	-	-	-	-	-	-	-	(74)
1851382	0	19	to	IN	-	-	-	-	-	-	-	-
1851382	0	20	mammals	NNS	-	-	-	-	-	-	-	(71)
1851382	0	21	,	,	-	-	-	-	-	-	-	-
1851382	0	22	and	CC	-	-	-	-	-	-	-	-
1851382	0	23	functions	VBZ	-	-	-	-	-	-	-	-
1851382	0	24	to	TO	-	-	-	-	-	-	-	-
1851382	0	25	modulate	VB	-	-	-	-	-	-	-	-
1851382	0	26	energy	NN	-	-	-	-	-	-	-	-
1851382	0	27	metabolism	NN	-	-	-	-	-	-	-	-
1851382	0	28	and	CC	-	-	-	-	-	-	-	-
1851382	0	29	lifespan	NN	-	-	-	-	-	-	-	-
1851382	0	30	in	IN	-	-	-	-	-	-	-	-
1851382	0	31	lower	JJR	-	-	-	-	-	-	-	(13
1851382	0	32	organisms	NNS	-	-	-	-	-	-	-	13)
1851382	0	33	.	.	-	-	-	-	-	-	-	-

1851382	0	1	The	DT	-	-	-	-	-	-	-	-
1851382	0	2	mammalian	JJ	-	-	-	-	-	-	-	-
1851382	0	3	Akt	NN	-	-	-	-	-	-	-	-
1851382	0	4	kinase	NN	-	-	-	-	-	-	-	-
1851382	0	5	family	NN	-	-	-	-	-	-	-	-
1851382	0	6	has	VBZ	-	-	-	-	-	-	-	-
1851382	0	7	three	CD	-	-	-	-	-	-	-	-
1851382	0	8	members	NNS	-	-	-	-	-	-	-	-
1851382	0	9	,	,	-	-	-	-	-	-	-	-
1851382	0	10	Akt1	NN	-	-	-	-	-	-	-	(279)
1851382	0	11	–	SYM	-	-	-	-	-	-	-	-
1851382	0	12	Akt3	NN	-	-	-	-	-	-	-	-
1851382	0	13	,	,	-	-	-	-	-	-	-	-
1851382	0	14	which	WDT	-	-	-	-	-	-	-	-
1851382	0	15	provide	VBP	-	-	-	-	-	-	-	-
1851382	0	16	specificity	NN	-	-	-	-	-	-	-	-
1851382	0	17	and	CC	-	-	-	-	-	-	-	-
1851382	0	18	versatility	NN	-	-	-	-	-	-	-	-
1851382	0	19	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Mice	NNS	-	-	-	-	-	-	-	(280|(281
1851382	0	2	lacking	VBG	-	-	-	-	-	-	-	-
1851382	0	3	both	CC	-	-	-	-	-	-	-	(282
1851382	0	4	the	DT	-	-	-	-	-	-	-	(279a
1851382	0	5	Akt1	NN	-	-	-	-	-	-	-	279a)
1851382	0	6	and	CC	-	-	-	-	-	-	-	-
1851382	0	7	Akt2	NN	-	-	-	-	-	-	-	(283
1851382	0	8	genes	NNS	-	-	-	-	-	-	-	(279a)|283)|282)|280)
1851382	0	9	display	VBP	-	-	-	-	-	-	-	-
1851382	0	10	perinatal	JJ	-	-	-	-	-	-	-	-
1851382	0	11	lethal	JJ	-	-	-	-	-	-	-	-
1851382	0	12	and	CC	-	-	-	-	-	-	-	-
1851382	0	13	growth	NN	-	-	-	-	-	-	-	(42
1851382	0	14	retardation	NN	-	-	-	-	-	-	-	42)
1851382	0	15	phenotypes	NNS	-	-	-	-	-	-	-	-
1851382	0	16	that	WDT	-	-	-	-	-	-	-	-
1851382	0	17	are	VBP	-	-	-	-	-	-	-	-
1851382	0	18	strikingly	RB	-	-	-	-	-	-	-	-
1851382	0	19	similar	JJ	-	-	-	-	-	-	-	-
1851382	0	20	to	IN	-	-	-	-	-	-	-	-
1851382	0	21	that	DT	-	-	-	-	-	-	-	-
1851382	0	22	of	IN	-	-	-	-	-	-	-	-
1851382	0	23	either	CC	-	-	-	-	-	-	-	-
1851382	0	24	IGF	NN	-	-	-	-	-	-	-	(115a|(8
1851382	0	25	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	26	1	CD	-	-	-	-	-	-	-	8)|115a)
1851382	0	27	or	CC	-	-	-	-	-	-	-	-
1851382	0	28	IGF	NN	-	-	-	-	-	-	-	(284|(8
1851382	0	29	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	30	1	CD	-	-	-	-	-	-	-	8)
1851382	0	31	receptor	NN	-	-	-	-	-	-	-	-
1851382	0	32	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	33	deficient	JJ	-	-	-	-	-	-	-	(115a
1851382	0	34	mice	NNS	-	-	-	-	-	-	-	284)|281)|115a)
1851382	0	35	[	-LRB-	-	-	-	-	-	-	-	-
1851382	0	36	46	CD	-	-	-	-	-	-	-	-
1851382	0	37	]	-RRB-	-	-	-	-	-	-	-	-
1851382	0	38	.	.	-	-	-	-	-	-	-	-

1851382	0	1	In	IN	-	-	-	-	-	-	-	-
1851382	0	2	this	DT	-	-	-	-	-	-	-	(281
1851382	0	3	regard	NN	-	-	-	-	-	-	-	281)
1851382	0	4	,	,	-	-	-	-	-	-	-	-
1851382	0	5	SirT1ko	NN	-	-	-	-	-	-	-	(22|(24
1851382	0	6	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	7	ko	NN	-	-	-	-	-	-	-	24)
1851382	0	8	mice	NNS	-	-	-	-	-	-	-	22)
1851382	0	9	,	,	-	-	-	-	-	-	-	-
1851382	0	10	as	RB	-	-	-	-	-	-	-	-
1851382	0	11	well	RB	-	-	-	-	-	-	-	-
1851382	0	12	as	IN	-	-	-	-	-	-	-	-
1851382	0	13	other	JJ	-	-	-	-	-	-	-	(172
1851382	0	14	strains	NNS	-	-	-	-	-	-	-	-
1851382	0	15	of	IN	-	-	-	-	-	-	-	-
1851382	0	16	SirT1	NN	-	-	-	-	-	-	-	(22
1851382	0	17	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	18	deficienct	JJ	-	-	-	-	-	-	-	-
1851382	0	19	mice	NNS	-	-	-	-	-	-	-	22)|172)
1851382	0	20	,	,	-	-	-	-	-	-	-	-
1851382	0	21	also	RB	-	-	-	-	-	-	-	-
1851382	0	22	exhibit	VBP	-	-	-	-	-	-	-	-
1851382	0	23	perinatal	JJ	-	-	-	-	-	-	-	(90a|(91
1851382	0	24	lethal	JJ	-	-	-	-	-	-	-	90a)
1851382	0	25	and	CC	-	-	-	-	-	-	-	-
1851382	0	26	growth	NN	-	-	-	-	-	-	-	(41|(42
1851382	0	27	retardation	NN	-	-	-	-	-	-	-	42)
1851382	0	28	phenotypes	NNS	-	-	-	-	-	-	-	(90a)|91)|41)
1851382	0	29	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	30	Figure	NN	-	-	-	-	-	-	-	(175|(176
1851382	0	31	1c	NN	-	-	-	-	-	-	-	176)
1851382	0	32	and	CC	-	-	-	-	-	-	-	-
1851382	0	33	Table	NN	-	-	-	-	-	-	-	(174
1851382	0	34	1	CD	-	-	-	-	-	-	-	175)|174)
1851382	0	35	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	36	[	-LRB-	-	-	-	-	-	-	-	-
1851382	0	37	22	CD	-	-	-	-	-	-	-	-
1851382	0	38	,	,	-	-	-	-	-	-	-	-
1851382	0	39	23	CD	-	-	-	-	-	-	-	-
1851382	0	40	]	-RRB-	-	-	-	-	-	-	-	-
1851382	0	41	.	.	-	-	-	-	-	-	-	-

1851382	0	1	The	DT	-	-	-	-	-	-	-	-
1851382	0	2	consistent	JJ	-	-	-	-	-	-	-	-
1851382	0	3	observation	NN	-	-	-	-	-	-	-	-
1851382	0	4	of	IN	-	-	-	-	-	-	-	-
1851382	0	5	perinatal	JJ	-	-	-	-	-	-	-	(90b|(91
1851382	0	6	lethal	JJ	-	-	-	-	-	-	-	90b)
1851382	0	7	and	CC	-	-	-	-	-	-	-	-
1851382	0	8	growth	NN	-	-	-	-	-	-	-	(41|(42
1851382	0	9	retardation	NN	-	-	-	-	-	-	-	42)
1851382	0	10	phenotypes	NNS	-	-	-	-	-	-	-	(90b
1851382	0	11	from	IN	-	-	-	-	-	-	-	-
1851382	0	12	our	PRP$	-	-	-	-	-	-	-	(21|(95)
1851382	0	13	study	NN	-	-	-	-	-	-	-	91)|90b)|41)|21)
1851382	0	14	and	CC	-	-	-	-	-	-	-	-
1851382	0	15	studies	NNS	-	-	-	-	-	-	-	-
1851382	0	16	with	IN	-	-	-	-	-	-	-	-
1851382	0	17	mice	NNS	-	-	-	-	-	-	-	(115|(280a|(284a
1851382	0	18	lacking	VBG	-	-	-	-	-	-	-	284a)|280a)
1851382	0	19	IGF	NN	-	-	-	-	-	-	-	(8
1851382	0	20	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	21	1	CD	-	-	-	-	-	-	-	8)|115)
1851382	0	22	,	,	-	-	-	-	-	-	-	-
1851382	0	23	the	DT	-	-	-	-	-	-	-	(278|(284a
1851382	0	24	IGF	NN	-	-	-	-	-	-	-	(8
1851382	0	25	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	26	1	CD	-	-	-	-	-	-	-	8)
1851382	0	27	receptor	NN	-	-	-	-	-	-	-	284a)|278)
1851382	0	28	,	,	-	-	-	-	-	-	-	-
1851382	0	29	or	CC	-	-	-	-	-	-	-	-
1851382	0	30	Akt1	NN	-	-	-	-	-	-	-	(280a|(282|(279)
1851382	0	31	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	32	Akt2	NN	-	-	-	-	-	-	-	(283)|282)|280a)
1851382	0	33	suggests	VBZ	-	-	-	-	-	-	-	-
1851382	0	34	that	IN	-	-	-	-	-	-	-	-
1851382	0	35	upregulated	VBN	-	-	-	-	-	-	-	-
1851382	0	36	FoxO	NN	-	-	-	-	-	-	-	-
1851382	0	37	activity	NN	-	-	-	-	-	-	-	-
1851382	0	38	unleashes	VBZ	-	-	-	-	-	-	-	-
1851382	0	39	the	DT	-	-	-	-	-	-	-	-
1851382	0	40	expression	NN	-	-	-	-	-	-	-	-
1851382	0	41	of	IN	-	-	-	-	-	-	-	-
1851382	0	42	downstream	JJ	-	-	-	-	-	-	-	-
1851382	0	43	effector	NN	-	-	-	-	-	-	-	-
1851382	0	44	genes	NNS	-	-	-	-	-	-	-	-
1851382	0	45	that	WDT	-	-	-	-	-	-	-	-
1851382	0	46	lead	VBP	-	-	-	-	-	-	-	-
1851382	0	47	to	IN	-	-	-	-	-	-	-	-
1851382	0	48	the	DT	-	-	-	-	-	-	-	(285
1851382	0	49	birth	NN	-	-	-	-	-	-	-	-
1851382	0	50	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	51	related	VBN	-	-	-	-	-	-	-	-
1851382	0	52	stress	NN	-	-	-	-	-	-	-	285)
1851382	0	53	.	.	-	-	-	-	-	-	-	-

1851382	0	1	This	DT	-	-	-	-	-	-	-	(285
1851382	0	2	birth	NN	-	-	-	-	-	-	-	-
1851382	0	3	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	4	related	VBN	-	-	-	-	-	-	-	-
1851382	0	5	stress	NN	-	-	-	-	-	-	-	285)
1851382	0	6	may	MD	-	-	-	-	-	-	-	-
1851382	0	7	be	VB	-	-	-	-	-	-	-	-
1851382	0	8	related	VBN	-	-	-	-	-	-	-	-
1851382	0	9	to	IN	-	-	-	-	-	-	-	-
1851382	0	10	the	DT	-	-	-	-	-	-	-	-
1851382	0	11	switch	NN	-	-	-	-	-	-	-	-
1851382	0	12	from	IN	-	-	-	-	-	-	-	-
1851382	0	13	a	DT	-	-	-	-	-	-	-	-
1851382	0	14	maternal	JJ	-	-	-	-	-	-	-	-
1851382	0	15	level	NN	-	-	-	-	-	-	-	-
1851382	0	16	of	IN	-	-	-	-	-	-	-	-
1851382	0	17	IGF	NN	-	-	-	-	-	-	-	(8
1851382	0	18	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	19	1	CD	-	-	-	-	-	-	-	8)
1851382	0	20	to	IN	-	-	-	-	-	-	-	-
1851382	0	21	a	DT	-	-	-	-	-	-	-	-
1851382	0	22	neonatal	JJ	-	-	-	-	-	-	-	-
1851382	0	23	level	NN	-	-	-	-	-	-	-	-
1851382	0	24	of	IN	-	-	-	-	-	-	-	-
1851382	0	25	IGF	NN	-	-	-	-	-	-	-	(8
1851382	0	26	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	27	1	CD	-	-	-	-	-	-	-	8)
1851382	0	28	because	IN	-	-	-	-	-	-	-	-
1851382	0	29	the	DT	-	-	-	-	-	-	-	(173|(286
1851382	0	30	surviving	VBG	-	-	-	-	-	-	-	-
1851382	0	31	SirT1ko	NN	-	-	-	-	-	-	-	-
1851382	0	32	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	33	ko	NN	-	-	-	-	-	-	-	-
1851382	0	34	mice	NNS	-	-	-	-	-	-	-	173)
1851382	0	35	can	MD	-	-	-	-	-	-	-	-
1851382	0	36	live	VB	-	-	-	-	-	-	-	-
1851382	0	37	into	IN	-	-	-	-	-	-	-	-
1851382	0	38	adulthood	NN	-	-	-	-	-	-	-	-
1851382	0	39	and	CC	-	-	-	-	-	-	-	-
1851382	0	40	can	MD	-	-	-	-	-	-	-	-
1851382	0	41	reproduce	VB	-	-	-	-	-	-	-	-
1851382	0	42	despite	IN	-	-	-	-	-	-	-	-
1851382	0	43	the	DT	-	-	-	-	-	-	-	(41
1851382	0	44	growth	NN	-	-	-	-	-	-	-	(42
1851382	0	45	retardation	NN	-	-	-	-	-	-	-	42)
1851382	0	46	phenotype	NN	-	-	-	-	-	-	-	41)|286)
1851382	0	47	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	48	Figure	NN	-	-	-	-	-	-	-	(176
1851382	0	49	1c	NN	-	-	-	-	-	-	-	176)
1851382	0	50	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	51	.	.	-	-	-	-	-	-	-	-

1851382	0	1	In	IN	-	-	-	-	-	-	-	-
1851382	0	2	this	DT	-	-	-	-	-	-	-	(286
1851382	0	3	context	NN	-	-	-	-	-	-	-	286)
1851382	0	4	,	,	-	-	-	-	-	-	-	-
1851382	0	5	at	RB	-	-	-	-	-	-	-	-
1851382	0	6	least	RBS	-	-	-	-	-	-	-	-
1851382	0	7	one	CD	-	-	-	-	-	-	-	-
1851382	0	8	of	IN	-	-	-	-	-	-	-	-
1851382	0	9	the	DT	-	-	-	-	-	-	-	-
1851382	0	10	FoxO	NN	-	-	-	-	-	-	-	-
1851382	0	11	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	12	deficient	JJ	-	-	-	-	-	-	-	-
1851382	0	13	mice	NNS	-	-	-	-	-	-	-	-
1851382	0	14	strains	NNS	-	-	-	-	-	-	-	-
1851382	0	15	,	,	-	-	-	-	-	-	-	-
1851382	0	16	FoxO3	NN	-	-	-	-	-	-	-	(287
1851382	0	17	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	18	Foxo3a	NN	-	-	-	-	-	-	-	-
1851382	0	19	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	20	FKHRL1	NN	-	-	-	-	-	-	-	-
1851382	0	21	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	22	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	23	deficient	JJ	-	-	-	-	-	-	-	-
1851382	0	24	mice	NNS	-	-	-	-	-	-	-	287)
1851382	0	25	,	,	-	-	-	-	-	-	-	-
1851382	0	26	grow	VB	-	-	-	-	-	-	-	-
1851382	0	27	normally	RB	-	-	-	-	-	-	-	-
1851382	0	28	and	CC	-	-	-	-	-	-	-	-
1851382	0	29	develop	VB	-	-	-	-	-	-	-	-
1851382	0	30	functional	JJ	-	-	-	-	-	-	-	(20
1851382	0	31	mammary	JJ	-	-	-	-	-	-	-	-
1851382	0	32	glands	NNS	-	-	-	-	-	-	-	20)
1851382	0	33	[	-LRB-	-	-	-	-	-	-	-	-
1851382	0	34	47	CD	-	-	-	-	-	-	-	-
1851382	0	35	]	-RRB-	-	-	-	-	-	-	-	-
1851382	0	36	.	.	-	-	-	-	-	-	-	-

1851382	0	1	IGFBP	NN	-	-	-	-	-	-	-	(47
1851382	0	2	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	3	1	CD	-	-	-	-	-	-	-	47)
1851382	0	4	is	VBZ	-	-	-	-	-	-	-	-
1851382	0	5	one	CD	-	-	-	-	-	-	-	-
1851382	0	6	of	IN	-	-	-	-	-	-	-	-
1851382	0	7	six	CD	-	-	-	-	-	-	-	(288
1851382	0	8	IGF	NN	-	-	-	-	-	-	-	-
1851382	0	9	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	10	1	CD	-	-	-	-	-	-	-	-
1851382	0	11	binding	NN	-	-	-	-	-	-	-	-
1851382	0	12	proteins	NN	-	-	-	-	-	-	-	288)
1851382	0	13	,	,	-	-	-	-	-	-	-	-
1851382	0	14	but	CC	-	-	-	-	-	-	-	-
1851382	0	15	is	VBZ	-	-	-	-	-	-	-	-
1851382	0	16	the	DT	-	-	-	-	-	-	-	-
1851382	0	17	only	JJ	-	-	-	-	-	-	-	-
1851382	0	18	one	NN	-	-	-	-	-	-	-	-
1851382	0	19	that	WDT	-	-	-	-	-	-	-	-
1851382	0	20	can	MD	-	-	-	-	-	-	-	-
1851382	0	21	be	VB	-	-	-	-	-	-	-	-
1851382	0	22	negatively	RB	-	-	-	-	-	-	-	-
1851382	0	23	regulated	VBN	-	-	-	-	-	-	-	-
1851382	0	24	by	IN	-	-	-	-	-	-	-	-
1851382	0	25	insulin	NN	-	-	-	-	-	-	-	(12)
1851382	0	26	[	-LRB-	-	-	-	-	-	-	-	-
1851382	0	27	48	CD	-	-	-	-	-	-	-	-
1851382	0	28	]	-RRB-	-	-	-	-	-	-	-	-
1851382	0	29	.	.	-	-	-	-	-	-	-	-

1851382	0	1	IGF	NN	-	-	-	-	-	-	-	(288|(8
1851382	0	2	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	3	1	CD	-	-	-	-	-	-	-	8)
1851382	0	4	binding	NN	-	-	-	-	-	-	-	-
1851382	0	5	proteins	NN	-	-	-	-	-	-	-	288)
1851382	0	6	inhibit	VBP	-	-	-	-	-	-	-	-
1851382	0	7	the	DT	-	-	-	-	-	-	-	-
1851382	0	8	action	NN	-	-	-	-	-	-	-	-
1851382	0	9	of	IN	-	-	-	-	-	-	-	-
1851382	0	10	local	JJ	-	-	-	-	-	-	-	(54
1851382	0	11	IGF	NN	-	-	-	-	-	-	-	-
1851382	0	12	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	13	1	CD	-	-	-	-	-	-	-	54)
1851382	0	14	in	IN	-	-	-	-	-	-	-	-
1851382	0	15	a	DT	-	-	-	-	-	-	-	-
1851382	0	16	spatial	JJ	-	-	-	-	-	-	-	-
1851382	0	17	and	CC	-	-	-	-	-	-	-	-
1851382	0	18	temporal	JJ	-	-	-	-	-	-	-	-
1851382	0	19	manner	NN	-	-	-	-	-	-	-	-
1851382	0	20	[	-LRB-	-	-	-	-	-	-	-	-
1851382	0	21	40	CD	-	-	-	-	-	-	-	-
1851382	0	22	,	,	-	-	-	-	-	-	-	-
1851382	0	23	49	CD	-	-	-	-	-	-	-	-
1851382	0	24	]	-RRB-	-	-	-	-	-	-	-	-
1851382	0	25	.	.	-	-	-	-	-	-	-	-

1851382	0	1	In	IN	-	-	-	-	-	-	-	-
1851382	0	2	mammalian	JJ	-	-	-	-	-	-	-	(17
1851382	0	3	cells	NNS	-	-	-	-	-	-	-	17)
1851382	0	4	,	,	-	-	-	-	-	-	-	-
1851382	0	5	FoxO3	NN	-	-	-	-	-	-	-	(289)
1851382	0	6	can	MD	-	-	-	-	-	-	-	-
1851382	0	7	directly	RB	-	-	-	-	-	-	-	-
1851382	0	8	bind	VB	-	-	-	-	-	-	-	-
1851382	0	9	to	IN	-	-	-	-	-	-	-	-
1851382	0	10	the	DT	-	-	-	-	-	-	-	-
1851382	0	11	promoter	NN	-	-	-	-	-	-	-	-
1851382	0	12	of	IN	-	-	-	-	-	-	-	-
1851382	0	13	the	DT	-	-	-	-	-	-	-	-
1851382	0	14	IGFBP	NN	-	-	-	-	-	-	-	(47
1851382	0	15	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	16	1	CD	-	-	-	-	-	-	-	47)
1851382	0	17	gene	NN	-	-	-	-	-	-	-	-
1851382	0	18	and	CC	-	-	-	-	-	-	-	-
1851382	0	19	activate	VBP	-	-	-	-	-	-	-	-
1851382	0	20	the	DT	-	-	-	-	-	-	-	(14
1851382	0	21	transcription	NN	-	-	-	-	-	-	-	14)
1851382	0	22	[	-LRB-	-	-	-	-	-	-	-	-
1851382	0	23	50	CD	-	-	-	-	-	-	-	-
1851382	0	24	-	SYM	-	-	-	-	-	-	-	-
1851382	0	25	52	CD	-	-	-	-	-	-	-	-
1851382	0	26	]	-RRB-	-	-	-	-	-	-	-	-
1851382	0	27	.	.	-	-	-	-	-	-	-	-

1851382	0	1	SirT1	NN	-	-	-	-	-	-	-	(290|(1)
1851382	0	2	acts	VBZ	-	-	-	-	-	-	-	-
1851382	0	3	to	TO	-	-	-	-	-	-	-	-
1851382	0	4	negatively	RB	-	-	-	-	-	-	-	-
1851382	0	5	regulate	VB	-	-	-	-	-	-	-	-
1851382	0	6	the	DT	-	-	-	-	-	-	-	-
1851382	0	7	activity	NN	-	-	-	-	-	-	-	-
1851382	0	8	of	IN	-	-	-	-	-	-	-	-
1851382	0	9	nuclear	JJ	-	-	-	-	-	-	-	-
1851382	0	10	FoxO3	NN	-	-	-	-	-	-	-	-
1851382	0	11	and	CC	-	-	-	-	-	-	-	-
1851382	0	12	to	TO	-	-	-	-	-	-	-	-
1851382	0	13	decrease	VB	-	-	-	-	-	-	-	-
1851382	0	14	the	DT	-	-	-	-	-	-	-	-
1851382	0	15	expression	NN	-	-	-	-	-	-	-	-
1851382	0	16	of	IN	-	-	-	-	-	-	-	-
1851382	0	17	IGFBP	NN	-	-	-	-	-	-	-	(47
1851382	0	18	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	19	1	CD	-	-	-	-	-	-	-	47)
1851382	0	20	when	WRB	-	-	-	-	-	-	-	-
1851382	0	21	the	DT	-	-	-	-	-	-	-	(85
1851382	0	22	IGF	NN	-	-	-	-	-	-	-	(8
1851382	0	23	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	24	1	CD	-	-	-	-	-	-	-	8)
1851382	0	25	signal	NN	-	-	-	-	-	-	-	85)
1851382	0	26	is	VBZ	-	-	-	-	-	-	-	-
1851382	0	27	low	JJ	-	-	-	-	-	-	-	290)
1851382	0	28	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	29	Figure	NN	-	-	-	-	-	-	-	(275
1851382	0	30	7a	NN	-	-	-	-	-	-	-	275)
1851382	0	31	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	32	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Increased	VBN	-	-	-	-	-	-	-	(253
1851382	0	2	levels	NNS	-	-	-	-	-	-	-	-
1851382	0	3	of	IN	-	-	-	-	-	-	-	-
1851382	0	4	IGFBP	NN	-	-	-	-	-	-	-	(47
1851382	0	5	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	6	1	CD	-	-	-	-	-	-	-	47)|253)
1851382	0	7	can	MD	-	-	-	-	-	-	-	-
1851382	0	8	diminish	VB	-	-	-	-	-	-	-	-
1851382	0	9	the	DT	-	-	-	-	-	-	-	-
1851382	0	10	action	NN	-	-	-	-	-	-	-	-
1851382	0	11	of	IN	-	-	-	-	-	-	-	-
1851382	0	12	IGF	NN	-	-	-	-	-	-	-	(8|(85
1851382	0	13	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	14	1	CD	-	-	-	-	-	-	-	8)
1851382	0	15	signals	NNS	-	-	-	-	-	-	-	85)
1851382	0	16	in	FW	-	-	-	-	-	-	-	-
1851382	0	17	vivo	FW	-	-	-	-	-	-	-	-
1851382	0	18	.	.	-	-	-	-	-	-	-	-

1851382	0	1	In	IN	-	-	-	-	-	-	-	-
1851382	0	2	that	DT	-	-	-	-	-	-	-	(290
1851382	0	3	way	NN	-	-	-	-	-	-	-	290)
1851382	0	4	,	,	-	-	-	-	-	-	-	-
1851382	0	5	SirT1	NN	-	-	-	-	-	-	-	(1)
1851382	0	6	balances	VBZ	-	-	-	-	-	-	-	-
1851382	0	7	the	DT	-	-	-	-	-	-	-	(271b|(272|(273
1851382	0	8	homeostasis	NN	-	-	-	-	-	-	-	-
1851382	0	9	of	IN	-	-	-	-	-	-	-	271b)
1851382	0	10	IGF	NN	-	-	-	-	-	-	-	(274|(8
1851382	0	11	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	12	1	CD	-	-	-	-	-	-	-	8)|273)
1851382	0	13	and	CC	-	-	-	-	-	-	-	-
1851382	0	14	IGFBP	NN	-	-	-	-	-	-	-	(271b|(47
1851382	0	15	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	16	1	CD	-	-	-	-	-	-	-	47)|274)|272)|271b)
1851382	0	17	for	IN	-	-	-	-	-	-	-	-
1851382	0	18	varying	VBG	-	-	-	-	-	-	-	-
1851382	0	19	levels	NNS	-	-	-	-	-	-	-	-
1851382	0	20	of	IN	-	-	-	-	-	-	-	-
1851382	0	21	IGF	NN	-	-	-	-	-	-	-	(8|(85
1851382	0	22	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	23	1	CD	-	-	-	-	-	-	-	8)
1851382	0	24	signals	NNS	-	-	-	-	-	-	-	85)
1851382	0	25	.	.	-	-	-	-	-	-	-	-

1851382	0	1	The	DT	-	-	-	-	-	-	-	(271c|(272|(273
1851382	0	2	homeostasis	NN	-	-	-	-	-	-	-	-
1851382	0	3	of	IN	-	-	-	-	-	-	-	271c)
1851382	0	4	IGF	NN	-	-	-	-	-	-	-	(274|(8
1851382	0	5	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	6	1	CD	-	-	-	-	-	-	-	8)|273)
1851382	0	7	and	CC	-	-	-	-	-	-	-	-
1851382	0	8	IGFBP	NN	-	-	-	-	-	-	-	(271c|(47
1851382	0	9	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	10	1	CD	-	-	-	-	-	-	-	47)|274)|272)|271c)
1851382	0	11	clearly	RB	-	-	-	-	-	-	-	-
1851382	0	12	affects	VBZ	-	-	-	-	-	-	-	-
1851382	0	13	fertility	NN	-	-	-	-	-	-	-	(291)
1851382	0	14	,	,	-	-	-	-	-	-	-	-
1851382	0	15	as	IN	-	-	-	-	-	-	-	-
1851382	0	16	shown	VBN	-	-	-	-	-	-	-	-
1851382	0	17	by	IN	-	-	-	-	-	-	-	-
1851382	0	18	the	DT	-	-	-	-	-	-	-	-
1851382	0	19	infertility	NN	-	-	-	-	-	-	-	-
1851382	0	20	phenotype	NN	-	-	-	-	-	-	-	-
1851382	0	21	in	IN	-	-	-	-	-	-	-	-
1851382	0	22	both	CC	-	-	-	-	-	-	-	-
1851382	0	23	IGF	NN	-	-	-	-	-	-	-	(115
1851382	0	24	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	25	1	CD	-	-	-	-	-	-	-	-
1851382	0	26	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	27	deficient	JJ	-	-	-	-	-	-	-	-
1851382	0	28	mice	NNS	-	-	-	-	-	-	-	115)
1851382	0	29	and	CC	-	-	-	-	-	-	-	-
1851382	0	30	IGFBP	NN	-	-	-	-	-	-	-	(47
1851382	0	31	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	32	1	CD	-	-	-	-	-	-	-	47)
1851382	0	33	transgenic	JJ	-	-	-	-	-	-	-	-
1851382	0	34	mice	NNS	-	-	-	-	-	-	-	-
1851382	0	35	[	-LRB-	-	-	-	-	-	-	-	-
1851382	0	36	28	CD	-	-	-	-	-	-	-	-
1851382	0	37	,	,	-	-	-	-	-	-	-	-
1851382	0	38	40	CD	-	-	-	-	-	-	-	-
1851382	0	39	,	,	-	-	-	-	-	-	-	-
1851382	0	40	49	CD	-	-	-	-	-	-	-	-
1851382	0	41	]	-RRB-	-	-	-	-	-	-	-	-
1851382	0	42	.	.	-	-	-	-	-	-	-	-

1851382	0	1	The	DT	-	-	-	-	-	-	-	-
1851382	0	2	serum	NN	-	-	-	-	-	-	-	-
1851382	0	3	level	NN	-	-	-	-	-	-	-	-
1851382	0	4	of	IN	-	-	-	-	-	-	-	-
1851382	0	5	estrogen	NN	-	-	-	-	-	-	-	-
1851382	0	6	in	IN	-	-	-	-	-	-	-	-
1851382	0	7	IGF	NN	-	-	-	-	-	-	-	-
1851382	0	8	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	9	1	CD	-	-	-	-	-	-	-	-
1851382	0	10	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	11	deficient	JJ	-	-	-	-	-	-	-	-
1851382	0	12	female	JJ	-	-	-	-	-	-	-	-
1851382	0	13	mice	NNS	-	-	-	-	-	-	-	-
1851382	0	14	appears	VBZ	-	-	-	-	-	-	-	-
1851382	0	15	significantly	RB	-	-	-	-	-	-	-	-
1851382	0	16	reduced	JJ	-	-	-	-	-	-	-	-
1851382	0	17	,	,	-	-	-	-	-	-	-	-
1851382	0	18	whereas	IN	-	-	-	-	-	-	-	-
1851382	0	19	in	IN	-	-	-	-	-	-	-	-
1851382	0	20	ERα	NN	-	-	-	-	-	-	-	(117
1851382	0	21	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	22	deficient	JJ	-	-	-	-	-	-	-	-
1851382	0	23	mice	NNS	-	-	-	-	-	-	-	117)
1851382	0	24	,	,	-	-	-	-	-	-	-	-
1851382	0	25	which	WDT	-	-	-	-	-	-	-	-
1851382	0	26	are	VBP	-	-	-	-	-	-	-	-
1851382	0	27	also	RB	-	-	-	-	-	-	-	-
1851382	0	28	infertile	JJ	-	-	-	-	-	-	-	-
1851382	0	29	,	,	-	-	-	-	-	-	-	-
1851382	0	30	there	EX	-	-	-	-	-	-	-	-
1851382	0	31	is	VBZ	-	-	-	-	-	-	-	-
1851382	0	32	a	DT	-	-	-	-	-	-	-	-
1851382	0	33	threefold	JJ	-	-	-	-	-	-	-	-
1851382	0	34	increase	NN	-	-	-	-	-	-	-	-
1851382	0	35	[	-LRB-	-	-	-	-	-	-	-	-
1851382	0	36	53	CD	-	-	-	-	-	-	-	-
1851382	0	37	]	-RRB-	-	-	-	-	-	-	-	-
1851382	0	38	.	.	-	-	-	-	-	-	-	-

1851382	0	1	In	IN	-	-	-	-	-	-	-	-
1851382	0	2	contrast	NN	-	-	-	-	-	-	-	-
1851382	0	3	,	,	-	-	-	-	-	-	-	-
1851382	0	4	SirT1ko	NN	-	-	-	-	-	-	-	(22|(24
1851382	0	5	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	6	ko	NN	-	-	-	-	-	-	-	24)
1851382	0	7	mice	NNS	-	-	-	-	-	-	-	22)
1851382	0	8	can	MD	-	-	-	-	-	-	-	-
1851382	0	9	be	VB	-	-	-	-	-	-	-	-
1851382	0	10	fertile	JJ	-	-	-	-	-	-	-	-
1851382	0	11	despite	IN	-	-	-	-	-	-	-	-
1851382	0	12	the	DT	-	-	-	-	-	-	-	-
1851382	0	13	fact	NN	-	-	-	-	-	-	-	-
1851382	0	14	that	IN	-	-	-	-	-	-	-	-
1851382	0	15	the	DT	-	-	-	-	-	-	-	(291
1851382	0	16	fertility	NN	-	-	-	-	-	-	-	291)
1851382	0	17	was	VBD	-	-	-	-	-	-	-	-
1851382	0	18	reduced	JJ	-	-	-	-	-	-	-	-
1851382	0	19	as	IN	-	-	-	-	-	-	-	-
1851382	0	20	compared	VBN	-	-	-	-	-	-	-	-
1851382	0	21	with	IN	-	-	-	-	-	-	-	-
1851382	0	22	that	DT	-	-	-	-	-	-	-	-
1851382	0	23	of	IN	-	-	-	-	-	-	-	-
1851382	0	24	wild	JJ	-	-	-	-	-	-	-	(137|(196
1851382	0	25	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	26	type	NN	-	-	-	-	-	-	-	137)
1851382	0	27	females	NNS	-	-	-	-	-	-	-	196)
1851382	0	28	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	29	Table	NN	-	-	-	-	-	-	-	(174
1851382	0	30	1	CD	-	-	-	-	-	-	-	174)
1851382	0	31	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	32	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Although	IN	-	-	-	-	-	-	-	-
1851382	0	2	our	PRP$	-	-	-	-	-	-	-	(95)
1851382	0	3	preliminary	JJ	-	-	-	-	-	-	-	-
1851382	0	4	assessment	NN	-	-	-	-	-	-	-	-
1851382	0	5	indicated	VBD	-	-	-	-	-	-	-	-
1851382	0	6	that	IN	-	-	-	-	-	-	-	-
1851382	0	7	the	DT	-	-	-	-	-	-	-	(292
1851382	0	8	serum	NN	-	-	-	-	-	-	-	-
1851382	0	9	level	NN	-	-	-	-	-	-	-	-
1851382	0	10	of	IN	-	-	-	-	-	-	-	-
1851382	0	11	estrogen	NN	-	-	-	-	-	-	-	-
1851382	0	12	in	IN	-	-	-	-	-	-	-	-
1851382	0	13	SirT1ko	NN	-	-	-	-	-	-	-	(24|(40
1851382	0	14	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	15	ko	NN	-	-	-	-	-	-	-	24)
1851382	0	16	female	JJ	-	-	-	-	-	-	-	-
1851382	0	17	mice	NNS	-	-	-	-	-	-	-	40)|292)
1851382	0	18	was	VBD	-	-	-	-	-	-	-	-
1851382	0	19	not	RB	-	-	-	-	-	-	-	-
1851382	0	20	overtly	RB	-	-	-	-	-	-	-	-
1851382	0	21	altered	VBN	-	-	-	-	-	-	-	-
1851382	0	22	,	,	-	-	-	-	-	-	-	-
1851382	0	23	it	PRP	-	-	-	-	-	-	-	-
1851382	0	24	remains	VBZ	-	-	-	-	-	-	-	-
1851382	0	25	possible	JJ	-	-	-	-	-	-	-	-
1851382	0	26	that	IN	-	-	-	-	-	-	-	-
1851382	0	27	a	DT	-	-	-	-	-	-	-	-
1851382	0	28	subtle	JJ	-	-	-	-	-	-	-	-
1851382	0	29	irregularity	NN	-	-	-	-	-	-	-	-
1851382	0	30	or	CC	-	-	-	-	-	-	-	-
1851382	0	31	an	DT	-	-	-	-	-	-	-	-
1851382	0	32	individual	JJ	-	-	-	-	-	-	-	-
1851382	0	33	variation	NN	-	-	-	-	-	-	-	-
1851382	0	34	of	IN	-	-	-	-	-	-	-	-
1851382	0	35	the	DT	-	-	-	-	-	-	-	(292
1851382	0	36	estrogen	NN	-	-	-	-	-	-	-	(7)
1851382	0	37	level	NN	-	-	-	-	-	-	-	292)
1851382	0	38	or	CC	-	-	-	-	-	-	-	-
1851382	0	39	ERα	NN	-	-	-	-	-	-	-	(121)
1851382	0	40	expression	NN	-	-	-	-	-	-	-	-
1851382	0	41	might	MD	-	-	-	-	-	-	-	-
1851382	0	42	be	VB	-	-	-	-	-	-	-	-
1851382	0	43	attributed	VBN	-	-	-	-	-	-	-	-
1851382	0	44	to	IN	-	-	-	-	-	-	-	-
1851382	0	45	the	DT	-	-	-	-	-	-	-	(293
1851382	0	46	reduced	VBN	-	-	-	-	-	-	-	-
1851382	0	47	fertility	NN	-	-	-	-	-	-	-	293)
1851382	0	48	.	.	-	-	-	-	-	-	-	-

1851382	0	1	An	DT	-	-	-	-	-	-	-	-
1851382	0	2	alternative	JJ	-	-	-	-	-	-	-	-
1851382	0	3	explanation	NN	-	-	-	-	-	-	-	-
1851382	0	4	for	IN	-	-	-	-	-	-	-	-
1851382	0	5	reduced	VBN	-	-	-	-	-	-	-	(293
1851382	0	6	fertility	NN	-	-	-	-	-	-	-	293)
1851382	0	7	is	VBZ	-	-	-	-	-	-	-	-
1851382	0	8	that	IN	-	-	-	-	-	-	-	-
1851382	0	9	SirT1	NN	-	-	-	-	-	-	-	(227|(1)
1851382	0	10	deficiency	NN	-	-	-	-	-	-	-	227)
1851382	0	11	deregulates	VBZ	-	-	-	-	-	-	-	-
1851382	0	12	the	DT	-	-	-	-	-	-	-	-
1851382	0	13	activity	NN	-	-	-	-	-	-	-	-
1851382	0	14	of	IN	-	-	-	-	-	-	-	-
1851382	0	15	FoxO3	NN	-	-	-	-	-	-	-	(289)
1851382	0	16	and	CC	-	-	-	-	-	-	-	-
1851382	0	17	manifests	VBZ	-	-	-	-	-	-	-	-
1851382	0	18	an	DT	-	-	-	-	-	-	-	-
1851382	0	19	opposite	JJ	-	-	-	-	-	-	-	-
1851382	0	20	effect	NN	-	-	-	-	-	-	-	-
1851382	0	21	of	IN	-	-	-	-	-	-	-	-
1851382	0	22	FoxO3	NN	-	-	-	-	-	-	-	(289)
1851382	0	23	deficiency	NN	-	-	-	-	-	-	-	-
1851382	0	24	.	.	-	-	-	-	-	-	-	-

1851382	0	1	FoxO3	NN	-	-	-	-	-	-	-	(287
1851382	0	2	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	3	deficient	JJ	-	-	-	-	-	-	-	-
1851382	0	4	mice	NNS	-	-	-	-	-	-	-	287)
1851382	0	5	exhibit	VBP	-	-	-	-	-	-	-	-
1851382	0	6	early	JJ	-	-	-	-	-	-	-	-
1851382	0	7	depletion	NN	-	-	-	-	-	-	-	-
1851382	0	8	of	IN	-	-	-	-	-	-	-	-
1851382	0	9	ovarian	JJ	-	-	-	-	-	-	-	(294
1851382	0	10	follicles	NNS	-	-	-	-	-	-	-	294)
1851382	0	11	,	,	-	-	-	-	-	-	-	-
1851382	0	12	which	WDT	-	-	-	-	-	-	-	-
1851382	0	13	is	VBZ	-	-	-	-	-	-	-	-
1851382	0	14	reminiscent	JJ	-	-	-	-	-	-	-	-
1851382	0	15	of	IN	-	-	-	-	-	-	-	-
1851382	0	16	premature	JJ	-	-	-	-	-	-	-	(295
1851382	0	17	ovarian	JJ	-	-	-	-	-	-	-	-
1851382	0	18	failure	NN	-	-	-	-	-	-	-	-
1851382	0	19	in	IN	-	-	-	-	-	-	-	-
1851382	0	20	women	NNS	-	-	-	-	-	-	-	(101)|295)
1851382	0	21	[	-LRB-	-	-	-	-	-	-	-	-
1851382	0	22	47	CD	-	-	-	-	-	-	-	-
1851382	0	23	,	,	-	-	-	-	-	-	-	-
1851382	0	24	54	CD	-	-	-	-	-	-	-	-
1851382	0	25	]	-RRB-	-	-	-	-	-	-	-	-
1851382	0	26	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Premature	JJ	-	-	-	-	-	-	-	(295
1851382	0	2	ovarian	JJ	-	-	-	-	-	-	-	-
1851382	0	3	failure	NN	-	-	-	-	-	-	-	295)
1851382	0	4	manifests	VBZ	-	-	-	-	-	-	-	-
1851382	0	5	as	IN	-	-	-	-	-	-	-	-
1851382	0	6	early	JJ	-	-	-	-	-	-	-	-
1851382	0	7	cessation	NN	-	-	-	-	-	-	-	-
1851382	0	8	of	IN	-	-	-	-	-	-	-	-
1851382	0	9	ovarian	JJ	-	-	-	-	-	-	-	-
1851382	0	10	function	NN	-	-	-	-	-	-	-	-
1851382	0	11	and	CC	-	-	-	-	-	-	-	-
1851382	0	12	as	IN	-	-	-	-	-	-	-	-
1851382	0	13	premature	JJ	-	-	-	-	-	-	-	-
1851382	0	14	menopause	NN	-	-	-	-	-	-	-	-
1851382	0	15	caused	VBN	-	-	-	-	-	-	-	-
1851382	0	16	by	IN	-	-	-	-	-	-	-	-
1851382	0	17	genetic	JJ	-	-	-	-	-	-	-	-
1851382	0	18	mutations	NNS	-	-	-	-	-	-	-	-
1851382	0	19	,	,	-	-	-	-	-	-	-	-
1851382	0	20	chemo	NN	-	-	-	-	-	-	-	-
1851382	0	21	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	22	radiation	NN	-	-	-	-	-	-	-	-
1851382	0	23	therapy	NN	-	-	-	-	-	-	-	-
1851382	0	24	,	,	-	-	-	-	-	-	-	-
1851382	0	25	or	CC	-	-	-	-	-	-	-	-
1851382	0	26	other	JJ	-	-	-	-	-	-	-	-
1851382	0	27	unknown	JJ	-	-	-	-	-	-	-	-
1851382	0	28	factors	NNS	-	-	-	-	-	-	-	-
1851382	0	29	.	.	-	-	-	-	-	-	-	-

1851382	0	1	It	PRP	-	-	-	-	-	-	-	-
1851382	0	2	is	VBZ	-	-	-	-	-	-	-	-
1851382	0	3	possible	JJ	-	-	-	-	-	-	-	-
1851382	0	4	that	IN	-	-	-	-	-	-	-	-
1851382	0	5	SirT1	NN	-	-	-	-	-	-	-	(227|(1)
1851382	0	6	deficiency	NN	-	-	-	-	-	-	-	227)
1851382	0	7	counterbalances	VBZ	-	-	-	-	-	-	-	-
1851382	0	8	normal	JJ	-	-	-	-	-	-	-	-
1851382	0	9	release	NN	-	-	-	-	-	-	-	-
1851382	0	10	of	IN	-	-	-	-	-	-	-	-
1851382	0	11	ovarian	JJ	-	-	-	-	-	-	-	(294
1851382	0	12	follicles	NNS	-	-	-	-	-	-	-	294)
1851382	0	13	and	CC	-	-	-	-	-	-	-	-
1851382	0	14	reduces	VBZ	-	-	-	-	-	-	-	-
1851382	0	15	the	DT	-	-	-	-	-	-	-	(291
1851382	0	16	fertility	NN	-	-	-	-	-	-	-	-
1851382	0	17	in	IN	-	-	-	-	-	-	-	-
1851382	0	18	mice	NNS	-	-	-	-	-	-	-	(6)|291)
1851382	0	19	.	.	-	-	-	-	-	-	-	-

1851382	0	1	SirT1	NN	-	-	-	-	-	-	-	(1)
1851382	0	2	modulates	VBZ	-	-	-	-	-	-	-	-
1851382	0	3	the	DT	-	-	-	-	-	-	-	(125
1851382	0	4	efficacy	NN	-	-	-	-	-	-	-	-
1851382	0	5	of	IN	-	-	-	-	-	-	-	-
1851382	0	6	the	DT	-	-	-	-	-	-	-	(85
1851382	0	7	IGF	NN	-	-	-	-	-	-	-	(8
1851382	0	8	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	9	1	CD	-	-	-	-	-	-	-	8)
1851382	0	10	signal	NN	-	-	-	-	-	-	-	85)
1851382	0	11	for	IN	-	-	-	-	-	-	-	-
1851382	0	12	ductal	JJ	-	-	-	-	-	-	-	(62
1851382	0	13	morphogenesis	NN	-	-	-	-	-	-	-	62)|125)

1851382	0	1	We	PRP	-	-	-	-	-	-	-	(95)
1851382	0	2	hypothesize	VBP	-	-	-	-	-	-	-	-
1851382	0	3	that	IN	-	-	-	-	-	-	-	-
1851382	0	4	,	,	-	-	-	-	-	-	-	-
1851382	0	5	in	IN	-	-	-	-	-	-	-	(296
1851382	0	6	virgin	JJ	-	-	-	-	-	-	-	(32
1851382	0	7	SirT1ko	NN	-	-	-	-	-	-	-	-
1851382	0	8	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	9	ko	NN	-	-	-	-	-	-	-	-
1851382	0	10	mice	NNS	-	-	-	-	-	-	-	32)
1851382	0	11	,	,	-	-	-	-	-	-	-	-
1851382	0	12	increased	VBN	-	-	-	-	-	-	-	(297
1851382	0	13	levels	NNS	-	-	-	-	-	-	-	-
1851382	0	14	of	IN	-	-	-	-	-	-	-	-
1851382	0	15	IGFBP	NN	-	-	-	-	-	-	-	(245
1851382	0	16	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	17	1	CD	-	-	-	-	-	-	-	-
1851382	0	18	in	IN	-	-	-	-	-	-	-	-
1851382	0	19	adipose	JJ	-	-	-	-	-	-	-	(246
1851382	0	20	tissues	NNS	-	-	-	-	-	-	-	297)|246)|245)
1851382	0	21	effectively	RB	-	-	-	-	-	-	-	-
1851382	0	22	diminish	VBP	-	-	-	-	-	-	-	-
1851382	0	23	IGF	NN	-	-	-	-	-	-	-	(8
1851382	0	24	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	25	1	CD	-	-	-	-	-	-	-	8)
1851382	0	26	signals	NNS	-	-	-	-	-	-	-	-
1851382	0	27	,	,	-	-	-	-	-	-	-	-
1851382	0	28	including	VBG	-	-	-	-	-	-	-	-
1851382	0	29	the	DT	-	-	-	-	-	-	-	(2
1851382	0	30	estrogen	NN	-	-	-	-	-	-	-	(3
1851382	0	31	–	HYPH	-	-	-	-	-	-	-	-
1851382	0	32	IGF	NN	-	-	-	-	-	-	-	-
1851382	0	33	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	34	1	CD	-	-	-	-	-	-	-	3)
1851382	0	35	signaling	NN	-	-	-	-	-	-	-	2)
1851382	0	36	,	,	-	-	-	-	-	-	-	-
1851382	0	37	and	CC	-	-	-	-	-	-	-	-
1851382	0	38	halt	VBP	-	-	-	-	-	-	-	-
1851382	0	39	the	DT	-	-	-	-	-	-	-	(214
1851382	0	40	differentiation	NN	-	-	-	-	-	-	-	-
1851382	0	41	of	IN	-	-	-	-	-	-	-	-
1851382	0	42	mammary	JJ	-	-	-	-	-	-	-	(104
1851382	0	43	epithelial	JJ	-	-	-	-	-	-	-	-
1851382	0	44	progenitor	NN	-	-	-	-	-	-	-	-
1851382	0	45	cells	NNS	-	-	-	-	-	-	-	296)|214)|104)
1851382	0	46	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	47	Figure	NN	-	-	-	-	-	-	-	(298
1851382	0	48	7b	NN	-	-	-	-	-	-	-	298)
1851382	0	49	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	50	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Several	JJ	-	-	-	-	-	-	-	(299
1851382	0	2	results	NNS	-	-	-	-	-	-	-	-
1851382	0	3	of	IN	-	-	-	-	-	-	-	-
1851382	0	4	this	DT	-	-	-	-	-	-	-	(21
1851382	0	5	study	NN	-	-	-	-	-	-	-	299)|21)
1851382	0	6	provided	VBD	-	-	-	-	-	-	-	-
1851382	0	7	support	NN	-	-	-	-	-	-	-	-
1851382	0	8	for	IN	-	-	-	-	-	-	-	-
1851382	0	9	this	DT	-	-	-	-	-	-	-	(296
1851382	0	10	hypothesis	NN	-	-	-	-	-	-	-	296)
1851382	0	11	.	.	-	-	-	-	-	-	-	-

1851382	0	1	First	RB	-	-	-	-	-	-	-	-
1851382	0	2	,	,	-	-	-	-	-	-	-	-
1851382	0	3	the	DT	-	-	-	-	-	-	-	(48
1851382	0	4	expression	NN	-	-	-	-	-	-	-	-
1851382	0	5	of	IN	-	-	-	-	-	-	-	-
1851382	0	6	IGFBP	NN	-	-	-	-	-	-	-	(47
1851382	0	7	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	8	1	CD	-	-	-	-	-	-	-	48)|47)
1851382	0	9	is	VBZ	-	-	-	-	-	-	-	-
1851382	0	10	increased	VBN	-	-	-	-	-	-	-	-
1851382	0	11	in	IN	-	-	-	-	-	-	-	-
1851382	0	12	mammary	JJ	-	-	-	-	-	-	-	(107
1851382	0	13	fat	NN	-	-	-	-	-	-	-	107)
1851382	0	14	pads	NNS	-	-	-	-	-	-	-	-
1851382	0	15	from	IN	-	-	-	-	-	-	-	-
1851382	0	16	virgin	JJ	-	-	-	-	-	-	-	(32
1851382	0	17	SirT1ko	NN	-	-	-	-	-	-	-	-
1851382	0	18	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	19	ko	NN	-	-	-	-	-	-	-	-
1851382	0	20	mice	NNS	-	-	-	-	-	-	-	32)
1851382	0	21	,	,	-	-	-	-	-	-	-	-
1851382	0	22	in	IN	-	-	-	-	-	-	-	-
1851382	0	23	which	WDT	-	-	-	-	-	-	-	-
1851382	0	24	there	EX	-	-	-	-	-	-	-	-
1851382	0	25	is	VBZ	-	-	-	-	-	-	-	-
1851382	0	26	no	DT	-	-	-	-	-	-	-	-
1851382	0	27	evidence	NN	-	-	-	-	-	-	-	-
1851382	0	28	of	IN	-	-	-	-	-	-	-	-
1851382	0	29	any	DT	-	-	-	-	-	-	-	-
1851382	0	30	duct	NN	-	-	-	-	-	-	-	-
1851382	0	31	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	32	Figures	NNS	-	-	-	-	-	-	-	(183|(195c)
1851382	0	33	2a	NN	-	-	-	-	-	-	-	183)
1851382	0	34	and	CC	-	-	-	-	-	-	-	-
1851382	0	35	3a	NN	-	-	-	-	-	-	-	(195c)
1851382	0	36	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	37	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Second	RB	-	-	-	-	-	-	-	-
1851382	0	2	,	,	-	-	-	-	-	-	-	-
1851382	0	3	both	CC	-	-	-	-	-	-	-	-
1851382	0	4	pregnancy	NN	-	-	-	-	-	-	-	(185)
1851382	0	5	and	CC	-	-	-	-	-	-	-	-
1851382	0	6	estrogen	NN	-	-	-	-	-	-	-	(46|(7)
1851382	0	7	implantation	NN	-	-	-	-	-	-	-	46)
1851382	0	8	can	MD	-	-	-	-	-	-	-	-
1851382	0	9	rescue	VB	-	-	-	-	-	-	-	-
1851382	0	10	impeded	VBN	-	-	-	-	-	-	-	(62
1851382	0	11	ductal	JJ	-	-	-	-	-	-	-	-
1851382	0	12	morphogenesis	NN	-	-	-	-	-	-	-	-
1851382	0	13	in	IN	-	-	-	-	-	-	-	-
1851382	0	14	SirT1ko	NN	-	-	-	-	-	-	-	(22|(24
1851382	0	15	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	16	ko	NN	-	-	-	-	-	-	-	24)
1851382	0	17	mice	NNS	-	-	-	-	-	-	-	62)|22)
1851382	0	18	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	19	Figures	NNS	-	-	-	-	-	-	-	(195|(210a)
1851382	0	20	3a	NN	-	-	-	-	-	-	-	195)
1851382	0	21	and	CC	-	-	-	-	-	-	-	-
1851382	0	22	4a	NN	-	-	-	-	-	-	-	(210a)
1851382	0	23	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	24	,	,	-	-	-	-	-	-	-	-
1851382	0	25	demonstrating	VBG	-	-	-	-	-	-	-	-
1851382	0	26	that	IN	-	-	-	-	-	-	-	-
1851382	0	27	increased	VBN	-	-	-	-	-	-	-	(52
1851382	0	28	levels	NNS	-	-	-	-	-	-	-	-
1851382	0	29	of	IN	-	-	-	-	-	-	-	-
1851382	0	30	estrogen	NN	-	-	-	-	-	-	-	(7)|52)
1851382	0	31	can	MD	-	-	-	-	-	-	-	-
1851382	0	32	enhance	VB	-	-	-	-	-	-	-	-
1851382	0	33	the	DT	-	-	-	-	-	-	-	(53
1851382	0	34	production	NN	-	-	-	-	-	-	-	-
1851382	0	35	of	IN	-	-	-	-	-	-	-	-
1851382	0	36	local	JJ	-	-	-	-	-	-	-	(54
1851382	0	37	IGF	NN	-	-	-	-	-	-	-	-
1851382	0	38	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	39	1	CD	-	-	-	-	-	-	-	54)|53)
1851382	0	40	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Moreover	RB	-	-	-	-	-	-	-	-
1851382	0	2	,	,	-	-	-	-	-	-	-	-
1851382	0	3	the	DT	-	-	-	-	-	-	-	-
1851382	0	4	varying	VBG	-	-	-	-	-	-	-	-
1851382	0	5	degrees	NNS	-	-	-	-	-	-	-	-
1851382	0	6	of	IN	-	-	-	-	-	-	-	-
1851382	0	7	rescue	NN	-	-	-	-	-	-	-	-
1851382	0	8	among	IN	-	-	-	-	-	-	-	-
1851382	0	9	individual	JJ	-	-	-	-	-	-	-	(269
1851382	0	10	mice	NNS	-	-	-	-	-	-	-	269)
1851382	0	11	,	,	-	-	-	-	-	-	-	-
1851382	0	12	as	RB	-	-	-	-	-	-	-	-
1851382	0	13	well	RB	-	-	-	-	-	-	-	-
1851382	0	14	as	IN	-	-	-	-	-	-	-	-
1851382	0	15	individual	JJ	-	-	-	-	-	-	-	-
1851382	0	16	mammary	JJ	-	-	-	-	-	-	-	-
1851382	0	17	fat	NN	-	-	-	-	-	-	-	-
1851382	0	18	pads	NNS	-	-	-	-	-	-	-	-
1851382	0	19	of	IN	-	-	-	-	-	-	-	-
1851382	0	20	the	DT	-	-	-	-	-	-	-	(269
1851382	0	21	same	JJ	-	-	-	-	-	-	-	-
1851382	0	22	mouse	NN	-	-	-	-	-	-	-	269)
1851382	0	23	,	,	-	-	-	-	-	-	-	-
1851382	0	24	also	RB	-	-	-	-	-	-	-	-
1851382	0	25	indicated	VBD	-	-	-	-	-	-	-	-
1851382	0	26	that	IN	-	-	-	-	-	-	-	-
1851382	0	27	local	JJ	-	-	-	-	-	-	-	(54
1851382	0	28	IGF	NN	-	-	-	-	-	-	-	-
1851382	0	29	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	30	1	CD	-	-	-	-	-	-	-	54)
1851382	0	31	must	MD	-	-	-	-	-	-	-	-
1851382	0	32	be	VB	-	-	-	-	-	-	-	-
1851382	0	33	halted	VBN	-	-	-	-	-	-	-	-
1851382	0	34	in	IN	-	-	-	-	-	-	-	-
1851382	0	35	SirT1ko	NN	-	-	-	-	-	-	-	(22|(24
1851382	0	36	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	37	ko	NN	-	-	-	-	-	-	-	24)
1851382	0	38	mice	NNS	-	-	-	-	-	-	-	22)
1851382	0	39	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	40	Figure	NN	-	-	-	-	-	-	-	(195
1851382	0	41	3a	NN	-	-	-	-	-	-	-	195)
1851382	0	42	,	,	-	-	-	-	-	-	-	-
1851382	0	43	and	CC	-	-	-	-	-	-	-	-
1851382	0	44	data	NNS	-	-	-	-	-	-	-	-
1851382	0	45	not	RB	-	-	-	-	-	-	-	-
1851382	0	46	shown	VBN	-	-	-	-	-	-	-	-
1851382	0	47	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	48	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Finally	RB	-	-	-	-	-	-	-	-
1851382	0	2	,	,	-	-	-	-	-	-	-	-
1851382	0	3	increased	VBN	-	-	-	-	-	-	-	(52
1851382	0	4	levels	NNS	-	-	-	-	-	-	-	-
1851382	0	5	of	IN	-	-	-	-	-	-	-	-
1851382	0	6	estrogen	NN	-	-	-	-	-	-	-	(7)|52)
1851382	0	7	specifically	RB	-	-	-	-	-	-	-	-
1851382	0	8	activate	VBP	-	-	-	-	-	-	-	-
1851382	0	9	the	DT	-	-	-	-	-	-	-	-
1851382	0	10	IGF	NN	-	-	-	-	-	-	-	(8
1851382	0	11	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	12	1	CD	-	-	-	-	-	-	-	8)
1851382	0	13	signaling	NN	-	-	-	-	-	-	-	-
1851382	0	14	in	IN	-	-	-	-	-	-	-	-
1851382	0	15	mammary	JJ	-	-	-	-	-	-	-	(160
1851382	0	16	tissues	NNS	-	-	-	-	-	-	-	160)
1851382	0	17	,	,	-	-	-	-	-	-	-	-
1851382	0	18	as	IN	-	-	-	-	-	-	-	-
1851382	0	19	shown	VBN	-	-	-	-	-	-	-	-
1851382	0	20	by	IN	-	-	-	-	-	-	-	-
1851382	0	21	the	DT	-	-	-	-	-	-	-	-
1851382	0	22	reversal	NN	-	-	-	-	-	-	-	-
1851382	0	23	of	IN	-	-	-	-	-	-	-	-
1851382	0	24	IGFBP	NN	-	-	-	-	-	-	-	(47
1851382	0	25	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	26	1	CD	-	-	-	-	-	-	-	47)
1851382	0	27	expression	NN	-	-	-	-	-	-	-	-
1851382	0	28	in	IN	-	-	-	-	-	-	-	-
1851382	0	29	SirT1ko	NN	-	-	-	-	-	-	-	(22|(24
1851382	0	30	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	31	ko	NN	-	-	-	-	-	-	-	24)
1851382	0	32	mice	NNS	-	-	-	-	-	-	-	22)
1851382	0	33	after	IN	-	-	-	-	-	-	-	-
1851382	0	34	estrogen	NN	-	-	-	-	-	-	-	(46|(7)
1851382	0	35	implantation	NN	-	-	-	-	-	-	-	46)
1851382	0	36	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	37	Figure	NN	-	-	-	-	-	-	-	(251
1851382	0	38	4b	NN	-	-	-	-	-	-	-	251)
1851382	0	39	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	40	.	.	-	-	-	-	-	-	-	-

1851382	0	1	These	DT	-	-	-	-	-	-	-	(299
1851382	0	2	results	NNS	-	-	-	-	-	-	-	299)
1851382	0	3	indicate	VBP	-	-	-	-	-	-	-	-
1851382	0	4	that	IN	-	-	-	-	-	-	-	-
1851382	0	5	a	DT	-	-	-	-	-	-	-	-
1851382	0	6	gradient	NN	-	-	-	-	-	-	-	-
1851382	0	7	of	IN	-	-	-	-	-	-	-	-
1851382	0	8	IGF	NN	-	-	-	-	-	-	-	(8
1851382	0	9	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	10	1	CD	-	-	-	-	-	-	-	8)
1851382	0	11	signals	NNS	-	-	-	-	-	-	-	-
1851382	0	12	,	,	-	-	-	-	-	-	-	-
1851382	0	13	including	VBG	-	-	-	-	-	-	-	-
1851382	0	14	both	CC	-	-	-	-	-	-	-	(300
1851382	0	15	circulating	VBG	-	-	-	-	-	-	-	(301a)
1851382	0	16	and	CC	-	-	-	-	-	-	-	-
1851382	0	17	local	JJ	-	-	-	-	-	-	-	(54
1851382	0	18	IGF	NN	-	-	-	-	-	-	-	(301a
1851382	0	19	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	20	1	CD	-	-	-	-	-	-	-	54)|301a)|300)
1851382	0	21	,	,	-	-	-	-	-	-	-	-
1851382	0	22	may	MD	-	-	-	-	-	-	-	-
1851382	0	23	regulate	VB	-	-	-	-	-	-	-	-
1851382	0	24	mammary	JJ	-	-	-	-	-	-	-	(9
1851382	0	25	gland	NN	-	-	-	-	-	-	-	9)
1851382	0	26	development	NN	-	-	-	-	-	-	-	-
1851382	0	27	at	IN	-	-	-	-	-	-	-	-
1851382	0	28	embryonic	JJ	-	-	-	-	-	-	-	-
1851382	0	29	,	,	-	-	-	-	-	-	-	-
1851382	0	30	postnatal	JJ	-	-	-	-	-	-	-	-
1851382	0	31	,	,	-	-	-	-	-	-	-	-
1851382	0	32	and	CC	-	-	-	-	-	-	-	-
1851382	0	33	reproductive	JJ	-	-	-	-	-	-	-	-
1851382	0	34	stages	NNS	-	-	-	-	-	-	-	-
1851382	0	35	,	,	-	-	-	-	-	-	-	-
1851382	0	36	and	CC	-	-	-	-	-	-	-	-
1851382	0	37	that	IN	-	-	-	-	-	-	-	-
1851382	0	38	increased	VBN	-	-	-	-	-	-	-	(297
1851382	0	39	expression	NN	-	-	-	-	-	-	-	-
1851382	0	40	of	IN	-	-	-	-	-	-	-	-
1851382	0	41	IGFBP	NN	-	-	-	-	-	-	-	(47
1851382	0	42	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	43	1	CD	-	-	-	-	-	-	-	47)|297)
1851382	0	44	decreases	VBZ	-	-	-	-	-	-	-	-
1851382	0	45	the	DT	-	-	-	-	-	-	-	(125
1851382	0	46	efficacy	NN	-	-	-	-	-	-	-	-
1851382	0	47	of	IN	-	-	-	-	-	-	-	-
1851382	0	48	IGF	NN	-	-	-	-	-	-	-	(8
1851382	0	49	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	50	1	CD	-	-	-	-	-	-	-	8)
1851382	0	51	signals	NNS	-	-	-	-	-	-	-	125)
1851382	0	52	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Mammary	JJ	-	-	-	-	-	-	-	(10
1851382	0	2	development	NN	-	-	-	-	-	-	-	10)
1851382	0	3	may	MD	-	-	-	-	-	-	-	-
1851382	0	4	undergo	VB	-	-	-	-	-	-	-	-
1851382	0	5	estrogen	NN	-	-	-	-	-	-	-	-
1851382	0	6	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	7	IGF	NN	-	-	-	-	-	-	-	-
1851382	0	8	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	9	1	CD	-	-	-	-	-	-	-	-
1851382	0	10	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	11	independent	JJ	-	-	-	-	-	-	-	-
1851382	0	12	phases	NNS	-	-	-	-	-	-	-	-
1851382	0	13	and	CC	-	-	-	-	-	-	-	-
1851382	0	14	estrogen	NN	-	-	-	-	-	-	-	-
1851382	0	15	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	16	IGF	NN	-	-	-	-	-	-	-	-
1851382	0	17	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	18	1	CD	-	-	-	-	-	-	-	-
1851382	0	19	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	20	dependent	JJ	-	-	-	-	-	-	-	-
1851382	0	21	phases	NNS	-	-	-	-	-	-	-	-
1851382	0	22	,	,	-	-	-	-	-	-	-	-
1851382	0	23	which	WDT	-	-	-	-	-	-	-	-
1851382	0	24	encompasses	VBZ	-	-	-	-	-	-	-	-
1851382	0	25	a	DT	-	-	-	-	-	-	-	-
1851382	0	26	late	JJ	-	-	-	-	-	-	-	-
1851382	0	27	stage	NN	-	-	-	-	-	-	-	-
1851382	0	28	of	IN	-	-	-	-	-	-	-	-
1851382	0	29	embryonic	JJ	-	-	-	-	-	-	-	-
1851382	0	30	development	NN	-	-	-	-	-	-	-	-
1851382	0	31	to	IN	-	-	-	-	-	-	-	-
1851382	0	32	the	DT	-	-	-	-	-	-	-	(102
1851382	0	33	onset	NN	-	-	-	-	-	-	-	-
1851382	0	34	of	IN	-	-	-	-	-	-	-	-
1851382	0	35	puberty	NN	-	-	-	-	-	-	-	(103)|102)
1851382	0	36	and	CC	-	-	-	-	-	-	-	-
1851382	0	37	involves	VBZ	-	-	-	-	-	-	-	-
1851382	0	38	maternal	JJ	-	-	-	-	-	-	-	(302|(303
1851382	0	39	IGF	NN	-	-	-	-	-	-	-	-
1851382	0	40	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	41	1	CD	-	-	-	-	-	-	-	302)
1851382	0	42	,	,	-	-	-	-	-	-	-	-
1851382	0	43	circulating	VBG	-	-	-	-	-	-	-	(300|(301
1851382	0	44	IGF	NN	-	-	-	-	-	-	-	-
1851382	0	45	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	46	1	CD	-	-	-	-	-	-	-	301)
1851382	0	47	,	,	-	-	-	-	-	-	-	-
1851382	0	48	and	CC	-	-	-	-	-	-	-	-
1851382	0	49	estrogen	NN	-	-	-	-	-	-	-	(54
1851382	0	50	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	51	stimulated	VBN	-	-	-	-	-	-	-	-
1851382	0	52	local	JJ	-	-	-	-	-	-	-	-
1851382	0	53	IGF	NN	-	-	-	-	-	-	-	-
1851382	0	54	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	55	1	CD	-	-	-	-	-	-	-	54)|303)|300)
1851382	0	56	.	.	-	-	-	-	-	-	-	-

1851382	0	1	By	IN	-	-	-	-	-	-	-	-
1851382	0	2	embryonic	JJ	-	-	-	-	-	-	-	-
1851382	0	3	day	NN	-	-	-	-	-	-	-	-
1851382	0	4	16.5	CD	-	-	-	-	-	-	-	-
1851382	0	5	,	,	-	-	-	-	-	-	-	-
1851382	0	6	mammary	JJ	-	-	-	-	-	-	-	(304
1851382	0	7	mesenchymes	NNS	-	-	-	-	-	-	-	-
1851382	0	8	are	VBP	-	-	-	-	-	-	-	-
1851382	0	9	connected	VBN	-	-	-	-	-	-	-	-
1851382	0	10	to	IN	-	-	-	-	-	-	-	-
1851382	0	11	primitive	JJ	-	-	-	-	-	-	-	-
1851382	0	12	fat	NN	-	-	-	-	-	-	-	-
1851382	0	13	pads	NNS	-	-	-	-	-	-	-	-
1851382	0	14	and	CC	-	-	-	-	-	-	-	-
1851382	0	15	begin	VBP	-	-	-	-	-	-	-	-
1851382	0	16	to	TO	-	-	-	-	-	-	-	-
1851382	0	17	proliferate	VB	-	-	-	-	-	-	-	-
1851382	0	18	,	,	-	-	-	-	-	-	-	-
1851382	0	19	which	WDT	-	-	-	-	-	-	-	-
1851382	0	20	results	VBZ	-	-	-	-	-	-	-	-
1851382	0	21	in	IN	-	-	-	-	-	-	-	-
1851382	0	22	rudimentary	JJ	-	-	-	-	-	-	-	(305
1851382	0	23	ducts	NNS	-	-	-	-	-	-	-	305)|304)
1851382	0	24	[	-LRB-	-	-	-	-	-	-	-	-
1851382	0	25	17	CD	-	-	-	-	-	-	-	-
1851382	0	26	,	,	-	-	-	-	-	-	-	-
1851382	0	27	25	CD	-	-	-	-	-	-	-	-
1851382	0	28	,	,	-	-	-	-	-	-	-	-
1851382	0	29	55	CD	-	-	-	-	-	-	-	-
1851382	0	30	,	,	-	-	-	-	-	-	-	-
1851382	0	31	56	CD	-	-	-	-	-	-	-	-
1851382	0	32	]	-RRB-	-	-	-	-	-	-	-	-
1851382	0	33	.	.	-	-	-	-	-	-	-	-

1851382	0	1	We	PRP	-	-	-	-	-	-	-	(95)
1851382	0	2	propose	VBP	-	-	-	-	-	-	-	-
1851382	0	3	that	IN	-	-	-	-	-	-	-	-
1851382	0	4	this	DT	-	-	-	-	-	-	-	(304
1851382	0	5	process	NN	-	-	-	-	-	-	-	304)
1851382	0	6	marks	VBZ	-	-	-	-	-	-	-	-
1851382	0	7	the	DT	-	-	-	-	-	-	-	-
1851382	0	8	transition	NN	-	-	-	-	-	-	-	-
1851382	0	9	from	IN	-	-	-	-	-	-	-	-
1851382	0	10	estrogen	NN	-	-	-	-	-	-	-	-
1851382	0	11	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	12	IGF	NN	-	-	-	-	-	-	-	-
1851382	0	13	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	14	1	CD	-	-	-	-	-	-	-	-
1851382	0	15	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	16	independent	JJ	-	-	-	-	-	-	-	-
1851382	0	17	mammary	JJ	-	-	-	-	-	-	-	-
1851382	0	18	stem	NN	-	-	-	-	-	-	-	-
1851382	0	19	cells	NNS	-	-	-	-	-	-	-	-
1851382	0	20	to	IN	-	-	-	-	-	-	-	-
1851382	0	21	IGF	NN	-	-	-	-	-	-	-	-
1851382	0	22	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	23	1	CD	-	-	-	-	-	-	-	-
1851382	0	24	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	25	dependent	JJ	-	-	-	-	-	-	-	-
1851382	0	26	epithelial	JJ	-	-	-	-	-	-	-	-
1851382	0	27	progenitor	NN	-	-	-	-	-	-	-	-
1851382	0	28	cells	NNS	-	-	-	-	-	-	-	-
1851382	0	29	,	,	-	-	-	-	-	-	-	-
1851382	0	30	and	CC	-	-	-	-	-	-	-	-
1851382	0	31	that	IN	-	-	-	-	-	-	-	-
1851382	0	32	maternal	JJ	-	-	-	-	-	-	-	(302|(306
1851382	0	33	IGF	NN	-	-	-	-	-	-	-	-
1851382	0	34	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	35	1	CD	-	-	-	-	-	-	-	302)
1851382	0	36	is	VBZ	-	-	-	-	-	-	-	-
1851382	0	37	sufficient	JJ	-	-	-	-	-	-	-	-
1851382	0	38	to	TO	-	-	-	-	-	-	-	-
1851382	0	39	stimulate	VB	-	-	-	-	-	-	-	-
1851382	0	40	the	DT	-	-	-	-	-	-	-	-
1851382	0	41	differentiation	NN	-	-	-	-	-	-	-	-
1851382	0	42	of	IN	-	-	-	-	-	-	-	-
1851382	0	43	epithelial	JJ	-	-	-	-	-	-	-	(104
1851382	0	44	progenitor	NN	-	-	-	-	-	-	-	-
1851382	0	45	cells	NNS	-	-	-	-	-	-	-	104)
1851382	0	46	to	IN	-	-	-	-	-	-	-	-
1851382	0	47	estrogen	NN	-	-	-	-	-	-	-	(307
1851382	0	48	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	49	independent	JJ	-	-	-	-	-	-	-	-
1851382	0	50	ductal	JJ	-	-	-	-	-	-	-	-
1851382	0	51	epithelial	JJ	-	-	-	-	-	-	-	-
1851382	0	52	cells	NNS	-	-	-	-	-	-	-	307)
1851382	0	53	but	CC	-	-	-	-	-	-	-	-
1851382	0	54	not	RB	-	-	-	-	-	-	-	-
1851382	0	55	estrogen	NN	-	-	-	-	-	-	-	(308
1851382	0	56	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	57	dependent	JJ	-	-	-	-	-	-	-	-
1851382	0	58	epithelial	JJ	-	-	-	-	-	-	-	-
1851382	0	59	cells	NNS	-	-	-	-	-	-	-	308)|306)
1851382	0	60	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	61	Figure	NN	-	-	-	-	-	-	-	(298
1851382	0	62	7b	NN	-	-	-	-	-	-	-	298)
1851382	0	63	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	64	.	.	-	-	-	-	-	-	-	-

1851382	0	1	This	DT	-	-	-	-	-	-	-	(306)
1851382	0	2	explains	VBZ	-	-	-	-	-	-	-	-
1851382	0	3	why	WRB	-	-	-	-	-	-	-	-
1851382	0	4	the	DT	-	-	-	-	-	-	-	-
1851382	0	5	development	NN	-	-	-	-	-	-	-	-
1851382	0	6	of	IN	-	-	-	-	-	-	-	-
1851382	0	7	rudimentary	JJ	-	-	-	-	-	-	-	(305
1851382	0	8	ducts	NNS	-	-	-	-	-	-	-	305)
1851382	0	9	is	VBZ	-	-	-	-	-	-	-	-
1851382	0	10	normal	JJ	-	-	-	-	-	-	-	-
1851382	0	11	in	IN	-	-	-	-	-	-	-	-
1851382	0	12	either	CC	-	-	-	-	-	-	-	(118
1851382	0	13	IGF	NN	-	-	-	-	-	-	-	(115c|(8
1851382	0	14	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	15	1	CD	-	-	-	-	-	-	-	8)|115c)
1851382	0	16	or	CC	-	-	-	-	-	-	-	-
1851382	0	17	ERα	NN	-	-	-	-	-	-	-	(117|(121)
1851382	0	18	knockout	NN	-	-	-	-	-	-	-	(115c
1851382	0	19	mice	NNS	-	-	-	-	-	-	-	118)|117)|115c)
1851382	0	20	and	CC	-	-	-	-	-	-	-	-
1851382	0	21	that	IN	-	-	-	-	-	-	-	-
1851382	0	22	TEBs	NNS	-	-	-	-	-	-	-	(194)
1851382	0	23	form	VBP	-	-	-	-	-	-	-	-
1851382	0	24	and	CC	-	-	-	-	-	-	-	-
1851382	0	25	regress	VBP	-	-	-	-	-	-	-	-
1851382	0	26	immediately	RB	-	-	-	-	-	-	-	-
1851382	0	27	before	IN	-	-	-	-	-	-	-	-
1851382	0	28	and	CC	-	-	-	-	-	-	-	-
1851382	0	29	after	IN	-	-	-	-	-	-	-	-
1851382	0	30	birth	NN	-	-	-	-	-	-	-	(100)
1851382	0	31	,	,	-	-	-	-	-	-	-	-
1851382	0	32	respectively	RB	-	-	-	-	-	-	-	-
1851382	0	33	[	-LRB-	-	-	-	-	-	-	-	-
1851382	0	34	17	CD	-	-	-	-	-	-	-	-
1851382	0	35	,	,	-	-	-	-	-	-	-	-
1851382	0	36	26	CD	-	-	-	-	-	-	-	-
1851382	0	37	,	,	-	-	-	-	-	-	-	-
1851382	0	38	27	CD	-	-	-	-	-	-	-	-
1851382	0	39	]	-RRB-	-	-	-	-	-	-	-	-
1851382	0	40	.	.	-	-	-	-	-	-	-	-

1851382	0	1	During	IN	-	-	-	-	-	-	-	-
1851382	0	2	the	DT	-	-	-	-	-	-	-	-
1851382	0	3	prepubertal	JJ	-	-	-	-	-	-	-	-
1851382	0	4	period	NN	-	-	-	-	-	-	-	-
1851382	0	5	,	,	-	-	-	-	-	-	-	-
1851382	0	6	the	DT	-	-	-	-	-	-	-	(305
1851382	0	7	rudimentary	JJ	-	-	-	-	-	-	-	-
1851382	0	8	ducts	NNS	-	-	-	-	-	-	-	305)
1851382	0	9	grow	VBP	-	-	-	-	-	-	-	-
1851382	0	10	isometrically	RB	-	-	-	-	-	-	-	-
1851382	0	11	under	IN	-	-	-	-	-	-	-	-
1851382	0	12	the	DT	-	-	-	-	-	-	-	-
1851382	0	13	influence	NN	-	-	-	-	-	-	-	-
1851382	0	14	of	IN	-	-	-	-	-	-	-	-
1851382	0	15	circulating	VBG	-	-	-	-	-	-	-	(301
1851382	0	16	IGF	NN	-	-	-	-	-	-	-	-
1851382	0	17	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	18	1	CD	-	-	-	-	-	-	-	301)
1851382	0	19	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Like	IN	-	-	-	-	-	-	-	-
1851382	0	2	maternal	JJ	-	-	-	-	-	-	-	(302
1851382	0	3	IGF	NN	-	-	-	-	-	-	-	-
1851382	0	4	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	5	1	CD	-	-	-	-	-	-	-	302)
1851382	0	6	,	,	-	-	-	-	-	-	-	-
1851382	0	7	circulating	VBG	-	-	-	-	-	-	-	(301
1851382	0	8	IGF	NN	-	-	-	-	-	-	-	-
1851382	0	9	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	10	1	CD	-	-	-	-	-	-	-	301)
1851382	0	11	is	VBZ	-	-	-	-	-	-	-	-
1851382	0	12	not	RB	-	-	-	-	-	-	-	-
1851382	0	13	sufficient	JJ	-	-	-	-	-	-	-	-
1851382	0	14	to	TO	-	-	-	-	-	-	-	-
1851382	0	15	induce	VB	-	-	-	-	-	-	-	-
1851382	0	16	the	DT	-	-	-	-	-	-	-	(309
1851382	0	17	differentiation	NN	-	-	-	-	-	-	-	-
1851382	0	18	of	IN	-	-	-	-	-	-	-	-
1851382	0	19	estrogen	NN	-	-	-	-	-	-	-	(307
1851382	0	20	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	21	independent	JJ	-	-	-	-	-	-	-	-
1851382	0	22	ductal	JJ	-	-	-	-	-	-	-	-
1851382	0	23	epithelial	JJ	-	-	-	-	-	-	-	-
1851382	0	24	cells	NNS	-	-	-	-	-	-	-	307)
1851382	0	25	into	IN	-	-	-	-	-	-	-	-
1851382	0	26	estrogen	NN	-	-	-	-	-	-	-	(308
1851382	0	27	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	28	dependent	JJ	-	-	-	-	-	-	-	-
1851382	0	29	epithelial	JJ	-	-	-	-	-	-	-	-
1851382	0	30	cells	NNS	-	-	-	-	-	-	-	309)|308)
1851382	0	31	,	,	-	-	-	-	-	-	-	-
1851382	0	32	which	WDT	-	-	-	-	-	-	-	-
1851382	0	33	will	MD	-	-	-	-	-	-	-	-
1851382	0	34	express	VB	-	-	-	-	-	-	-	-
1851382	0	35	ERα	NN	-	-	-	-	-	-	-	(121)
1851382	0	36	and	CC	-	-	-	-	-	-	-	-
1851382	0	37	become	VB	-	-	-	-	-	-	-	-
1851382	0	38	estrogen	NN	-	-	-	-	-	-	-	(7)
1851382	0	39	dependent	JJ	-	-	-	-	-	-	-	-
1851382	0	40	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	41	Figure	NN	-	-	-	-	-	-	-	(298
1851382	0	42	7b	NN	-	-	-	-	-	-	-	298)
1851382	0	43	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	44	.	.	-	-	-	-	-	-	-	-

1851382	0	1	At	IN	-	-	-	-	-	-	-	-
1851382	0	2	the	DT	-	-	-	-	-	-	-	(102
1851382	0	3	onset	NN	-	-	-	-	-	-	-	-
1851382	0	4	of	IN	-	-	-	-	-	-	-	-
1851382	0	5	puberty	NN	-	-	-	-	-	-	-	(103)|102)
1851382	0	6	,	,	-	-	-	-	-	-	-	-
1851382	0	7	ovarian	JJ	-	-	-	-	-	-	-	(109
1851382	0	8	estrogen	NN	-	-	-	-	-	-	-	-
1851382	0	9	,	,	-	-	-	-	-	-	-	-
1851382	0	10	in	IN	-	-	-	-	-	-	-	-
1851382	0	11	synergy	NN	-	-	-	-	-	-	-	(110
1851382	0	12	with	IN	-	-	-	-	-	-	-	-
1851382	0	13	pituitary	JJ	-	-	-	-	-	-	-	(111
1851382	0	14	GH	NN	-	-	-	-	-	-	-	111)|110)|109)
1851382	0	15	,	,	-	-	-	-	-	-	-	-
1851382	0	16	causes	VBZ	-	-	-	-	-	-	-	-
1851382	0	17	a	DT	-	-	-	-	-	-	-	-
1851382	0	18	surge	NN	-	-	-	-	-	-	-	-
1851382	0	19	in	IN	-	-	-	-	-	-	-	-
1851382	0	20	the	DT	-	-	-	-	-	-	-	(53
1851382	0	21	production	NN	-	-	-	-	-	-	-	-
1851382	0	22	of	IN	-	-	-	-	-	-	-	-
1851382	0	23	stromal	JJ	-	-	-	-	-	-	-	(54
1851382	0	24	cell	NN	-	-	-	-	-	-	-	-
1851382	0	25	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	26	derived	VBN	-	-	-	-	-	-	-	-
1851382	0	27	local	JJ	-	-	-	-	-	-	-	-
1851382	0	28	IGF	NN	-	-	-	-	-	-	-	-
1851382	0	29	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	30	1	CD	-	-	-	-	-	-	-	54)|53)
1851382	0	31	and	CC	-	-	-	-	-	-	-	-
1851382	0	32	stimulates	VBZ	-	-	-	-	-	-	-	-
1851382	0	33	the	DT	-	-	-	-	-	-	-	(309
1851382	0	34	differentiation	NN	-	-	-	-	-	-	-	-
1851382	0	35	of	IN	-	-	-	-	-	-	-	-
1851382	0	36	estrogen	NN	-	-	-	-	-	-	-	(307
1851382	0	37	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	38	independent	JJ	-	-	-	-	-	-	-	-
1851382	0	39	ductal	JJ	-	-	-	-	-	-	-	-
1851382	0	40	epithelial	JJ	-	-	-	-	-	-	-	-
1851382	0	41	cells	NNS	-	-	-	-	-	-	-	307)
1851382	0	42	to	IN	-	-	-	-	-	-	-	-
1851382	0	43	estrogen	NN	-	-	-	-	-	-	-	(308
1851382	0	44	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	45	dependent	JJ	-	-	-	-	-	-	-	-
1851382	0	46	epithelial	JJ	-	-	-	-	-	-	-	-
1851382	0	47	cells	NNS	-	-	-	-	-	-	-	309)|308)
1851382	0	48	,	,	-	-	-	-	-	-	-	-
1851382	0	49	which	WDT	-	-	-	-	-	-	-	-
1851382	0	50	begins	VBZ	-	-	-	-	-	-	-	-
1851382	0	51	postnatal	JJ	-	-	-	-	-	-	-	(4
1851382	0	52	development	NN	-	-	-	-	-	-	-	-
1851382	0	53	of	IN	-	-	-	-	-	-	-	-
1851382	0	54	mammary	JJ	-	-	-	-	-	-	-	(5
1851382	0	55	gland	NN	-	-	-	-	-	-	-	5)|4)
1851382	0	56	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	57	Figure	NN	-	-	-	-	-	-	-	(298
1851382	0	58	7b	NN	-	-	-	-	-	-	-	298)
1851382	0	59	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	60	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Impeded	VBN	-	-	-	-	-	-	-	(43
1851382	0	2	ductal	JJ	-	-	-	-	-	-	-	-
1851382	0	3	morphogenesis	NN	-	-	-	-	-	-	-	43)
1851382	0	4	results	VBZ	-	-	-	-	-	-	-	-
1851382	0	5	in	IN	-	-	-	-	-	-	-	-
1851382	0	6	virgin	JJ	-	-	-	-	-	-	-	(32
1851382	0	7	SirT1ko	NN	-	-	-	-	-	-	-	-
1851382	0	8	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	9	ko	NN	-	-	-	-	-	-	-	-
1851382	0	10	mice	NNS	-	-	-	-	-	-	-	32)
1851382	0	11	because	IN	-	-	-	-	-	-	-	-
1851382	0	12	local	JJ	-	-	-	-	-	-	-	(54
1851382	0	13	IGF	NN	-	-	-	-	-	-	-	-
1851382	0	14	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	15	1	CD	-	-	-	-	-	-	-	54)
1851382	0	16	is	VBZ	-	-	-	-	-	-	-	-
1851382	0	17	apparently	RB	-	-	-	-	-	-	-	-
1851382	0	18	not	RB	-	-	-	-	-	-	-	-
1851382	0	19	sufficient	JJ	-	-	-	-	-	-	-	-
1851382	0	20	to	TO	-	-	-	-	-	-	-	-
1851382	0	21	overcome	VB	-	-	-	-	-	-	-	-
1851382	0	22	increased	VBN	-	-	-	-	-	-	-	(297
1851382	0	23	IGFBP	NN	-	-	-	-	-	-	-	-
1851382	0	24	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	25	1	CD	-	-	-	-	-	-	-	-
1851382	0	26	in	IN	-	-	-	-	-	-	-	-
1851382	0	27	mammary	JJ	-	-	-	-	-	-	-	(246
1851382	0	28	adipose	NN	-	-	-	-	-	-	-	-
1851382	0	29	tissues	NNS	-	-	-	-	-	-	-	297)|246)
1851382	0	30	.	.	-	-	-	-	-	-	-	-

1851382	0	1	SirT1	NN	-	-	-	-	-	-	-	(1)
1851382	0	2	therefore	RB	-	-	-	-	-	-	-	-
1851382	0	3	positively	RB	-	-	-	-	-	-	-	-
1851382	0	4	regulates	VBZ	-	-	-	-	-	-	-	-
1851382	0	5	the	DT	-	-	-	-	-	-	-	-
1851382	0	6	efficacy	NN	-	-	-	-	-	-	-	-
1851382	0	7	of	IN	-	-	-	-	-	-	-	-
1851382	0	8	the	DT	-	-	-	-	-	-	-	(2
1851382	0	9	estrogen	NN	-	-	-	-	-	-	-	(3
1851382	0	10	–	HYPH	-	-	-	-	-	-	-	-
1851382	0	11	IGF	NN	-	-	-	-	-	-	-	-
1851382	0	12	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	13	1	CD	-	-	-	-	-	-	-	3)
1851382	0	14	signaling	NN	-	-	-	-	-	-	-	2)
1851382	0	15	for	IN	-	-	-	-	-	-	-	-
1851382	0	16	ductal	JJ	-	-	-	-	-	-	-	(224
1851382	0	17	epithelial	JJ	-	-	-	-	-	-	-	-
1851382	0	18	cell	NN	-	-	-	-	-	-	-	224)
1851382	0	19	proliferation	NN	-	-	-	-	-	-	-	-
1851382	0	20	and	CC	-	-	-	-	-	-	-	-
1851382	0	21	differentiation	NN	-	-	-	-	-	-	-	-
1851382	0	22	.	.	-	-	-	-	-	-	-	-

1851382	0	1	The	DT	-	-	-	-	-	-	-	-
1851382	0	2	potential	JJ	-	-	-	-	-	-	-	-
1851382	0	3	effect	NN	-	-	-	-	-	-	-	-
1851382	0	4	of	IN	-	-	-	-	-	-	-	-
1851382	0	5	modulating	VBG	-	-	-	-	-	-	-	-
1851382	0	6	SirT1	NN	-	-	-	-	-	-	-	(63|(1)
1851382	0	7	activity	NN	-	-	-	-	-	-	-	63)

1851382	0	1	Breast	NN	-	-	-	-	-	-	-	(11
1851382	0	2	cancer	NN	-	-	-	-	-	-	-	11)
1851382	0	3	results	VBZ	-	-	-	-	-	-	-	-
1851382	0	4	from	IN	-	-	-	-	-	-	-	-
1851382	0	5	the	DT	-	-	-	-	-	-	-	-
1851382	0	6	accumulation	NN	-	-	-	-	-	-	-	-
1851382	0	7	of	IN	-	-	-	-	-	-	-	-
1851382	0	8	inherited	VBN	-	-	-	-	-	-	-	-
1851382	0	9	and	CC	-	-	-	-	-	-	-	-
1851382	0	10	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	11	or	CC	-	-	-	-	-	-	-	-
1851382	0	12	somatic	JJ	-	-	-	-	-	-	-	-
1851382	0	13	mutations	NNS	-	-	-	-	-	-	-	-
1851382	0	14	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Lifetime	NN	-	-	-	-	-	-	-	-
1851382	0	2	exposure	NN	-	-	-	-	-	-	-	-
1851382	0	3	to	IN	-	-	-	-	-	-	-	-
1851382	0	4	estrogen	NN	-	-	-	-	-	-	-	(7)
1851382	0	5	is	VBZ	-	-	-	-	-	-	-	-
1851382	0	6	a	DT	-	-	-	-	-	-	-	-
1851382	0	7	major	JJ	-	-	-	-	-	-	-	-
1851382	0	8	risk	NN	-	-	-	-	-	-	-	-
1851382	0	9	factor	NN	-	-	-	-	-	-	-	-
1851382	0	10	for	IN	-	-	-	-	-	-	-	-
1851382	0	11	breast	NN	-	-	-	-	-	-	-	(11
1851382	0	12	cancer	NN	-	-	-	-	-	-	-	11)
1851382	0	13	,	,	-	-	-	-	-	-	-	-
1851382	0	14	and	CC	-	-	-	-	-	-	-	-
1851382	0	15	a	DT	-	-	-	-	-	-	-	(310
1851382	0	16	number	NN	-	-	-	-	-	-	-	-
1851382	0	17	of	IN	-	-	-	-	-	-	-	-
1851382	0	18	lifestyle	NN	-	-	-	-	-	-	-	-
1851382	0	19	factors	NNS	-	-	-	-	-	-	-	-
1851382	0	20	,	,	-	-	-	-	-	-	-	-
1851382	0	21	such	JJ	-	-	-	-	-	-	-	-
1851382	0	22	as	IN	-	-	-	-	-	-	-	-
1851382	0	23	diet	NN	-	-	-	-	-	-	-	-
1851382	0	24	,	,	-	-	-	-	-	-	-	-
1851382	0	25	body	NN	-	-	-	-	-	-	-	-
1851382	0	26	fat	NN	-	-	-	-	-	-	-	-
1851382	0	27	,	,	-	-	-	-	-	-	-	-
1851382	0	28	alcohol	NN	-	-	-	-	-	-	-	-
1851382	0	29	consumption	NN	-	-	-	-	-	-	-	-
1851382	0	30	,	,	-	-	-	-	-	-	-	-
1851382	0	31	exercise	NN	-	-	-	-	-	-	-	-
1851382	0	32	,	,	-	-	-	-	-	-	-	-
1851382	0	33	parity	NN	-	-	-	-	-	-	-	-
1851382	0	34	,	,	-	-	-	-	-	-	-	-
1851382	0	35	and	CC	-	-	-	-	-	-	-	-
1851382	0	36	hormone	NN	-	-	-	-	-	-	-	-
1851382	0	37	replacement	NN	-	-	-	-	-	-	-	-
1851382	0	38	therapy	NN	-	-	-	-	-	-	-	310)
1851382	0	39	,	,	-	-	-	-	-	-	-	-
1851382	0	40	may	MD	-	-	-	-	-	-	-	-
1851382	0	41	influence	VB	-	-	-	-	-	-	-	-
1851382	0	42	a	DT	-	-	-	-	-	-	-	-
1851382	0	43	woman	NN	-	-	-	-	-	-	-	(101
1851382	0	44	's	POS	-	-	-	-	-	-	-	101)
1851382	0	45	exposure	NN	-	-	-	-	-	-	-	-
1851382	0	46	to	IN	-	-	-	-	-	-	-	-
1851382	0	47	estrogen	NN	-	-	-	-	-	-	-	(7)
1851382	0	48	.	.	-	-	-	-	-	-	-	-

1851382	0	1	The	DT	-	-	-	-	-	-	-	-
1851382	0	2	compound	NN	-	-	-	-	-	-	-	-
1851382	0	3	personal	JJ	-	-	-	-	-	-	-	-
1851382	0	4	risk	NN	-	-	-	-	-	-	-	-
1851382	0	5	to	IN	-	-	-	-	-	-	-	-
1851382	0	6	a	DT	-	-	-	-	-	-	-	-
1851382	0	7	woman	NN	-	-	-	-	-	-	-	-
1851382	0	8	is	VBZ	-	-	-	-	-	-	-	-
1851382	0	9	difficult	JJ	-	-	-	-	-	-	-	-
1851382	0	10	to	TO	-	-	-	-	-	-	-	-
1851382	0	11	assess	VB	-	-	-	-	-	-	-	-
1851382	0	12	because	IN	-	-	-	-	-	-	-	-
1851382	0	13	the	DT	-	-	-	-	-	-	-	-
1851382	0	14	molecular	JJ	-	-	-	-	-	-	-	-
1851382	0	15	link	NN	-	-	-	-	-	-	-	-
1851382	0	16	between	IN	-	-	-	-	-	-	-	-
1851382	0	17	these	DT	-	-	-	-	-	-	-	(310
1851382	0	18	factors	NNS	-	-	-	-	-	-	-	310)
1851382	0	19	and	CC	-	-	-	-	-	-	-	-
1851382	0	20	the	DT	-	-	-	-	-	-	-	(34
1851382	0	21	effect	NN	-	-	-	-	-	-	-	-
1851382	0	22	of	IN	-	-	-	-	-	-	-	-
1851382	0	23	estrogen	NN	-	-	-	-	-	-	-	(7)|34)
1851382	0	24	is	VBZ	-	-	-	-	-	-	-	-
1851382	0	25	poorly	RB	-	-	-	-	-	-	-	-
1851382	0	26	understood	VBN	-	-	-	-	-	-	-	-
1851382	0	27	.	.	-	-	-	-	-	-	-	-

1851382	0	1	The	DT	-	-	-	-	-	-	-	-
1851382	0	2	result	NN	-	-	-	-	-	-	-	-
1851382	0	3	of	IN	-	-	-	-	-	-	-	-
1851382	0	4	this	DT	-	-	-	-	-	-	-	(21
1851382	0	5	study	NN	-	-	-	-	-	-	-	21)
1851382	0	6	demonstrated	VBD	-	-	-	-	-	-	-	-
1851382	0	7	that	IN	-	-	-	-	-	-	-	-
1851382	0	8	SirT1	NN	-	-	-	-	-	-	-	(311|(1)
1851382	0	9	positively	RB	-	-	-	-	-	-	-	-
1851382	0	10	modulates	VBZ	-	-	-	-	-	-	-	-
1851382	0	11	the	DT	-	-	-	-	-	-	-	(125
1851382	0	12	efficacy	NN	-	-	-	-	-	-	-	-
1851382	0	13	of	IN	-	-	-	-	-	-	-	-
1851382	0	14	the	DT	-	-	-	-	-	-	-	(2
1851382	0	15	estrogen	NN	-	-	-	-	-	-	-	(3
1851382	0	16	–	HYPH	-	-	-	-	-	-	-	-
1851382	0	17	IGF	NN	-	-	-	-	-	-	-	-
1851382	0	18	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	19	1	CD	-	-	-	-	-	-	-	3)
1851382	0	20	signal	NN	-	-	-	-	-	-	-	311)|2)|125)
1851382	0	21	.	.	-	-	-	-	-	-	-	-

1851382	0	1	This	DT	-	-	-	-	-	-	-	(311)
1851382	0	2	suggests	VBZ	-	-	-	-	-	-	-	-
1851382	0	3	that	IN	-	-	-	-	-	-	-	-
1851382	0	4	if	IN	-	-	-	-	-	-	-	-
1851382	0	5	SirT1	NN	-	-	-	-	-	-	-	(1)
1851382	0	6	serves	VBZ	-	-	-	-	-	-	-	-
1851382	0	7	as	IN	-	-	-	-	-	-	-	-
1851382	0	8	a	DT	-	-	-	-	-	-	-	-
1851382	0	9	lifetime	NN	-	-	-	-	-	-	-	-
1851382	0	10	sensor	NN	-	-	-	-	-	-	-	-
1851382	0	11	to	IN	-	-	-	-	-	-	-	-
1851382	0	12	dietary	JJ	-	-	-	-	-	-	-	-
1851382	0	13	restriction	NN	-	-	-	-	-	-	-	-
1851382	0	14	and	CC	-	-	-	-	-	-	-	-
1851382	0	15	acute	JJ	-	-	-	-	-	-	-	-
1851382	0	16	withdrawal	NN	-	-	-	-	-	-	-	-
1851382	0	17	of	IN	-	-	-	-	-	-	-	-
1851382	0	18	nutrients	NNS	-	-	-	-	-	-	-	(89)
1851382	0	19	[	-LRB-	-	-	-	-	-	-	-	-
1851382	0	20	14	CD	-	-	-	-	-	-	-	-
1851382	0	21	,	,	-	-	-	-	-	-	-	-
1851382	0	22	57	CD	-	-	-	-	-	-	-	-
1851382	0	23	]	-RRB-	-	-	-	-	-	-	-	-
1851382	0	24	,	,	-	-	-	-	-	-	-	-
1851382	0	25	its	PRP$	-	-	-	-	-	-	-	(63|(1)
1851382	0	26	activity	NN	-	-	-	-	-	-	-	63)
1851382	0	27	could	MD	-	-	-	-	-	-	-	-
1851382	0	28	ultimately	RB	-	-	-	-	-	-	-	-
1851382	0	29	influence	VB	-	-	-	-	-	-	-	-
1851382	0	30	the	DT	-	-	-	-	-	-	-	(312
1851382	0	31	risk	NN	-	-	-	-	-	-	-	-
1851382	0	32	of	IN	-	-	-	-	-	-	-	-
1851382	0	33	breast	NN	-	-	-	-	-	-	-	(11
1851382	0	34	cancer	NN	-	-	-	-	-	-	-	312)|11)
1851382	0	35	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Interestingly	RB	-	-	-	-	-	-	-	-
1851382	0	2	,	,	-	-	-	-	-	-	-	-
1851382	0	3	an	DT	-	-	-	-	-	-	-	-
1851382	0	4	epidemiological	JJ	-	-	-	-	-	-	-	-
1851382	0	5	study	NN	-	-	-	-	-	-	-	-
1851382	0	6	of	IN	-	-	-	-	-	-	-	-
1851382	0	7	Dutch	NNP	-	-	-	-	-	-	-	(313
1851382	0	8	famine	NN	-	-	-	-	-	-	-	-
1851382	0	9	in	IN	-	-	-	-	-	-	-	-
1851382	0	10	1945	CD	-	-	-	-	-	-	-	313)
1851382	0	11	indicated	VBD	-	-	-	-	-	-	-	-
1851382	0	12	that	IN	-	-	-	-	-	-	-	-
1851382	0	13	an	DT	-	-	-	-	-	-	-	-
1851382	0	14	exposure	NN	-	-	-	-	-	-	-	-
1851382	0	15	to	IN	-	-	-	-	-	-	-	-
1851382	0	16	famine	NN	-	-	-	-	-	-	-	(313)
1851382	0	17	at	IN	-	-	-	-	-	-	-	-
1851382	0	18	prepubertal	JJ	-	-	-	-	-	-	-	-
1851382	0	19	age	NN	-	-	-	-	-	-	-	-
1851382	0	20	increased	VBD	-	-	-	-	-	-	-	-
1851382	0	21	the	DT	-	-	-	-	-	-	-	(312
1851382	0	22	risk	NN	-	-	-	-	-	-	-	-
1851382	0	23	of	IN	-	-	-	-	-	-	-	-
1851382	0	24	breast	NN	-	-	-	-	-	-	-	(11
1851382	0	25	cancer	NN	-	-	-	-	-	-	-	312)|11)
1851382	0	26	,	,	-	-	-	-	-	-	-	-
1851382	0	27	most	RBS	-	-	-	-	-	-	-	-
1851382	0	28	clearly	RB	-	-	-	-	-	-	-	-
1851382	0	29	seen	VBN	-	-	-	-	-	-	-	-
1851382	0	30	in	IN	-	-	-	-	-	-	-	-
1851382	0	31	women	NNS	-	-	-	-	-	-	-	-
1851382	0	32	who	WP	-	-	-	-	-	-	-	-
1851382	0	33	never	RB	-	-	-	-	-	-	-	-
1851382	0	34	gave	VBD	-	-	-	-	-	-	-	-
1851382	0	35	birth	NN	-	-	-	-	-	-	-	-
1851382	0	36	[	-LRB-	-	-	-	-	-	-	-	-
1851382	0	37	58	CD	-	-	-	-	-	-	-	-
1851382	0	38	]	-RRB-	-	-	-	-	-	-	-	-
1851382	0	39	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Moreover	RB	-	-	-	-	-	-	-	-
1851382	0	2	,	,	-	-	-	-	-	-	-	-
1851382	0	3	the	DT	-	-	-	-	-	-	-	(252
1851382	0	4	serum	NN	-	-	-	-	-	-	-	-
1851382	0	5	levels	NNS	-	-	-	-	-	-	-	-
1851382	0	6	of	IN	-	-	-	-	-	-	-	-
1851382	0	7	estrogen	NN	-	-	-	-	-	-	-	(3|(7)|252)
1851382	0	8	and	CC	-	-	-	-	-	-	-	-
1851382	0	9	IGF	NN	-	-	-	-	-	-	-	(8
1851382	0	10	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	11	1	CD	-	-	-	-	-	-	-	8)|3)
1851382	0	12	were	VBD	-	-	-	-	-	-	-	-
1851382	0	13	increased	VBN	-	-	-	-	-	-	-	-
1851382	0	14	among	IN	-	-	-	-	-	-	-	-
1851382	0	15	those	DT	-	-	-	-	-	-	-	-
1851382	0	16	exposed	VBN	-	-	-	-	-	-	-	-
1851382	0	17	to	IN	-	-	-	-	-	-	-	-
1851382	0	18	the	DT	-	-	-	-	-	-	-	(313
1851382	0	19	famine	NN	-	-	-	-	-	-	-	313)
1851382	0	20	,	,	-	-	-	-	-	-	-	-
1851382	0	21	which	WDT	-	-	-	-	-	-	-	-
1851382	0	22	suggests	VBZ	-	-	-	-	-	-	-	-
1851382	0	23	that	IN	-	-	-	-	-	-	-	-
1851382	0	24	an	DT	-	-	-	-	-	-	-	-
1851382	0	25	epigenetic	JJ	-	-	-	-	-	-	-	-
1851382	0	26	adaptation	NN	-	-	-	-	-	-	-	-
1851382	0	27	phenomenon	NN	-	-	-	-	-	-	-	-
1851382	0	28	may	MD	-	-	-	-	-	-	-	-
1851382	0	29	take	VB	-	-	-	-	-	-	-	-
1851382	0	30	place	NN	-	-	-	-	-	-	-	-
1851382	0	31	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Assessing	VBG	-	-	-	-	-	-	-	-
1851382	0	2	the	DT	-	-	-	-	-	-	-	-
1851382	0	3	potential	JJ	-	-	-	-	-	-	-	-
1851382	0	4	correlation	NN	-	-	-	-	-	-	-	-
1851382	0	5	between	IN	-	-	-	-	-	-	-	-
1851382	0	6	the	DT	-	-	-	-	-	-	-	(63
1851382	0	7	enzymatic	JJ	-	-	-	-	-	-	-	-
1851382	0	8	activity	NN	-	-	-	-	-	-	-	-
1851382	0	9	of	IN	-	-	-	-	-	-	-	-
1851382	0	10	SirT1	NN	-	-	-	-	-	-	-	(1)|63)
1851382	0	11	and	CC	-	-	-	-	-	-	-	-
1851382	0	12	the	DT	-	-	-	-	-	-	-	(312
1851382	0	13	risk	NN	-	-	-	-	-	-	-	-
1851382	0	14	of	IN	-	-	-	-	-	-	-	-
1851382	0	15	breast	NN	-	-	-	-	-	-	-	(11
1851382	0	16	cancer	NN	-	-	-	-	-	-	-	312)|11)
1851382	0	17	is	VBZ	-	-	-	-	-	-	-	-
1851382	0	18	therefore	RB	-	-	-	-	-	-	-	-
1851382	0	19	of	IN	-	-	-	-	-	-	-	-
1851382	0	20	great	JJ	-	-	-	-	-	-	-	-
1851382	0	21	interest	NN	-	-	-	-	-	-	-	-
1851382	0	22	in	IN	-	-	-	-	-	-	-	-
1851382	0	23	order	NN	-	-	-	-	-	-	-	-
1851382	0	24	to	TO	-	-	-	-	-	-	-	-
1851382	0	25	identify	VB	-	-	-	-	-	-	-	-
1851382	0	26	feasible	JJ	-	-	-	-	-	-	-	-
1851382	0	27	targets	NNS	-	-	-	-	-	-	-	-
1851382	0	28	for	IN	-	-	-	-	-	-	-	-
1851382	0	29	chemoprevention	NN	-	-	-	-	-	-	-	(314
1851382	0	30	against	IN	-	-	-	-	-	-	-	-
1851382	0	31	breast	NN	-	-	-	-	-	-	-	(11
1851382	0	32	cancer	NN	-	-	-	-	-	-	-	314)|11)
1851382	0	33	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Several	JJ	-	-	-	-	-	-	-	(315
1851382	0	2	dietary	JJ	-	-	-	-	-	-	-	-
1851382	0	3	polyphenols	NNS	-	-	-	-	-	-	-	-
1851382	0	4	as	RB	-	-	-	-	-	-	-	-
1851382	0	5	well	RB	-	-	-	-	-	-	-	-
1851382	0	6	as	IN	-	-	-	-	-	-	-	-
1851382	0	7	small	JJ	-	-	-	-	-	-	-	-
1851382	0	8	molecules	NNS	-	-	-	-	-	-	-	315)
1851382	0	9	have	VBP	-	-	-	-	-	-	-	-
1851382	0	10	been	VBN	-	-	-	-	-	-	-	-
1851382	0	11	identified	VBN	-	-	-	-	-	-	-	-
1851382	0	12	as	IN	-	-	-	-	-	-	-	-
1851382	0	13	either	CC	-	-	-	-	-	-	-	-
1851382	0	14	agonists	NNS	-	-	-	-	-	-	-	-
1851382	0	15	or	CC	-	-	-	-	-	-	-	-
1851382	0	16	antagonists	NNS	-	-	-	-	-	-	-	(316
1851382	0	17	of	IN	-	-	-	-	-	-	-	-
1851382	0	18	SirT1	NN	-	-	-	-	-	-	-	(1)|316)
1851382	0	19	[	-LRB-	-	-	-	-	-	-	-	-
1851382	0	20	59	CD	-	-	-	-	-	-	-	-
1851382	0	21	,	,	-	-	-	-	-	-	-	-
1851382	0	22	60	CD	-	-	-	-	-	-	-	-
1851382	0	23	]	-RRB-	-	-	-	-	-	-	-	-
1851382	0	24	.	.	-	-	-	-	-	-	-	-

1851382	0	1	The	DT	-	-	-	-	-	-	-	-
1851382	0	2	pharmacological	JJ	-	-	-	-	-	-	-	-
1851382	0	3	effects	NNS	-	-	-	-	-	-	-	-
1851382	0	4	of	IN	-	-	-	-	-	-	-	-
1851382	0	5	these	DT	-	-	-	-	-	-	-	(315
1851382	0	6	compounds	NNS	-	-	-	-	-	-	-	315)
1851382	0	7	in	IN	-	-	-	-	-	-	-	-
1851382	0	8	humans	NNS	-	-	-	-	-	-	-	(77)
1851382	0	9	remain	VBP	-	-	-	-	-	-	-	-
1851382	0	10	elusive	JJ	-	-	-	-	-	-	-	-
1851382	0	11	given	VBN	-	-	-	-	-	-	-	-
1851382	0	12	that	IN	-	-	-	-	-	-	-	-
1851382	0	13	SirT1	NN	-	-	-	-	-	-	-	(1)
1851382	0	14	targets	VBZ	-	-	-	-	-	-	-	-
1851382	0	15	multiple	JJ	-	-	-	-	-	-	-	-
1851382	0	16	transcription	NN	-	-	-	-	-	-	-	-
1851382	0	17	factors	NNS	-	-	-	-	-	-	-	-
1851382	0	18	and	CC	-	-	-	-	-	-	-	-
1851382	0	19	exerts	VBZ	-	-	-	-	-	-	-	-
1851382	0	20	pleiotropic	JJ	-	-	-	-	-	-	-	-
1851382	0	21	effects	NNS	-	-	-	-	-	-	-	-
1851382	0	22	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Nonetheless	RB	-	-	-	-	-	-	-	-
1851382	0	2	,	,	-	-	-	-	-	-	-	-
1851382	0	3	our	PRP$	-	-	-	-	-	-	-	(21|(95)
1851382	0	4	study	NN	-	-	-	-	-	-	-	-
1851382	0	5	of	IN	-	-	-	-	-	-	-	-
1851382	0	6	SirT1ko	NN	-	-	-	-	-	-	-	(22|(24
1851382	0	7	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	8	ko	NN	-	-	-	-	-	-	-	24)
1851382	0	9	mice	NNS	-	-	-	-	-	-	-	22)|21)
1851382	0	10	demonstrated	VBD	-	-	-	-	-	-	-	-
1851382	0	11	the	DT	-	-	-	-	-	-	-	-
1851382	0	12	potential	JJ	-	-	-	-	-	-	-	-
1851382	0	13	utility	NN	-	-	-	-	-	-	-	-
1851382	0	14	of	IN	-	-	-	-	-	-	-	-
1851382	0	15	SirT1	NN	-	-	-	-	-	-	-	(316|(1)
1851382	0	16	antagonists	NNS	-	-	-	-	-	-	-	316)
1851382	0	17	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Specifically	RB	-	-	-	-	-	-	-	-
1851382	0	2	,	,	-	-	-	-	-	-	-	-
1851382	0	3	reducing	VBG	-	-	-	-	-	-	-	-
1851382	0	4	SirT1	NN	-	-	-	-	-	-	-	(63|(1)
1851382	0	5	activity	NN	-	-	-	-	-	-	-	63)
1851382	0	6	alters	VBZ	-	-	-	-	-	-	-	-
1851382	0	7	the	DT	-	-	-	-	-	-	-	-
1851382	0	8	homeostasis	NN	-	-	-	-	-	-	-	-
1851382	0	9	of	IN	-	-	-	-	-	-	-	-
1851382	0	10	cellular	JJ	-	-	-	-	-	-	-	-
1851382	0	11	responses	NNS	-	-	-	-	-	-	-	-
1851382	0	12	,	,	-	-	-	-	-	-	-	-
1851382	0	13	including	VBG	-	-	-	-	-	-	-	-
1851382	0	14	deregulation	NN	-	-	-	-	-	-	-	(248|(250a
1851382	0	15	of	IN	-	-	-	-	-	-	-	-
1851382	0	16	the	DT	-	-	-	-	-	-	-	(48|(51a
1851382	0	17	expression	NN	-	-	-	-	-	-	-	-
1851382	0	18	of	IN	-	-	-	-	-	-	-	51a)|250a)
1851382	0	19	IGFBP	NN	-	-	-	-	-	-	-	(239|(47
1851382	0	20	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	21	1	CD	-	-	-	-	-	-	-	48)|47)|248)
1851382	0	22	and	CC	-	-	-	-	-	-	-	-
1851382	0	23	IκBα	NN	-	-	-	-	-	-	-	(250a)|(50)|(51a)|239)
1851382	0	24	,	,	-	-	-	-	-	-	-	-
1851382	0	25	which	WDT	-	-	-	-	-	-	-	-
1851382	0	26	can	MD	-	-	-	-	-	-	-	-
1851382	0	27	attenuate	VB	-	-	-	-	-	-	-	-
1851382	0	28	the	DT	-	-	-	-	-	-	-	-
1851382	0	29	stimulation	NN	-	-	-	-	-	-	-	-
1851382	0	30	from	IN	-	-	-	-	-	-	-	-
1851382	0	31	the	DT	-	-	-	-	-	-	-	(2
1851382	0	32	estrogen	NN	-	-	-	-	-	-	-	(3
1851382	0	33	–	HYPH	-	-	-	-	-	-	-	-
1851382	0	34	IGF	NN	-	-	-	-	-	-	-	-
1851382	0	35	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	36	1	CD	-	-	-	-	-	-	-	3)
1851382	0	37	signaling	NN	-	-	-	-	-	-	-	2)
1851382	0	38	and	CC	-	-	-	-	-	-	-	-
1851382	0	39	potentially	RB	-	-	-	-	-	-	-	-
1851382	0	40	desensitize	VBP	-	-	-	-	-	-	-	-
1851382	0	41	mammary	JJ	-	-	-	-	-	-	-	(64
1851382	0	42	epithelial	JJ	-	-	-	-	-	-	-	-
1851382	0	43	cells	NNS	-	-	-	-	-	-	-	64)
1851382	0	44	to	IN	-	-	-	-	-	-	-	-
1851382	0	45	NF	NN	-	-	-	-	-	-	-	(16|(233
1851382	0	46	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	47	κB	NN	-	-	-	-	-	-	-	16)
1851382	0	48	activation	NN	-	-	-	-	-	-	-	233)
1851382	0	49	.	.	-	-	-	-	-	-	-	-

1851382	0	1	SirT1	NN	-	-	-	-	-	-	-	(1)
1851382	0	2	is	VBZ	-	-	-	-	-	-	-	-
1851382	0	3	therefore	RB	-	-	-	-	-	-	-	-
1851382	0	4	a	DT	-	-	-	-	-	-	-	-
1851382	0	5	candidate	NN	-	-	-	-	-	-	-	-
1851382	0	6	target	NN	-	-	-	-	-	-	-	-
1851382	0	7	for	IN	-	-	-	-	-	-	-	-
1851382	0	8	chemoprevention	NN	-	-	-	-	-	-	-	(314
1851382	0	9	against	IN	-	-	-	-	-	-	-	-
1851382	0	10	breast	NN	-	-	-	-	-	-	-	(11
1851382	0	11	cancer	NN	-	-	-	-	-	-	-	314)|11)
1851382	0	12	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Conclusion	NN	-	-	-	-	-	-	-	(59)

1851382	0	1	The	DT	-	-	-	-	-	-	-	-
1851382	0	2	study	NN	-	-	-	-	-	-	-	-
1851382	0	3	of	IN	-	-	-	-	-	-	-	-
1851382	0	4	mammary	JJ	-	-	-	-	-	-	-	(10|(9
1851382	0	5	gland	NN	-	-	-	-	-	-	-	9)
1851382	0	6	development	NN	-	-	-	-	-	-	-	10)
1851382	0	7	is	VBZ	-	-	-	-	-	-	-	-
1851382	0	8	an	DT	-	-	-	-	-	-	-	-
1851382	0	9	excellent	JJ	-	-	-	-	-	-	-	-
1851382	0	10	model	NN	-	-	-	-	-	-	-	-
1851382	0	11	system	NN	-	-	-	-	-	-	-	-
1851382	0	12	for	IN	-	-	-	-	-	-	-	-
1851382	0	13	unraveling	VBG	-	-	-	-	-	-	-	-
1851382	0	14	how	WRB	-	-	-	-	-	-	-	-
1851382	0	15	SirT1	NN	-	-	-	-	-	-	-	(1)
1851382	0	16	modulates	VBZ	-	-	-	-	-	-	-	-
1851382	0	17	the	DT	-	-	-	-	-	-	-	(125
1851382	0	18	efficacy	NN	-	-	-	-	-	-	-	-
1851382	0	19	of	IN	-	-	-	-	-	-	-	-
1851382	0	20	the	DT	-	-	-	-	-	-	-	(2
1851382	0	21	estrogen	NN	-	-	-	-	-	-	-	(3
1851382	0	22	–	HYPH	-	-	-	-	-	-	-	-
1851382	0	23	IGF	NN	-	-	-	-	-	-	-	-
1851382	0	24	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	25	1	CD	-	-	-	-	-	-	-	3)
1851382	0	26	signaling	NN	-	-	-	-	-	-	-	2)|125)
1851382	0	27	and	CC	-	-	-	-	-	-	-	-
1851382	0	28	regulates	VBZ	-	-	-	-	-	-	-	-
1851382	0	29	the	DT	-	-	-	-	-	-	-	-
1851382	0	30	timing	NN	-	-	-	-	-	-	-	-
1851382	0	31	of	IN	-	-	-	-	-	-	-	-
1851382	0	32	ductal	JJ	-	-	-	-	-	-	-	(62
1851382	0	33	morphogenesis	NN	-	-	-	-	-	-	-	62)
1851382	0	34	.	.	-	-	-	-	-	-	-	-

1851382	0	1	These	DT	-	-	-	-	-	-	-	-
1851382	0	2	new	JJ	-	-	-	-	-	-	-	-
1851382	0	3	mechanistic	JJ	-	-	-	-	-	-	-	-
1851382	0	4	insights	NNS	-	-	-	-	-	-	-	-
1851382	0	5	may	MD	-	-	-	-	-	-	-	-
1851382	0	6	also	RB	-	-	-	-	-	-	-	-
1851382	0	7	aid	VB	-	-	-	-	-	-	-	-
1851382	0	8	in	IN	-	-	-	-	-	-	-	-
1851382	0	9	understanding	VBG	-	-	-	-	-	-	-	-
1851382	0	10	the	DT	-	-	-	-	-	-	-	-
1851382	0	11	role	NN	-	-	-	-	-	-	-	-
1851382	0	12	of	IN	-	-	-	-	-	-	-	-
1851382	0	13	SirT1	NN	-	-	-	-	-	-	-	(1)
1851382	0	14	in	IN	-	-	-	-	-	-	-	-
1851382	0	15	breast	NN	-	-	-	-	-	-	-	(11
1851382	0	16	cancer	NN	-	-	-	-	-	-	-	11)
1851382	0	17	as	RB	-	-	-	-	-	-	-	-
1851382	0	18	well	RB	-	-	-	-	-	-	-	-
1851382	0	19	as	IN	-	-	-	-	-	-	-	-
1851382	0	20	in	IN	-	-	-	-	-	-	-	-
1851382	0	21	other	JJ	-	-	-	-	-	-	-	-
1851382	0	22	organs	NNS	-	-	-	-	-	-	-	-
1851382	0	23	in	IN	-	-	-	-	-	-	-	-
1851382	0	24	which	WDT	-	-	-	-	-	-	-	-
1851382	0	25	local	JJ	-	-	-	-	-	-	-	(54
1851382	0	26	IGF	NN	-	-	-	-	-	-	-	-
1851382	0	27	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	28	1	CD	-	-	-	-	-	-	-	54)
1851382	0	29	plays	VBZ	-	-	-	-	-	-	-	-
1851382	0	30	an	DT	-	-	-	-	-	-	-	-
1851382	0	31	important	JJ	-	-	-	-	-	-	-	-
1851382	0	32	role	NN	-	-	-	-	-	-	-	-
1851382	0	33	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Abbreviations	NNS	-	-	-	-	-	-	-	-

1851382	0	1	Atm	NN	-	-	-	-	-	-	-	-
1851382	0	2	=	SYM	-	-	-	-	-	-	-	-
1851382	0	3	ataxia	NN	-	-	-	-	-	-	-	-
1851382	0	4	telangiectasia	NN	-	-	-	-	-	-	-	-
1851382	0	5	;	:	-	-	-	-	-	-	-	-
1851382	0	6	BrdU	NN	-	-	-	-	-	-	-	(154)
1851382	0	7	=	SYM	-	-	-	-	-	-	-	-
1851382	0	8	bromodeoxyurdine	NN	-	-	-	-	-	-	-	-
1851382	0	9	;	:	-	-	-	-	-	-	-	-
1851382	0	10	CMV	NN	-	-	-	-	-	-	-	-
1851382	0	11	=	SYM	-	-	-	-	-	-	-	-
1851382	0	12	cytomegalovirus	NN	-	-	-	-	-	-	-	-
1851382	0	13	;	:	-	-	-	-	-	-	-	-
1851382	0	14	ERα	NN	-	-	-	-	-	-	-	(121)
1851382	0	15	=	SYM	-	-	-	-	-	-	-	-
1851382	0	16	estrogen	NN	-	-	-	-	-	-	-	(7)
1851382	0	17	receptor	NN	-	-	-	-	-	-	-	-
1851382	0	18	alpha	NN	-	-	-	-	-	-	-	-
1851382	0	19	;	:	-	-	-	-	-	-	-	-
1851382	0	20	FoxO	NN	-	-	-	-	-	-	-	(80)
1851382	0	21	=	SYM	-	-	-	-	-	-	-	-
1851382	0	22	forkhead	NN	-	-	-	-	-	-	-	-
1851382	0	23	box	NN	-	-	-	-	-	-	-	-
1851382	0	24	'	``	-	-	-	-	-	-	-	-
1851382	0	25	other	JJ	-	-	-	-	-	-	-	-
1851382	0	26	'	''	-	-	-	-	-	-	-	-
1851382	0	27	protein	NN	-	-	-	-	-	-	-	-
1851382	0	28	;	:	-	-	-	-	-	-	-	-
1851382	0	29	GH	NN	-	-	-	-	-	-	-	(112)
1851382	0	30	=	SYM	-	-	-	-	-	-	-	-
1851382	0	31	growth	NN	-	-	-	-	-	-	-	-
1851382	0	32	hormone	NN	-	-	-	-	-	-	-	-
1851382	0	33	;	:	-	-	-	-	-	-	-	-
1851382	0	34	IGF	NN	-	-	-	-	-	-	-	(8
1851382	0	35	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	36	1	CD	-	-	-	-	-	-	-	8)
1851382	0	37	=	SYM	-	-	-	-	-	-	-	-
1851382	0	38	insulin	NN	-	-	-	-	-	-	-	-
1851382	0	39	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	40	like	JJ	-	-	-	-	-	-	-	-
1851382	0	41	growth	NN	-	-	-	-	-	-	-	-
1851382	0	42	factor	NN	-	-	-	-	-	-	-	-
1851382	0	43	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	44	1	CD	-	-	-	-	-	-	-	-
1851382	0	45	;	:	-	-	-	-	-	-	-	-
1851382	0	46	IGFBP	NN	-	-	-	-	-	-	-	(47
1851382	0	47	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	48	1	CD	-	-	-	-	-	-	-	47)
1851382	0	49	=	SYM	-	-	-	-	-	-	-	-
1851382	0	50	insulin	NN	-	-	-	-	-	-	-	(8
1851382	0	51	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	52	like	JJ	-	-	-	-	-	-	-	-
1851382	0	53	growth	NN	-	-	-	-	-	-	-	-
1851382	0	54	factor	NN	-	-	-	-	-	-	-	-
1851382	0	55	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	56	1	CD	-	-	-	-	-	-	-	8)
1851382	0	57	binding	NN	-	-	-	-	-	-	-	-
1851382	0	58	protein	NN	-	-	-	-	-	-	-	-
1851382	0	59	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	60	1	CD	-	-	-	-	-	-	-	-
1851382	0	61	;	:	-	-	-	-	-	-	-	-
1851382	0	62	H	NN	-	-	-	-	-	-	-	-
1851382	0	63	&	CC	-	-	-	-	-	-	-	-
1851382	0	64	E	NN	-	-	-	-	-	-	-	-
1851382	0	65	=	SYM	-	-	-	-	-	-	-	-
1851382	0	66	hemotoxylin	NN	-	-	-	-	-	-	-	-
1851382	0	67	and	CC	-	-	-	-	-	-	-	-
1851382	0	68	eosin	NN	-	-	-	-	-	-	-	-
1851382	0	69	;	:	-	-	-	-	-	-	-	-
1851382	0	70	IIS	NN	-	-	-	-	-	-	-	(73)
1851382	0	71	=	SYM	-	-	-	-	-	-	-	-
1851382	0	72	insulin	NN	-	-	-	-	-	-	-	(12)
1851382	0	73	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	74	insulin	NN	-	-	-	-	-	-	-	(8
1851382	0	75	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	76	like	JJ	-	-	-	-	-	-	-	-
1851382	0	77	growth	NN	-	-	-	-	-	-	-	-
1851382	0	78	factor	NN	-	-	-	-	-	-	-	-
1851382	0	79	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	80	1	CD	-	-	-	-	-	-	-	8)
1851382	0	81	signaling	NN	-	-	-	-	-	-	-	-
1851382	0	82	;	:	-	-	-	-	-	-	-	-
1851382	0	83	IκBα	NN	-	-	-	-	-	-	-	(50)
1851382	0	84	=	SYM	-	-	-	-	-	-	-	-
1851382	0	85	inhibitors	NNS	-	-	-	-	-	-	-	-
1851382	0	86	of	IN	-	-	-	-	-	-	-	-
1851382	0	87	NF	NN	-	-	-	-	-	-	-	(16|(231
1851382	0	88	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	89	κB	NN	-	-	-	-	-	-	-	16)
1851382	0	90	alpha	NN	-	-	-	-	-	-	-	-
1851382	0	91	subunit	NN	-	-	-	-	-	-	-	231)
1851382	0	92	;	:	-	-	-	-	-	-	-	-
1851382	0	93	IKKα	NN	-	-	-	-	-	-	-	(231)
1851382	0	94	=	SYM	-	-	-	-	-	-	-	-
1851382	0	95	IκB	NN	-	-	-	-	-	-	-	(262
1851382	0	96	kinase	NN	-	-	-	-	-	-	-	262)
1851382	0	97	alpha	NN	-	-	-	-	-	-	-	-
1851382	0	98	;	:	-	-	-	-	-	-	-	-
1851382	0	99	MEF	NN	-	-	-	-	-	-	-	(138)
1851382	0	100	=	SYM	-	-	-	-	-	-	-	-
1851382	0	101	murine	JJ	-	-	-	-	-	-	-	-
1851382	0	102	embryonic	JJ	-	-	-	-	-	-	-	-
1851382	0	103	fibroblast	NN	-	-	-	-	-	-	-	-
1851382	0	104	;	:	-	-	-	-	-	-	-	-
1851382	0	105	NF	NN	-	-	-	-	-	-	-	-
1851382	0	106	=	SYM	-	-	-	-	-	-	-	-
1851382	0	107	nuclear	JJ	-	-	-	-	-	-	-	-
1851382	0	108	factor	NN	-	-	-	-	-	-	-	-
1851382	0	109	;	:	-	-	-	-	-	-	-	-
1851382	0	110	PCR	NN	-	-	-	-	-	-	-	-
1851382	0	111	=	SYM	-	-	-	-	-	-	-	-
1851382	0	112	polymerase	NN	-	-	-	-	-	-	-	-
1851382	0	113	chain	NN	-	-	-	-	-	-	-	-
1851382	0	114	reaction	NN	-	-	-	-	-	-	-	-
1851382	0	115	;	:	-	-	-	-	-	-	-	-
1851382	0	116	RANK	NN	-	-	-	-	-	-	-	(266)
1851382	0	117	=	SYM	-	-	-	-	-	-	-	-
1851382	0	118	receptor	NN	-	-	-	-	-	-	-	-
1851382	0	119	activator	NN	-	-	-	-	-	-	-	-
1851382	0	120	of	IN	-	-	-	-	-	-	-	-
1851382	0	121	NF	NN	-	-	-	-	-	-	-	(16
1851382	0	122	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	123	κB	NN	-	-	-	-	-	-	-	16)
1851382	0	124	;	:	-	-	-	-	-	-	-	-
1851382	0	125	Sir	NN	-	-	-	-	-	-	-	-
1851382	0	126	=	SYM	-	-	-	-	-	-	-	-
1851382	0	127	silencing	NN	-	-	-	-	-	-	-	-
1851382	0	128	information	NN	-	-	-	-	-	-	-	-
1851382	0	129	regulator	NN	-	-	-	-	-	-	-	-
1851382	0	130	;	:	-	-	-	-	-	-	-	-
1851382	0	131	TEB	NN	-	-	-	-	-	-	-	(194)
1851382	0	132	=	SYM	-	-	-	-	-	-	-	-
1851382	0	133	terminal	JJ	-	-	-	-	-	-	-	-
1851382	0	134	end	NN	-	-	-	-	-	-	-	-
1851382	0	135	bud	NN	-	-	-	-	-	-	-	-
1851382	0	136	;	:	-	-	-	-	-	-	-	-
1851382	0	137	TNF	NN	-	-	-	-	-	-	-	-
1851382	0	138	=	SYM	-	-	-	-	-	-	-	-
1851382	0	139	tumor	NN	-	-	-	-	-	-	-	-
1851382	0	140	necrosis	NN	-	-	-	-	-	-	-	-
1851382	0	141	factor	NN	-	-	-	-	-	-	-	-
1851382	0	142	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Competing	VBG	-	-	-	-	-	-	-	-
1851382	0	2	interests	NNS	-	-	-	-	-	-	-	-

1851382	0	1	The	DT	-	-	-	-	-	-	-	(317
1851382	0	2	authors	NNS	-	-	-	-	-	-	-	317)
1851382	0	3	declare	VBP	-	-	-	-	-	-	-	-
1851382	0	4	that	IN	-	-	-	-	-	-	-	-
1851382	0	5	they	PRP	-	-	-	-	-	-	-	(317)
1851382	0	6	have	VBP	-	-	-	-	-	-	-	-
1851382	0	7	no	DT	-	-	-	-	-	-	-	-
1851382	0	8	competing	VBG	-	-	-	-	-	-	-	-
1851382	0	9	interests	NNS	-	-	-	-	-	-	-	-
1851382	0	10	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Authors	NNS	-	-	-	-	-	-	-	(317
1851382	0	2	'	POS	-	-	-	-	-	-	-	317)
1851382	0	3	contributions	NNS	-	-	-	-	-	-	-	-

1851382	0	1	HL	NNP	-	-	-	-	-	-	-	-
1851382	0	2	characterized	VBD	-	-	-	-	-	-	-	-
1851382	0	3	the	DT	-	-	-	-	-	-	-	(318
1851382	0	4	phenotypes	NNS	-	-	-	-	-	-	-	-
1851382	0	5	of	IN	-	-	-	-	-	-	-	-
1851382	0	6	the	DT	-	-	-	-	-	-	-	(319
1851382	0	7	SirT1	NN	-	-	-	-	-	-	-	(1)
1851382	0	8	mutant	NN	-	-	-	-	-	-	-	-
1851382	0	9	mice	NNS	-	-	-	-	-	-	-	319)|318)
1851382	0	10	,	,	-	-	-	-	-	-	-	-
1851382	0	11	participated	VBD	-	-	-	-	-	-	-	-
1851382	0	12	in	IN	-	-	-	-	-	-	-	-
1851382	0	13	the	DT	-	-	-	-	-	-	-	(320
1851382	0	14	design	NN	-	-	-	-	-	-	-	-
1851382	0	15	of	IN	-	-	-	-	-	-	-	-
1851382	0	16	the	DT	-	-	-	-	-	-	-	(21
1851382	0	17	study	NN	-	-	-	-	-	-	-	320)|21)
1851382	0	18	,	,	-	-	-	-	-	-	-	-
1851382	0	19	and	CC	-	-	-	-	-	-	-	-
1851382	0	20	helped	VBD	-	-	-	-	-	-	-	-
1851382	0	21	to	TO	-	-	-	-	-	-	-	-
1851382	0	22	draft	VB	-	-	-	-	-	-	-	-
1851382	0	23	the	DT	-	-	-	-	-	-	-	(321
1851382	0	24	manuscript	NN	-	-	-	-	-	-	-	321)
1851382	0	25	.	.	-	-	-	-	-	-	-	-

1851382	0	1	GKR	NNP	-	-	-	-	-	-	-	-
1851382	0	2	and	CC	-	-	-	-	-	-	-	-
1851382	0	3	NL	NNP	-	-	-	-	-	-	-	-
1851382	0	4	helped	VBD	-	-	-	-	-	-	-	-
1851382	0	5	to	TO	-	-	-	-	-	-	-	-
1851382	0	6	characterize	VB	-	-	-	-	-	-	-	-
1851382	0	7	the	DT	-	-	-	-	-	-	-	(318
1851382	0	8	phenotypes	NNS	-	-	-	-	-	-	-	318)
1851382	0	9	.	.	-	-	-	-	-	-	-	-

1851382	0	1	CW	NNP	-	-	-	-	-	-	-	-
1851382	0	2	generated	VBD	-	-	-	-	-	-	-	-
1851382	0	3	the	DT	-	-	-	-	-	-	-	(142|(319a
1851382	0	4	SirT1	NN	-	-	-	-	-	-	-	(1)
1851382	0	5	mutant	NN	-	-	-	-	-	-	-	319a)
1851382	0	6	embryonic	JJ	-	-	-	-	-	-	-	-
1851382	0	7	stem	NN	-	-	-	-	-	-	-	-
1851382	0	8	cells	NNS	-	-	-	-	-	-	-	142)
1851382	0	9	and	CC	-	-	-	-	-	-	-	-
1851382	0	10	mice	NNS	-	-	-	-	-	-	-	(319a)
1851382	0	11	.	.	-	-	-	-	-	-	-	-

1851382	0	1	BPR	NNP	-	-	-	-	-	-	-	-
1851382	0	2	helped	VBD	-	-	-	-	-	-	-	-
1851382	0	3	analyze	VB	-	-	-	-	-	-	-	-
1851382	0	4	the	DT	-	-	-	-	-	-	-	-
1851382	0	5	histology	NN	-	-	-	-	-	-	-	-
1851382	0	6	data	NNS	-	-	-	-	-	-	-	-
1851382	0	7	.	.	-	-	-	-	-	-	-	-

1851382	0	1	YG	NNP	-	-	-	-	-	-	-	(322)
1851382	0	2	conceived	VBD	-	-	-	-	-	-	-	-
1851382	0	3	of	IN	-	-	-	-	-	-	-	-
1851382	0	4	the	DT	-	-	-	-	-	-	-	(21
1851382	0	5	study	NN	-	-	-	-	-	-	-	21)
1851382	0	6	,	,	-	-	-	-	-	-	-	-
1851382	0	7	participated	VBD	-	-	-	-	-	-	-	-
1851382	0	8	in	IN	-	-	-	-	-	-	-	-
1851382	0	9	its	PRP$	-	-	-	-	-	-	-	(320|(21)
1851382	0	10	design	NN	-	-	-	-	-	-	-	320)
1851382	0	11	and	CC	-	-	-	-	-	-	-	-
1851382	0	12	coordination	NN	-	-	-	-	-	-	-	-
1851382	0	13	,	,	-	-	-	-	-	-	-	-
1851382	0	14	and	CC	-	-	-	-	-	-	-	-
1851382	0	15	drafted	VBD	-	-	-	-	-	-	-	-
1851382	0	16	the	DT	-	-	-	-	-	-	-	(321
1851382	0	17	manuscript	NN	-	-	-	-	-	-	-	321)
1851382	0	18	.	.	-	-	-	-	-	-	-	-

1851382	0	1	All	DT	-	-	-	-	-	-	-	-
1851382	0	2	authors	NNS	-	-	-	-	-	-	-	-
1851382	0	3	read	VBD	-	-	-	-	-	-	-	-
1851382	0	4	and	CC	-	-	-	-	-	-	-	-
1851382	0	5	approved	VBD	-	-	-	-	-	-	-	-
1851382	0	6	the	DT	-	-	-	-	-	-	-	-
1851382	0	7	final	JJ	-	-	-	-	-	-	-	-
1851382	0	8	manuscript	NN	-	-	-	-	-	-	-	-
1851382	0	9	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Supplementary	JJ	-	-	-	-	-	-	-	-
1851382	0	2	Material	NN	-	-	-	-	-	-	-	-

1851382	0	1	Additional	JJ	-	-	-	-	-	-	-	(129
1851382	0	2	file	NN	-	-	-	-	-	-	-	-
1851382	0	3	1	CD	-	-	-	-	-	-	-	129)

1851382	0	1	A	DT	-	-	-	-	-	-	-	-
1851382	0	2	pdf	NN	-	-	-	-	-	-	-	-
1851382	0	3	file	NN	-	-	-	-	-	-	-	-
1851382	0	4	containing	VBG	-	-	-	-	-	-	-	-
1851382	0	5	the	DT	-	-	-	-	-	-	-	-
1851382	0	6	materials	NNS	-	-	-	-	-	-	-	-
1851382	0	7	and	CC	-	-	-	-	-	-	-	-
1851382	0	8	methods	NNS	-	-	-	-	-	-	-	-
1851382	0	9	for	IN	-	-	-	-	-	-	-	-
1851382	0	10	the	DT	-	-	-	-	-	-	-	(323
1851382	0	11	generation	NN	-	-	-	-	-	-	-	-
1851382	0	12	of	IN	-	-	-	-	-	-	-	-
1851382	0	13	SirT1ko	NN	-	-	-	-	-	-	-	(22|(24
1851382	0	14	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	15	ko	NN	-	-	-	-	-	-	-	24)
1851382	0	16	mice	NNS	-	-	-	-	-	-	-	323)|22)
1851382	0	17	.	.	-	-	-	-	-	-	-	-

1851382	0	1	This	DT	-	-	-	-	-	-	-	(129
1851382	0	2	supporting	VBG	-	-	-	-	-	-	-	-
1851382	0	3	file	NN	-	-	-	-	-	-	-	129)
1851382	0	4	documented	VBD	-	-	-	-	-	-	-	-
1851382	0	5	the	DT	-	-	-	-	-	-	-	-
1851382	0	6	details	NNS	-	-	-	-	-	-	-	-
1851382	0	7	of	IN	-	-	-	-	-	-	-	-
1851382	0	8	materials	NNS	-	-	-	-	-	-	-	(127|(126a)
1851382	0	9	and	CC	-	-	-	-	-	-	-	-
1851382	0	10	methods	NNS	-	-	-	-	-	-	-	(23
1851382	0	11	used	VBN	-	-	-	-	-	-	-	(126a
1851382	0	12	to	TO	-	-	-	-	-	-	-	-
1851382	0	13	generate	VB	-	-	-	-	-	-	-	-
1851382	0	14	both	CC	-	-	-	-	-	-	-	(135
1851382	0	15	SirT1co	NN	-	-	-	-	-	-	-	(25|(26
1851382	0	16	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	17	co	NN	-	-	-	-	-	-	-	26)
1851382	0	18	mice	NNS	-	-	-	-	-	-	-	25)
1851382	0	19	and	CC	-	-	-	-	-	-	-	-
1851382	0	20	SirT1ko	NN	-	-	-	-	-	-	-	(22|(24
1851382	0	21	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	22	ko	NN	-	-	-	-	-	-	-	24)
1851382	0	23	mice	NNS	-	-	-	-	-	-	-	23)|22)|135)|127)|126a)
1851382	0	24	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Click	VB	-	-	-	-	-	-	-	-
1851382	0	2	here	RB	-	-	-	-	-	-	-	-
1851382	0	3	for	IN	-	-	-	-	-	-	-	-
1851382	0	4	file	NN	-	-	-	-	-	-	-	(129)

1851382	0	1	Acknowledgements	NNS	-	-	-	-	-	-	-	-

1851382	0	1	The	DT	-	-	-	-	-	-	-	(21
1851382	0	2	study	NN	-	-	-	-	-	-	-	21)
1851382	0	3	is	VBZ	-	-	-	-	-	-	-	-
1851382	0	4	supported	VBN	-	-	-	-	-	-	-	-
1851382	0	5	by	IN	-	-	-	-	-	-	-	-
1851382	0	6	grants	NNS	-	-	-	-	-	-	-	-
1851382	0	7	from	IN	-	-	-	-	-	-	-	-
1851382	0	8	the	DT	-	-	-	-	-	-	-	-
1851382	0	9	American	NNP	-	-	-	-	-	-	-	-
1851382	0	10	Cancer	NNP	-	-	-	-	-	-	-	-
1851382	0	11	Society	NNP	-	-	-	-	-	-	-	-
1851382	0	12	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	13	RSG	NN	-	-	-	-	-	-	-	-
1851382	0	14	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	15	04	CD	-	-	-	-	-	-	-	-
1851382	0	16	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	17	019	CD	-	-	-	-	-	-	-	-
1851382	0	18	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	19	01	CD	-	-	-	-	-	-	-	-
1851382	0	20	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	21	CNE	NN	-	-	-	-	-	-	-	-
1851382	0	22	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	23	and	CC	-	-	-	-	-	-	-	-
1851382	0	24	the	DT	-	-	-	-	-	-	-	-
1851382	0	25	Nathan	NNP	-	-	-	-	-	-	-	-
1851382	0	26	Shock	NNP	-	-	-	-	-	-	-	-
1851382	0	27	Center	NNP	-	-	-	-	-	-	-	-
1851382	0	28	of	IN	-	-	-	-	-	-	-	-
1851382	0	29	Excellence	NNP	-	-	-	-	-	-	-	-
1851382	0	30	in	IN	-	-	-	-	-	-	-	-
1851382	0	31	the	DT	-	-	-	-	-	-	-	-
1851382	0	32	Biology	NNP	-	-	-	-	-	-	-	-
1851382	0	33	of	IN	-	-	-	-	-	-	-	-
1851382	0	34	Aging	NNP	-	-	-	-	-	-	-	-
1851382	0	35	at	IN	-	-	-	-	-	-	-	-
1851382	0	36	the	DT	-	-	-	-	-	-	-	(136
1851382	0	37	University	NNP	-	-	-	-	-	-	-	-
1851382	0	38	of	IN	-	-	-	-	-	-	-	-
1851382	0	39	Washington	NNP	-	-	-	-	-	-	-	136)
1851382	0	40	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	41	to	IN	-	-	-	-	-	-	-	-
1851382	0	42	YG	NNP	-	-	-	-	-	-	-	(322)
1851382	0	43	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	44	.	.	-	-	-	-	-	-	-	-

1851382	0	1	The	DT	-	-	-	-	-	-	-	(317
1851382	0	2	authors	NNS	-	-	-	-	-	-	-	317)
1851382	0	3	thank	VBP	-	-	-	-	-	-	-	-
1851382	0	4	Jennifer	NNP	-	-	-	-	-	-	-	(324
1851382	0	5	Blasi	NNP	-	-	-	-	-	-	-	-
1851382	0	6	,	,	-	-	-	-	-	-	-	-
1851382	0	7	Thomas	NNP	-	-	-	-	-	-	-	-
1851382	0	8	Gernon	NNP	-	-	-	-	-	-	-	-
1851382	0	9	,	,	-	-	-	-	-	-	-	-
1851382	0	10	Janet	NNP	-	-	-	-	-	-	-	-
1851382	0	11	Leath	NNP	-	-	-	-	-	-	-	-
1851382	0	12	,	,	-	-	-	-	-	-	-	-
1851382	0	13	Jennifer	NNP	-	-	-	-	-	-	-	-
1851382	0	14	Lee	NNP	-	-	-	-	-	-	-	-
1851382	0	15	,	,	-	-	-	-	-	-	-	-
1851382	0	16	Bryce	NNP	-	-	-	-	-	-	-	-
1851382	0	17	Sopher	NNP	-	-	-	-	-	-	-	-
1851382	0	18	,	,	-	-	-	-	-	-	-	-
1851382	0	19	Loraine	NNP	-	-	-	-	-	-	-	-
1851382	0	20	Warner	NNP	-	-	-	-	-	-	-	-
1851382	0	21	,	,	-	-	-	-	-	-	-	-
1851382	0	22	and	CC	-	-	-	-	-	-	-	-
1851382	0	23	Heather	NNP	-	-	-	-	-	-	-	-
1851382	0	24	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	25	Marie	NNP	-	-	-	-	-	-	-	-
1851382	0	26	Wilson	NNP	-	-	-	-	-	-	-	324)
1851382	0	27	for	IN	-	-	-	-	-	-	-	-
1851382	0	28	their	PRP$	-	-	-	-	-	-	-	(324)
1851382	0	29	contributions	NNS	-	-	-	-	-	-	-	-
1851382	0	30	in	IN	-	-	-	-	-	-	-	-
1851382	0	31	the	DT	-	-	-	-	-	-	-	-
1851382	0	32	early	JJ	-	-	-	-	-	-	-	-
1851382	0	33	phases	NNS	-	-	-	-	-	-	-	-
1851382	0	34	of	IN	-	-	-	-	-	-	-	-
1851382	0	35	the	DT	-	-	-	-	-	-	-	(21
1851382	0	36	study	NN	-	-	-	-	-	-	-	21)
1851382	0	37	,	,	-	-	-	-	-	-	-	-
1851382	0	38	and	CC	-	-	-	-	-	-	-	-
1851382	0	39	Dr	NNP	-	-	-	-	-	-	-	(325
1851382	0	40	Fred	NNP	-	-	-	-	-	-	-	-
1851382	0	41	Alt	NNP	-	-	-	-	-	-	-	-
1851382	0	42	,	,	-	-	-	-	-	-	-	-
1851382	0	43	Dr	NNP	-	-	-	-	-	-	-	-
1851382	0	44	Mary	NNP	-	-	-	-	-	-	-	-
1851382	0	45	Helen	NNP	-	-	-	-	-	-	-	-
1851382	0	46	Barcellos	NNP	-	-	-	-	-	-	-	-
1851382	0	47	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	48	Hoff	NNP	-	-	-	-	-	-	-	-
1851382	0	49	,	,	-	-	-	-	-	-	-	-
1851382	0	50	Dr	NNP	-	-	-	-	-	-	-	-
1851382	0	51	Mark	NNP	-	-	-	-	-	-	-	-
1851382	0	52	Groudine	NNP	-	-	-	-	-	-	-	-
1851382	0	53	,	,	-	-	-	-	-	-	-	-
1851382	0	54	Dr	NNP	-	-	-	-	-	-	-	-
1851382	0	55	Warren	NNP	-	-	-	-	-	-	-	-
1851382	0	56	Ladiges	NNP	-	-	-	-	-	-	-	-
1851382	0	57	,	,	-	-	-	-	-	-	-	-
1851382	0	58	Dr	NNP	-	-	-	-	-	-	-	-
1851382	0	59	George	NNP	-	-	-	-	-	-	-	-
1851382	0	60	Martin	NNP	-	-	-	-	-	-	-	-
1851382	0	61	,	,	-	-	-	-	-	-	-	-
1851382	0	62	Dr	NNP	-	-	-	-	-	-	-	-
1851382	0	63	Peter	NNP	-	-	-	-	-	-	-	-
1851382	0	64	Rabinovitch	NNP	-	-	-	-	-	-	-	-
1851382	0	65	,	,	-	-	-	-	-	-	-	-
1851382	0	66	and	CC	-	-	-	-	-	-	-	-
1851382	0	67	Dr	NNP	-	-	-	-	-	-	-	-
1851382	0	68	Jeffrey	NNP	-	-	-	-	-	-	-	-
1851382	0	69	Schwartz	NNP	-	-	-	-	-	-	-	325)
1851382	0	70	for	IN	-	-	-	-	-	-	-	-
1851382	0	71	their	PRP$	-	-	-	-	-	-	-	(325)
1851382	0	72	support	NN	-	-	-	-	-	-	-	-
1851382	0	73	and	CC	-	-	-	-	-	-	-	-
1851382	0	74	advice	NN	-	-	-	-	-	-	-	-
1851382	0	75	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Figures	NNS	-	-	-	-	-	-	-	-
1851382	0	2	and	CC	-	-	-	-	-	-	-	-
1851382	0	3	Tables	NNS	-	-	-	-	-	-	-	-

1851382	0	1	Figure	NN	-	-	-	-	-	-	-	-
1851382	0	2	1	CD	-	-	-	-	-	-	-	-

1851382	0	1	Generation	NN	-	-	-	-	-	-	-	(323a)
1851382	0	2	and	CC	-	-	-	-	-	-	-	-
1851382	0	3	characterization	NN	-	-	-	-	-	-	-	-
1851382	0	4	of	IN	-	-	-	-	-	-	-	(323a)
1851382	0	5	SirT1co	NN	-	-	-	-	-	-	-	(135|(25a|(26
1851382	0	6	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	7	co	NN	-	-	-	-	-	-	-	26)|25a)
1851382	0	8	and	CC	-	-	-	-	-	-	-	-
1851382	0	9	SirT1ko	NN	-	-	-	-	-	-	-	(22|(24|(323a
1851382	0	10	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	11	ko	NN	-	-	-	-	-	-	-	24)
1851382	0	12	mice	NNS	-	-	-	-	-	-	-	(25a)|323a)|22)|135)
1851382	0	13	.	.	-	-	-	-	-	-	-	-

1851382	0	1	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	2	a	LS	-	-	-	-	-	-	-	-
1851382	0	3	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	4	Mouse	NN	-	-	-	-	-	-	-	(6)
1851382	0	5	SirT1	NN	-	-	-	-	-	-	-	-
1851382	0	6	wild	JJ	-	-	-	-	-	-	-	-
1851382	0	7	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	8	type	NN	-	-	-	-	-	-	-	-
1851382	0	9	allele	NN	-	-	-	-	-	-	-	-
1851382	0	10	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	11	SirT1	NN	-	-	-	-	-	-	-	-
1851382	0	12	+	SYM	-	-	-	-	-	-	-	-
1851382	0	13	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	14	,	,	-	-	-	-	-	-	-	-
1851382	0	15	conditional	JJ	-	-	-	-	-	-	-	-
1851382	0	16	targeted	VBN	-	-	-	-	-	-	-	-
1851382	0	17	allele	NN	-	-	-	-	-	-	-	-
1851382	0	18	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	19	SirT1co	NN	-	-	-	-	-	-	-	-
1851382	0	20	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	21	,	,	-	-	-	-	-	-	-	-
1851382	0	22	and	CC	-	-	-	-	-	-	-	-
1851382	0	23	knockout	NN	-	-	-	-	-	-	-	-
1851382	0	24	allele	NN	-	-	-	-	-	-	-	-
1851382	0	25	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	26	SirT1ko	NN	-	-	-	-	-	-	-	-
1851382	0	27	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	28	.	.	-	-	-	-	-	-	-	-

1851382	0	1	B	NN	-	-	-	-	-	-	-	-
1851382	0	2	,	,	-	-	-	-	-	-	-	-
1851382	0	3	BamHI	NN	-	-	-	-	-	-	-	-
1851382	0	4	.	.	-	-	-	-	-	-	-	-

1851382	0	1	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	2	b	LS	-	-	-	-	-	-	-	-
1851382	0	3	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	4	Western	NNP	-	-	-	-	-	-	-	-
1851382	0	5	blot	NN	-	-	-	-	-	-	-	-
1851382	0	6	analysis	NN	-	-	-	-	-	-	-	-
1851382	0	7	of	IN	-	-	-	-	-	-	-	-
1851382	0	8	SirT1	NN	-	-	-	-	-	-	-	(1)
1851382	0	9	expression	NN	-	-	-	-	-	-	-	-
1851382	0	10	in	IN	-	-	-	-	-	-	-	-
1851382	0	11	wild	JJ	-	-	-	-	-	-	-	(223a|(259a|(326a
1851382	0	12	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	13	type	NN	-	-	-	-	-	-	-	326a)|259a)|223a)
1851382	0	14	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	15	+	SYM	-	-	-	-	-	-	-	-
1851382	0	16	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	17	+	SYM	-	-	-	-	-	-	-	-
1851382	0	18	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	19	,	,	-	-	-	-	-	-	-	-
1851382	0	20	conditional	JJ	-	-	-	-	-	-	-	-
1851382	0	21	targeted	VBN	-	-	-	-	-	-	-	-
1851382	0	22	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	23	co	NN	-	-	-	-	-	-	-	-
1851382	0	24	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	25	co	NN	-	-	-	-	-	-	-	-
1851382	0	26	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	27	,	,	-	-	-	-	-	-	-	-
1851382	0	28	heterozygote	NN	-	-	-	-	-	-	-	-
1851382	0	29	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	30	+	SYM	-	-	-	-	-	-	-	-
1851382	0	31	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	32	ko	NN	-	-	-	-	-	-	-	-
1851382	0	33	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	34	,	,	-	-	-	-	-	-	-	-
1851382	0	35	and	CC	-	-	-	-	-	-	-	(326a
1851382	0	36	knockout	NN	-	-	-	-	-	-	-	(255|(49b
1851382	0	37	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	38	ko	NN	-	-	-	-	-	-	-	-
1851382	0	39	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	40	ko	NN	-	-	-	-	-	-	-	-
1851382	0	41	)	-RRB-	-	-	-	-	-	-	-	49b)
1851382	0	42	murine	JJ	-	-	-	-	-	-	-	(138|(259a
1851382	0	43	embryonic	JJ	-	-	-	-	-	-	-	-
1851382	0	44	fibroblasts	NNS	-	-	-	-	-	-	-	326a)|259a)|255)|138)
1851382	0	45	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	46	MEFs	NNS	-	-	-	-	-	-	-	-
1851382	0	47	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	48	and	CC	-	-	-	-	-	-	-	-
1851382	0	49	mammary	JJ	-	-	-	-	-	-	-	(160|(223a|(49b
1851382	0	50	tissues	NNS	-	-	-	-	-	-	-	49b)|223a)|160)
1851382	0	51	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	52	MG	NN	-	-	-	-	-	-	-	-
1851382	0	53	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	54	.	.	-	-	-	-	-	-	-	-

1851382	0	1	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	2	c	LS	-	-	-	-	-	-	-	-
1851382	0	3	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	4	Growth	NN	-	-	-	-	-	-	-	-
1851382	0	5	retardation	NN	-	-	-	-	-	-	-	-
1851382	0	6	in	IN	-	-	-	-	-	-	-	-
1851382	0	7	surviving	VBG	-	-	-	-	-	-	-	(173
1851382	0	8	SirT1ko	NN	-	-	-	-	-	-	-	-
1851382	0	9	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	10	ko	NN	-	-	-	-	-	-	-	-
1851382	0	11	mice	NNS	-	-	-	-	-	-	-	173)
1851382	0	12	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	13	open	JJ	-	-	-	-	-	-	-	-
1851382	0	14	bar	NN	-	-	-	-	-	-	-	-
1851382	0	15	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	16	using	VBG	-	-	-	-	-	-	-	-
1851382	0	17	sibling	VBG	-	-	-	-	-	-	-	-
1851382	0	18	mice	NNS	-	-	-	-	-	-	-	-
1851382	0	19	or	CC	-	-	-	-	-	-	-	-
1851382	0	20	age	NN	-	-	-	-	-	-	-	-
1851382	0	21	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	22	matched	VBN	-	-	-	-	-	-	-	-
1851382	0	23	mice	NNS	-	-	-	-	-	-	-	-
1851382	0	24	of	IN	-	-	-	-	-	-	-	-
1851382	0	25	control	NN	-	-	-	-	-	-	-	-
1851382	0	26	genotypes	NNS	-	-	-	-	-	-	-	-
1851382	0	27	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	28	filled	VBN	-	-	-	-	-	-	-	-
1851382	0	29	bar	NN	-	-	-	-	-	-	-	-
1851382	0	30	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	31	.	.	-	-	-	-	-	-	-	-

1851382	0	1	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	2	d	LS	-	-	-	-	-	-	-	-
1851382	0	3	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	4	The	DT	-	-	-	-	-	-	-	-
1851382	0	5	serum	NN	-	-	-	-	-	-	-	-
1851382	0	6	levels	NNS	-	-	-	-	-	-	-	-
1851382	0	7	of	IN	-	-	-	-	-	-	-	-
1851382	0	8	insulin	NN	-	-	-	-	-	-	-	(8
1851382	0	9	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	10	like	JJ	-	-	-	-	-	-	-	-
1851382	0	11	growth	NN	-	-	-	-	-	-	-	-
1851382	0	12	factor	NN	-	-	-	-	-	-	-	-
1851382	0	13	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	14	1	CD	-	-	-	-	-	-	-	8)
1851382	0	15	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	16	IGF	NN	-	-	-	-	-	-	-	-
1851382	0	17	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	18	1	CD	-	-	-	-	-	-	-	-
1851382	0	19	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	20	in	IN	-	-	-	-	-	-	-	-
1851382	0	21	wild	JJ	-	-	-	-	-	-	-	(137|(165a
1851382	0	22	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	23	type	NN	-	-	-	-	-	-	-	165a)|137)
1851382	0	24	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	25	+	SYM	-	-	-	-	-	-	-	-
1851382	0	26	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	27	+	SYM	-	-	-	-	-	-	-	-
1851382	0	28	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	29	,	,	-	-	-	-	-	-	-	-
1851382	0	30	SirT1	NN	-	-	-	-	-	-	-	(133a
1851382	0	31	+	SYM	-	-	-	-	-	-	-	-
1851382	0	32	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	33	ko	NN	-	-	-	-	-	-	-	133a)
1851382	0	34	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	35	+	SYM	-	-	-	-	-	-	-	-
1851382	0	36	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	37	ko	NN	-	-	-	-	-	-	-	-
1851382	0	38	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	39	,	,	-	-	-	-	-	-	-	-
1851382	0	40	and	CC	-	-	-	-	-	-	-	-
1851382	0	41	SirT1ko	NN	-	-	-	-	-	-	-	(22|(24
1851382	0	42	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	43	ko	NN	-	-	-	-	-	-	-	24)
1851382	0	44	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	45	ko	NN	-	-	-	-	-	-	-	-
1851382	0	46	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	47	ko	NN	-	-	-	-	-	-	-	-
1851382	0	48	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	49	mice	NNS	-	-	-	-	-	-	-	(133a)|(165a)|22)
1851382	0	50	.	.	-	-	-	-	-	-	-	-

1851382	0	1	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	2	e	LS	-	-	-	-	-	-	-	-
1851382	0	3	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	4	The	DT	-	-	-	-	-	-	-	-
1851382	0	5	survival	NN	-	-	-	-	-	-	-	(141)
1851382	0	6	curves	NNS	-	-	-	-	-	-	-	-
1851382	0	7	of	IN	-	-	-	-	-	-	-	-
1851382	0	8	wild	JJ	-	-	-	-	-	-	-	(137
1851382	0	9	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	10	type	NN	-	-	-	-	-	-	-	137)
1851382	0	11	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	12	WT	NN	-	-	-	-	-	-	-	-
1851382	0	13	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	14	,	,	-	-	-	-	-	-	-	-
1851382	0	15	SirT1co	NN	-	-	-	-	-	-	-	(26
1851382	0	16	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	17	co	NN	-	-	-	-	-	-	-	26)
1851382	0	18	,	,	-	-	-	-	-	-	-	-
1851382	0	19	SirT1ko	NN	-	-	-	-	-	-	-	(24
1851382	0	20	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	21	ko	NN	-	-	-	-	-	-	-	24)
1851382	0	22	,	,	-	-	-	-	-	-	-	-
1851382	0	23	and	CC	-	-	-	-	-	-	-	-
1851382	0	24	Ku70	NN	-	-	-	-	-	-	-	-
1851382	0	25	-	SYM	-	-	-	-	-	-	-	-
1851382	0	26	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	27	-	SYM	-	-	-	-	-	-	-	-
1851382	0	28	embryonic	JJ	-	-	-	-	-	-	-	-
1851382	0	29	stem	NN	-	-	-	-	-	-	-	-
1851382	0	30	cells	NNS	-	-	-	-	-	-	-	-
1851382	0	31	after	IN	-	-	-	-	-	-	-	-
1851382	0	32	ionizing	VBG	-	-	-	-	-	-	-	(143
1851382	0	33	radiation	NN	-	-	-	-	-	-	-	143)
1851382	0	34	.	.	-	-	-	-	-	-	-	-

1851382	0	1	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	2	f	LS	-	-	-	-	-	-	-	-
1851382	0	3	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	4	The	DT	-	-	-	-	-	-	-	-
1851382	0	5	survival	NN	-	-	-	-	-	-	-	(141)
1851382	0	6	curve	NN	-	-	-	-	-	-	-	-
1851382	0	7	of	IN	-	-	-	-	-	-	-	-
1851382	0	8	wild	JJ	-	-	-	-	-	-	-	(137
1851382	0	9	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	10	type	NN	-	-	-	-	-	-	-	137)
1851382	0	11	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	12	WT	NN	-	-	-	-	-	-	-	-
1851382	0	13	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	14	,	,	-	-	-	-	-	-	-	-
1851382	0	15	SirT1ko	NN	-	-	-	-	-	-	-	(24
1851382	0	16	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	17	ko	NN	-	-	-	-	-	-	-	24)
1851382	0	18	,	,	-	-	-	-	-	-	-	-
1851382	0	19	Ku70	NN	-	-	-	-	-	-	-	-
1851382	0	20	-	SYM	-	-	-	-	-	-	-	-
1851382	0	21	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	22	-	SYM	-	-	-	-	-	-	-	-
1851382	0	23	,	,	-	-	-	-	-	-	-	-
1851382	0	24	and	CC	-	-	-	-	-	-	-	-
1851382	0	25	Atm	NN	-	-	-	-	-	-	-	(178
1851382	0	26	-	SYM	-	-	-	-	-	-	-	-
1851382	0	27	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	28	-	SYM	-	-	-	-	-	-	-	-
1851382	0	29	embryonic	JJ	-	-	-	-	-	-	-	-
1851382	0	30	stem	NN	-	-	-	-	-	-	-	-
1851382	0	31	cells	NNS	-	-	-	-	-	-	-	-
1851382	0	32	after	IN	-	-	-	-	-	-	-	-
1851382	0	33	treatment	NN	-	-	-	-	-	-	-	(146
1851382	0	34	with	IN	-	-	-	-	-	-	-	-
1851382	0	35	hydrogen	NN	-	-	-	-	-	-	-	(145
1851382	0	36	peroxide	NN	-	-	-	-	-	-	-	178)|146)|145)
1851382	0	37	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Figure	NN	-	-	-	-	-	-	-	-
1851382	0	2	2	CD	-	-	-	-	-	-	-	-

1851382	0	1	Lactation	NN	-	-	-	-	-	-	-	(45|(44)
1851382	0	2	failure	NN	-	-	-	-	-	-	-	-
1851382	0	3	in	IN	-	-	-	-	-	-	-	-
1851382	0	4	SirT1ko	NN	-	-	-	-	-	-	-	(22|(24
1851382	0	5	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	6	ko	NN	-	-	-	-	-	-	-	24)
1851382	0	7	mice	NNS	-	-	-	-	-	-	-	45)|22)
1851382	0	8	.	.	-	-	-	-	-	-	-	-

1851382	0	1	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	2	a	LS	-	-	-	-	-	-	-	-
1851382	0	3	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	4	Whole	JJ	-	-	-	-	-	-	-	-
1851382	0	5	mount	NN	-	-	-	-	-	-	-	-
1851382	0	6	analysis	NN	-	-	-	-	-	-	-	-
1851382	0	7	of	IN	-	-	-	-	-	-	-	-
1851382	0	8	the	DT	-	-	-	-	-	-	-	(327b|(49a
1851382	0	9	mammary	JJ	-	-	-	-	-	-	-	-
1851382	0	10	tissues	NNS	-	-	-	-	-	-	-	-
1851382	0	11	from	IN	-	-	-	-	-	-	-	49a)
1851382	0	12	virgin	JJ	-	-	-	-	-	-	-	(328b
1851382	0	13	wild	JJ	-	-	-	-	-	-	-	-
1851382	0	14	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	15	type	NN	-	-	-	-	-	-	-	328b)|327b)
1851382	0	16	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	17	+	SYM	-	-	-	-	-	-	-	-
1851382	0	18	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	19	+	SYM	-	-	-	-	-	-	-	-
1851382	0	20	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	21	and	CC	-	-	-	-	-	-	-	-
1851382	0	22	SirT1ko	NN	-	-	-	-	-	-	-	(24|(49a
1851382	0	23	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	24	ko	NN	-	-	-	-	-	-	-	24)
1851382	0	25	mice	NNS	-	-	-	-	-	-	-	(327b)|(328b)|49a)
1851382	0	26	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	27	ko	NN	-	-	-	-	-	-	-	-
1851382	0	28	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	29	ko	NN	-	-	-	-	-	-	-	-
1851382	0	30	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	31	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Scale	NN	-	-	-	-	-	-	-	(329
1851382	0	2	bar	NN	-	-	-	-	-	-	-	329)
1851382	0	3	=	SYM	-	-	-	-	-	-	-	-
1851382	0	4	2	CD	-	-	-	-	-	-	-	-
1851382	0	5	mm	NN	-	-	-	-	-	-	-	-
1851382	0	6	.	.	-	-	-	-	-	-	-	-

1851382	0	1	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	2	b	LS	-	-	-	-	-	-	-	-
1851382	0	3	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	4	Histological	JJ	-	-	-	-	-	-	-	-
1851382	0	5	analysis	NN	-	-	-	-	-	-	-	-
1851382	0	6	of	IN	-	-	-	-	-	-	-	-
1851382	0	7	the	DT	-	-	-	-	-	-	-	(191a|(200a|(330a|(331a|(332a|(333c
1851382	0	8	mammary	JJ	-	-	-	-	-	-	-	-
1851382	0	9	tissues	NNS	-	-	-	-	-	-	-	-
1851382	0	10	harvested	VBN	-	-	-	-	-	-	-	-
1851382	0	11	from	IN	-	-	-	-	-	-	-	331a)|191a)
1851382	0	12	wild	JJ	-	-	-	-	-	-	-	(225a|(334a|(335b
1851382	0	13	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	14	type	NN	-	-	-	-	-	-	-	332a)|200a)
1851382	0	15	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	16	+	SYM	-	-	-	-	-	-	-	-
1851382	0	17	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	18	+	SYM	-	-	-	-	-	-	-	-
1851382	0	19	)	-RRB-	-	-	-	-	-	-	-	225a)
1851382	0	20	and	CC	-	-	-	-	-	-	-	-
1851382	0	21	SirT1ko	NN	-	-	-	-	-	-	-	(191a|(192b|(24|(331a|(336a
1851382	0	22	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	23	ko	NN	-	-	-	-	-	-	-	24)
1851382	0	24	female	JJ	-	-	-	-	-	-	-	(200a|(225a|(332a
1851382	0	25	mice	NNS	-	-	-	-	-	-	-	-
1851382	0	26	on	IN	-	-	-	-	-	-	-	336a)|335b)|334a)|333c)|332a)|331a)|330a)|225a)|200a)|192b)|191a)
1851382	0	27	either	CC	-	-	-	-	-	-	-	-
1851382	0	28	day	NN	-	-	-	-	-	-	-	(184|(200a|(225a|(330a|(331a|(334a|(336a
1851382	0	29	13	CD	-	-	-	-	-	-	-	-
1851382	0	30	of	IN	-	-	-	-	-	-	-	-
1851382	0	31	pregnancy	NN	-	-	-	-	-	-	-	(185)|336a)|334a)|331a)|330a)|225a)|200a)|184)
1851382	0	32	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	33	P13	NN	-	-	-	-	-	-	-	-
1851382	0	34	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	35	or	CC	-	-	-	-	-	-	-	-
1851382	0	36	lactation	NN	-	-	-	-	-	-	-	(191a|(192b|(193|(332a|(333c|(335b|(44)
1851382	0	37	day	NN	-	-	-	-	-	-	-	-
1851382	0	38	1	CD	-	-	-	-	-	-	-	335b)|333c)|332a)|193)|192b)|191a)
1851382	0	39	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	40	L1	NN	-	-	-	-	-	-	-	-
1851382	0	41	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	42	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Scale	NN	-	-	-	-	-	-	-	(329|(337
1851382	0	2	bars	NNS	-	-	-	-	-	-	-	329)
1851382	0	3	=	SYM	-	-	-	-	-	-	-	-
1851382	0	4	100	CD	-	-	-	-	-	-	-	-
1851382	0	5	μm	NN	-	-	-	-	-	-	-	337)
1851382	0	6	.	.	-	-	-	-	-	-	-	-

1851382	0	1	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	2	c	LS	-	-	-	-	-	-	-	-
1851382	0	3	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	4	Immunofluorescence	NN	-	-	-	-	-	-	-	-
1851382	0	5	staining	NN	-	-	-	-	-	-	-	-
1851382	0	6	of	IN	-	-	-	-	-	-	-	-
1851382	0	7	milk	NN	-	-	-	-	-	-	-	(156)
1851382	0	8	production	NN	-	-	-	-	-	-	-	-
1851382	0	9	in	IN	-	-	-	-	-	-	-	-
1851382	0	10	the	DT	-	-	-	-	-	-	-	(191c|(332c|(333
1851382	0	11	mammary	JJ	-	-	-	-	-	-	-	-
1851382	0	12	tissues	NNS	-	-	-	-	-	-	-	-
1851382	0	13	from	IN	-	-	-	-	-	-	-	191c)
1851382	0	14	wild	JJ	-	-	-	-	-	-	-	(202c|(335
1851382	0	15	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	16	type	NN	-	-	-	-	-	-	-	332c)|202c)
1851382	0	17	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	18	+	SYM	-	-	-	-	-	-	-	-
1851382	0	19	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	20	+	SYM	-	-	-	-	-	-	-	-
1851382	0	21	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	22	and	CC	-	-	-	-	-	-	-	-
1851382	0	23	SirT1ko	NN	-	-	-	-	-	-	-	(191c|(192|(24
1851382	0	24	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	25	ko	NN	-	-	-	-	-	-	-	24)
1851382	0	26	mice	NNS	-	-	-	-	-	-	-	(202c|(332c
1851382	0	27	on	IN	-	-	-	-	-	-	-	-
1851382	0	28	L1	NN	-	-	-	-	-	-	-	(193)|335)|333)|332c)|202c)|192)|191c)
1851382	0	29	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Red	JJ	-	-	-	-	-	-	-	-
1851382	0	2	and	CC	-	-	-	-	-	-	-	-
1851382	0	3	smear	NN	-	-	-	-	-	-	-	-
1851382	0	4	stains	NNS	-	-	-	-	-	-	-	-
1851382	0	5	,	,	-	-	-	-	-	-	-	-
1851382	0	6	mouse	NN	-	-	-	-	-	-	-	(156|(157
1851382	0	7	milk	NN	-	-	-	-	-	-	-	156)
1851382	0	8	proteins	NN	-	-	-	-	-	-	-	157)
1851382	0	9	;	:	-	-	-	-	-	-	-	-
1851382	0	10	blue	JJ	-	-	-	-	-	-	-	-
1851382	0	11	dots	NNS	-	-	-	-	-	-	-	-
1851382	0	12	,	,	-	-	-	-	-	-	-	-
1851382	0	13	nuclear	JJ	-	-	-	-	-	-	-	-
1851382	0	14	staining	NN	-	-	-	-	-	-	-	-
1851382	0	15	of	IN	-	-	-	-	-	-	-	-
1851382	0	16	adipocytes	NNS	-	-	-	-	-	-	-	(105b)
1851382	0	17	,	,	-	-	-	-	-	-	-	-
1851382	0	18	epithelial	JJ	-	-	-	-	-	-	-	(64a
1851382	0	19	cells	NNS	-	-	-	-	-	-	-	64a)
1851382	0	20	,	,	-	-	-	-	-	-	-	-
1851382	0	21	and	CC	-	-	-	-	-	-	-	-
1851382	0	22	other	JJ	-	-	-	-	-	-	-	-
1851382	0	23	cells	NNS	-	-	-	-	-	-	-	-
1851382	0	24	in	IN	-	-	-	-	-	-	-	(105b|(64a
1851382	0	25	mammary	JJ	-	-	-	-	-	-	-	(160
1851382	0	26	tissues	NNS	-	-	-	-	-	-	-	64a)|160)|105b)
1851382	0	27	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Scale	NN	-	-	-	-	-	-	-	(329|(337
1851382	0	2	bars	NNS	-	-	-	-	-	-	-	329)
1851382	0	3	=	SYM	-	-	-	-	-	-	-	-
1851382	0	4	100	CD	-	-	-	-	-	-	-	-
1851382	0	5	μm	NN	-	-	-	-	-	-	-	337)
1851382	0	6	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Figure	NN	-	-	-	-	-	-	-	-
1851382	0	2	3	CD	-	-	-	-	-	-	-	-

1851382	0	1	Pregnancy	NN	-	-	-	-	-	-	-	(338
1851382	0	2	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	3	induced	VBN	-	-	-	-	-	-	-	-
1851382	0	4	ductal	JJ	-	-	-	-	-	-	-	-
1851382	0	5	morphogenesis	NN	-	-	-	-	-	-	-	338)
1851382	0	6	.	.	-	-	-	-	-	-	-	-

1851382	0	1	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	2	a	LS	-	-	-	-	-	-	-	-
1851382	0	3	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	4	Whole	JJ	-	-	-	-	-	-	-	-
1851382	0	5	mount	NN	-	-	-	-	-	-	-	-
1851382	0	6	analysis	NN	-	-	-	-	-	-	-	-
1851382	0	7	of	IN	-	-	-	-	-	-	-	-
1851382	0	8	mammary	JJ	-	-	-	-	-	-	-	(10|(9
1851382	0	9	gland	NN	-	-	-	-	-	-	-	9)
1851382	0	10	development	NN	-	-	-	-	-	-	-	10)
1851382	0	11	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Upper	JJ	-	-	-	-	-	-	-	-
1851382	0	2	panel	NN	-	-	-	-	-	-	-	-
1851382	0	3	:	:	-	-	-	-	-	-	-	-
1851382	0	4	wild	JJ	-	-	-	-	-	-	-	(165
1851382	0	5	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	6	type	NN	-	-	-	-	-	-	-	-
1851382	0	7	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	8	+	SYM	-	-	-	-	-	-	-	-
1851382	0	9	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	10	+	SYM	-	-	-	-	-	-	-	-
1851382	0	11	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	12	mice	NNS	-	-	-	-	-	-	-	165)
1851382	0	13	show	VBP	-	-	-	-	-	-	-	-
1851382	0	14	terminal	JJ	-	-	-	-	-	-	-	-
1851382	0	15	end	NN	-	-	-	-	-	-	-	-
1851382	0	16	buds	NNS	-	-	-	-	-	-	-	-
1851382	0	17	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	18	TEBs	NNS	-	-	-	-	-	-	-	-
1851382	0	19	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	20	at	IN	-	-	-	-	-	-	-	-
1851382	0	21	the	DT	-	-	-	-	-	-	-	(102
1851382	0	22	onset	NN	-	-	-	-	-	-	-	-
1851382	0	23	of	IN	-	-	-	-	-	-	-	-
1851382	0	24	puberty	NN	-	-	-	-	-	-	-	(103)|102)
1851382	0	25	,	,	-	-	-	-	-	-	-	-
1851382	0	26	elongated	VBN	-	-	-	-	-	-	-	(212
1851382	0	27	ducts	NNS	-	-	-	-	-	-	-	212)
1851382	0	28	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	29	virgin	JJ	-	-	-	-	-	-	-	(328
1851382	0	30	mice	NNS	-	-	-	-	-	-	-	328)
1851382	0	31	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	32	,	,	-	-	-	-	-	-	-	-
1851382	0	33	site	NN	-	-	-	-	-	-	-	-
1851382	0	34	branching	NN	-	-	-	-	-	-	-	-
1851382	0	35	during	IN	-	-	-	-	-	-	-	-
1851382	0	36	pregnancy	NN	-	-	-	-	-	-	-	(185)
1851382	0	37	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	38	P13	NN	-	-	-	-	-	-	-	(184)
1851382	0	39	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	40	,	,	-	-	-	-	-	-	-	-
1851382	0	41	and	CC	-	-	-	-	-	-	-	-
1851382	0	42	lobuloalveolar	JJ	-	-	-	-	-	-	-	-
1851382	0	43	structures	NNS	-	-	-	-	-	-	-	-
1851382	0	44	for	IN	-	-	-	-	-	-	-	-
1851382	0	45	milk	NN	-	-	-	-	-	-	-	(156)
1851382	0	46	production	NN	-	-	-	-	-	-	-	-
1851382	0	47	on	IN	-	-	-	-	-	-	-	-
1851382	0	48	lactation	NN	-	-	-	-	-	-	-	(193|(44)
1851382	0	49	day	NN	-	-	-	-	-	-	-	-
1851382	0	50	1	CD	-	-	-	-	-	-	-	193)
1851382	0	51	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	52	L1	NN	-	-	-	-	-	-	-	-
1851382	0	53	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	54	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Lower	JJ	-	-	-	-	-	-	-	(339
1851382	0	2	panel	NN	-	-	-	-	-	-	-	339)
1851382	0	3	:	:	-	-	-	-	-	-	-	-
1851382	0	4	virgin	JJ	-	-	-	-	-	-	-	(32
1851382	0	5	SirT1ko	NN	-	-	-	-	-	-	-	-
1851382	0	6	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	7	ko	NN	-	-	-	-	-	-	-	-
1851382	0	8	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	9	ko	NN	-	-	-	-	-	-	-	-
1851382	0	10	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	11	ko	NN	-	-	-	-	-	-	-	-
1851382	0	12	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	13	mice	NNS	-	-	-	-	-	-	-	32)
1851382	0	14	show	VBP	-	-	-	-	-	-	-	-
1851382	0	15	impeded	VBN	-	-	-	-	-	-	-	(43
1851382	0	16	ductal	JJ	-	-	-	-	-	-	-	-
1851382	0	17	morphogenesis	NN	-	-	-	-	-	-	-	43)
1851382	0	18	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Pregnancy	NN	-	-	-	-	-	-	-	(338
1851382	0	2	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	3	induced	VBN	-	-	-	-	-	-	-	-
1851382	0	4	ductal	JJ	-	-	-	-	-	-	-	-
1851382	0	5	morphogenesis	NN	-	-	-	-	-	-	-	338)
1851382	0	6	manifests	VBZ	-	-	-	-	-	-	-	-
1851382	0	7	transitional	JJ	-	-	-	-	-	-	-	-
1851382	0	8	TEBs	NNS	-	-	-	-	-	-	-	-
1851382	0	9	,	,	-	-	-	-	-	-	-	-
1851382	0	10	ductal	JJ	-	-	-	-	-	-	-	-
1851382	0	11	elongation	NN	-	-	-	-	-	-	-	-
1851382	0	12	,	,	-	-	-	-	-	-	-	-
1851382	0	13	and	CC	-	-	-	-	-	-	-	-
1851382	0	14	side	NN	-	-	-	-	-	-	-	-
1851382	0	15	branching	NN	-	-	-	-	-	-	-	-
1851382	0	16	with	IN	-	-	-	-	-	-	-	-
1851382	0	17	variety	NN	-	-	-	-	-	-	-	-
1851382	0	18	in	IN	-	-	-	-	-	-	-	-
1851382	0	19	three	CD	-	-	-	-	-	-	-	-
1851382	0	20	SirT1ko	NN	-	-	-	-	-	-	-	-
1851382	0	21	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	22	ko	NN	-	-	-	-	-	-	-	-
1851382	0	23	mice	NNS	-	-	-	-	-	-	-	-
1851382	0	24	on	IN	-	-	-	-	-	-	-	-
1851382	0	25	L1	NN	-	-	-	-	-	-	-	(193)
1851382	0	26	.	.	-	-	-	-	-	-	-	-

1851382	0	1	All	DT	-	-	-	-	-	-	-	-
1851382	0	2	scale	NN	-	-	-	-	-	-	-	-
1851382	0	3	bars	NN	-	-	-	-	-	-	-	-
1851382	0	4	=	SYM	-	-	-	-	-	-	-	-
1851382	0	5	200	CD	-	-	-	-	-	-	-	-
1851382	0	6	μm	NN	-	-	-	-	-	-	-	-
1851382	0	7	.	.	-	-	-	-	-	-	-	-

1851382	0	1	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	2	b	LS	-	-	-	-	-	-	-	-
1851382	0	3	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	4	Western	NNP	-	-	-	-	-	-	-	-
1851382	0	5	blot	NN	-	-	-	-	-	-	-	-
1851382	0	6	analysis	NN	-	-	-	-	-	-	-	-
1851382	0	7	of	IN	-	-	-	-	-	-	-	-
1851382	0	8	both	CC	-	-	-	-	-	-	-	(241
1851382	0	9	insulin	NN	-	-	-	-	-	-	-	(242b|(8
1851382	0	10	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	11	like	JJ	-	-	-	-	-	-	-	-
1851382	0	12	growth	NN	-	-	-	-	-	-	-	-
1851382	0	13	factor	NN	-	-	-	-	-	-	-	-
1851382	0	14	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	15	1	CD	-	-	-	-	-	-	-	8)
1851382	0	16	binding	VBG	-	-	-	-	-	-	-	-
1851382	0	17	protein	NN	-	-	-	-	-	-	-	-
1851382	0	18	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	19	1	CD	-	-	-	-	-	-	-	242b)
1851382	0	20	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	21	IGFBP	NN	-	-	-	-	-	-	-	-
1851382	0	22	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	23	1	CD	-	-	-	-	-	-	-	-
1851382	0	24	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	25	and	CC	-	-	-	-	-	-	-	-
1851382	0	26	IκBα	NN	-	-	-	-	-	-	-	(243
1851382	0	27	in	IN	-	-	-	-	-	-	-	(242b
1851382	0	28	mammary	JJ	-	-	-	-	-	-	-	(191d|(327a|(332d|(333a
1851382	0	29	tissues	NNS	-	-	-	-	-	-	-	-
1851382	0	30	of	IN	-	-	-	-	-	-	-	333a)|332d)|327a)|191d)
1851382	0	31	male	JJ	-	-	-	-	-	-	-	(39b
1851382	0	32	mice	NNS	-	-	-	-	-	-	-	39b)
1851382	0	33	,	,	-	-	-	-	-	-	-	-
1851382	0	34	virgin	JJ	-	-	-	-	-	-	-	(327a|(328a|(32b
1851382	0	35	mice	NNS	-	-	-	-	-	-	-	32b)|328a)|327a)
1851382	0	36	,	,	-	-	-	-	-	-	-	-
1851382	0	37	and	CC	-	-	-	-	-	-	-	-
1851382	0	38	L1	NN	-	-	-	-	-	-	-	(191d|(192a|(202|(332d|(333a|(335|(193)
1851382	0	39	female	JJ	-	-	-	-	-	-	-	-
1851382	0	40	mice	NNS	-	-	-	-	-	-	-	-
1851382	0	41	of	IN	-	-	-	-	-	-	-	(327a|(328a|(32b)|(39b)|192a)|191d)
1851382	0	42	wild	JJ	-	-	-	-	-	-	-	-
1851382	0	43	type	NN	-	-	-	-	-	-	-	332d)|328a)|327a)|243)|242b)|241)|202)
1851382	0	44	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	45	+	SYM	-	-	-	-	-	-	-	-
1851382	0	46	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	47	+	SYM	-	-	-	-	-	-	-	-
1851382	0	48	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	49	and	CC	-	-	-	-	-	-	-	-
1851382	0	50	SirT1ko	NN	-	-	-	-	-	-	-	(191d|(192a|(24|(32b|(39b
1851382	0	51	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	52	ko	NN	-	-	-	-	-	-	-	39b)|335)|333a)|32b)|24)|192a)|191d)
1851382	0	53	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	54	ko	NN	-	-	-	-	-	-	-	-
1851382	0	55	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	56	ko	NN	-	-	-	-	-	-	-	-
1851382	0	57	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	58	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Actin	NN	-	-	-	-	-	-	-	(340)
1851382	0	2	is	VBZ	-	-	-	-	-	-	-	-
1851382	0	3	used	VBN	-	-	-	-	-	-	-	-
1851382	0	4	as	IN	-	-	-	-	-	-	-	-
1851382	0	5	a	DT	-	-	-	-	-	-	-	-
1851382	0	6	loading	NN	-	-	-	-	-	-	-	-
1851382	0	7	control	NN	-	-	-	-	-	-	-	-
1851382	0	8	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Lower	JJ	-	-	-	-	-	-	-	(339
1851382	0	2	panel	NN	-	-	-	-	-	-	-	339)
1851382	0	3	scores	VBZ	-	-	-	-	-	-	-	-
1851382	0	4	the	DT	-	-	-	-	-	-	-	-
1851382	0	5	estimated	VBN	-	-	-	-	-	-	-	-
1851382	0	6	density	NN	-	-	-	-	-	-	-	-
1851382	0	7	of	IN	-	-	-	-	-	-	-	-
1851382	0	8	indicated	VBN	-	-	-	-	-	-	-	-
1851382	0	9	lineages	NNS	-	-	-	-	-	-	-	-
1851382	0	10	of	IN	-	-	-	-	-	-	-	-
1851382	0	11	cells	NNS	-	-	-	-	-	-	-	-
1851382	0	12	in	IN	-	-	-	-	-	-	-	-
1851382	0	13	the	DT	-	-	-	-	-	-	-	(159
1851382	0	14	protein	NN	-	-	-	-	-	-	-	-
1851382	0	15	extracts	NNS	-	-	-	-	-	-	-	159)
1851382	0	16	,	,	-	-	-	-	-	-	-	-
1851382	0	17	which	WDT	-	-	-	-	-	-	-	-
1851382	0	18	are	VBP	-	-	-	-	-	-	-	-
1851382	0	19	based	VBN	-	-	-	-	-	-	-	-
1851382	0	20	on	IN	-	-	-	-	-	-	-	-
1851382	0	21	the	DT	-	-	-	-	-	-	-	-
1851382	0	22	morphological	JJ	-	-	-	-	-	-	-	-
1851382	0	23	analyses	NNS	-	-	-	-	-	-	-	-
1851382	0	24	in	IN	-	-	-	-	-	-	-	-
1851382	0	25	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	26	a	NN	-	-	-	-	-	-	-	-
1851382	0	27	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	28	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Figure	NN	-	-	-	-	-	-	-	-
1851382	0	2	4	CD	-	-	-	-	-	-	-	-

1851382	0	1	Estrogen	NN	-	-	-	-	-	-	-	(46|(7)
1851382	0	2	implantation	NN	-	-	-	-	-	-	-	46)
1851382	0	3	stimulates	VBZ	-	-	-	-	-	-	-	-
1851382	0	4	ductal	JJ	-	-	-	-	-	-	-	(212|(213
1851382	0	5	elongation	NN	-	-	-	-	-	-	-	212)
1851382	0	6	and	CC	-	-	-	-	-	-	-	-
1851382	0	7	site	NN	-	-	-	-	-	-	-	(208
1851382	0	8	branching	NN	-	-	-	-	-	-	-	213)|208)
1851382	0	9	.	.	-	-	-	-	-	-	-	-

1851382	0	1	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	2	a	LS	-	-	-	-	-	-	-	-
1851382	0	3	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	4	Whole	JJ	-	-	-	-	-	-	-	-
1851382	0	5	mount	NN	-	-	-	-	-	-	-	-
1851382	0	6	analysis	NN	-	-	-	-	-	-	-	-
1851382	0	7	of	IN	-	-	-	-	-	-	-	-
1851382	0	8	the	DT	-	-	-	-	-	-	-	(204
1851382	0	9	mammary	JJ	-	-	-	-	-	-	-	-
1851382	0	10	tissues	NNS	-	-	-	-	-	-	-	-
1851382	0	11	from	IN	-	-	-	-	-	-	-	-
1851382	0	12	the	DT	-	-	-	-	-	-	-	(207a
1851382	0	13	virgin	JJ	-	-	-	-	-	-	-	-
1851382	0	14	wild	JJ	-	-	-	-	-	-	-	-
1851382	0	15	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	16	type	NN	-	-	-	-	-	-	-	207a)
1851382	0	17	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	18	+	SYM	-	-	-	-	-	-	-	-
1851382	0	19	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	20	+	SYM	-	-	-	-	-	-	-	-
1851382	0	21	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	22	and	CC	-	-	-	-	-	-	-	-
1851382	0	23	SirT1ko	NN	-	-	-	-	-	-	-	(211|(24
1851382	0	24	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	25	ko	NN	-	-	-	-	-	-	-	24)
1851382	0	26	mice	NNS	-	-	-	-	-	-	-	(207a
1851382	0	27	implanted	VBN	-	-	-	-	-	-	-	-
1851382	0	28	with	IN	-	-	-	-	-	-	-	-
1851382	0	29	estrogen	NN	-	-	-	-	-	-	-	(148|(7)
1851382	0	30	pellets	NNS	-	-	-	-	-	-	-	211)|207a)|148)
1851382	0	31	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	32	+	SYM	-	-	-	-	-	-	-	-
1851382	0	33	E2	NN	-	-	-	-	-	-	-	-
1851382	0	34	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	35	on	IN	-	-	-	-	-	-	-	-
1851382	0	36	day	NN	-	-	-	-	-	-	-	(205|(206
1851382	0	37	14	CD	-	-	-	-	-	-	-	206)
1851382	0	38	and	CC	-	-	-	-	-	-	-	-
1851382	0	39	day	NN	-	-	-	-	-	-	-	(149
1851382	0	40	21	CD	-	-	-	-	-	-	-	205)|204)|149)
1851382	0	41	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Scale	NN	-	-	-	-	-	-	-	(329
1851382	0	2	bars	NNS	-	-	-	-	-	-	-	329)
1851382	0	3	=	SYM	-	-	-	-	-	-	-	-
1851382	0	4	200	CD	-	-	-	-	-	-	-	-
1851382	0	5	μm	NN	-	-	-	-	-	-	-	-
1851382	0	6	.	.	-	-	-	-	-	-	-	-

1851382	0	1	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	2	b	LS	-	-	-	-	-	-	-	-
1851382	0	3	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	4	Western	NNP	-	-	-	-	-	-	-	-
1851382	0	5	blot	NN	-	-	-	-	-	-	-	-
1851382	0	6	analysis	NN	-	-	-	-	-	-	-	-
1851382	0	7	of	IN	-	-	-	-	-	-	-	-
1851382	0	8	the	DT	-	-	-	-	-	-	-	-
1851382	0	9	expression	NN	-	-	-	-	-	-	-	-
1851382	0	10	of	IN	-	-	-	-	-	-	-	-
1851382	0	11	insulin	NN	-	-	-	-	-	-	-	(47|(8
1851382	0	12	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	13	like	JJ	-	-	-	-	-	-	-	-
1851382	0	14	growth	NN	-	-	-	-	-	-	-	-
1851382	0	15	factor	NN	-	-	-	-	-	-	-	-
1851382	0	16	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	17	1	CD	-	-	-	-	-	-	-	8)
1851382	0	18	binding	NN	-	-	-	-	-	-	-	-
1851382	0	19	protein	NN	-	-	-	-	-	-	-	-
1851382	0	20	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	21	1	CD	-	-	-	-	-	-	-	47)
1851382	0	22	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	23	IGFBP	NN	-	-	-	-	-	-	-	-
1851382	0	24	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	25	1	CD	-	-	-	-	-	-	-	-
1851382	0	26	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	27	and	CC	-	-	-	-	-	-	-	-
1851382	0	28	IκBα	NN	-	-	-	-	-	-	-	(50)
1851382	0	29	,	,	-	-	-	-	-	-	-	-
1851382	0	30	with	IN	-	-	-	-	-	-	-	-
1851382	0	31	actin	NN	-	-	-	-	-	-	-	(340
1851382	0	32	as	IN	-	-	-	-	-	-	-	-
1851382	0	33	a	DT	-	-	-	-	-	-	-	-
1851382	0	34	loading	NN	-	-	-	-	-	-	-	-
1851382	0	35	control	NN	-	-	-	-	-	-	-	340)
1851382	0	36	,	,	-	-	-	-	-	-	-	-
1851382	0	37	in	IN	-	-	-	-	-	-	-	-
1851382	0	38	mammary	JJ	-	-	-	-	-	-	-	-
1851382	0	39	tissues	NNS	-	-	-	-	-	-	-	-
1851382	0	40	from	IN	-	-	-	-	-	-	-	-
1851382	0	41	the	DT	-	-	-	-	-	-	-	-
1851382	0	42	virgin	JJ	-	-	-	-	-	-	-	-
1851382	0	43	wild	JJ	-	-	-	-	-	-	-	-
1851382	0	44	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	45	type	NN	-	-	-	-	-	-	-	-
1851382	0	46	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	47	+	SYM	-	-	-	-	-	-	-	-
1851382	0	48	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	49	+	SYM	-	-	-	-	-	-	-	-
1851382	0	50	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	51	and	CC	-	-	-	-	-	-	-	-
1851382	0	52	SirT1ko	NN	-	-	-	-	-	-	-	(24
1851382	0	53	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	54	ko	NN	-	-	-	-	-	-	-	24)
1851382	0	55	mice	NNS	-	-	-	-	-	-	-	-
1851382	0	56	implanted	VBN	-	-	-	-	-	-	-	-
1851382	0	57	with	IN	-	-	-	-	-	-	-	-
1851382	0	58	estrogen	NN	-	-	-	-	-	-	-	(148|(7)
1851382	0	59	pellets	NNS	-	-	-	-	-	-	-	148)
1851382	0	60	on	IN	-	-	-	-	-	-	-	-
1851382	0	61	day	NN	-	-	-	-	-	-	-	(149
1851382	0	62	21	CD	-	-	-	-	-	-	-	149)
1851382	0	63	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Figure	NN	-	-	-	-	-	-	-	-
1851382	0	2	5	CD	-	-	-	-	-	-	-	-

1851382	0	1	Mammary	JJ	-	-	-	-	-	-	-	(64
1851382	0	2	epithelial	JJ	-	-	-	-	-	-	-	-
1851382	0	3	cell	NN	-	-	-	-	-	-	-	64)
1851382	0	4	proliferation	NN	-	-	-	-	-	-	-	-
1851382	0	5	and	CC	-	-	-	-	-	-	-	-
1851382	0	6	apoptosis	NN	-	-	-	-	-	-	-	-
1851382	0	7	in	IN	-	-	-	-	-	-	-	-
1851382	0	8	SirT1ko	NN	-	-	-	-	-	-	-	(192|(22|(24
1851382	0	9	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	10	ko	NN	-	-	-	-	-	-	-	24)
1851382	0	11	mice	NNS	-	-	-	-	-	-	-	22)
1851382	0	12	on	IN	-	-	-	-	-	-	-	-
1851382	0	13	lactation	NN	-	-	-	-	-	-	-	(193|(44)
1851382	0	14	day	NN	-	-	-	-	-	-	-	-
1851382	0	15	1	CD	-	-	-	-	-	-	-	193)|192)
1851382	0	16	.	.	-	-	-	-	-	-	-	-

1851382	0	1	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	2	a	LS	-	-	-	-	-	-	-	-
1851382	0	3	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	4	Upper	JJ	-	-	-	-	-	-	-	-
1851382	0	5	panel	NN	-	-	-	-	-	-	-	-
1851382	0	6	:	:	-	-	-	-	-	-	-	-
1851382	0	7	bromodeoxyurdine	NN	-	-	-	-	-	-	-	(341|(154)
1851382	0	8	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	9	BrdU	NN	-	-	-	-	-	-	-	-
1851382	0	10	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	11	staining	NN	-	-	-	-	-	-	-	-
1851382	0	12	of	IN	-	-	-	-	-	-	-	-
1851382	0	13	the	DT	-	-	-	-	-	-	-	(191b|(200b|(330|(331b|(332b|(333b
1851382	0	14	mammary	JJ	-	-	-	-	-	-	-	-
1851382	0	15	sections	NNS	-	-	-	-	-	-	-	-
1851382	0	16	from	IN	-	-	-	-	-	-	-	332b)|200b)
1851382	0	17	SirT1ko	NN	-	-	-	-	-	-	-	(192c|(24|(334|(335a|(336b
1851382	0	18	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	19	ko	NN	-	-	-	-	-	-	-	336b)|24)|192c)|191b)
1851382	0	20	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	21	ko	NN	-	-	-	-	-	-	-	-
1851382	0	22	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	23	ko	NN	-	-	-	-	-	-	-	-
1851382	0	24	)	-RRB-	-	-	-	-	-	-	-	331b)
1851382	0	25	and	CC	-	-	-	-	-	-	-	-
1851382	0	26	wild	JJ	-	-	-	-	-	-	-	(137|(200b|(202d|(225|(332b|(342
1851382	0	27	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	28	type	NN	-	-	-	-	-	-	-	137)
1851382	0	29	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	30	+	SYM	-	-	-	-	-	-	-	-
1851382	0	31	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	32	+	SYM	-	-	-	-	-	-	-	-
1851382	0	33	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	34	mice	NNS	-	-	-	-	-	-	-	(191b|(192c|(331b|(336b
1851382	0	35	on	IN	-	-	-	-	-	-	-	335a)|333b)|332b)|202d)|192c)|191b)
1851382	0	36	day	NN	-	-	-	-	-	-	-	(184|(343
1851382	0	37	13	CD	-	-	-	-	-	-	-	-
1851382	0	38	of	IN	-	-	-	-	-	-	-	-
1851382	0	39	pregnancy	NN	-	-	-	-	-	-	-	(185)|336b)|334)|331b)|225)|200b)|184)
1851382	0	40	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	41	P13	NN	-	-	-	-	-	-	-	-
1851382	0	42	)	-RRB-	-	-	-	-	-	-	-	330)
1851382	0	43	and	CC	-	-	-	-	-	-	-	-
1851382	0	44	lactation	NN	-	-	-	-	-	-	-	(191b|(192c|(193|(202d|(332b|(333b|(335a|(44)
1851382	0	45	day	NN	-	-	-	-	-	-	-	-
1851382	0	46	1	CD	-	-	-	-	-	-	-	343)|342)|341)|335a)|333b)|332b)|202d)|193)|192c)|191b)
1851382	0	47	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	48	L1	NN	-	-	-	-	-	-	-	-
1851382	0	49	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	50	.	.	-	-	-	-	-	-	-	-

1851382	0	1	From	IN	-	-	-	-	-	-	-	-
1851382	0	2	left	JJ	-	-	-	-	-	-	-	-
1851382	0	3	to	IN	-	-	-	-	-	-	-	-
1851382	0	4	right	JJ	-	-	-	-	-	-	-	-
1851382	0	5	,	,	-	-	-	-	-	-	-	-
1851382	0	6	three	CD	-	-	-	-	-	-	-	-
1851382	0	7	terminal	JJ	-	-	-	-	-	-	-	-
1851382	0	8	end	NN	-	-	-	-	-	-	-	-
1851382	0	9	buds	NNS	-	-	-	-	-	-	-	-
1851382	0	10	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	11	TEBs	NNS	-	-	-	-	-	-	-	-
1851382	0	12	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	13	at	IN	-	-	-	-	-	-	-	-
1851382	0	14	a	DT	-	-	-	-	-	-	-	-
1851382	0	15	scale	NN	-	-	-	-	-	-	-	-
1851382	0	16	of	IN	-	-	-	-	-	-	-	-
1851382	0	17	100	CD	-	-	-	-	-	-	-	-
1851382	0	18	μm	NN	-	-	-	-	-	-	-	-
1851382	0	19	,	,	-	-	-	-	-	-	-	-
1851382	0	20	a	DT	-	-	-	-	-	-	-	-
1851382	0	21	single	JJ	-	-	-	-	-	-	-	-
1851382	0	22	TEB	NN	-	-	-	-	-	-	-	-
1851382	0	23	,	,	-	-	-	-	-	-	-	-
1851382	0	24	ducts	NNS	-	-	-	-	-	-	-	-
1851382	0	25	,	,	-	-	-	-	-	-	-	-
1851382	0	26	and	CC	-	-	-	-	-	-	-	-
1851382	0	27	alveolus	NN	-	-	-	-	-	-	-	-
1851382	0	28	of	IN	-	-	-	-	-	-	-	-
1851382	0	29	SirT1ko	NN	-	-	-	-	-	-	-	(22|(24
1851382	0	30	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	31	ko	NN	-	-	-	-	-	-	-	24)
1851382	0	32	mice	NNS	-	-	-	-	-	-	-	22)
1851382	0	33	at	IN	-	-	-	-	-	-	-	-
1851382	0	34	a	DT	-	-	-	-	-	-	-	-
1851382	0	35	scale	NN	-	-	-	-	-	-	-	-
1851382	0	36	of	IN	-	-	-	-	-	-	-	-
1851382	0	37	20	CD	-	-	-	-	-	-	-	-
1851382	0	38	μm	NN	-	-	-	-	-	-	-	-
1851382	0	39	,	,	-	-	-	-	-	-	-	-
1851382	0	40	and	CC	-	-	-	-	-	-	-	-
1851382	0	41	ducts	NNS	-	-	-	-	-	-	-	-
1851382	0	42	and	CC	-	-	-	-	-	-	-	-
1851382	0	43	alveolus	NN	-	-	-	-	-	-	-	-
1851382	0	44	of	IN	-	-	-	-	-	-	-	-
1851382	0	45	wild	JJ	-	-	-	-	-	-	-	(137|(202a|(225|(342
1851382	0	46	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	47	type	NN	-	-	-	-	-	-	-	137)
1851382	0	48	mice	NNS	-	-	-	-	-	-	-	-
1851382	0	49	on	IN	-	-	-	-	-	-	-	202a)
1851382	0	50	P13	NN	-	-	-	-	-	-	-	(343|(184)|225)
1851382	0	51	and	CC	-	-	-	-	-	-	-	-
1851382	0	52	L1	NN	-	-	-	-	-	-	-	(193)|(202a)|343)|342)
1851382	0	53	at	IN	-	-	-	-	-	-	-	-
1851382	0	54	a	DT	-	-	-	-	-	-	-	-
1851382	0	55	scale	NN	-	-	-	-	-	-	-	-
1851382	0	56	of	IN	-	-	-	-	-	-	-	-
1851382	0	57	20	CD	-	-	-	-	-	-	-	-
1851382	0	58	μm	NN	-	-	-	-	-	-	-	-
1851382	0	59	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Lower	JJ	-	-	-	-	-	-	-	-
1851382	0	2	panel	NN	-	-	-	-	-	-	-	-
1851382	0	3	:	:	-	-	-	-	-	-	-	-
1851382	0	4	TUNEL	NN	-	-	-	-	-	-	-	(217
1851382	0	5	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	6	Terminal	JJ	-	-	-	-	-	-	-	-
1851382	0	7	deoxynucleotidyl	NN	-	-	-	-	-	-	-	-
1851382	0	8	transferase	NN	-	-	-	-	-	-	-	-
1851382	0	9	mediated	VBN	-	-	-	-	-	-	-	-
1851382	0	10	dUTP	NN	-	-	-	-	-	-	-	-
1851382	0	11	Nick	NN	-	-	-	-	-	-	-	-
1851382	0	12	End	NN	-	-	-	-	-	-	-	-
1851382	0	13	Labeling	NN	-	-	-	-	-	-	-	-
1851382	0	14	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	15	assay	NN	-	-	-	-	-	-	-	-
1851382	0	16	for	IN	-	-	-	-	-	-	-	-
1851382	0	17	apoptotic	JJ	-	-	-	-	-	-	-	(155
1851382	0	18	cells	NNS	-	-	-	-	-	-	-	155)
1851382	0	19	using	VBG	-	-	-	-	-	-	-	-
1851382	0	20	sections	NNS	-	-	-	-	-	-	-	-
1851382	0	21	neighbored	VBN	-	-	-	-	-	-	-	-
1851382	0	22	to	IN	-	-	-	-	-	-	-	-
1851382	0	23	the	DT	-	-	-	-	-	-	-	-
1851382	0	24	sections	NNS	-	-	-	-	-	-	-	-
1851382	0	25	for	IN	-	-	-	-	-	-	-	-
1851382	0	26	BrdU	NN	-	-	-	-	-	-	-	(341|(154)
1851382	0	27	staining	NN	-	-	-	-	-	-	-	341)|217)
1851382	0	28	.	.	-	-	-	-	-	-	-	-

1851382	0	1	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	2	b	LS	-	-	-	-	-	-	-	-
1851382	0	3	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	4	The	DT	-	-	-	-	-	-	-	-
1851382	0	5	quantitative	JJ	-	-	-	-	-	-	-	-
1851382	0	6	analysis	NN	-	-	-	-	-	-	-	-
1851382	0	7	of	IN	-	-	-	-	-	-	-	-
1851382	0	8	BrdU	NN	-	-	-	-	-	-	-	(220
1851382	0	9	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	10	positive	JJ	-	-	-	-	-	-	-	-
1851382	0	11	epithelial	JJ	-	-	-	-	-	-	-	-
1851382	0	12	cells	NNS	-	-	-	-	-	-	-	-
1851382	0	13	in	IN	-	-	-	-	-	-	-	-
1851382	0	14	TEBs	NNS	-	-	-	-	-	-	-	-
1851382	0	15	,	,	-	-	-	-	-	-	-	-
1851382	0	16	ducts	NNS	-	-	-	-	-	-	-	-
1851382	0	17	,	,	-	-	-	-	-	-	-	-
1851382	0	18	and	CC	-	-	-	-	-	-	-	-
1851382	0	19	alveoli	NNS	-	-	-	-	-	-	-	-
1851382	0	20	of	IN	-	-	-	-	-	-	-	-
1851382	0	21	SirT1ko	NN	-	-	-	-	-	-	-	(192|(24
1851382	0	22	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	23	ko	NN	-	-	-	-	-	-	-	24)
1851382	0	24	mice	NNS	-	-	-	-	-	-	-	-
1851382	0	25	on	IN	-	-	-	-	-	-	-	-
1851382	0	26	L1	NN	-	-	-	-	-	-	-	(193)|192)
1851382	0	27	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	28	open	JJ	-	-	-	-	-	-	-	-
1851382	0	29	bar	NN	-	-	-	-	-	-	-	-
1851382	0	30	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	31	and	CC	-	-	-	-	-	-	-	-
1851382	0	32	wild	JJ	-	-	-	-	-	-	-	(137|(202b|(225|(342
1851382	0	33	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	34	type	NN	-	-	-	-	-	-	-	137)
1851382	0	35	mice	NNS	-	-	-	-	-	-	-	-
1851382	0	36	on	IN	-	-	-	-	-	-	-	202b)
1851382	0	37	P13	NN	-	-	-	-	-	-	-	(343|(184)|225)
1851382	0	38	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	39	grey	JJ	-	-	-	-	-	-	-	-
1851382	0	40	bar	NN	-	-	-	-	-	-	-	-
1851382	0	41	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	42	and	CC	-	-	-	-	-	-	-	-
1851382	0	43	L1	NN	-	-	-	-	-	-	-	(193)|(202b)|343)|342)|220)
1851382	0	44	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	45	solid	JJ	-	-	-	-	-	-	-	-
1851382	0	46	bar	NN	-	-	-	-	-	-	-	-
1851382	0	47	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	48	.	.	-	-	-	-	-	-	-	-

1851382	0	1	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	2	c	LS	-	-	-	-	-	-	-	-
1851382	0	3	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	4	The	DT	-	-	-	-	-	-	-	-
1851382	0	5	quantitative	JJ	-	-	-	-	-	-	-	-
1851382	0	6	analysis	NN	-	-	-	-	-	-	-	-
1851382	0	7	of	IN	-	-	-	-	-	-	-	-
1851382	0	8	TUNEL	NN	-	-	-	-	-	-	-	-
1851382	0	9	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	10	positive	JJ	-	-	-	-	-	-	-	-
1851382	0	11	cells	NNS	-	-	-	-	-	-	-	-
1851382	0	12	in	IN	-	-	-	-	-	-	-	-
1851382	0	13	neighboring	VBG	-	-	-	-	-	-	-	-
1851382	0	14	sections	NNS	-	-	-	-	-	-	-	-
1851382	0	15	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Figure	NN	-	-	-	-	-	-	-	(260
1851382	0	2	6	CD	-	-	-	-	-	-	-	260)

1851382	0	1	SirT1	NN	-	-	-	-	-	-	-	(227|(1)
1851382	0	2	deficiency	NN	-	-	-	-	-	-	-	227)
1851382	0	3	derails	VBZ	-	-	-	-	-	-	-	-
1851382	0	4	NF	NN	-	-	-	-	-	-	-	(16|(261
1851382	0	5	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	6	κB	NN	-	-	-	-	-	-	-	16)
1851382	0	7	signaling	NN	-	-	-	-	-	-	-	261)
1851382	0	8	in	IN	-	-	-	-	-	-	-	-
1851382	0	9	response	NN	-	-	-	-	-	-	-	-
1851382	0	10	to	IN	-	-	-	-	-	-	-	-
1851382	0	11	TNFα	NN	-	-	-	-	-	-	-	(263|(55)
1851382	0	12	stimulation	NN	-	-	-	-	-	-	-	263)
1851382	0	13	.	.	-	-	-	-	-	-	-	-

1851382	0	1	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	2	a	LS	-	-	-	-	-	-	-	-
1851382	0	3	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	4	Western	NNP	-	-	-	-	-	-	-	-
1851382	0	5	blot	NN	-	-	-	-	-	-	-	-
1851382	0	6	analysis	NN	-	-	-	-	-	-	-	-
1851382	0	7	of	IN	-	-	-	-	-	-	-	-
1851382	0	8	IκBα	NN	-	-	-	-	-	-	-	(50)
1851382	0	9	expression	NN	-	-	-	-	-	-	-	-
1851382	0	10	in	IN	-	-	-	-	-	-	-	-
1851382	0	11	SirT1ko	NN	-	-	-	-	-	-	-	(24|(255a|(326
1851382	0	12	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	13	ko	NN	-	-	-	-	-	-	-	255a)|24)
1851382	0	14	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	15	ko	NN	-	-	-	-	-	-	-	-
1851382	0	16	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	17	ko	NN	-	-	-	-	-	-	-	-
1851382	0	18	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	19	and	CC	-	-	-	-	-	-	-	-
1851382	0	20	wild	JJ	-	-	-	-	-	-	-	(259
1851382	0	21	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	22	type	NN	-	-	-	-	-	-	-	-
1851382	0	23	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	24	+	SYM	-	-	-	-	-	-	-	-
1851382	0	25	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	26	+	SYM	-	-	-	-	-	-	-	-
1851382	0	27	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	28	murine	JJ	-	-	-	-	-	-	-	(138|(255a
1851382	0	29	embryonic	JJ	-	-	-	-	-	-	-	-
1851382	0	30	fibroblasts	NNS	-	-	-	-	-	-	-	326)|259)|255a)|138)
1851382	0	31	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	32	MEFs	NNS	-	-	-	-	-	-	-	-
1851382	0	33	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	34	within	IN	-	-	-	-	-	-	-	-
1851382	0	35	the	DT	-	-	-	-	-	-	-	(264
1851382	0	36	first	JJ	-	-	-	-	-	-	-	-
1851382	0	37	hour	NN	-	-	-	-	-	-	-	-
1851382	0	38	after	IN	-	-	-	-	-	-	-	-
1851382	0	39	TNFα	NN	-	-	-	-	-	-	-	(263|(55)
1851382	0	40	stimulation	NN	-	-	-	-	-	-	-	264)|263)
1851382	0	41	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Actin	NN	-	-	-	-	-	-	-	(340)
1851382	0	2	is	VBZ	-	-	-	-	-	-	-	-
1851382	0	3	used	VBN	-	-	-	-	-	-	-	-
1851382	0	4	as	IN	-	-	-	-	-	-	-	-
1851382	0	5	a	DT	-	-	-	-	-	-	-	-
1851382	0	6	loading	NN	-	-	-	-	-	-	-	-
1851382	0	7	control	NN	-	-	-	-	-	-	-	-
1851382	0	8	.	.	-	-	-	-	-	-	-	-

1851382	0	1	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	2	b	LS	-	-	-	-	-	-	-	-
1851382	0	3	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	4	The	DT	-	-	-	-	-	-	-	(256
1851382	0	5	relative	JJ	-	-	-	-	-	-	-	-
1851382	0	6	levels	NNS	-	-	-	-	-	-	-	-
1851382	0	7	of	IN	-	-	-	-	-	-	-	-
1851382	0	8	newly	RB	-	-	-	-	-	-	-	(258
1851382	0	9	synthesized	VBN	-	-	-	-	-	-	-	-
1851382	0	10	IκBα	NN	-	-	-	-	-	-	-	-
1851382	0	11	in	IN	-	-	-	-	-	-	-	-
1851382	0	12	three	CD	-	-	-	-	-	-	-	(254
1851382	0	13	independent	JJ	-	-	-	-	-	-	-	-
1851382	0	14	SirT1ko	NN	-	-	-	-	-	-	-	-
1851382	0	15	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	16	ko	NN	-	-	-	-	-	-	-	-
1851382	0	17	MEF	NN	-	-	-	-	-	-	-	-
1851382	0	18	lines	NNS	-	-	-	-	-	-	-	258)|256)|254)
1851382	0	19	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	20	red	JJ	-	-	-	-	-	-	-	-
1851382	0	21	circles	NNS	-	-	-	-	-	-	-	-
1851382	0	22	,	,	-	-	-	-	-	-	-	-
1851382	0	23	blue	JJ	-	-	-	-	-	-	-	-
1851382	0	24	and	CC	-	-	-	-	-	-	-	-
1851382	0	25	green	JJ	-	-	-	-	-	-	-	-
1851382	0	26	triangles	NNS	-	-	-	-	-	-	-	-
1851382	0	27	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	28	and	CC	-	-	-	-	-	-	-	-
1851382	0	29	wild	JJ	-	-	-	-	-	-	-	(137|(259
1851382	0	30	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	31	type	NN	-	-	-	-	-	-	-	137)
1851382	0	32	MEFs	NNS	-	-	-	-	-	-	-	259)
1851382	0	33	after	IN	-	-	-	-	-	-	-	-
1851382	0	34	TNFα	NN	-	-	-	-	-	-	-	(263|(55)
1851382	0	35	stimulation	NN	-	-	-	-	-	-	-	263)
1851382	0	36	.	.	-	-	-	-	-	-	-	-

1851382	0	1	For	IN	-	-	-	-	-	-	-	-
1851382	0	2	each	DT	-	-	-	-	-	-	-	-
1851382	0	3	line	NN	-	-	-	-	-	-	-	-
1851382	0	4	of	IN	-	-	-	-	-	-	-	-
1851382	0	5	MEFs	NNS	-	-	-	-	-	-	-	(254)
1851382	0	6	,	,	-	-	-	-	-	-	-	-
1851382	0	7	the	DT	-	-	-	-	-	-	-	-
1851382	0	8	unit	NN	-	-	-	-	-	-	-	-
1851382	0	9	of	IN	-	-	-	-	-	-	-	-
1851382	0	10	IκBα	NN	-	-	-	-	-	-	-	(50)
1851382	0	11	protein	NN	-	-	-	-	-	-	-	-
1851382	0	12	at	IN	-	-	-	-	-	-	-	-
1851382	0	13	each	DT	-	-	-	-	-	-	-	-
1851382	0	14	time	NN	-	-	-	-	-	-	-	-
1851382	0	15	point	NN	-	-	-	-	-	-	-	-
1851382	0	16	is	VBZ	-	-	-	-	-	-	-	-
1851382	0	17	relative	JJ	-	-	-	-	-	-	-	-
1851382	0	18	to	IN	-	-	-	-	-	-	-	-
1851382	0	19	the	DT	-	-	-	-	-	-	-	-
1851382	0	20	unit	NN	-	-	-	-	-	-	-	-
1851382	0	21	0	CD	-	-	-	-	-	-	-	-
1851382	0	22	minutes	NNS	-	-	-	-	-	-	-	-
1851382	0	23	after	IN	-	-	-	-	-	-	-	-
1851382	0	24	normalization	NN	-	-	-	-	-	-	-	-
1851382	0	25	with	IN	-	-	-	-	-	-	-	-
1851382	0	26	actin	NN	-	-	-	-	-	-	-	(340)
1851382	0	27	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Figure	NN	-	-	-	-	-	-	-	-
1851382	0	2	7	CD	-	-	-	-	-	-	-	-

1851382	0	1	SirT1	NN	-	-	-	-	-	-	-	(1)
1851382	0	2	modulates	VBZ	-	-	-	-	-	-	-	-
1851382	0	3	estrogen	NN	-	-	-	-	-	-	-	(3
1851382	0	4	–	HYPH	-	-	-	-	-	-	-	-
1851382	0	5	insulin	NN	-	-	-	-	-	-	-	-
1851382	0	6	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	7	like	JJ	-	-	-	-	-	-	-	-
1851382	0	8	growth	NN	-	-	-	-	-	-	-	-
1851382	0	9	factor	NN	-	-	-	-	-	-	-	-
1851382	0	10	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	11	1	CD	-	-	-	-	-	-	-	3)
1851382	0	12	signaling	NN	-	-	-	-	-	-	-	-
1851382	0	13	for	IN	-	-	-	-	-	-	-	-
1851382	0	14	ductal	JJ	-	-	-	-	-	-	-	(62
1851382	0	15	morphogenesis	NN	-	-	-	-	-	-	-	62)
1851382	0	16	:	:	-	-	-	-	-	-	-	-
1851382	0	17	a	DT	-	-	-	-	-	-	-	-
1851382	0	18	model	NN	-	-	-	-	-	-	-	-
1851382	0	19	.	.	-	-	-	-	-	-	-	-

1851382	0	1	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	2	a	LS	-	-	-	-	-	-	-	-
1851382	0	3	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	4	The	DT	-	-	-	-	-	-	-	(72
1851382	0	5	insulin	NN	-	-	-	-	-	-	-	(73|(12)
1851382	0	6	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	7	insulin	NN	-	-	-	-	-	-	-	(8
1851382	0	8	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	9	like	JJ	-	-	-	-	-	-	-	-
1851382	0	10	growth	NN	-	-	-	-	-	-	-	-
1851382	0	11	factor	NN	-	-	-	-	-	-	-	-
1851382	0	12	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	13	1	CD	-	-	-	-	-	-	-	8)
1851382	0	14	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	15	IGF	NN	-	-	-	-	-	-	-	-
1851382	0	16	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	17	1	CD	-	-	-	-	-	-	-	-
1851382	0	18	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	19	signaling	NN	-	-	-	-	-	-	-	73)
1851382	0	20	system	NN	-	-	-	-	-	-	-	72)
1851382	0	21	:	:	-	-	-	-	-	-	-	-
1851382	0	22	both	CC	-	-	-	-	-	-	-	-
1851382	0	23	SirT1	NN	-	-	-	-	-	-	-	(1)
1851382	0	24	and	CC	-	-	-	-	-	-	-	-
1851382	0	25	Akt	NN	-	-	-	-	-	-	-	(83
1851382	0	26	kinases	NNS	-	-	-	-	-	-	-	83)
1851382	0	27	can	MD	-	-	-	-	-	-	-	-
1851382	0	28	negatively	RB	-	-	-	-	-	-	-	-
1851382	0	29	regulate	VB	-	-	-	-	-	-	-	-
1851382	0	30	the	DT	-	-	-	-	-	-	-	(81
1851382	0	31	transcription	NN	-	-	-	-	-	-	-	(14)
1851382	0	32	activity	NN	-	-	-	-	-	-	-	-
1851382	0	33	of	IN	-	-	-	-	-	-	-	-
1851382	0	34	forkhead	NN	-	-	-	-	-	-	-	(80
1851382	0	35	box	NN	-	-	-	-	-	-	-	-
1851382	0	36	'	``	-	-	-	-	-	-	-	-
1851382	0	37	other	JJ	-	-	-	-	-	-	-	-
1851382	0	38	'	''	-	-	-	-	-	-	-	-
1851382	0	39	protein	NN	-	-	-	-	-	-	-	-
1851382	0	40	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	41	FoxO	NN	-	-	-	-	-	-	-	-
1851382	0	42	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	43	proteins	NN	-	-	-	-	-	-	-	81)|80)
1851382	0	44	.	.	-	-	-	-	-	-	-	-

1851382	0	1	SirT1	NN	-	-	-	-	-	-	-	(227|(1)
1851382	0	2	deficiency	NN	-	-	-	-	-	-	-	227)
1851382	0	3	deregulates	VBZ	-	-	-	-	-	-	-	-
1851382	0	4	the	DT	-	-	-	-	-	-	-	(48
1851382	0	5	expression	NN	-	-	-	-	-	-	-	-
1851382	0	6	of	IN	-	-	-	-	-	-	-	-
1851382	0	7	insulin	NN	-	-	-	-	-	-	-	(47|(8
1851382	0	8	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	9	like	JJ	-	-	-	-	-	-	-	-
1851382	0	10	growth	NN	-	-	-	-	-	-	-	-
1851382	0	11	factor	NN	-	-	-	-	-	-	-	-
1851382	0	12	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	13	1	CD	-	-	-	-	-	-	-	8)
1851382	0	14	binding	NN	-	-	-	-	-	-	-	-
1851382	0	15	protein	NN	-	-	-	-	-	-	-	-
1851382	0	16	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	17	1	CD	-	-	-	-	-	-	-	48)|47)
1851382	0	18	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	19	IGFBP	NN	-	-	-	-	-	-	-	-
1851382	0	20	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	21	1	CD	-	-	-	-	-	-	-	-
1851382	0	22	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	23	,	,	-	-	-	-	-	-	-	-
1851382	0	24	which	WDT	-	-	-	-	-	-	-	-
1851382	0	25	may	MD	-	-	-	-	-	-	-	-
1851382	0	26	exert	VB	-	-	-	-	-	-	-	-
1851382	0	27	autocrine	JJ	-	-	-	-	-	-	-	-
1851382	0	28	and	CC	-	-	-	-	-	-	-	-
1851382	0	29	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	30	or	CC	-	-	-	-	-	-	-	-
1851382	0	31	paracrine	JJ	-	-	-	-	-	-	-	-
1851382	0	32	effects	NNS	-	-	-	-	-	-	-	-
1851382	0	33	to	TO	-	-	-	-	-	-	-	-
1851382	0	34	inhibit	VB	-	-	-	-	-	-	-	-
1851382	0	35	IGF	NN	-	-	-	-	-	-	-	(8
1851382	0	36	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	37	1	CD	-	-	-	-	-	-	-	8)
1851382	0	38	.	.	-	-	-	-	-	-	-	-

1851382	0	1	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	2	b	LS	-	-	-	-	-	-	-	-
1851382	0	3	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	4	Mammary	JJ	-	-	-	-	-	-	-	-
1851382	0	5	epithelial	JJ	-	-	-	-	-	-	-	-
1851382	0	6	precursor	NN	-	-	-	-	-	-	-	-
1851382	0	7	cells	NNS	-	-	-	-	-	-	-	-
1851382	0	8	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	9	EPC	NN	-	-	-	-	-	-	-	-
1851382	0	10	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	11	express	VBP	-	-	-	-	-	-	-	-
1851382	0	12	IGF	NN	-	-	-	-	-	-	-	(278|(8
1851382	0	13	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	14	1	CD	-	-	-	-	-	-	-	8)
1851382	0	15	receptor	NN	-	-	-	-	-	-	-	278)
1851382	0	16	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	17	IGF	NN	-	-	-	-	-	-	-	-
1851382	0	18	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	19	1R	NN	-	-	-	-	-	-	-	-
1851382	0	20	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	21	and	CC	-	-	-	-	-	-	-	-
1851382	0	22	can	MD	-	-	-	-	-	-	-	-
1851382	0	23	differentiate	VB	-	-	-	-	-	-	-	-
1851382	0	24	into	IN	-	-	-	-	-	-	-	-
1851382	0	25	estrogen	NN	-	-	-	-	-	-	-	(344|(7)
1851382	0	26	receptor	NN	-	-	-	-	-	-	-	-
1851382	0	27	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	28	ER	NN	-	-	-	-	-	-	-	-
1851382	0	29	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	30	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	31	negative	JJ	-	-	-	-	-	-	-	-
1851382	0	32	ductal	JJ	-	-	-	-	-	-	-	-
1851382	0	33	epithelial	JJ	-	-	-	-	-	-	-	-
1851382	0	34	cells	NNS	-	-	-	-	-	-	-	344)
1851382	0	35	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	36	DEC	NN	-	-	-	-	-	-	-	-
1851382	0	37	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	38	I	NN	-	-	-	-	-	-	-	-
1851382	0	39	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	40	in	IN	-	-	-	-	-	-	-	-
1851382	0	41	response	NN	-	-	-	-	-	-	-	-
1851382	0	42	to	IN	-	-	-	-	-	-	-	-
1851382	0	43	maternal	JJ	-	-	-	-	-	-	-	(303|(302a)
1851382	0	44	,	,	-	-	-	-	-	-	-	-
1851382	0	45	circulating	VBG	-	-	-	-	-	-	-	-
1851382	0	46	,	,	-	-	-	-	-	-	-	-
1851382	0	47	or	CC	-	-	-	-	-	-	-	-
1851382	0	48	estrogen	NN	-	-	-	-	-	-	-	(54
1851382	0	49	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	50	stimulated	VBN	-	-	-	-	-	-	-	-
1851382	0	51	,	,	-	-	-	-	-	-	-	-
1851382	0	52	stromal	JJ	-	-	-	-	-	-	-	-
1851382	0	53	cell	NN	-	-	-	-	-	-	-	-
1851382	0	54	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	55	S	NN	-	-	-	-	-	-	-	-
1851382	0	56	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	57	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	58	derived	VBN	-	-	-	-	-	-	-	-
1851382	0	59	local	JJ	-	-	-	-	-	-	-	-
1851382	0	60	IGF	NN	-	-	-	-	-	-	-	(302a
1851382	0	61	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	62	1	CD	-	-	-	-	-	-	-	54)|303)|302a)
1851382	0	63	.	.	-	-	-	-	-	-	-	-

1851382	0	1	At	IN	-	-	-	-	-	-	-	-
1851382	0	2	the	DT	-	-	-	-	-	-	-	(102
1851382	0	3	onset	NN	-	-	-	-	-	-	-	-
1851382	0	4	of	IN	-	-	-	-	-	-	-	-
1851382	0	5	puberty	NN	-	-	-	-	-	-	-	(103)|102)
1851382	0	6	,	,	-	-	-	-	-	-	-	-
1851382	0	7	ovarian	JJ	-	-	-	-	-	-	-	(109
1851382	0	8	estrogen	NN	-	-	-	-	-	-	-	-
1851382	0	9	,	,	-	-	-	-	-	-	-	-
1851382	0	10	in	IN	-	-	-	-	-	-	-	-
1851382	0	11	synergy	NN	-	-	-	-	-	-	-	(110
1851382	0	12	with	IN	-	-	-	-	-	-	-	-
1851382	0	13	growth	NN	-	-	-	-	-	-	-	(112
1851382	0	14	hormone	NN	-	-	-	-	-	-	-	112)|110)|109)
1851382	0	15	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	16	GH	NN	-	-	-	-	-	-	-	-
1851382	0	17	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	18	,	,	-	-	-	-	-	-	-	-
1851382	0	19	enhances	VBZ	-	-	-	-	-	-	-	-
1851382	0	20	the	DT	-	-	-	-	-	-	-	(53
1851382	0	21	production	NN	-	-	-	-	-	-	-	-
1851382	0	22	of	IN	-	-	-	-	-	-	-	-
1851382	0	23	local	JJ	-	-	-	-	-	-	-	(54
1851382	0	24	IGF	NN	-	-	-	-	-	-	-	-
1851382	0	25	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	26	1	CD	-	-	-	-	-	-	-	54)|53)
1851382	0	27	and	CC	-	-	-	-	-	-	-	-
1851382	0	28	stimulates	VBZ	-	-	-	-	-	-	-	-
1851382	0	29	the	DT	-	-	-	-	-	-	-	-
1851382	0	30	differentiation	NN	-	-	-	-	-	-	-	-
1851382	0	31	of	IN	-	-	-	-	-	-	-	-
1851382	0	32	DEC	NN	-	-	-	-	-	-	-	(344
1851382	0	33	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	34	I	NN	-	-	-	-	-	-	-	344)
1851382	0	35	to	IN	-	-	-	-	-	-	-	-
1851382	0	36	ER	NN	-	-	-	-	-	-	-	-
1851382	0	37	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	38	positive	JJ	-	-	-	-	-	-	-	-
1851382	0	39	ductal	JJ	-	-	-	-	-	-	-	-
1851382	0	40	epithelial	JJ	-	-	-	-	-	-	-	-
1851382	0	41	cells	NNS	-	-	-	-	-	-	-	-
1851382	0	42	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	43	DEC	NN	-	-	-	-	-	-	-	-
1851382	0	44	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	45	II	NN	-	-	-	-	-	-	-	-
1851382	0	46	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	47	.	.	-	-	-	-	-	-	-	-

1851382	0	1	SirT1	NN	-	-	-	-	-	-	-	(227|(1)
1851382	0	2	deficiency	NN	-	-	-	-	-	-	-	227)
1851382	0	3	deregulates	VBZ	-	-	-	-	-	-	-	-
1851382	0	4	the	DT	-	-	-	-	-	-	-	-
1851382	0	5	expression	NN	-	-	-	-	-	-	-	-
1851382	0	6	of	IN	-	-	-	-	-	-	-	-
1851382	0	7	IGFBP	NN	-	-	-	-	-	-	-	(245
1851382	0	8	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	9	1	CD	-	-	-	-	-	-	-	-
1851382	0	10	in	IN	-	-	-	-	-	-	-	-
1851382	0	11	adipose	JJ	-	-	-	-	-	-	-	(246
1851382	0	12	tissues	NNS	-	-	-	-	-	-	-	246)|245)
1851382	0	13	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	14	a	NN	-	-	-	-	-	-	-	-
1851382	0	15	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	16	,	,	-	-	-	-	-	-	-	-
1851382	0	17	however	RB	-	-	-	-	-	-	-	-
1851382	0	18	,	,	-	-	-	-	-	-	-	-
1851382	0	19	which	WDT	-	-	-	-	-	-	-	-
1851382	0	20	attenuates	VBZ	-	-	-	-	-	-	-	-
1851382	0	21	the	DT	-	-	-	-	-	-	-	(125
1851382	0	22	efficacy	NN	-	-	-	-	-	-	-	-
1851382	0	23	of	IN	-	-	-	-	-	-	-	-
1851382	0	24	the	DT	-	-	-	-	-	-	-	(19
1851382	0	25	IGF	NN	-	-	-	-	-	-	-	(8
1851382	0	26	-	HYPH	-	-	-	-	-	-	-	-
1851382	0	27	1	CD	-	-	-	-	-	-	-	8)
1851382	0	28	signaling	NN	-	-	-	-	-	-	-	19)|125)
1851382	0	29	and	CC	-	-	-	-	-	-	-	-
1851382	0	30	causes	VBZ	-	-	-	-	-	-	-	-
1851382	0	31	impeded	VBN	-	-	-	-	-	-	-	(43
1851382	0	32	ductal	JJ	-	-	-	-	-	-	-	-
1851382	0	33	morphogenesis	NN	-	-	-	-	-	-	-	-
1851382	0	34	in	IN	-	-	-	-	-	-	-	-
1851382	0	35	virgin	JJ	-	-	-	-	-	-	-	(32
1851382	0	36	SirT1ko	NN	-	-	-	-	-	-	-	-
1851382	0	37	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	38	ko	NN	-	-	-	-	-	-	-	-
1851382	0	39	mice	NNS	-	-	-	-	-	-	-	43)|32)
1851382	0	40	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Either	CC	-	-	-	-	-	-	-	-
1851382	0	2	pregnancy	NN	-	-	-	-	-	-	-	(185)
1851382	0	3	or	CC	-	-	-	-	-	-	-	-
1851382	0	4	exogenous	JJ	-	-	-	-	-	-	-	(7
1851382	0	5	estrogen	NN	-	-	-	-	-	-	-	7)
1851382	0	6	can	MD	-	-	-	-	-	-	-	-
1851382	0	7	overcome	VB	-	-	-	-	-	-	-	-
1851382	0	8	the	DT	-	-	-	-	-	-	-	(43
1851382	0	9	impeded	VBN	-	-	-	-	-	-	-	-
1851382	0	10	ductal	JJ	-	-	-	-	-	-	-	-
1851382	0	11	morphogenesis	NN	-	-	-	-	-	-	-	-
1851382	0	12	in	IN	-	-	-	-	-	-	-	-
1851382	0	13	virgin	JJ	-	-	-	-	-	-	-	(32
1851382	0	14	SirT1ko	NN	-	-	-	-	-	-	-	-
1851382	0	15	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	16	ko	NN	-	-	-	-	-	-	-	-
1851382	0	17	mice	NNS	-	-	-	-	-	-	-	43)|32)
1851382	0	18	and	CC	-	-	-	-	-	-	-	-
1851382	0	19	can	MD	-	-	-	-	-	-	-	-
1851382	0	20	stimulate	VB	-	-	-	-	-	-	-	-
1851382	0	21	the	DT	-	-	-	-	-	-	-	-
1851382	0	22	differentiation	NN	-	-	-	-	-	-	-	-
1851382	0	23	of	IN	-	-	-	-	-	-	-	-
1851382	0	24	EPC	NN	-	-	-	-	-	-	-	-
1851382	0	25	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Table	NN	-	-	-	-	-	-	-	(174
1851382	0	2	1	CD	-	-	-	-	-	-	-	174)

1851382	0	1	Perinatal	JJ	-	-	-	-	-	-	-	(93a
1851382	0	2	lethality	NN	-	-	-	-	-	-	-	93a)
1851382	0	3	,	,	-	-	-	-	-	-	-	-
1851382	0	4	fertility	NN	-	-	-	-	-	-	-	-
1851382	0	5	,	,	-	-	-	-	-	-	-	-
1851382	0	6	and	CC	-	-	-	-	-	-	-	-
1851382	0	7	lactation	NN	-	-	-	-	-	-	-	(182|(44)
1851382	0	8	defect	NN	-	-	-	-	-	-	-	-
1851382	0	9	in	IN	-	-	-	-	-	-	-	(93a
1851382	0	10	SirT1ko	NN	-	-	-	-	-	-	-	(22|(24
1851382	0	11	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	12	ko	NN	-	-	-	-	-	-	-	24)
1851382	0	13	mice	NNS	-	-	-	-	-	-	-	93a)|22)|182)

1851382	0	1	More	JJR	-	-	-	-	-	-	-	-
1851382	0	2	than	IN	-	-	-	-	-	-	-	-
1851382	0	3	10	CD	-	-	-	-	-	-	-	-
1851382	0	4	pairs	NNS	-	-	-	-	-	-	-	-
1851382	0	5	of	IN	-	-	-	-	-	-	-	-
1851382	0	6	SirT1	NN	-	-	-	-	-	-	-	(132|(168|(169
1851382	0	7	+	SYM	-	-	-	-	-	-	-	-
1851382	0	8	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	9	ko	NN	-	-	-	-	-	-	-	132)
1851382	0	10	male	JJ	-	-	-	-	-	-	-	-
1851382	0	11	mice	NNS	-	-	-	-	-	-	-	168)
1851382	0	12	and	CC	-	-	-	-	-	-	-	-
1851382	0	13	SirT1	NN	-	-	-	-	-	-	-	(132|(170
1851382	0	14	+	SYM	-	-	-	-	-	-	-	-
1851382	0	15	/	HYPH	-	-	-	-	-	-	-	-
1851382	0	16	ko	NN	-	-	-	-	-	-	-	132)
1851382	0	17	female	JJ	-	-	-	-	-	-	-	-
1851382	0	18	mice	NNS	-	-	-	-	-	-	-	170)|169)
1851382	0	19	were	VBD	-	-	-	-	-	-	-	-
1851382	0	20	used	VBN	-	-	-	-	-	-	-	-
1851382	0	21	for	IN	-	-	-	-	-	-	-	-
1851382	0	22	breeding	NN	-	-	-	-	-	-	-	(134)
1851382	0	23	.	.	-	-	-	-	-	-	-	-

1851382	0	1	Data	NNS	-	-	-	-	-	-	-	-
1851382	0	2	in	IN	-	-	-	-	-	-	-	-
1851382	0	3	parentheses	NNS	-	-	-	-	-	-	-	-
1851382	0	4	indicate	VBP	-	-	-	-	-	-	-	-
1851382	0	5	the	DT	-	-	-	-	-	-	-	-
1851382	0	6	number	NN	-	-	-	-	-	-	-	-
1851382	0	7	of	IN	-	-	-	-	-	-	-	-
1851382	0	8	pups	NNS	-	-	-	-	-	-	-	(226
1851382	0	9	of	IN	-	-	-	-	-	-	-	-
1851382	0	10	this	DT	-	-	-	-	-	-	-	(132
1851382	0	11	genotype	NN	-	-	-	-	-	-	-	226)|132)
1851382	0	12	found	VBN	-	-	-	-	-	-	-	-
1851382	0	13	dead	JJ	-	-	-	-	-	-	-	-
1851382	0	14	within	IN	-	-	-	-	-	-	-	-
1851382	0	15	3	CD	-	-	-	-	-	-	-	-
1851382	0	16	days	NNS	-	-	-	-	-	-	-	-
1851382	0	17	after	IN	-	-	-	-	-	-	-	-
1851382	0	18	their	PRP$	-	-	-	-	-	-	-	(226)
1851382	0	19	birth	NN	-	-	-	-	-	-	-	-
1851382	0	20	.	.	-	-	-	-	-	-	-	-

1851382	0	1	a	LS	-	-	-	-	-	-	-	-
1851382	0	2	Total	JJ	-	-	-	-	-	-	-	-
1851382	0	3	number	NN	-	-	-	-	-	-	-	-
1851382	0	4	of	IN	-	-	-	-	-	-	-	-
1851382	0	5	surviving	VBG	-	-	-	-	-	-	-	-
1851382	0	6	pups	NNS	-	-	-	-	-	-	-	-
1851382	0	7	at	IN	-	-	-	-	-	-	-	-
1851382	0	8	weaning	NN	-	-	-	-	-	-	-	-
1851382	0	9	(	-LRB-	-	-	-	-	-	-	-	-
1851382	0	10	postnatal	JJ	-	-	-	-	-	-	-	-
1851382	0	11	day	NN	-	-	-	-	-	-	-	-
1851382	0	12	21	CD	-	-	-	-	-	-	-	-
1851382	0	13	)	-RRB-	-	-	-	-	-	-	-	-
1851382	0	14	.	.	-	-	-	-	-	-	-	-

